DrugA,DrugB,Interaction,Mechanism,risk_level
Trimethadione,Butobarbital,The risk or severity of CNS depression can be increased when Trimethadione is combined with Butobarbital.,increase,risk
Trimethadione,Butorphanol,The risk or severity of CNS depression can be increased when Trimethadione is combined with Butorphanol.,increase,risk
Trimethadione,Butriptyline,The risk or severity of CNS depression can be increased when Trimethadione is combined with Butriptyline.,increase,risk
Trimethadione,Gabapentin,The risk or severity of CNS depression can be increased when Trimethadione is combined with Gabapentin.,increase,risk
Trimethadione,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Trimethadione is combined with Gabapentin enacarbil.,increase,risk
Trimethadione,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Gadobenic acid.,increase,risk
Trimethadione,Galantamine,Trimethadione may increase the bradycardic activities of Galantamine.,increase,no risk
Trimethadione,Gallamine triethiodide,Trimethadione may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Trimethadione,Gamolenic acid,The therapeutic efficacy of Trimethadione can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Trimethadione,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Trimethadione is combined with Ganaxolone.",increase,risk
Trimethadione,Ganciclovir,The therapeutic efficacy of Trimethadione can be decreased when used in combination with Ganciclovir.,decrease,no risk
Trimethadione,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Gatifloxacin.,increase,risk
Trimethadione,Gemfibrozil,The metabolism of Trimethadione can be decreased when combined with Gemfibrozil.,decrease,no risk
Trimethadione,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Gemifloxacin.,increase,risk
Trimethadione,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Trimethadione.,increase,risk
Trimethadione,Gestrinone,The metabolism of Gestrinone can be increased when combined with Trimethadione.,increase,no risk
Trimethadione,Gilteritinib,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Gilteritinib.,increase,risk
Trimethadione,Ginkgo biloba,The metabolism of Trimethadione can be decreased when combined with Ginkgo biloba.,decrease,no risk
Trimethadione,Glasdegib,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Glasdegib.,increase,risk
Trimethadione,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Glimepiride,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Glimepiride.,increase,risk
Trimethadione,Glipizide,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Glipizide.,increase,risk
Trimethadione,Gliquidone,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Gliquidone.,increase,risk
Trimethadione,Glofitamab,The serum concentration of Trimethadione can be increased when it is combined with Glofitamab.,increase,no risk
Trimethadione,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Trimethadione.,decrease,no risk
Trimethadione,Glutethimide,The risk or severity of CNS depression can be increased when Trimethadione is combined with Glutethimide.,increase,risk
Trimethadione,Glyburide,The metabolism of Glyburide can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Glycerin,The metabolism of Trimethadione can be increased when combined with Glycerin.,increase,no risk
Trimethadione,Glymidine,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Glymidine.,increase,risk
Trimethadione,Golimumab,The metabolism of Trimethadione can be increased when combined with Golimumab.,increase,no risk
Trimethadione,Goserelin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Goserelin.,increase,risk
Trimethadione,Granisetron,The risk or severity of CNS depression can be increased when Trimethadione is combined with Granisetron.,increase,risk
Trimethadione,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Grepafloxacin.,increase,risk
Trimethadione,Guanfacine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Guanfacine.,increase,risk
Trimethadione,Halazepam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Halazepam.,increase,risk
Trimethadione,Halofantrine,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Halofantrine.,increase,risk
Trimethadione,Haloperidol,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Haloperidol.,increase,risk
Trimethadione,Halothane,The risk or severity of CNS depression can be increased when Trimethadione is combined with Halothane.,increase,risk
Trimethadione,Heparin,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Heparin.,increase,risk
Trimethadione,Hexafluronium,The risk or severity of CNS depression can be increased when Trimethadione is combined with Hexafluronium.,increase,risk
Trimethadione,Histrelin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Histrelin.,increase,risk
Trimethadione,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Hydrochlorothiazide.,increase,risk
Trimethadione,Hydrocodone,Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Trimethadione,Hydrocortisone,The metabolism of Trimethadione can be increased when combined with Hydrocortisone.,increase,no risk
Trimethadione,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Trimethadione.,increase,risk
Trimethadione,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Trimethadione.,increase,risk
Trimethadione,Hydroxychloroquine,The therapeutic efficacy of Trimethadione can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Trimethadione,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Trimethadione.,increase,no risk
Trimethadione,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Hydroxyzine.,increase,risk
Trimethadione,Hyoscyamine,Trimethadione may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Trimethadione,Ketamine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Ketamine.,increase,risk
Trimethadione,Ketazolam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Ketazolam.,increase,risk
Trimethadione,Ketoconazole,The metabolism of Trimethadione can be decreased when combined with Ketoconazole.,decrease,no risk
Trimethadione,Ketoprofen,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Ketoprofen.,increase,risk
Trimethadione,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Trimethadione.,increase,no risk
Trimethadione,Ofloxacin,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Ofloxacin.,increase,risk
Trimethadione,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Trimethadione.,increase,risk
Trimethadione,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Trimethadione is combined with Oliceridine.",increase,risk
Trimethadione,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Trimethadione.,increase,risk
Trimethadione,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Omaveloxolone,The serum concentration of Trimethadione can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Trimethadione,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Omeprazole,The metabolism of Trimethadione can be decreased when combined with Omeprazole.,decrease,no risk
Trimethadione,Ondansetron,The risk or severity of CNS depression can be increased when Trimethadione is combined with Ondansetron.,increase,risk
Trimethadione,Opium,The risk or severity of CNS depression can be increased when Trimethadione is combined with Opium.,increase,risk
Trimethadione,Oritavancin,The metabolism of Trimethadione can be decreased when combined with Oritavancin.,decrease,no risk
Trimethadione,Orlistat,Orlistat can cause a decrease in the absorption of Trimethadione resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Trimethadione,Orphenadrine,Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Trimethadione,Osilodrostat,The metabolism of Trimethadione can be decreased when combined with Osilodrostat.,decrease,no risk
Trimethadione,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Trimethadione.,increase,no risk
Trimethadione,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Trimethadione.,increase,no risk
Trimethadione,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Trimethadione.,increase,risk
Trimethadione,Oxandrolone,The metabolism of Trimethadione can be decreased when combined with Oxandrolone.,decrease,no risk
Trimethadione,Oxaprozin,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Oxaprozin.,increase,risk
Trimethadione,Oxatomide,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Oxatomide.,increase,risk
Trimethadione,Oxazepam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Oxazepam.,increase,risk
Trimethadione,Oxcarbazepine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Oxcarbazepine.,increase,risk
Trimethadione,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Oxetacaine.,increase,risk
Trimethadione,Oxitriptan,The risk or severity of CNS depression can be increased when Trimethadione is combined with Oxitriptan.,increase,risk
Trimethadione,Oxprenolol,Trimethadione may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Trimethadione,Oxtriphylline,Trimethadione may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimethadione,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trimethadione is combined with Oxybuprocaine.,increase,risk
Trimethadione,Oxybutynin,The metabolism of Trimethadione can be decreased when combined with Oxybutynin.,decrease,no risk
Trimethadione,Oxycodone,The risk or severity of CNS depression can be increased when Trimethadione is combined with Oxycodone.,increase,risk
Trimethadione,Oxymorphone,The risk or severity of CNS depression can be increased when Trimethadione is combined with Oxymorphone.,increase,risk
Trimethadione,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Oxyphenbutazone.,increase,risk
Trimethadione,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Trimethadione.,decrease,no risk
Trimethadione,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Trimethadione.,increase,risk
Trimethadione,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Quazepam,The risk or severity of CNS depression can be increased when Trimethadione is combined with Quazepam.,increase,risk
Trimethadione,Quetiapine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Quetiapine.,increase,risk
Trimethadione,Quinapril,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Quinapril.,increase,risk
Trimethadione,Quinidine,Trimethadione may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Trimethadione,Quinine,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Quinine.,increase,risk
Trimethadione,Quinupramine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Quinupramine.,increase,risk
Trimethadione,Quizartinib,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Quizartinib.,increase,risk
Trimethadione,Ulipristal,The metabolism of Ulipristal can be increased when combined with Trimethadione.,increase,no risk
Trimethadione,Urethane,The risk or severity of CNS depression can be increased when Trimethadione is combined with Urethane.,increase,risk
Trimethadione,Vadadustat,The serum concentration of Trimethadione can be increased when it is combined with Vadadustat.,increase,no risk
Trimethadione,Valdecoxib,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Valdecoxib.,increase,risk
Trimethadione,Valganciclovir,The therapeutic efficacy of Trimethadione can be decreased when used in combination with Valganciclovir.,decrease,no risk
Trimethadione,Valproic acid,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Valproic acid.,increase,risk
Trimethadione,Valsartan,The metabolism of Trimethadione can be decreased when combined with Valsartan.,decrease,no risk
Trimethadione,Vandetanib,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Vandetanib.,increase,risk
Trimethadione,Vardenafil,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Vardenafil.,increase,risk
Trimethadione,Vayarin,The metabolism of Trimethadione can be decreased when combined with Vayarin.,decrease,no risk
Trimethadione,Vecuronium,Trimethadione may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Trimethadione,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Trimethadione.,increase,risk
Trimethadione,Venetoclax,The metabolism of Trimethadione can be decreased when combined with Venetoclax.,decrease,no risk
Trimethadione,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Trimethadione.,increase,risk
Trimethadione,Verapamil,Trimethadione may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Trimethadione,Vernakalant,Trimethadione may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Trimethadione,Vigabatrin,The risk or severity of CNS depression can be increased when Trimethadione is combined with Vigabatrin.,increase,risk
Trimethadione,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Trimethadione.,increase,risk
Trimethadione,Vilazodone,The risk or severity of CNS depression can be increased when Trimethadione is combined with Vilazodone.,increase,risk
Trimethadione,Vildagliptin,The risk or severity of hypoglycemia can be increased when Trimethadione is combined with Vildagliptin.,increase,risk
Trimethadione,Viloxazine,The metabolism of Trimethadione can be decreased when combined with Viloxazine.,decrease,no risk
Trimethadione,Vonoprazan,The metabolism of Trimethadione can be decreased when combined with Vonoprazan.,decrease,no risk
Trimethadione,Voriconazole,The metabolism of Trimethadione can be decreased when combined with Voriconazole.,decrease,no risk
Trimethadione,Vorinostat,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Vorinostat.,increase,risk
Trimethadione,Vortioxetine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Vortioxetine.,increase,risk
Trimethadione,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Warfarin,The metabolism of Trimethadione can be increased when combined with Warfarin.,increase,no risk
Trimethadione,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Xylometazoline,Trimethadione may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Trimethadione,Yohimbine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Yohimbine.,increase,risk
Trimethadione,Zafirlukast,The metabolism of Trimethadione can be decreased when combined with Zafirlukast.,decrease,no risk
Trimethadione,Zaleplon,The risk or severity of CNS depression can be increased when Trimethadione is combined with Zaleplon.,increase,risk
Trimethadione,Ziconotide,The risk or severity of CNS depression can be increased when Trimethadione is combined with Ziconotide.,increase,risk
Trimethadione,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Zileuton,The metabolism of Zileuton can be decreased when combined with Trimethadione.,decrease,no risk
Trimethadione,Zimelidine,The risk or severity of adverse effects can be increased when Trimethadione is combined with Zimelidine.,increase,risk
Trimethadione,Ziprasidone,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Ziprasidone.,increase,risk
Trimethadione,Zofenopril,The risk or severity of hyperkalemia can be increased when Trimethadione is combined with Zofenopril.,increase,risk
Trimethadione,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Trimethadione.,increase,risk
Trimethadione,Zolpidem,Trimethadione may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Trimethadione,Zonisamide,Trimethadione may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Trimethadione,Zopiclone,The risk or severity of adverse effects can be increased when Trimethadione is combined with Zopiclone.,increase,risk
Trimethadione,Zotepine,The risk or severity of CNS depression can be increased when Trimethadione is combined with Zotepine.,increase,risk
Trimethadione,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Trimethadione is combined with Zuclopenthixol.,increase,risk
Trimethadione,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Trimethadione.,increase,risk
Clobazam,Bacitracin,Bacitracin may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Baclofen,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Baclofen.",increase,risk
Clobazam,Balsalazide,Balsalazide may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Baricitinib,Clobazam may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Clobazam,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Belumosudil,The serum concentration of Clobazam can be increased when it is combined with Belumosudil.,increase,no risk
Clobazam,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Benorilate,Benorilate may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Benperidol,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Benperidol.",increase,risk
Clobazam,Benserazide,Clobazam may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Clobazam,Benzatropine,The serum concentration of Benzatropine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Benzhydrocodone,The risk or severity of respiratory depression can be increased when Clobazam is combined with Benzhydrocodone.,increase,risk
Clobazam,Benznidazole,Clobazam may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Clobazam,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Benzphetamine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Benzphetamine.",increase,risk
Clobazam,Benzthiazide,Benzthiazide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Benzydamine,Benzydamine may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bepotastine,Clobazam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Clobazam,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Berotralstat,The metabolism of Clobazam can be decreased when combined with Berotralstat.,decrease,no risk
Clobazam,Betamethasone,The metabolism of Clobazam can be increased when combined with Betamethasone.,increase,no risk
Clobazam,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Clobazam.,increase,no risk
Clobazam,Bicisate,Clobazam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Clobazam,Bimekizumab,The metabolism of Clobazam can be increased when combined with Bimekizumab.,increase,no risk
Clobazam,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bismuth subgallate,Clobazam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Clobazam,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bisoxatin,Clobazam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Clobazam,Bleomycin,Bleomycin may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Boceprevir,The metabolism of Clobazam can be decreased when combined with Boceprevir.,decrease,no risk
Clobazam,Borage oil,The therapeutic efficacy of Clobazam can be decreased when used in combination with Borage oil.,decrease,no risk
Clobazam,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Bosutinib,The metabolism of Bosutinib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Botulinum toxin type A,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Botulinum toxin type A.",increase,risk
Clobazam,Botulinum toxin type B,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Botulinum toxin type B.",increase,risk
Clobazam,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Clobazam.,increase,no risk
Clobazam,Brexanolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Brexanolone.",increase,risk
Clobazam,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Brigatinib,The metabolism of Brigatinib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Brimonidine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Brimonidine.",increase,risk
Clobazam,Brivaracetam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Brivaracetam.",increase,risk
Clobazam,Bromazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Bromazepam.",increase,risk
Clobazam,Bromocriptine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Bromocriptine.",increase,risk
Clobazam,Bromotheophylline,The therapeutic efficacy of Clobazam can be decreased when used in combination with Bromotheophylline.,decrease,no risk
Clobazam,Bromperidol,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Bromperidol.",increase,risk
Clobazam,Brompheniramine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Brompheniramine.",increase,risk
Clobazam,Budesonide,Clobazam may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Clobazam,Bumadizone,Bumadizone may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Bumetanide,Bumetanide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Buprenorphine,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Clobazam,Bupropion,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Bupropion.",increase,risk
Clobazam,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Busulfan,The metabolism of Busulfan can be increased when combined with Clobazam.,increase,no risk
Clobazam,Butabarbital,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butabarbital.",increase,risk
Clobazam,Butacaine,The risk or severity of methemoglobinemia can be increased when Clobazam is combined with Butacaine.,increase,risk
Clobazam,Butalbital,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butalbital.",increase,risk
Clobazam,Butamben,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butamben.",increase,risk
Clobazam,Butaperazine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butaperazine.",increase,risk
Clobazam,Butobarbital,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butobarbital.",increase,risk
Clobazam,Butorphanol,The risk or severity of respiratory depression can be increased when Clobazam is combined with Butorphanol.,increase,risk
Clobazam,Butriptyline,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Butriptyline.",increase,risk
Clobazam,Gabapentin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Gabapentin.",increase,risk
Clobazam,Gabapentin enacarbil,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Gabapentin enacarbil.",increase,risk
Clobazam,Gadobenic acid,Clobazam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Clobazam,Gadodiamide,Gadodiamide may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Gadofosveset trisodium,Clobazam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Clobazam,Gadopentetic acid,Clobazam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Clobazam,Gadoteric acid,Clobazam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Clobazam,Gadoteridol,Clobazam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Clobazam,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Gallamine triethiodide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Gallamine triethiodide.",increase,risk
Clobazam,Gamolenic acid,The therapeutic efficacy of Clobazam can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Clobazam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Ganaxolone.",increase,risk
Clobazam,Ganciclovir,The therapeutic efficacy of Clobazam can be decreased when used in combination with Ganciclovir.,decrease,no risk
Clobazam,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Gemfibrozil,The serum concentration of Clobazam can be increased when it is combined with Gemfibrozil.,increase,no risk
Clobazam,Gentamicin,Clobazam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Clobazam,Gepirone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Gepirone.",increase,risk
Clobazam,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Clobazam.,decrease,no risk
Clobazam,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Gimeracil,Clobazam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Clobazam,Givosiran,Givosiran may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Glasdegib,The serum concentration of Clobazam can be increased when it is combined with Glasdegib.,increase,no risk
Clobazam,Glecaprevir,The serum concentration of Clobazam can be increased when it is combined with Glecaprevir.,increase,no risk
Clobazam,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Glipizide,Clobazam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Clobazam,Glofitamab,The serum concentration of Clobazam can be increased when it is combined with Glofitamab.,increase,no risk
Clobazam,Glutethimide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Glutethimide.",increase,risk
Clobazam,Glyburide,The metabolism of Glyburide can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Glycerol phenylbutyrate,Clobazam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Clobazam,Golimumab,The metabolism of Clobazam can be increased when combined with Golimumab.,increase,no risk
Clobazam,Golodirsen,Clobazam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Clobazam,Goserelin,Goserelin may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Granisetron,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Granisetron.",increase,risk
Clobazam,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Guanethidine,Clobazam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Clobazam,Guanfacine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Guanfacine.",increase,risk
Clobazam,Halazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Halazepam.",increase,risk
Clobazam,Halofantrine,The therapeutic efficacy of Clobazam can be decreased when used in combination with Halofantrine.,decrease,no risk
Clobazam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Clobazam.,increase,risk
Clobazam,Halothane,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Halothane.",increase,risk
Clobazam,Hexafluronium,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Hexafluronium.",increase,risk
Clobazam,Hydralazine,Clobazam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Clobazam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Hydrocodone,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Clobazam,Hydrocortisone,The metabolism of Clobazam can be increased when combined with Hydrocortisone.,increase,no risk
Clobazam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Hydromorphone,The risk or severity of respiratory depression can be increased when Clobazam is combined with Hydromorphone.,increase,risk
Clobazam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Hydroxychloroquine,The therapeutic efficacy of Clobazam can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Clobazam,Hydroxyethyl Starch,Clobazam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Clobazam,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Clobazam.,decrease,no risk
Clobazam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clobazam.,increase,no risk
Clobazam,Kanamycin,Clobazam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Clobazam,Ketamine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Ketamine.",increase,risk
Clobazam,Ketazolam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Ketazolam.",increase,risk
Clobazam,Ketoconazole,The metabolism of Clobazam can be decreased when combined with Ketoconazole.,decrease,no risk
Clobazam,Ketoprofen,Ketoprofen may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Ketorolac,Ketorolac may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Octinoxate,Clobazam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Clobazam,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Olaparib,The metabolism of Olaparib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Clobazam is combined with Oliceridine.",increase,risk
Clobazam,Olsalazine,Olsalazine may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Omaveloxolone,The serum concentration of Clobazam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Clobazam,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Omeprazole,The serum concentration of Clobazam can be increased when it is combined with Omeprazole.,increase,no risk
Clobazam,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Opium,The risk or severity of respiratory depression can be increased when Clobazam is combined with Opium.,increase,risk
Clobazam,Oritavancin,The metabolism of Clobazam can be decreased when combined with Oritavancin.,decrease,no risk
Clobazam,Orlistat,Orlistat can cause a decrease in the absorption of Clobazam resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clobazam,Orphenadrine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Orphenadrine.",increase,risk
Clobazam,Oseltamivir,Oseltamivir may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Osilodrostat,The metabolism of Clobazam can be decreased when combined with Osilodrostat.,decrease,no risk
Clobazam,Osimertinib,The metabolism of Osimertinib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Oxacillin,Clobazam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Clobazam,Oxaprozin,Oxaprozin may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Oxazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Oxazepam.",increase,risk
Clobazam,Oxcarbazepine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Oxcarbazepine.",increase,risk
Clobazam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clobazam is combined with Oxetacaine.,increase,risk
Clobazam,Oxitriptan,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Oxitriptan.",increase,risk
Clobazam,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Oxtriphylline,The therapeutic efficacy of Clobazam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Clobazam,Oxybenzone,Clobazam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Clobazam,Oxybuprocaine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Oxybuprocaine.",increase,risk
Clobazam,Oxycodone,The risk or severity of respiratory depression can be increased when Clobazam is combined with Oxycodone.,increase,risk
Clobazam,Oxymorphone,The risk or severity of respiratory depression can be increased when Clobazam is combined with Oxymorphone.,increase,risk
Clobazam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Oxyquinoline,Clobazam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Clobazam,Quazepam,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Quazepam.",increase,risk
Clobazam,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Quinethazone,Quinethazone may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clobazam,Quinidine,The metabolism of Quinidine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Quinine,The serum concentration of Quinine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Quinupramine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Quinupramine.",increase,risk
Clobazam,Quizartinib,The serum concentration of Clobazam can be increased when it is combined with Quizartinib.,increase,no risk
Clobazam,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Clobazam.,decrease,no risk
Clobazam,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Clobazam.,decrease,no risk
Clobazam,Umbralisib,The serum concentration of Clobazam can be increased when it is combined with Umbralisib.,increase,no risk
Clobazam,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Urethane,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Urethane.",increase,risk
Clobazam,Vaborbactam,Clobazam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Clobazam,Vadadustat,The serum concentration of Clobazam can be decreased when it is combined with Vadadustat.,decrease,no risk
Clobazam,Valaciclovir,Valaciclovir may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Valdecoxib,Valdecoxib may decrease the excretion rate of Clobazam which could result in a higher serum level.,decrease,no risk
Clobazam,Valganciclovir,The therapeutic efficacy of Clobazam can be decreased when used in combination with Valganciclovir.,decrease,no risk
Clobazam,Valproic acid,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Valproic acid.",increase,risk
Clobazam,Vancomycin,Clobazam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Clobazam,Vandetanib,The metabolism of Vandetanib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Vardenafil,The serum concentration of Clobazam can be increased when it is combined with Vardenafil.,increase,no risk
Clobazam,Varenicline,Clobazam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Clobazam,Vecuronium,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Vecuronium.",increase,risk
Clobazam,Velpatasvir,The serum concentration of Clobazam can be increased when it is combined with Velpatasvir.,increase,no risk
Clobazam,Vemurafenib,The serum concentration of Clobazam can be increased when it is combined with Vemurafenib.,increase,no risk
Clobazam,Venetoclax,The metabolism of Venetoclax can be increased when combined with Clobazam.,increase,no risk
Clobazam,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Verapamil,The metabolism of Clobazam can be decreased when combined with Verapamil.,decrease,no risk
Clobazam,Vernakalant,The serum concentration of Vernakalant can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Vigabatrin,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Vigabatrin.",increase,risk
Clobazam,Vilanterol,Clobazam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Clobazam,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Viloxazine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Viloxazine.",increase,risk
Clobazam,Vinblastine,The metabolism of Vinblastine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Vincristine,The metabolism of Vincristine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Vindesine,The metabolism of Vindesine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Vinflunine,The metabolism of Vinflunine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Clobazam.,increase,no risk
Clobazam,Voclosporin,The serum concentration of Clobazam can be increased when it is combined with Voclosporin.,increase,no risk
Clobazam,Vonoprazan,The metabolism of Clobazam can be decreased when combined with Vonoprazan.,decrease,no risk
Clobazam,Vorapaxar,The serum concentration of Clobazam can be increased when it is combined with Vorapaxar.,increase,no risk
Clobazam,Voriconazole,The serum concentration of Clobazam can be increased when it is combined with Voriconazole.,increase,no risk
Clobazam,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Clobazam.,decrease,no risk
Clobazam,Voxilaprevir,The serum concentration of Clobazam can be increased when it is combined with Voxilaprevir.,increase,no risk
Clobazam,Warfarin,The metabolism of Warfarin can be increased when combined with Clobazam.,increase,no risk
Clobazam,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Zafirlukast,The serum concentration of Clobazam can be increased when it is combined with Zafirlukast.,increase,no risk
Clobazam,Zaleplon,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zaleplon.",increase,risk
Clobazam,Zanamivir,Clobazam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Clobazam,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Clobazam.,increase,no risk
Clobazam,Ziconotide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Ziconotide.",increase,risk
Clobazam,Zimelidine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zimelidine.",increase,risk
Clobazam,Ziprasidone,The risk or severity of adverse effects can be increased when Clobazam is combined with Ziprasidone.,increase,risk
Clobazam,Zolmitriptan,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zolmitriptan.",increase,risk
Clobazam,Zolpidem,Clobazam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Clobazam,Zonisamide,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zonisamide.",increase,risk
Clobazam,Zopiclone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zopiclone.",increase,risk
Clobazam,Zotepine,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zotepine.",increase,risk
Clobazam,Zucapsaicin,The serum concentration of Clobazam can be increased when it is combined with Zucapsaicin.,increase,no risk
Clobazam,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Clobazam.,increase,no risk
Clobazam,Zuranolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clobazam is combined with Zuranolone.",increase,risk
Minoxidil,Gemfibrozil,The metabolism of Minoxidil can be decreased when combined with Gemfibrozil.,decrease,no risk
Minoxidil,Glecaprevir,The metabolism of Minoxidil can be decreased when combined with Glecaprevir.,decrease,no risk
Minoxidil,Glycol salicylate,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Minoxidil,Guanabenz,Guanabenz may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Guanadrel,Guanadrel may increase the hypotensive activities of Minoxidil.,increase,no risk
Minoxidil,Guanethidine,Minoxidil may increase the hypotensive activities of Guanethidine.,increase,no risk
Minoxidil,Guanfacine,Guanfacine may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Guanoxan,Minoxidil may increase the hypotensive activities of Guanoxan.,increase,no risk
Minoxidil,Halothane,Halothane may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Hydralazine,Minoxidil may increase the hypotensive activities of Hydralazine.,increase,no risk
Minoxidil,Hydrochlorothiazide,The therapeutic efficacy of Minoxidil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Minoxidil,Hydroflumethiazide,The therapeutic efficacy of Minoxidil can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Minoxidil,Ketoconazole,The metabolism of Minoxidil can be decreased when combined with Ketoconazole.,decrease,no risk
Minoxidil,Ketoprofen,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Ketoprofen.,decrease,no risk
Minoxidil,Ketorolac,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Ketorolac.,decrease,no risk
Minoxidil,Obinutuzumab,Minoxidil may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Minoxidil,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Minoxidil.,increase,risk
Minoxidil,Olmesartan,Olmesartan may increase the hypotensive activities of Minoxidil.,increase,no risk
Minoxidil,Olodaterol,Olodaterol may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Ombitasvir,The metabolism of Minoxidil can be decreased when combined with Ombitasvir.,decrease,no risk
Minoxidil,Opicapone,The risk or severity of adverse effects can be increased when Minoxidil is combined with Opicapone.,increase,risk
Minoxidil,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Oxaprozin,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Oxaprozin.,decrease,no risk
Minoxidil,Oxprenolol,Minoxidil may increase the hypotensive activities of Oxprenolol.,increase,no risk
Minoxidil,Oxymetazoline,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Minoxidil,Oxyphenbutazone,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Minoxidil,Quetiapine,Quetiapine may increase the hypotensive activities of Minoxidil.,increase,no risk
Minoxidil,Quinapril,Minoxidil may increase the hypotensive activities of Quinapril.,increase,no risk
Minoxidil,Quinidine,Quinidine may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Quinine,Quinine may increase the hypotensive activities of Minoxidil.,increase,no risk
Minoxidil,Quinupramine,Quinupramine may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Quizartinib,The metabolism of Minoxidil can be decreased when combined with Quizartinib.,decrease,no risk
Minoxidil,Udenafil,Udenafil may increase the antihypertensive activities of Minoxidil.,increase,no risk
Minoxidil,Unoprostone,Minoxidil may increase the hypotensive activities of Unoprostone.,increase,no risk
Minoxidil,Valdecoxib,The therapeutic efficacy of Minoxidil can be decreased when used in combination with Valdecoxib.,decrease,no risk
Minoxidil,Valproic acid,The metabolism of Minoxidil can be decreased when combined with Valproic acid.,decrease,no risk
Minoxidil,Valsartan,Valsartan may increase the hypotensive activities of Minoxidil.,increase,no risk
Minoxidil,Vardenafil,Vardenafil may increase the antihypertensive activities of Minoxidil.,increase,no risk
Minoxidil,Verapamil,The risk or severity of adverse effects can be increased when Minoxidil is combined with Verapamil.,increase,risk
Minoxidil,Vericiguat,The risk or severity of adverse effects can be increased when Minoxidil is combined with Vericiguat.,increase,risk
Minoxidil,Vilanterol,Vilanterol may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Vilazodone,Vilazodone may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Xamoterol,Xamoterol may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Yohimbine,Yohimbine may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Zidovudine,The metabolism of Minoxidil can be increased when combined with Zidovudine.,increase,no risk
Minoxidil,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Minoxidil.,increase,no risk
Minoxidil,Zofenopril,Minoxidil may increase the hypotensive activities of Zofenopril.,increase,no risk
Minoxidil,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Minoxidil,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Minoxidil.,decrease,no risk
Megestrol acetate,Bicisate,Megestrol acetate may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bismuth subgallate,Megestrol acetate may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bisoprolol,Megestrol acetate may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bisoxatin,Megestrol acetate may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bivalirudin,The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Bivalirudin.,increase,risk
Megestrol acetate,Bleomycin,Bleomycin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Boceprevir,The serum concentration of Megestrol acetate can be increased when it is combined with Boceprevir.,increase,no risk
Megestrol acetate,Bosentan,The serum concentration of Megestrol acetate can be decreased when it is combined with Bosentan.,decrease,no risk
Megestrol acetate,Brexanolone,The metabolism of Megestrol acetate can be increased when combined with Brexanolone.,increase,no risk
Megestrol acetate,Brivaracetam,The metabolism of Megestrol acetate can be increased when combined with Brivaracetam.,increase,no risk
Megestrol acetate,Bromazepam,Megestrol acetate may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Bromotheophylline,Bromotheophylline may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Megestrol acetate,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Bumadizone,Bumadizone may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Bumetanide,Bumetanide may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Megestrol acetate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Megestrol acetate is combined with Bupivacaine.,increase,risk
Megestrol acetate,Bupropion,Megestrol acetate may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Buspirone,Megestrol acetate may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Butabarbital,Butabarbital may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Butacaine,The risk or severity of methemoglobinemia can be increased when Megestrol acetate is combined with Butacaine.,increase,risk
Megestrol acetate,Butalbital,The metabolism of Megestrol acetate can be increased when combined with Butalbital.,increase,no risk
Megestrol acetate,Butamben,The risk or severity of methemoglobinemia can be increased when Megestrol acetate is combined with Butamben.,increase,risk
Megestrol acetate,Gabapentin,The metabolism of Megestrol acetate can be increased when combined with Gabapentin.,increase,no risk
Megestrol acetate,Gabapentin enacarbil,Megestrol acetate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadobenic acid,Megestrol acetate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadodiamide,Gadodiamide may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadofosveset trisodium,Megestrol acetate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadopentetic acid,Megestrol acetate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadoteric acid,Megestrol acetate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gadoteridol,Megestrol acetate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ganaxolone,The metabolism of Megestrol acetate can be increased when combined with Ganaxolone.,increase,no risk
Megestrol acetate,Ganciclovir,Megestrol acetate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gemcitabine,Megestrol acetate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gemfibrozil,Megestrol acetate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gentamicin,Megestrol acetate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gimeracil,Megestrol acetate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Givosiran,Givosiran may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Glofitamab,The serum concentration of Megestrol acetate can be increased when it is combined with Glofitamab.,increase,no risk
Megestrol acetate,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Glycerol phenylbutyrate,The metabolism of Megestrol acetate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Megestrol acetate,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Golodirsen,Megestrol acetate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Goserelin,Goserelin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Griseofulvin,The metabolism of Megestrol acetate can be increased when combined with Griseofulvin.,increase,no risk
Megestrol acetate,Guanethidine,Megestrol acetate may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Guanfacine,Megestrol acetate may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Heparin,The risk or severity of adverse effects can be increased when Megestrol acetate is combined with Heparin.,increase,risk
Megestrol acetate,Hetacillin,The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Hetacillin.,decrease,no risk
Megestrol acetate,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Megestrol acetate is combined with Human C1-esterase inhibitor.,increase,risk
Megestrol acetate,Hydralazine,Megestrol acetate may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Megestrol acetate,Hydrocortamate,The metabolism of Megestrol acetate can be increased when combined with Hydrocortamate.,increase,no risk
Megestrol acetate,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Megestrol acetate.,increase,no risk
Megestrol acetate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Megestrol acetate,Hydromorphone,Hydromorphone may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Hydroxyethyl Starch,Megestrol acetate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Kanamycin,Megestrol acetate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ketamine,Megestrol acetate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ketazolam,Megestrol acetate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ketoconazole,The metabolism of Megestrol acetate can be decreased when combined with Ketoconazole.,decrease,no risk
Megestrol acetate,Ketoprofen,Ketoprofen may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ketorolac,Ketorolac may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Octinoxate,Megestrol acetate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Octreotide,The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Octreotide.,decrease,no risk
Megestrol acetate,Olsalazine,Olsalazine may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Olutasidenib,The metabolism of Megestrol acetate can be increased when combined with Olutasidenib.,increase,no risk
Megestrol acetate,Omadacycline,The serum concentration of Megestrol acetate can be decreased when it is combined with Omadacycline.,decrease,no risk
Megestrol acetate,Omaveloxolone,The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Megestrol acetate,Opium,Megestrol acetate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oritavancin,The metabolism of Megestrol acetate can be increased when combined with Oritavancin.,increase,no risk
Megestrol acetate,Oseltamivir,Oseltamivir may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Megestrol acetate,Oxacillin,The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Oxacillin.,decrease,no risk
Megestrol acetate,Oxaprozin,Oxaprozin may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oxazepam,Megestrol acetate may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oxcarbazepine,The metabolism of Megestrol acetate can be increased when combined with Oxcarbazepine.,increase,no risk
Megestrol acetate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Megestrol acetate is combined with Oxetacaine.,increase,risk
Megestrol acetate,Oxybenzone,Megestrol acetate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Megestrol acetate is combined with Oxybuprocaine.,increase,risk
Megestrol acetate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Megestrol acetate which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oxyquinoline,Megestrol acetate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Oxytetracycline,The serum concentration of Megestrol acetate can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Megestrol acetate,Quetiapine,Megestrol acetate may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Quinethazone,Quinethazone may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Megestrol acetate,Quinidine,Megestrol acetate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Megestrol acetate,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Megestrol acetate.,decrease,no risk
Tioguanine,Gemcitabine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Gemcitabine.,increase,risk
Tioguanine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tioguanine.,increase,risk
Tioguanine,Glatiramer,The risk or severity of adverse effects can be increased when Tioguanine is combined with Glatiramer.,increase,risk
Tioguanine,Golimumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Golimumab.,increase,risk
Tioguanine,Guselkumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Guselkumab.,increase,risk
Tioguanine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Tioguanine.,increase,risk
Tioguanine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Tioguanine.,increase,risk
Tioguanine,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Tioguanine.,increase,risk
Tioguanine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Tioguanine is combined with Hydrocortisone acetate.,increase,risk
Tioguanine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Tioguanine is combined with Hydrocortisone butyrate.,increase,risk
Tioguanine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Tioguanine is combined with Hydrocortisone succinate.,increase,risk
Tioguanine,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Tioguanine.,increase,risk
Tioguanine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Hydroxychloroquine.,increase,risk
Tioguanine,Hydroxyurea,The risk or severity of adverse effects can be increased when Tioguanine is combined with Hydroxyurea.,increase,risk
Tioguanine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Obinutuzumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Obinutuzumab.,increase,risk
Tioguanine,Ocrelizumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Ocrelizumab.,increase,risk
Tioguanine,Ofatumumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Ofatumumab.,increase,risk
Tioguanine,Olaparib,The risk or severity of adverse effects can be increased when Tioguanine is combined with Olaparib.,increase,risk
Tioguanine,Olsalazine,The risk or severity of myelosuppression can be increased when Tioguanine is combined with Olsalazine.,increase,risk
Tioguanine,Oxaliplatin,The risk or severity of adverse effects can be increased when Tioguanine is combined with Oxaliplatin.,increase,risk
Tioguanine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tioguanine is combined with Oxetacaine.,increase,risk
Tioguanine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tioguanine is combined with Oxybuprocaine.,increase,risk
Tioguanine,Ozanimod,The risk or severity of adverse effects can be increased when Tioguanine is combined with Ozanimod.,increase,risk
Tioguanine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Tioguanine.,increase,risk
Tioguanine,Upadacitinib,The risk or severity of adverse effects can be increased when Tioguanine is combined with Upadacitinib.,increase,risk
Tioguanine,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Tioguanine.,increase,risk
Tioguanine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tioguanine.,increase,risk
Tioguanine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Vedolizumab,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vedolizumab.,increase,risk
Tioguanine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tioguanine.,decrease,no risk
Tioguanine,Vilanterol,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vilanterol.,increase,risk
Tioguanine,Vinblastine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vinblastine.,increase,risk
Tioguanine,Vincristine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vincristine.,increase,risk
Tioguanine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Tioguanine.,increase,risk
Tioguanine,Vinorelbine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vinorelbine.,increase,risk
Tioguanine,Voclosporin,The risk or severity of adverse effects can be increased when Tioguanine is combined with Voclosporin.,increase,risk
Tioguanine,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Tioguanine.,increase,risk
Tioguanine,Vorinostat,The risk or severity of adverse effects can be increased when Tioguanine is combined with Vorinostat.,increase,risk
Tioguanine,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Tioguanine.,increase,risk
Tioguanine,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Tioguanine.,increase,risk
Tioguanine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Tioguanine.,increase,risk
Tioguanine,Zidovudine,The risk or severity of adverse effects can be increased when Tioguanine is combined with Zidovudine.,increase,risk
Methylergometrine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Methylergometrine.,decrease,no risk
Methylergometrine,Glofitamab,The serum concentration of Methylergometrine can be increased when it is combined with Glofitamab.,increase,no risk
Methylergometrine,Guanabenz,Methylergometrine may increase the hypertensive and vasoconstricting activities of Guanabenz.,increase,no risk
Methylergometrine,Guanadrel,Methylergometrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Methylergometrine,Guanethidine,Methylergometrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Methylergometrine,Guanfacine,Methylergometrine may increase the hypertensive and vasoconstricting activities of Guanfacine.,increase,no risk
Methylergometrine,Guanoxan,Methylergometrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Methylergometrine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Halothane,The risk or severity of hypertension can be increased when Methylergometrine is combined with Halothane.,increase,risk
Methylergometrine,Hydralazine,Methylergometrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Methylergometrine,Hydrochlorothiazide,Methylergometrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Methylergometrine,Hydroflumethiazide,Methylergometrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Methylergometrine,Ketoconazole,The serum concentration of Methylergometrine can be increased when it is combined with Ketoconazole.,increase,no risk
Methylergometrine,Ketoprofen,The risk or severity of hypertension can be increased when Methylergometrine is combined with Ketoprofen.,increase,risk
Methylergometrine,Ketorolac,The risk or severity of hypertension can be increased when Methylergometrine is combined with Ketorolac.,increase,risk
Methylergometrine,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Olmesartan,Methylergometrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Methylergometrine,Olodaterol,Methylergometrine may increase the hypertensive and vasoconstricting activities of Olodaterol.,increase,no risk
Methylergometrine,Omaveloxolone,The serum concentration of Methylergometrine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Methylergometrine,Orciprenaline,Methylergometrine may increase the hypertensive and vasoconstricting activities of Orciprenaline.,increase,no risk
Methylergometrine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Oxaprozin,The risk or severity of hypertension can be increased when Methylergometrine is combined with Oxaprozin.,increase,risk
Methylergometrine,Oxprenolol,Oxprenolol may increase the vasoconstricting activities of Methylergometrine.,increase,no risk
Methylergometrine,Oxymetazoline,Methylergometrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Methylergometrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Methylergometrine is combined with Oxyphenbutazone.,increase,risk
Methylergometrine,Quetiapine,The risk or severity of hypertension can be increased when Methylergometrine is combined with Quetiapine.,increase,risk
Methylergometrine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Methylergometrine.,decrease,no risk
Methylergometrine,Quinapril,Methylergometrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Methylergometrine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Quinupramine,The risk or severity of hypertension can be increased when Methylergometrine is combined with Quinupramine.,increase,risk
Methylergometrine,Vadadustat,The serum concentration of Methylergometrine can be increased when it is combined with Vadadustat.,increase,no risk
Methylergometrine,Valdecoxib,The risk or severity of hypertension can be increased when Methylergometrine is combined with Valdecoxib.,increase,risk
Methylergometrine,Valsartan,Methylergometrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Methylergometrine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Methylergometrine.,decrease,no risk
Methylergometrine,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Verapamil,The metabolism of Methylergometrine can be decreased when combined with Verapamil.,decrease,no risk
Methylergometrine,Vibegron,Methylergometrine may increase the hypertensive and vasoconstricting activities of Vibegron.,increase,no risk
Methylergometrine,Vilanterol,Methylergometrine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Methylergometrine,Vilazodone,Methylergometrine may increase the vasoconstricting activities of Vilazodone.,increase,no risk
Methylergometrine,Viloxazine,The metabolism of Methylergometrine can be decreased when combined with Viloxazine.,decrease,no risk
Methylergometrine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Methylergometrine.,decrease,no risk
Methylergometrine,Voriconazole,The serum concentration of Methylergometrine can be increased when it is combined with Voriconazole.,increase,no risk
Methylergometrine,Vortioxetine,Methylergometrine may increase the vasoconstricting activities of Vortioxetine.,increase,no risk
Methylergometrine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Xamoterol,Methylergometrine may increase the hypertensive and vasoconstricting activities of Xamoterol.,increase,no risk
Methylergometrine,Xylometazoline,Methylergometrine may increase the hypertensive and vasoconstricting activities of Xylometazoline.,increase,no risk
Methylergometrine,Yohimbine,The risk or severity of hypertension can be increased when Methylergometrine is combined with Yohimbine.,increase,risk
Methylergometrine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Methylergometrine.,increase,no risk
Methylergometrine,Zimelidine,The metabolism of Methylergometrine can be decreased when combined with Zimelidine.,decrease,no risk
Methylergometrine,Ziprasidone,Methylergometrine may increase the vasoconstricting activities of Ziprasidone.,increase,no risk
Methylergometrine,Zofenopril,Methylergometrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Methylergometrine,Zolmitriptan,Methylergometrine may increase the vasoconstricting activities of Zolmitriptan.,increase,no risk
Methylergometrine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Methylergometrine.,decrease,no risk
Methylergometrine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Methylergometrine.,decrease,no risk
Buclizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Gadobenic acid.,increase,risk
Buclizine,Galantamine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Galantamine.,decrease,no risk
Buclizine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Buclizine is combined with Gallamine triethiodide.,increase,risk
Buclizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Gatifloxacin.,increase,risk
Buclizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Gemifloxacin.,increase,risk
Buclizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Buclizine.,increase,risk
Buclizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Gilteritinib.,increase,risk
Buclizine,Ginkgo biloba,The therapeutic efficacy of Buclizine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Buclizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Glasdegib.,increase,risk
Buclizine,Glucagon,Buclizine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Buclizine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Buclizine.,decrease,no risk
Buclizine,Glycopyrronium,The risk or severity of adverse effects can be increased when Buclizine is combined with Glycopyrronium.,increase,risk
Buclizine,Goserelin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Goserelin.,increase,risk
Buclizine,Granisetron,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Granisetron.,increase,risk
Buclizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Grepafloxacin.,increase,risk
Buclizine,Guanabenz,The risk or severity of Tachycardia can be increased when Buclizine is combined with Guanabenz.,increase,risk
Buclizine,Guanfacine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Guanfacine.,increase,risk
Buclizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Halofantrine.,increase,risk
Buclizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Haloperidol.,increase,risk
Buclizine,Hexafluronium,The risk or severity of adverse effects can be increased when Buclizine is combined with Hexafluronium.,increase,risk
Buclizine,Hexocyclium,The risk or severity of adverse effects can be increased when Buclizine is combined with Hexocyclium.,increase,risk
Buclizine,Histrelin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Histrelin.,increase,risk
Buclizine,Homatropine,The risk or severity of adverse effects can be increased when Buclizine is combined with Homatropine.,increase,risk
Buclizine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Buclizine is combined with Homatropine methylbromide.,increase,risk
Buclizine,Huperzine A,The therapeutic efficacy of Buclizine can be decreased when used in combination with Huperzine A.,decrease,no risk
Buclizine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Buclizine.,increase,no risk
Buclizine,Hydrocodone,The risk or severity of adverse effects can be increased when Buclizine is combined with Hydrocodone.,increase,risk
Buclizine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Buclizine.,increase,no risk
Buclizine,Hydromorphone,The risk or severity of adverse effects can be increased when Buclizine is combined with Hydromorphone.,increase,risk
Buclizine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Hydroxychloroquine.,increase,risk
Buclizine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Hydroxyzine.,increase,risk
Buclizine,Hyoscyamine,Buclizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Buclizine,Ketamine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Ketamine.,decrease,no risk
Buclizine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ketoconazole.,increase,risk
Buclizine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Buclizine.,increase,risk
Buclizine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ofloxacin.,increase,risk
Buclizine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Buclizine.,increase,risk
Buclizine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Buclizine is combined with Oliceridine.",increase,risk
Buclizine,Olodaterol,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Olodaterol.,increase,risk
Buclizine,Ondansetron,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ondansetron.,increase,risk
Buclizine,Opium,The risk or severity of adverse effects can be increased when Buclizine is combined with Opium.,increase,risk
Buclizine,Orciprenaline,The risk or severity of Tachycardia can be increased when Buclizine is combined with Orciprenaline.,increase,risk
Buclizine,Orphenadrine,The risk or severity of adverse effects can be increased when Buclizine is combined with Orphenadrine.,increase,risk
Buclizine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Buclizine.,increase,risk
Buclizine,Oxatomide,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Oxatomide.,increase,risk
Buclizine,Oxybutynin,The risk or severity of adverse effects can be increased when Buclizine is combined with Oxybutynin.,increase,risk
Buclizine,Oxycodone,The risk or severity of adverse effects can be increased when Buclizine is combined with Oxycodone.,increase,risk
Buclizine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Buclizine is combined with Oxymetazoline.,increase,risk
Buclizine,Oxymorphone,The risk or severity of adverse effects can be increased when Buclizine is combined with Oxymorphone.,increase,risk
Buclizine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Buclizine is combined with Oxyphencyclimine.,increase,risk
Buclizine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Buclizine.,decrease,no risk
Buclizine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Buclizine.,increase,risk
Buclizine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Buclizine.,increase,risk
Buclizine,Quetiapine,The risk or severity of adverse effects can be increased when Buclizine is combined with Quetiapine.,increase,risk
Buclizine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Buclizine.,increase,no risk
Buclizine,Quinidine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinidine.,increase,risk
Buclizine,Quinine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinine.,increase,risk
Buclizine,Quinupramine,The risk or severity of adverse effects can be increased when Buclizine is combined with Quinupramine.,increase,risk
Buclizine,Quizartinib,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quizartinib.,increase,risk
Buclizine,Umeclidinium,The risk or severity of adverse effects can be increased when Buclizine is combined with Umeclidinium.,increase,risk
Buclizine,Valproic acid,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Valproic acid.,increase,risk
Buclizine,Vandetanib,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vandetanib.,increase,risk
Buclizine,Vardenafil,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vardenafil.,increase,risk
Buclizine,Vecuronium,The risk or severity of adverse effects can be increased when Buclizine is combined with Vecuronium.,increase,risk
Buclizine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Buclizine.,increase,risk
Buclizine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Buclizine.,increase,risk
Buclizine,Vernakalant,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vernakalant.,increase,risk
Buclizine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Buclizine.,increase,risk
Buclizine,Voriconazole,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Voriconazole.,increase,risk
Buclizine,Vorinostat,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Vorinostat.,increase,risk
Buclizine,Xamoterol,The risk or severity of Tachycardia can be increased when Buclizine is combined with Xamoterol.,increase,risk
Buclizine,Xylometazoline,The risk or severity of Tachycardia can be increased when Buclizine is combined with Xylometazoline.,increase,risk
Buclizine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Ziprasidone.,increase,risk
Buclizine,Zonisamide,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Zonisamide.,increase,risk
Buclizine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Zuclopenthixol.,increase,risk
Aztreonam,Gabapentin enacarbil,Aztreonam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadobenic acid,Aztreonam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadodiamide,Gadodiamide may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadofosveset trisodium,Aztreonam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadopentetic acid,Aztreonam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadoteric acid,Aztreonam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Aztreonam,Gadoteridol,Aztreonam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Aztreonam,Ganciclovir,Aztreonam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Aztreonam,Gemcitabine,Aztreonam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Aztreonam,Gemfibrozil,Aztreonam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Aztreonam,Gentamicin,Aztreonam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Aztreonam,Gimeracil,Aztreonam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Aztreonam,Givosiran,Givosiran may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Glipizide,Aztreonam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Aztreonam,Glycerol phenylbutyrate,Aztreonam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Aztreonam,Golodirsen,Aztreonam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Aztreonam,Goserelin,Goserelin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Guanethidine,Aztreonam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Aztreonam,Guanfacine,Aztreonam may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Aztreonam,Haloperidol,Aztreonam may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Aztreonam,Hydralazine,Aztreonam may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Aztreonam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aztreonam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aztreonam,Hydromorphone,Hydromorphone may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Hydroxyethyl Starch,Aztreonam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Aztreonam,Kanamycin,Aztreonam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Aztreonam,Ketamine,Aztreonam may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Aztreonam,Ketazolam,Aztreonam may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Aztreonam,Ketoprofen,Ketoprofen may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Ketorolac,Ketorolac may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Octinoxate,Aztreonam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Aztreonam,Olsalazine,Olsalazine may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Opium,Aztreonam may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Aztreonam,Oseltamivir,Oseltamivir may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxacillin,Aztreonam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxaprozin,Oxaprozin may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxazepam,Aztreonam may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aztreonam is combined with Oxetacaine.,increase,risk
Aztreonam,Oxybenzone,Aztreonam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aztreonam is combined with Oxybuprocaine.,increase,risk
Aztreonam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Oxyquinoline,Aztreonam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Aztreonam,Quetiapine,Aztreonam may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Aztreonam,Quinethazone,Quinethazone may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Aztreonam,Quinidine,Aztreonam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Aztreonam,Vaborbactam,Aztreonam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Aztreonam,Valaciclovir,Valaciclovir may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Valbenazine,Aztreonam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Aztreonam,Valdecoxib,Valdecoxib may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Valganciclovir,Aztreonam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Aztreonam,Vancomycin,Aztreonam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Aztreonam,Varenicline,Aztreonam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Aztreonam,Venlafaxine,Venlafaxine may decrease the excretion rate of Aztreonam which could result in a higher serum level.,decrease,no risk
Aztreonam,Verapamil,Aztreonam may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Aztreonam,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Aztreonam.,decrease,no risk
Aztreonam,Vilanterol,Aztreonam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Aztreonam,Viloxazine,Aztreonam may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Aztreonam,Vortioxetine,Aztreonam may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Aztreonam,Warfarin,Aztreonam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Aztreonam,Zaleplon,Aztreonam may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Aztreonam,Zanamivir,Aztreonam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Aztreonam,Zonisamide,Zonisamide may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Benznidazole,Chlorzoxazone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Benzocaine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Benzocaine.,increase,risk
Chlorzoxazone,Benzphetamine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Benzphetamine.,increase,risk
Chlorzoxazone,Benzthiazide,Benzthiazide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Benzydamine,Benzydamine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Benzyl alcohol,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Benzyl alcohol.,increase,risk
Chlorzoxazone,Bepotastine,Chlorzoxazone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bepridil,The metabolism of Chlorzoxazone can be decreased when combined with Bepridil.,decrease,no risk
Chlorzoxazone,Berotralstat,The metabolism of Chlorzoxazone can be decreased when combined with Berotralstat.,decrease,no risk
Chlorzoxazone,Betaxolol,The metabolism of Chlorzoxazone can be decreased when combined with Betaxolol.,decrease,no risk
Chlorzoxazone,Bicisate,Chlorzoxazone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bifonazole,The metabolism of Chlorzoxazone can be decreased when combined with Bifonazole.,decrease,no risk
Chlorzoxazone,Bimekizumab,The metabolism of Chlorzoxazone can be increased when combined with Bimekizumab.,increase,no risk
Chlorzoxazone,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Biperiden,The metabolism of Chlorzoxazone can be decreased when combined with Biperiden.,decrease,no risk
Chlorzoxazone,Bismuth subgallate,Chlorzoxazone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bisoprolol,Chlorzoxazone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bisoxatin,Chlorzoxazone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bleomycin,Bleomycin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Boceprevir,The metabolism of Chlorzoxazone can be decreased when combined with Boceprevir.,decrease,no risk
Chlorzoxazone,Bortezomib,The metabolism of Chlorzoxazone can be decreased when combined with Bortezomib.,decrease,no risk
Chlorzoxazone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Brexanolone,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Brexanolone.,increase,risk
Chlorzoxazone,Brexpiprazole,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Brexpiprazole.,increase,risk
Chlorzoxazone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.,increase,no risk
Chlorzoxazone,Brivaracetam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Brivaracetam.,increase,risk
Chlorzoxazone,Bromazepam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Bromazepam.,increase,risk
Chlorzoxazone,Bromocriptine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Bromocriptine.,increase,risk
Chlorzoxazone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Bromperidol,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Bromperidol.,increase,risk
Chlorzoxazone,Brompheniramine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Brompheniramine.,increase,risk
Chlorzoxazone,Budesonide,Chlorzoxazone may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bumadizone,Bumadizone may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Bumetanide,Bumetanide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Buprenorphine,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Chlorzoxazone,Bupropion,The metabolism of Chlorzoxazone can be decreased when combined with Bupropion.,decrease,no risk
Chlorzoxazone,Buspirone,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Buspirone.,increase,risk
Chlorzoxazone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Butaperazine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Butaperazine.,increase,risk
Chlorzoxazone,Butobarbital,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Butobarbital.,increase,risk
Chlorzoxazone,Butorphanol,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Butorphanol.,increase,risk
Chlorzoxazone,Butriptyline,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Butriptyline.,increase,risk
Chlorzoxazone,Gabapentin,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Gabapentin.,increase,risk
Chlorzoxazone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Gabapentin enacarbil.,increase,risk
Chlorzoxazone,Gadobenic acid,Chlorzoxazone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gadodiamide,Gadodiamide may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gadofosveset trisodium,Chlorzoxazone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gadopentetic acid,Chlorzoxazone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gadoteric acid,Chlorzoxazone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gadoteridol,Chlorzoxazone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Galantamine,The metabolism of Galantamine can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Gallamine triethiodide.,increase,risk
Chlorzoxazone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlorzoxazone is combined with Ganaxolone.",increase,risk
Chlorzoxazone,Ganciclovir,Chlorzoxazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gatifloxacin,The metabolism of Chlorzoxazone can be decreased when combined with Gatifloxacin.,decrease,no risk
Chlorzoxazone,Gefitinib,The metabolism of Chlorzoxazone can be decreased when combined with Gefitinib.,decrease,no risk
Chlorzoxazone,Gemcitabine,Chlorzoxazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gemfibrozil,The metabolism of Chlorzoxazone can be decreased when combined with Gemfibrozil.,decrease,no risk
Chlorzoxazone,Gemifloxacin,The metabolism of Chlorzoxazone can be decreased when combined with Gemifloxacin.,decrease,no risk
Chlorzoxazone,Gentamicin,Chlorzoxazone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Gepirone,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Gepirone.,increase,risk
Chlorzoxazone,Gimeracil,Chlorzoxazone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Givosiran,The serum concentration of Chlorzoxazone can be increased when it is combined with Givosiran.,increase,no risk
Chlorzoxazone,Glipizide,Chlorzoxazone may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Glofitamab,The serum concentration of Chlorzoxazone can be increased when it is combined with Glofitamab.,increase,no risk
Chlorzoxazone,Glutethimide,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Glutethimide.,increase,risk
Chlorzoxazone,Glycerin,The metabolism of Chlorzoxazone can be increased when combined with Glycerin.,increase,no risk
Chlorzoxazone,Glycerol phenylbutyrate,The metabolism of Chlorzoxazone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Chlorzoxazone,Golimumab,The metabolism of Chlorzoxazone can be increased when combined with Golimumab.,increase,no risk
Chlorzoxazone,Golodirsen,Chlorzoxazone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Goserelin,Goserelin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Granisetron,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Granisetron.,increase,risk
Chlorzoxazone,Grepafloxacin,The metabolism of Chlorzoxazone can be decreased when combined with Grepafloxacin.,decrease,no risk
Chlorzoxazone,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Guanethidine,Chlorzoxazone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Guanfacine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Guanfacine.,increase,risk
Chlorzoxazone,Halazepam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Halazepam.,increase,risk
Chlorzoxazone,Halofantrine,The metabolism of Chlorzoxazone can be decreased when combined with Halofantrine.,decrease,no risk
Chlorzoxazone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Halothane,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Halothane.,increase,risk
Chlorzoxazone,Hexafluronium,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Hexafluronium.,increase,risk
Chlorzoxazone,Hydralazine,Chlorzoxazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Hydrocodone,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlorzoxazone,Hydrocortisone,The metabolism of Chlorzoxazone can be increased when combined with Hydrocortisone.,increase,no risk
Chlorzoxazone,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Hydroxychloroquine,The metabolism of Chlorzoxazone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Chlorzoxazone,Hydroxyethyl Starch,Chlorzoxazone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlorzoxazone.,increase,no risk
Chlorzoxazone,Kanamycin,Chlorzoxazone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Ketamine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Ketamine.,increase,risk
Chlorzoxazone,Ketazolam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Ketazolam.,increase,risk
Chlorzoxazone,Ketoconazole,The metabolism of Chlorzoxazone can be decreased when combined with Ketoconazole.,decrease,no risk
Chlorzoxazone,Ketorolac,Ketorolac may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Obeticholic acid,The metabolism of Chlorzoxazone can be decreased when combined with Obeticholic acid.,decrease,no risk
Chlorzoxazone,Octinoxate,Chlorzoxazone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlorzoxazone is combined with Oliceridine.",increase,risk
Chlorzoxazone,Olsalazine,Olsalazine may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Omaveloxolone,The serum concentration of Chlorzoxazone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Chlorzoxazone,Ondansetron,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Ondansetron.,increase,risk
Chlorzoxazone,Opium,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Opium.,increase,risk
Chlorzoxazone,Oritavancin,The metabolism of Chlorzoxazone can be decreased when combined with Oritavancin.,decrease,no risk
Chlorzoxazone,Orphenadrine,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Chlorzoxazone,Oseltamivir,Oseltamivir may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Osilodrostat,The metabolism of Chlorzoxazone can be decreased when combined with Osilodrostat.,decrease,no risk
Chlorzoxazone,Osimertinib,The serum concentration of Chlorzoxazone can be decreased when it is combined with Osimertinib.,decrease,no risk
Chlorzoxazone,Ospemifene,The metabolism of Chlorzoxazone can be decreased when combined with Ospemifene.,decrease,no risk
Chlorzoxazone,Oxacillin,Chlorzoxazone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Oxamniquine,The metabolism of Chlorzoxazone can be decreased when combined with Oxamniquine.,decrease,no risk
Chlorzoxazone,Oxaprozin,Oxaprozin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Oxazepam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxazepam.,increase,risk
Chlorzoxazone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxcarbazepine.,increase,risk
Chlorzoxazone,Oxitriptan,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxitriptan.,increase,risk
Chlorzoxazone,Oxprenolol,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxprenolol.,increase,risk
Chlorzoxazone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Oxybenzone,Chlorzoxazone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxybuprocaine.,increase,risk
Chlorzoxazone,Oxybutynin,The metabolism of Chlorzoxazone can be decreased when combined with Oxybutynin.,decrease,no risk
Chlorzoxazone,Oxycodone,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxycodone.,increase,risk
Chlorzoxazone,Oxymorphone,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Oxymorphone.,increase,risk
Chlorzoxazone,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Oxyquinoline,Chlorzoxazone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Quazepam,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Quazepam.,increase,risk
Chlorzoxazone,Quetiapine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Quetiapine.,increase,risk
Chlorzoxazone,Quinethazone,Quinethazone may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorzoxazone,Quinidine,The metabolism of Chlorzoxazone can be decreased when combined with Quinidine.,decrease,no risk
Chlorzoxazone,Quinine,The metabolism of Chlorzoxazone can be decreased when combined with Quinine.,decrease,no risk
Chlorzoxazone,Quinupramine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Quinupramine.,increase,risk
Chlorzoxazone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Urethane,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Urethane.,increase,risk
Chlorzoxazone,Vaborbactam,Chlorzoxazone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Vadadustat,The serum concentration of Chlorzoxazone can be increased when it is combined with Vadadustat.,increase,no risk
Chlorzoxazone,Valaciclovir,Valaciclovir may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Valbenazine,Chlorzoxazone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Valdecoxib,Valdecoxib may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Valganciclovir,Chlorzoxazone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Vancomycin,Chlorzoxazone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Varenicline,Chlorzoxazone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Vayarin,The metabolism of Chlorzoxazone can be decreased when combined with Vayarin.,decrease,no risk
Chlorzoxazone,Vecuronium,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Vecuronium.,increase,risk
Chlorzoxazone,Vemurafenib,The serum concentration of Chlorzoxazone can be increased when it is combined with Vemurafenib.,increase,no risk
Chlorzoxazone,Venetoclax,The metabolism of Chlorzoxazone can be decreased when combined with Venetoclax.,decrease,no risk
Chlorzoxazone,Venlafaxine,The metabolism of Chlorzoxazone can be decreased when combined with Venlafaxine.,decrease,no risk
Chlorzoxazone,Verapamil,The metabolism of Chlorzoxazone can be decreased when combined with Verapamil.,decrease,no risk
Chlorzoxazone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Vigabatrin,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Vigabatrin.,increase,risk
Chlorzoxazone,Vilanterol,Chlorzoxazone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Vilazodone,The metabolism of Chlorzoxazone can be decreased when combined with Vilazodone.,decrease,no risk
Chlorzoxazone,Viloxazine,The metabolism of Chlorzoxazone can be decreased when combined with Viloxazine.,decrease,no risk
Chlorzoxazone,Vinblastine,The metabolism of Chlorzoxazone can be decreased when combined with Vinblastine.,decrease,no risk
Chlorzoxazone,Vinorelbine,The metabolism of Chlorzoxazone can be decreased when combined with Vinorelbine.,decrease,no risk
Chlorzoxazone,Voriconazole,The metabolism of Chlorzoxazone can be decreased when combined with Voriconazole.,decrease,no risk
Chlorzoxazone,Vortioxetine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Vortioxetine.,increase,risk
Chlorzoxazone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Warfarin,Chlorzoxazone may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Yohimbine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Yohimbine.,increase,risk
Chlorzoxazone,Zaleplon,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Zaleplon.,increase,risk
Chlorzoxazone,Zanamivir,Chlorzoxazone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Chlorzoxazone,Ziconotide,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Ziconotide.,increase,risk
Chlorzoxazone,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Chlorzoxazone.,decrease,no risk
Chlorzoxazone,Zileuton,The metabolism of Chlorzoxazone can be decreased when combined with Zileuton.,decrease,no risk
Chlorzoxazone,Zimelidine,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zimelidine.,increase,risk
Chlorzoxazone,Ziprasidone,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ziprasidone.,increase,risk
Chlorzoxazone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Chlorzoxazone.,increase,risk
Chlorzoxazone,Zolpidem,Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Chlorzoxazone,Zonisamide,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Zonisamide.,increase,risk
Chlorzoxazone,Zopiclone,The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Zopiclone.,increase,risk
Chlorzoxazone,Zotepine,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Zotepine.,increase,risk
Chlorzoxazone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Zuclopenthixol.,increase,risk
Chlorzoxazone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlorzoxazone.,increase,risk
Aminoglutethimide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Halcinonide,The therapeutic efficacy of Halcinonide can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone,The therapeutic efficacy of Hydrocortisone can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone acetate,The therapeutic efficacy of Hydrocortisone acetate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone butyrate,The therapeutic efficacy of Hydrocortisone butyrate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone cypionate,The therapeutic efficacy of Hydrocortisone cypionate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone probutate,The therapeutic efficacy of Hydrocortisone probutate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone succinate,The therapeutic efficacy of Hydrocortisone succinate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydrocortisone valerate,The therapeutic efficacy of Hydrocortisone valerate can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Olaparib,The metabolism of Olaparib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aminoglutethimide is combined with Oxetacaine.,increase,risk
Aminoglutethimide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aminoglutethimide is combined with Oxybuprocaine.,increase,risk
Aminoglutethimide,Quinidine,The metabolism of Quinidine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Ulobetasol,The therapeutic efficacy of Ulobetasol can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Vamorolone,The therapeutic efficacy of Vamorolone can be decreased when used in combination with Aminoglutethimide.,decrease,no risk
Aminoglutethimide,Vandetanib,The metabolism of Vandetanib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Venetoclax,The metabolism of Venetoclax can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vinblastine,The metabolism of Vinblastine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vincristine,The metabolism of Vincristine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vindesine,The metabolism of Vindesine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vinflunine,The metabolism of Vinflunine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Warfarin,The metabolism of Warfarin can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Zolpidem,The metabolism of Zolpidem can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Aminoglutethimide.,increase,no risk
Aminoglutethimide,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Aminoglutethimide.,decrease,no risk
Mefloquine,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Brompheniramine,The therapeutic efficacy of Brompheniramine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Buclizine,The therapeutic efficacy of Buclizine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Budesonide,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Budesonide.,decrease,no risk
Mefloquine,Bumetanide,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Bumetanide.",increase,risk
Mefloquine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Bupivacaine.,increase,risk
Mefloquine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Mefloquine.,increase,risk
Mefloquine,Buserelin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Buserelin.,increase,risk
Mefloquine,Butabarbital,The therapeutic efficacy of Butabarbital can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Butacaine,The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Butacaine.,increase,risk
Mefloquine,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Butamben,The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Butamben.,increase,risk
Mefloquine,Butaperazine,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Butaperazine.,increase,risk
Mefloquine,Butobarbital,The therapeutic efficacy of Butobarbital can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Butriptyline,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Butriptyline.,increase,risk
Mefloquine,Butylscopolamine,The therapeutic efficacy of Butylscopolamine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Gadobenic acid.,increase,risk
Mefloquine,Galantamine,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Galantamine.,increase,risk
Mefloquine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Ganciclovir.",increase,risk
Mefloquine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Gatifloxacin.,increase,risk
Mefloquine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Gemfibrozil.",increase,risk
Mefloquine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Gemifloxacin.,increase,risk
Mefloquine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Glasdegib,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Glasdegib.,increase,risk
Mefloquine,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Glofitamab,The serum concentration of Mefloquine can be increased when it is combined with Glofitamab.,increase,no risk
Mefloquine,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Goserelin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Goserelin.,increase,risk
Mefloquine,Granisetron,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Granisetron.,increase,risk
Mefloquine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Grepafloxacin.,increase,risk
Mefloquine,Halofantrine,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Halofantrine.,increase,risk
Mefloquine,Haloperidol,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Haloperidol.,increase,risk
Mefloquine,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Histrelin,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Histrelin.,increase,risk
Mefloquine,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Hydrochlorothiazide.,increase,risk
Mefloquine,Hydrocortisone,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Mefloquine,Hydrocortisone acetate,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Mefloquine,Hydrocortisone butyrate,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Mefloquine,Hydrocortisone cypionate,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Mefloquine,Hydrocortisone succinate,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Mefloquine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Mefloquine.,increase,risk
Mefloquine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Hydroxyzine.,increase,risk
Mefloquine,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Ketoconazole,Ketoconazole may decrease the excretion rate of Mefloquine which could result in a higher serum level.,decrease,no risk
Mefloquine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Mefloquine.,increase,risk
Mefloquine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Ofloxacin.",increase,risk
Mefloquine,Olanzapine,The therapeutic efficacy of Olanzapine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Olodaterol,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Olodaterol.,increase,risk
Mefloquine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Omaveloxolone,The serum concentration of Mefloquine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Mefloquine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Ondansetron,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Ondansetron.,increase,risk
Mefloquine,Orphenadrine,The therapeutic efficacy of Orphenadrine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Mefloquine.,increase,risk
Mefloquine,Oxatomide,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Oxatomide.,increase,risk
Mefloquine,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Oxetacaine.,increase,risk
Mefloquine,Oxprenolol,The risk or severity of QTc prolongation can be decreased when Mefloquine is combined with Oxprenolol.,decrease,risk
Mefloquine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mefloquine is combined with Oxybuprocaine.,increase,risk
Mefloquine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Mefloquine.,increase,risk
Mefloquine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Mefloquine.,increase,risk
Mefloquine,Quinine,The risk or severity of adverse effects can be increased when Quinine is combined with Mefloquine.,increase,risk
Mefloquine,Quizartinib,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Quizartinib.,increase,risk
Mefloquine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Ubidecarenone.",increase,risk
Mefloquine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Umbralisib,The serum concentration of Mefloquine can be increased when it is combined with Umbralisib.,increase,no risk
Mefloquine,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Vadadustat,The serum concentration of Mefloquine can be increased when it is combined with Vadadustat.,increase,no risk
Mefloquine,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Vamorolone,The therapeutic efficacy of Mefloquine can be decreased when used in combination with Vamorolone.,decrease,no risk
Mefloquine,Vandetanib,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Vandetanib.,increase,risk
Mefloquine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Mefloquine.,decrease,no risk
Mefloquine,Varenicline,The risk or severity of adverse effects can be increased when Mefloquine is combined with Varenicline.,increase,risk
Mefloquine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Mefloquine.,increase,risk
Mefloquine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Verapamil,The metabolism of Mefloquine can be decreased when combined with Verapamil.,decrease,no risk
Mefloquine,Vernakalant,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Vernakalant.,increase,risk
Mefloquine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Mefloquine.,increase,risk
Mefloquine,Viloxazine,The metabolism of Mefloquine can be decreased when combined with Viloxazine.,decrease,no risk
Mefloquine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Vincristine,The excretion of Vincristine can be decreased when combined with Mefloquine.,decrease,no risk
Mefloquine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Vorapaxar,The serum concentration of Mefloquine can be increased when it is combined with Vorapaxar.,increase,no risk
Mefloquine,Voriconazole,The metabolism of Mefloquine can be decreased when combined with Voriconazole.,decrease,no risk
Mefloquine,Vorinostat,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Vorinostat.,increase,risk
Mefloquine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Mefloquine.,increase,no risk
Mefloquine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Mefloquine is combined with Zidovudine.",increase,risk
Mefloquine,Zimelidine,The metabolism of Mefloquine can be decreased when combined with Zimelidine.,decrease,no risk
Mefloquine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Mefloquine is combined with Ziprasidone.,increase,risk
Mefloquine,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Mefloquine.,decrease,no risk
Mefloquine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Mefloquine.,decrease,no risk
Sulfadiazine,Benzydamine,Benzydamine may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Benzyl alcohol.,increase,risk
Sulfadiazine,Benzylpenicillin,Sulfadiazine may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bepotastine,Sulfadiazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Berotralstat,The metabolism of Sulfadiazine can be decreased when combined with Berotralstat.,decrease,no risk
Sulfadiazine,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Betaxolol,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Betaxolol.,increase,no risk
Sulfadiazine,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Sulfadiazine.,increase,no risk
Sulfadiazine,Bexarotene,The metabolism of Sulfadiazine can be decreased when combined with Bexarotene.,decrease,no risk
Sulfadiazine,Bezafibrate,The metabolism of Sulfadiazine can be decreased when combined with Bezafibrate.,decrease,no risk
Sulfadiazine,Bicisate,Sulfadiazine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bimekizumab,The metabolism of Sulfadiazine can be increased when combined with Bimekizumab.,increase,no risk
Sulfadiazine,Bismuth subgallate,Sulfadiazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Sulfadiazine.,increase,no risk
Sulfadiazine,Bisoprolol,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Bisoprolol.,increase,no risk
Sulfadiazine,Bisoxatin,Sulfadiazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bleomycin,Bleomycin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Boceprevir,The metabolism of Sulfadiazine can be decreased when combined with Boceprevir.,decrease,no risk
Sulfadiazine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Bosentan,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Bosentan.,increase,no risk
Sulfadiazine,Bosutinib,The metabolism of Sulfadiazine can be decreased when combined with Bosutinib.,decrease,no risk
Sulfadiazine,Brexpiprazole,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Sulfadiazine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Bromazepam,Sulfadiazine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Bromocriptine.,increase,risk
Sulfadiazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Sulfadiazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sulfadiazine,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Bumadizone,Bumadizone may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Bumetanide,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Bumetanide.,decrease,no risk
Sulfadiazine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Bupivacaine.,increase,risk
Sulfadiazine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Bupropion,The metabolism of Bupropion can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Buserelin,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Buserelin.,decrease,no risk
Sulfadiazine,Buspirone,Sulfadiazine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Butabarbital,Butabarbital may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Butacaine,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Butacaine.,increase,risk
Sulfadiazine,Butalbital,The risk or severity of methemoglobinemia can be increased when Butalbital is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Butamben,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Butamben.,increase,risk
Sulfadiazine,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Sulfadiazine.,decrease,no risk
Sulfadiazine,Gabapentin enacarbil,Sulfadiazine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadobenic acid,Sulfadiazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadofosveset trisodium,Sulfadiazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadopentetic acid,Sulfadiazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadoteric acid,Sulfadiazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gadoteridol,Sulfadiazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ganciclovir,Sulfadiazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gatifloxacin,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Gatifloxacin.,increase,no risk
Sulfadiazine,Gefapixant,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Gefapixant.,increase,no risk
Sulfadiazine,Gemcitabine,Sulfadiazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gemfibrozil,The metabolism of Sulfadiazine can be decreased when combined with Gemfibrozil.,decrease,no risk
Sulfadiazine,Gemifloxacin,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Gemifloxacin.,increase,no risk
Sulfadiazine,Gentamicin,Sulfadiazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Gimeracil,Sulfadiazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Givosiran,Givosiran may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Gliclazide,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Gliclazide.,increase,risk
Sulfadiazine,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Glipizide,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Glipizide.,increase,risk
Sulfadiazine,Gliquidone,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Gliquidone.,increase,risk
Sulfadiazine,Glofitamab,The serum concentration of Sulfadiazine can be increased when it is combined with Glofitamab.,increase,no risk
Sulfadiazine,Glyburide,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Glyburide.,increase,risk
Sulfadiazine,Glycerol phenylbutyrate,Sulfadiazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Glymidine,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Glymidine.,increase,risk
Sulfadiazine,Golimumab,The metabolism of Sulfadiazine can be increased when combined with Golimumab.,increase,no risk
Sulfadiazine,Golodirsen,Sulfadiazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Goserelin,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Goserelin.,decrease,no risk
Sulfadiazine,Grepafloxacin,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Grepafloxacin.,increase,no risk
Sulfadiazine,Guanethidine,Sulfadiazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Guanfacine,Sulfadiazine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sulfadiazine.,increase,no risk
Sulfadiazine,Halothane,The metabolism of Halothane can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Histrelin,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Histrelin.,decrease,no risk
Sulfadiazine,Hydralazine,Sulfadiazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Hydrochlorothiazide,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sulfadiazine,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Hydroflumethiazide,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sulfadiazine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Hydroxychloroquine,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Sulfadiazine,Hydroxyethyl Starch,Sulfadiazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Hydroxyprogesterone caproate,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Sulfadiazine,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Hydroxyurea.,increase,risk
Sulfadiazine,Kanamycin,Sulfadiazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ketamine,The metabolism of Ketamine can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Ketazolam,Sulfadiazine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ketoconazole,The metabolism of Sulfadiazine can be decreased when combined with Ketoconazole.,decrease,no risk
Sulfadiazine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Octinoxate,Sulfadiazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Octreotide,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Octreotide.,decrease,no risk
Sulfadiazine,Ofloxacin,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Ofloxacin.,increase,no risk
Sulfadiazine,Olanzapine,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Olanzapine.,decrease,no risk
Sulfadiazine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Olsalazine,Olsalazine may increase the hypoglycemic activities of Sulfadiazine.,increase,no risk
Sulfadiazine,Omaveloxolone,The serum concentration of Sulfadiazine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sulfadiazine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Opium,Sulfadiazine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oseltamivir,Oseltamivir may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Oxacillin,Sulfadiazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Sulfadiazine.,increase,no risk
Sulfadiazine,Oxaprozin,Oxaprozin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oxazepam,Sulfadiazine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Oxetacaine.,increase,risk
Sulfadiazine,Oxprenolol,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Oxprenolol.,increase,no risk
Sulfadiazine,Oxybenzone,Sulfadiazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Oxybuprocaine.,increase,risk
Sulfadiazine,Oxybutynin,The metabolism of Sulfadiazine can be decreased when combined with Oxybutynin.,decrease,no risk
Sulfadiazine,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Sulfadiazine.,increase,no risk
Sulfadiazine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Oxyquinoline,Sulfadiazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Quetiapine,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Quetiapine.,decrease,no risk
Sulfadiazine,Quinethazone,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Quinethazone.,decrease,no risk
Sulfadiazine,Quinidine,Sulfadiazine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Quinine,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Quinine.,increase,risk
Sulfadiazine,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Sulfadiazine.,decrease,no risk
Sulfadiazine,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Udenafil,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Udenafil.,increase,no risk
Sulfadiazine,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Vaborbactam,Sulfadiazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Vadadustat,The serum concentration of Sulfadiazine can be increased when it is combined with Vadadustat.,increase,no risk
Sulfadiazine,Valaciclovir,Valaciclovir may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Valbenazine,Sulfadiazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Valdecoxib,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Valdecoxib.,increase,no risk
Sulfadiazine,Valganciclovir,Sulfadiazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Valsartan,The metabolism of Valsartan can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Vancomycin,Sulfadiazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Varenicline,Sulfadiazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Vemurafenib,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Vemurafenib.,increase,no risk
Sulfadiazine,Venetoclax,The metabolism of Sulfadiazine can be decreased when combined with Venetoclax.,decrease,no risk
Sulfadiazine,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Verapamil,The metabolism of Sulfadiazine can be decreased when combined with Verapamil.,decrease,no risk
Sulfadiazine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Sulfadiazine.,decrease,no risk
Sulfadiazine,Vilanterol,Sulfadiazine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Sulfadiazine is combined with Vildagliptin.,increase,risk
Sulfadiazine,Viloxazine,The metabolism of Sulfadiazine can be decreased when combined with Viloxazine.,decrease,no risk
Sulfadiazine,Voriconazole,The metabolism of Sulfadiazine can be decreased when combined with Voriconazole.,decrease,no risk
Sulfadiazine,Vorinostat,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Vorinostat.,decrease,no risk
Sulfadiazine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Warfarin,The metabolism of Warfarin can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Zaleplon,Sulfadiazine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Zanamivir,Sulfadiazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Sulfadiazine,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Zileuton,The metabolism of Zileuton can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Sulfadiazine.,increase,risk
Sulfadiazine,Ziprasidone,The therapeutic efficacy of Sulfadiazine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Sulfadiazine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sulfadiazine.,decrease,no risk
Sulfadiazine,Zonisamide,The therapeutic efficacy of Sulfadiazine can be increased when used in combination with Zonisamide.,increase,no risk
Sapropterin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Quinine,The serum concentration of Quinine can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Udenafil,Sapropterin may increase the hypotensive activities of Udenafil.,increase,no risk
Sapropterin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Vardenafil,Sapropterin may increase the hypotensive activities of Vardenafil.,increase,no risk
Sapropterin,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Vincristine,The excretion of Vincristine can be decreased when combined with Sapropterin.,decrease,no risk
Sapropterin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Sapropterin.,increase,no risk
Sapropterin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Sapropterin.,increase,no risk
Vinorelbine,Betamethasone,The metabolism of Vinorelbine can be increased when combined with Betamethasone.,increase,no risk
Vinorelbine,Betamethasone phosphate,The metabolism of Vinorelbine can be increased when combined with Betamethasone phosphate.,increase,no risk
Vinorelbine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Vinorelbine.,decrease,no risk
Vinorelbine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Vinorelbine.,increase,risk
Vinorelbine,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Vinorelbine.,increase,risk
Vinorelbine,Bexarotene,The metabolism of Vinorelbine can be increased when combined with Bexarotene.,increase,no risk
Vinorelbine,Bicalutamide,The metabolism of Vinorelbine can be decreased when combined with Bicalutamide.,decrease,no risk
Vinorelbine,Bifonazole,The metabolism of Vinorelbine can be decreased when combined with Bifonazole.,decrease,no risk
Vinorelbine,Bimekizumab,The metabolism of Vinorelbine can be increased when combined with Bimekizumab.,increase,no risk
Vinorelbine,Bismuth subcitrate potassium,Vinorelbine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Vinorelbine,Bismuth subgallate,Vinorelbine may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Vinorelbine,Bismuth subnitrate,Vinorelbine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Vinorelbine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Vinorelbine.,increase,risk
Vinorelbine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vinorelbine.,increase,risk
Vinorelbine,Blinatumomab,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Blinatumomab.,increase,risk
Vinorelbine,Boceprevir,The metabolism of Vinorelbine can be decreased when combined with Boceprevir.,decrease,no risk
Vinorelbine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Vinorelbine.",decrease,no risk
Vinorelbine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Vinorelbine.,increase,risk
Vinorelbine,Bosentan,The metabolism of Vinorelbine can be increased when combined with Bosentan.,increase,no risk
Vinorelbine,Bosutinib,The metabolism of Vinorelbine can be decreased when combined with Bosutinib.,decrease,no risk
Vinorelbine,Brentuximab vedotin,The serum concentration of Vinorelbine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Vinorelbine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Vinorelbine.,decrease,no risk
Vinorelbine,Brodalumab,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Brodalumab.,increase,risk
Vinorelbine,Bromperidol,Vinorelbine may increase the neurotoxic activities of Bromperidol.,increase,no risk
Vinorelbine,Budesonide,The metabolism of Vinorelbine can be increased when combined with Budesonide.,increase,no risk
Vinorelbine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Bupivacaine.,increase,risk
Vinorelbine,Buprenorphine,The metabolism of Vinorelbine can be decreased when combined with Buprenorphine.,decrease,no risk
Vinorelbine,Buspirone,The metabolism of Buspirone can be decreased when combined with Vinorelbine.,decrease,no risk
Vinorelbine,Busulfan,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Busulfan.,increase,risk
Vinorelbine,Butacaine,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Butacaine.,increase,risk
Vinorelbine,Butalbital,The metabolism of Vinorelbine can be increased when combined with Butalbital.,increase,no risk
Vinorelbine,Butamben,The risk or severity of methemoglobinemia can be increased when Vinorelbine is combined with Butamben.,increase,risk
Vinorelbine,Butaperazine,Vinorelbine may increase the neurotoxic activities of Butaperazine.,increase,no risk
Vinorelbine,Butriptyline,Vinorelbine may increase the neurotoxic activities of Butriptyline.,increase,no risk
Anidulafungin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Anidulafungin.,increase,no risk
Clozapine,Bacitracin,Bacitracin may decrease the excretion rate of Clozapine which could result in a higher serum level.,decrease,no risk
Clozapine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Clozapine.,increase,no risk
Clozapine,Balsalazide,The risk or severity of hypertension can be increased when Clozapine is combined with Balsalazide.,increase,risk
Clozapine,Baricitinib,The metabolism of Baricitinib can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Beclomethasone dipropionate,The serum concentration of Clozapine can be decreased when it is combined with Beclomethasone dipropionate.,decrease,no risk
Clozapine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Bedaquiline is combined with Clozapine.,increase,risk
Clozapine,Belinostat,The risk or severity of neutropenia can be increased when Belinostat is combined with Clozapine.,increase,risk
Clozapine,Belladonna,The risk or severity of reduced gastrointestinal motility can be increased when Belladonna is combined with Clozapine.,increase,risk
Clozapine,Belumosudil,The metabolism of Belumosudil can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Benazepril,Clozapine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Clozapine,Bendamustine,The risk or severity of neutropenia can be increased when Bendamustine is combined with Clozapine.,increase,risk
Clozapine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clozapine,Benorilate,The risk or severity of hypertension can be increased when Clozapine is combined with Benorilate.,increase,risk
Clozapine,Benoxaprofen,The risk or severity of hypertension can be increased when Clozapine is combined with Benoxaprofen.,increase,risk
Clozapine,Benperidol,The risk or severity of CNS depression can be increased when Clozapine is combined with Benperidol.,increase,risk
Clozapine,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Benzatropine,The risk or severity of adverse effects can be increased when Clozapine is combined with Benzatropine.,increase,risk
Clozapine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Clozapine is combined with Benzhydrocodone.,increase,risk
Clozapine,Benznidazole,Clozapine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Clozapine,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Benzphetamine,Benzphetamine may decrease the sedative activities of Clozapine.,decrease,no risk
Clozapine,Benzthiazide,Benzthiazide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clozapine,Benzydamine,The risk or severity of hypertension can be increased when Clozapine is combined with Benzydamine.,increase,risk
Clozapine,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Benzylpenicilloyl polylysine,Clozapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Clozapine,Bepotastine,Clozapine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Clozapine,Bepridil,The serum concentration of Clozapine can be increased when it is combined with Bepridil.,increase,no risk
Clozapine,Berotralstat,The metabolism of Clozapine can be decreased when combined with Berotralstat.,decrease,no risk
Clozapine,Besifloxacin,The risk or severity of QTc prolongation can be increased when Besifloxacin is combined with Clozapine.,increase,risk
Clozapine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Betaine,The therapeutic efficacy of Clozapine can be decreased when used in combination with Betaine.,decrease,no risk
Clozapine,Betamethasone,The serum concentration of Clozapine can be decreased when it is combined with Betamethasone.,decrease,no risk
Clozapine,Betamethasone phosphate,The metabolism of Betamethasone phosphate can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Betaxolol,The risk or severity of QTc prolongation can be increased when Betaxolol is combined with Clozapine.,increase,risk
Clozapine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Bexarotene,The risk or severity of neutropenia can be increased when Bexarotene is combined with Clozapine.,increase,risk
Clozapine,Bezafibrate,The metabolism of Bezafibrate can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Bicalutamide,The serum concentration of Clozapine can be increased when it is combined with Bicalutamide.,increase,no risk
Clozapine,Bicisate,Clozapine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Clozapine,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Bifonazole,The serum concentration of Clozapine can be increased when it is combined with Bifonazole.,increase,no risk
Clozapine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Clozapine.,increase,risk
Clozapine,Bimekizumab,The metabolism of Clozapine can be increased when combined with Bimekizumab.,increase,no risk
Clozapine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Biperiden,The serum concentration of Clozapine can be increased when it is combined with Biperiden.,increase,no risk
Clozapine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Bismuth subcitrate potassium,Clozapine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Clozapine,Bismuth subgallate,Clozapine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Clozapine,Bismuth subnitrate,Clozapine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Clozapine,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Clozapine.,increase,no risk
Clozapine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Bleomycin,Bleomycin may decrease the excretion rate of Clozapine which could result in a higher serum level.,decrease,no risk
Clozapine,Blinatumomab,The risk or severity of neutropenia can be increased when Blinatumomab is combined with Clozapine.,increase,risk
Clozapine,Boceprevir,The serum concentration of Clozapine can be increased when it is combined with Boceprevir.,increase,no risk
Clozapine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Clozapine.,increase,risk
Clozapine,Bosentan,The serum concentration of Clozapine can be decreased when it is combined with Bosentan.,decrease,no risk
Clozapine,Bosutinib,The serum concentration of Clozapine can be increased when it is combined with Bosutinib.,increase,no risk
Clozapine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Clozapine is combined with Botulinum toxin type A.,increase,risk
Clozapine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Clozapine is combined with Botulinum toxin type B.,increase,risk
Clozapine,Brentuximab vedotin,The serum concentration of Clozapine can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Clozapine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Clozapine.,increase,risk
Clozapine,Brexanolone,The risk or severity of CNS depression can be increased when Clozapine is combined with Brexanolone.,increase,risk
Clozapine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Brigatinib,The serum concentration of Clozapine can be decreased when it is combined with Brigatinib.,decrease,no risk
Clozapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Clozapine.,increase,no risk
Clozapine,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Clozapine.,increase,risk
Clozapine,Bromocriptine,The serum concentration of Clozapine can be increased when it is combined with Bromocriptine.,increase,no risk
Clozapine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clozapine,Bromperidol,The risk or severity of CNS depression can be increased when Clozapine is combined with Bromperidol.,increase,risk
Clozapine,Brompheniramine,The risk or severity of reduced gastrointestinal motility can be increased when Brompheniramine is combined with Clozapine.,increase,risk
Clozapine,Buclizine,The risk or severity of reduced gastrointestinal motility can be increased when Buclizine is combined with Clozapine.,increase,risk
Clozapine,Budesonide,The serum concentration of Clozapine can be decreased when it is combined with Budesonide.,decrease,no risk
Clozapine,Bumadizone,The risk or severity of hypertension can be increased when Clozapine is combined with Bumadizone.,increase,risk
Clozapine,Bumetanide,Bumetanide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clozapine,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Buprenorphine,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Clozapine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Clozapine.,increase,risk
Clozapine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Clozapine.,increase,risk
Clozapine,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Busulfan,The risk or severity of neutropenia can be increased when Busulfan is combined with Clozapine.,increase,risk
Clozapine,Butabarbital,The risk or severity of reduced gastrointestinal motility can be increased when Butabarbital is combined with Clozapine.,increase,risk
Clozapine,Butalbital,The risk or severity of reduced gastrointestinal motility can be increased when Butalbital is combined with Clozapine.,increase,risk
Clozapine,Butaperazine,The risk or severity of CNS depression can be increased when Clozapine is combined with Butaperazine.,increase,risk
Clozapine,Butobarbital,The risk or severity of reduced gastrointestinal motility can be increased when Butobarbital is combined with Clozapine.,increase,risk
Clozapine,Butorphanol,The risk or severity of adverse effects can be increased when Clozapine is combined with Butorphanol.,increase,risk
Clozapine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Clozapine.,increase,risk
Clozapine,Butylscopolamine,The risk or severity of reduced gastrointestinal motility can be increased when Butylscopolamine is combined with Clozapine.,increase,risk
Clozapine,Gabapentin,The risk or severity of CNS depression can be increased when Clozapine is combined with Gabapentin.,increase,risk
Clozapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Clozapine is combined with Gabapentin enacarbil.,increase,risk
Clozapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Clozapine.,increase,risk
Clozapine,Gadodiamide,Gadodiamide may decrease the excretion rate of Clozapine which could result in a higher serum level.,decrease,no risk
Clozapine,Gadofosveset trisodium,Clozapine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Clozapine,Gadopentetic acid,Clozapine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Clozapine,Gadoteric acid,Clozapine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Clozapine,Gadoteridol,Clozapine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Clozapine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Clozapine.,increase,risk
Clozapine,Gallamine triethiodide,The risk or severity of reduced gastrointestinal motility can be increased when Gallamine triethiodide is combined with Clozapine.,increase,risk
Clozapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clozapine is combined with Ganaxolone.",increase,risk
Clozapine,Ganciclovir,Clozapine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Clozapine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Clozapine.,increase,risk
Clozapine,Gefitinib,The serum concentration of Clozapine can be increased when it is combined with Gefitinib.,increase,no risk
Clozapine,Gemcitabine,The risk or severity of neutropenia can be increased when Gemcitabine is combined with Clozapine.,increase,risk
Clozapine,Gemfibrozil,The metabolism of Clozapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Clozapine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Clozapine.,increase,risk
Clozapine,Gemtuzumab ozogamicin,The risk or severity of neutropenia can be increased when Gemtuzumab ozogamicin is combined with Clozapine.,increase,risk
Clozapine,Gentamicin,Clozapine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Clozapine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Clozapine.,increase,no risk
Clozapine,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Gilteritinib,The therapeutic efficacy of Clozapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Clozapine,Gimeracil,Clozapine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Clozapine,Ginkgo biloba,The metabolism of Clozapine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Clozapine,Givosiran,The serum concentration of Clozapine can be increased when it is combined with Givosiran.,increase,no risk
Clozapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Clozapine.,increase,risk
Clozapine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Glofitamab,The serum concentration of Clozapine can be increased when it is combined with Glofitamab.,increase,no risk
Clozapine,Glucagon,Clozapine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Clozapine,Glutethimide,The risk or severity of CNS depression can be increased when Clozapine is combined with Glutethimide.,increase,risk
Clozapine,Glyburide,The serum concentration of Clozapine can be increased when it is combined with Glyburide.,increase,no risk
Clozapine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Glycerol phenylbutyrate,The serum concentration of Clozapine can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Clozapine,Glycopyrronium,The risk or severity of adverse effects can be increased when Clozapine is combined with Glycopyrronium.,increase,risk
Clozapine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Golimumab,The metabolism of Clozapine can be increased when combined with Golimumab.,increase,no risk
Clozapine,Golodirsen,Clozapine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Clozapine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Clozapine.,increase,risk
Clozapine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Clozapine.,increase,risk
Clozapine,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Clozapine.,increase,risk
Clozapine,Griseofulvin,The serum concentration of Clozapine can be decreased when it is combined with Griseofulvin.,decrease,no risk
Clozapine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Guanadrel,Clozapine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Clozapine,Guanethidine,Clozapine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Clozapine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Clozapine.,decrease,no risk
Clozapine,Guanoxan,Clozapine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Clozapine,Halazepam,The risk or severity of adverse effects can be increased when Halazepam is combined with Clozapine.,increase,risk
Clozapine,Halofantrine,The serum concentration of Clozapine can be increased when it is combined with Halofantrine.,increase,no risk
Clozapine,Haloperidol,The risk or severity of QTc prolongation can be increased when Clozapine is combined with Haloperidol.,increase,risk
Clozapine,Halothane,The risk or severity of CNS depression can be increased when Clozapine is combined with Halothane.,increase,risk
Clozapine,Hexafluronium,The risk or severity of reduced gastrointestinal motility can be increased when Hexafluronium is combined with Clozapine.,increase,risk
Clozapine,Hexocyclium,The risk or severity of reduced gastrointestinal motility can be increased when Hexocyclium is combined with Clozapine.,increase,risk
Clozapine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Clozapine.,increase,risk
Clozapine,Homatropine,The risk or severity of reduced gastrointestinal motility can be increased when Homatropine is combined with Clozapine.,increase,risk
Clozapine,Homatropine methylbromide,The risk or severity of reduced gastrointestinal motility can be increased when Homatropine methylbromide is combined with Clozapine.,increase,risk
Clozapine,Huperzine A,The therapeutic efficacy of Clozapine can be decreased when used in combination with Huperzine A.,decrease,no risk
Clozapine,Hydralazine,The serum concentration of Clozapine can be increased when it is combined with Hydralazine.,increase,no risk
Clozapine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Clozapine.,increase,risk
Clozapine,Hydrocodone,Clozapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Clozapine,Hydrocortamate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortamate.,decrease,no risk
Clozapine,Hydrocortisone,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Clozapine,Hydrocortisone acetate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Clozapine,Hydrocortisone butyrate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Clozapine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Hydrocortisone probutate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Clozapine,Hydrocortisone succinate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Clozapine,Hydrocortisone valerate,The serum concentration of Clozapine can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Clozapine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clozapine,Hydromorphone,The risk or severity of adverse effects can be increased when Clozapine is combined with Hydromorphone.,increase,risk
Clozapine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Clozapine which could result in a higher serum level.,decrease,no risk
Clozapine,Hydroxychloroquine,The serum concentration of Clozapine can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Clozapine,Hydroxyethyl Starch,Clozapine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Clozapine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clozapine.,decrease,no risk
Clozapine,Hydroxyurea,The serum concentration of Clozapine can be increased when it is combined with Hydroxyurea.,increase,no risk
Clozapine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Clozapine is combined with Hydroxyzine.,increase,risk
Clozapine,Hyoscyamine,The risk or severity of reduced gastrointestinal motility can be increased when Hyoscyamine is combined with Clozapine.,increase,risk
Clozapine,Kanamycin,Clozapine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Clozapine,Ketamine,The serum concentration of Clozapine can be decreased when it is combined with Ketamine.,decrease,no risk
Clozapine,Ketazolam,The risk or severity of adverse effects can be increased when Ketazolam is combined with Clozapine.,increase,risk
Clozapine,Ketoconazole,The serum concentration of Clozapine can be increased when it is combined with Ketoconazole.,increase,no risk
Clozapine,Ketoprofen,The risk or severity of hypertension can be increased when Clozapine is combined with Ketoprofen.,increase,risk
Clozapine,Ketorolac,The risk or severity of hypertension can be increased when Clozapine is combined with Ketorolac.,increase,risk
Sucralfate,Gabapentin enacarbil,Sucralfate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadobenic acid,Sucralfate may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadodiamide,Gadodiamide may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadofosveset trisodium,Sucralfate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadopentetic acid,Sucralfate may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadoteric acid,Sucralfate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sucralfate,Gadoteridol,Sucralfate may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Sucralfate,Ganciclovir,Sucralfate may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Sucralfate,Gatifloxacin,Sucralfate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Gemcitabine,Sucralfate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Sucralfate,Gemfibrozil,Sucralfate may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Sucralfate,Gemifloxacin,Sucralfate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Gentamicin,Sucralfate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sucralfate,Gimeracil,Sucralfate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sucralfate,Givosiran,Givosiran may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Glipizide,Sucralfate may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Sucralfate,Glycerol phenylbutyrate,Sucralfate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Sucralfate,Golodirsen,Sucralfate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sucralfate,Goserelin,Goserelin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Grepafloxacin,Sucralfate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Guanethidine,Sucralfate may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Sucralfate,Guanfacine,Sucralfate may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Sucralfate,Halofantrine,Sucralfate can cause a decrease in the absorption of Halofantrine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Haloperidol,Sucralfate may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Sucralfate,Hydralazine,Sucralfate may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Sucralfate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sucralfate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sucralfate,Hydromorphone,Hydromorphone may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Hydroxyethyl Starch,Sucralfate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sucralfate,Kanamycin,Sucralfate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sucralfate,Ketamine,Sucralfate may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Sucralfate,Ketazolam,Sucralfate may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Sucralfate,Ketoconazole,Sucralfate can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Ketorolac,Ketorolac may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Obeticholic acid,Sucralfate can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Octinoxate,Sucralfate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sucralfate,Ofloxacin,Sucralfate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Olsalazine,Olsalazine may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Omadacycline,Sucralfate can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Opium,Sucralfate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Sucralfate,Oseltamivir,Oseltamivir may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Oteseconazole,Sucralfate can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Ox bile extract,The serum concentration of Ox bile extract can be decreased when it is combined with Sucralfate.,decrease,no risk
Sucralfate,Oxacillin,Sucralfate may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxaprozin,Oxaprozin may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxazepam,Sucralfate may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxybenzone,Sucralfate may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxyquinoline,Sucralfate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sucralfate,Oxytetracycline,Sucralfate can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Quetiapine,Sucralfate may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Sucralfate,Quinethazone,Quinethazone may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sucralfate,Quinidine,Sucralfate can cause a decrease in the absorption of Quinidine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Quinine,Sucralfate can cause a decrease in the absorption of Quinine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Ursodeoxycholic acid,Sucralfate can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Vaborbactam,Sucralfate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Sucralfate,Vadadustat,The serum concentration of Vadadustat can be decreased when it is combined with Sucralfate.,decrease,no risk
Sucralfate,Valaciclovir,Valaciclovir may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Valbenazine,Sucralfate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Sucralfate,Valdecoxib,Valdecoxib may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Valganciclovir,Sucralfate may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Sucralfate,Vancomycin,Sucralfate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Sucralfate,Varenicline,Sucralfate may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Sucralfate,Venlafaxine,Venlafaxine may decrease the excretion rate of Sucralfate which could result in a higher serum level.,decrease,no risk
Sucralfate,Verapamil,Sucralfate may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Sucralfate,Vilanterol,Sucralfate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Sucralfate,Viloxazine,Sucralfate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Sucralfate,Vitamin D,The serum concentration of Sucralfate can be increased when it is combined with Vitamin D.,increase,no risk
Sucralfate,Voriconazole,Sucralfate can cause a decrease in the absorption of Voriconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Sucralfate,Vortioxetine,Sucralfate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Sucralfate,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Sucralfate.,decrease,no risk
Sucralfate,Zaleplon,Sucralfate may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Sucralfate,Zanamivir,Sucralfate may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Sucralfate,Zonisamide,Zonisamide may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Grepafloxacin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Budesonide,The risk or severity of tendinopathy can be increased when Budesonide is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Bumadizone,Bumadizone may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Bumetanide,The excretion of Grepafloxacin can be decreased when combined with Bumetanide.,decrease,no risk
Grepafloxacin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Bupivacaine.,increase,risk
Grepafloxacin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Butacaine,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Butacaine.,increase,risk
Grepafloxacin,Butamben,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Butamben.,increase,risk
Grepafloxacin,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Ganciclovir,The excretion of Grepafloxacin can be decreased when combined with Ganciclovir.,decrease,no risk
Grepafloxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Gemfibrozil,The metabolism of Grepafloxacin can be decreased when combined with Gemfibrozil.,decrease,no risk
Grepafloxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Grepafloxacin.,increase,no risk
Grepafloxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Givosiran,The serum concentration of Grepafloxacin can be increased when it is combined with Givosiran.,increase,no risk
Grepafloxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Glasdegib.,increase,risk
Grepafloxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Glofitamab,The serum concentration of Grepafloxacin can be increased when it is combined with Glofitamab.,increase,no risk
Grepafloxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Golimumab,The metabolism of Grepafloxacin can be increased when combined with Golimumab.,increase,no risk
Grepafloxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Halofantrine.,increase,risk
Grepafloxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Haloperidol.,increase,risk
Grepafloxacin,Hetacillin,The serum concentration of Grepafloxacin can be increased when it is combined with Hetacillin.,increase,no risk
Grepafloxacin,Histamine,The serum concentration of Histamine can be increased when it is combined with Grepafloxacin.,increase,no risk
Grepafloxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Hydroxyzine.,increase,risk
Grepafloxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Ketoconazole,The metabolism of Grepafloxacin can be decreased when combined with Ketoconazole.,decrease,no risk
Grepafloxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Obeticholic acid,The metabolism of Grepafloxacin can be decreased when combined with Obeticholic acid.,decrease,no risk
Grepafloxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Omaveloxolone,The serum concentration of Grepafloxacin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Grepafloxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Osilodrostat,The metabolism of Grepafloxacin can be decreased when combined with Osilodrostat.,decrease,no risk
Grepafloxacin,Osimertinib,The serum concentration of Grepafloxacin can be decreased when it is combined with Osimertinib.,decrease,no risk
Grepafloxacin,Oxacillin,The serum concentration of Grepafloxacin can be increased when it is combined with Oxacillin.,increase,no risk
Grepafloxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Oxetacaine.,increase,risk
Grepafloxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Grepafloxacin is combined with Oxybuprocaine.,increase,risk
Grepafloxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Oxytetracycline,The excretion of Grepafloxacin can be decreased when combined with Oxytetracycline.,decrease,no risk
Grepafloxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Quinapril,Quinapril can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quinidine.,increase,risk
Grepafloxacin,Quinine,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quinine.,increase,risk
Grepafloxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Quizartinib.,increase,risk
Grepafloxacin,Vadadustat,The serum concentration of Grepafloxacin can be increased when it is combined with Vadadustat.,increase,no risk
Grepafloxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Grepafloxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Vandetanib.,increase,risk
Grepafloxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Varenicline,The excretion of Varenicline can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Vemurafenib,The serum concentration of Grepafloxacin can be increased when it is combined with Vemurafenib.,increase,no risk
Grepafloxacin,Venetoclax,The metabolism of Grepafloxacin can be decreased when combined with Venetoclax.,decrease,no risk
Grepafloxacin,Verapamil,The metabolism of Grepafloxacin can be decreased when combined with Verapamil.,decrease,no risk
Grepafloxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Grepafloxacin.,decrease,no risk
Grepafloxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Viloxazine,The metabolism of Grepafloxacin can be decreased when combined with Viloxazine.,decrease,no risk
Grepafloxacin,Voriconazole,The metabolism of Grepafloxacin can be decreased when combined with Voriconazole.,decrease,no risk
Grepafloxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Grepafloxacin.,increase,no risk
Grepafloxacin,Zileuton,The metabolism of Zileuton can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Zimelidine,The metabolism of Grepafloxacin can be decreased when combined with Zimelidine.,decrease,no risk
Grepafloxacin,Zinc,Zinc can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Grepafloxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Grepafloxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Ziprasidone.,increase,risk
Grepafloxacin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Grepafloxacin.,decrease,no risk
Grepafloxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Grepafloxacin.,increase,risk
Grepafloxacin,Zotepine,The metabolism of Zotepine can be decreased when combined with Grepafloxacin.,decrease,no risk
Doxylamine,Gabapentin,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Doxylamine,Gabapentin enacarbil,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Doxylamine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Gadobenic acid.,increase,risk
Doxylamine,Galantamine,The therapeutic efficacy of Doxylamine can be decreased when used in combination with Galantamine.,decrease,no risk
Doxylamine,Gallamine triethiodide,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Doxylamine,Ganaxolone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ganaxolone.,increase,no risk
Doxylamine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Gatifloxacin.,increase,risk
Doxylamine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Gemifloxacin.,increase,risk
Doxylamine,Gepirone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Doxylamine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Gilteritinib.,increase,risk
Doxylamine,Ginkgo biloba,The therapeutic efficacy of Doxylamine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Doxylamine,Glasdegib,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Glasdegib.,increase,risk
Doxylamine,Glucagon,Doxylamine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Doxylamine,Glutethimide,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Doxylamine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Doxylamine.,decrease,no risk
Doxylamine,Glycopyrronium,The risk or severity of adverse effects can be increased when Doxylamine is combined with Glycopyrronium.,increase,risk
Doxylamine,Goserelin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Goserelin.,increase,risk
Doxylamine,Granisetron,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Doxylamine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Grepafloxacin.,increase,risk
Doxylamine,Guanabenz,The risk or severity of Tachycardia can be increased when Doxylamine is combined with Guanabenz.,increase,risk
Doxylamine,Guanfacine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Doxylamine,Halazepam,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Doxylamine,Halofantrine,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Halofantrine.,increase,risk
Doxylamine,Haloperidol,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.,increase,no risk
Doxylamine,Halothane,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Doxylamine,Hexafluronium,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Doxylamine,Hexocyclium,The risk or severity of adverse effects can be increased when Doxylamine is combined with Hexocyclium.,increase,risk
Doxylamine,Histrelin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Histrelin.,increase,risk
Doxylamine,Homatropine,The risk or severity of adverse effects can be increased when Doxylamine is combined with Homatropine.,increase,risk
Doxylamine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Doxylamine is combined with Homatropine methylbromide.,increase,risk
Doxylamine,Huperzine A,The therapeutic efficacy of Doxylamine can be decreased when used in combination with Huperzine A.,decrease,no risk
Doxylamine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Doxylamine.,increase,no risk
Doxylamine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Doxylamine.,increase,no risk
Doxylamine,Hydromorphone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Doxylamine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Hydroxychloroquine.,increase,risk
Doxylamine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Hydroxyzine.,increase,risk
Doxylamine,Hyoscyamine,Doxylamine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Doxylamine,Ketamine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Doxylamine,Ketazolam,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Doxylamine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ketoconazole.,increase,risk
Doxylamine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Doxylamine.,increase,risk
Doxylamine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ofloxacin.,increase,risk
Doxylamine,Olanzapine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Doxylamine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Doxylamine is combined with Oliceridine.",increase,risk
Doxylamine,Olodaterol,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Olodaterol.,increase,risk
Doxylamine,Ondansetron,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Doxylamine,Opium,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Doxylamine,Orciprenaline,The risk or severity of Tachycardia can be increased when Doxylamine is combined with Orciprenaline.,increase,risk
Doxylamine,Orphenadrine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Doxylamine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Doxylamine.,increase,risk
Doxylamine,Oxatomide,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Oxatomide.,increase,risk
Doxylamine,Oxazepam,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Doxylamine,Oxcarbazepine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Doxylamine,Oxitriptan,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Doxylamine,Oxprenolol,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Doxylamine,Oxybuprocaine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Doxylamine,Oxybutynin,The risk or severity of adverse effects can be increased when Doxylamine is combined with Oxybutynin.,increase,risk
Doxylamine,Oxycodone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Doxylamine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Doxylamine is combined with Oxymetazoline.,increase,risk
Doxylamine,Oxymorphone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Doxylamine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Doxylamine is combined with Oxyphencyclimine.,increase,risk
Doxylamine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Doxylamine.,decrease,no risk
Doxylamine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Doxylamine.,increase,risk
Doxylamine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Doxylamine.,increase,risk
Doxylamine,Quazepam,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Doxylamine,Quetiapine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Doxylamine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Doxylamine.,increase,no risk
Doxylamine,Quinidine,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Quinidine.,increase,risk
Doxylamine,Quinine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quinine.,increase,no risk
Doxylamine,Quinupramine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Doxylamine,Quizartinib,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Quizartinib.,increase,risk
Doxylamine,Umeclidinium,The risk or severity of adverse effects can be increased when Doxylamine is combined with Umeclidinium.,increase,risk
Doxylamine,Urethane,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Doxylamine,Valproic acid,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Doxylamine,Vandetanib,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vandetanib.,increase,risk
Doxylamine,Vardenafil,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vardenafil.,increase,risk
Doxylamine,Vecuronium,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Doxylamine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Doxylamine.,increase,risk
Doxylamine,Venlafaxine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Doxylamine,Vernakalant,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vernakalant.,increase,risk
Doxylamine,Vigabatrin,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Doxylamine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Doxylamine.,increase,risk
Doxylamine,Vilazodone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Doxylamine,Viloxazine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.,increase,no risk
Doxylamine,Voriconazole,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Voriconazole.,increase,risk
Doxylamine,Vorinostat,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Vorinostat.,increase,risk
Doxylamine,Vortioxetine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Doxylamine,Xamoterol,The risk or severity of Tachycardia can be increased when Doxylamine is combined with Xamoterol.,increase,risk
Doxylamine,Xylometazoline,The risk or severity of Tachycardia can be increased when Doxylamine is combined with Xylometazoline.,increase,risk
Doxylamine,Yohimbine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Doxylamine,Zaleplon,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Doxylamine,Ziconotide,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Doxylamine,Zimelidine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Doxylamine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Ziprasidone.,increase,risk
Doxylamine,Zolmitriptan,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Doxylamine,Zolpidem,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Doxylamine,Zonisamide,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Doxylamine,Zopiclone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Doxylamine,Zotepine,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Doxylamine,Zuclopenthixol,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Doxylamine,Zuranolone,Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Zuranolone.,increase,no risk
Levonorgestrel,Gabapentin,The metabolism of Levonorgestrel can be increased when combined with Gabapentin.,increase,no risk
Levonorgestrel,Ganaxolone,The metabolism of Levonorgestrel can be increased when combined with Ganaxolone.,increase,no risk
Levonorgestrel,Gefitinib,The metabolism of Levonorgestrel can be decreased when combined with Gefitinib.,decrease,no risk
Levonorgestrel,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Glofitamab,The serum concentration of Levonorgestrel can be increased when it is combined with Glofitamab.,increase,no risk
Levonorgestrel,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Glycerol phenylbutyrate,The metabolism of Levonorgestrel can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Levonorgestrel,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Golimumab,The metabolism of Levonorgestrel can be increased when combined with Golimumab.,increase,no risk
Levonorgestrel,Griseofulvin,The metabolism of Levonorgestrel can be increased when combined with Griseofulvin.,increase,no risk
Levonorgestrel,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Heparin,The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Heparin.,increase,risk
Levonorgestrel,Hetacillin,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Hetacillin.,decrease,no risk
Levonorgestrel,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Levonorgestrel is combined with Human C1-esterase inhibitor.,increase,risk
Levonorgestrel,Hydrocortamate,The metabolism of Levonorgestrel can be increased when combined with Hydrocortamate.,increase,no risk
Levonorgestrel,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Ketoconazole,The metabolism of Levonorgestrel can be decreased when combined with Ketoconazole.,decrease,no risk
Levonorgestrel,Obeticholic acid,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Octreotide,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Octreotide.,decrease,no risk
Levonorgestrel,Olaparib,The metabolism of Olaparib can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Olutasidenib,The metabolism of Levonorgestrel can be increased when combined with Olutasidenib.,increase,no risk
Levonorgestrel,Omadacycline,The serum concentration of Levonorgestrel can be decreased when it is combined with Omadacycline.,decrease,no risk
Levonorgestrel,Omaveloxolone,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Levonorgestrel,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Oritavancin,The metabolism of Levonorgestrel can be increased when combined with Oritavancin.,increase,no risk
Levonorgestrel,Ox bile extract,The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Oxacillin,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Oxacillin.,decrease,no risk
Levonorgestrel,Oxcarbazepine,The serum concentration of Levonorgestrel can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Levonorgestrel,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Oxytetracycline,The serum concentration of Levonorgestrel can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Levonorgestrel,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Udenafil,The metabolism of Udenafil can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Ulipristal,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Ulipristal.,decrease,no risk
Levonorgestrel,Urokinase,The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Urokinase.,increase,risk
Levonorgestrel,Ursodeoxycholic acid,The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Vadadustat,The serum concentration of Levonorgestrel can be increased when it is combined with Vadadustat.,increase,no risk
Levonorgestrel,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Valproic acid,The metabolism of Levonorgestrel can be increased when combined with Valproic acid.,increase,no risk
Levonorgestrel,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Levonorgestrel.,increase,no risk
Levonorgestrel,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Vemurafenib,The metabolism of Levonorgestrel can be increased when combined with Vemurafenib.,increase,no risk
Levonorgestrel,Venetoclax,The metabolism of Levonorgestrel can be decreased when combined with Venetoclax.,decrease,no risk
Levonorgestrel,Verapamil,The metabolism of Levonorgestrel can be decreased when combined with Verapamil.,decrease,no risk
Levonorgestrel,Vigabatrin,The metabolism of Levonorgestrel can be increased when combined with Vigabatrin.,increase,no risk
Levonorgestrel,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Levonorgestrel.,decrease,no risk
Levonorgestrel,Viloxazine,The metabolism of Levonorgestrel can be decreased when combined with Viloxazine.,decrease,no risk
Levonorgestrel,Vinblastine,The metabolism of Levonorgestrel can be increased when combined with Vinblastine.,increase,no risk
Levonorgestrel,Vincristine,The metabolism of Vincristine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Vitamin A,The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Vitamin A.,decrease,no risk
Levonorgestrel,Vitamin E,The metabolism of Levonorgestrel can be increased when combined with Vitamin E.,increase,no risk
Levonorgestrel,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Vorapaxar,The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Vorapaxar.,increase,risk
Levonorgestrel,Voriconazole,The metabolism of Levonorgestrel can be decreased when combined with Voriconazole.,decrease,no risk
Levonorgestrel,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Levonorgestrel.,decrease,no risk
Levonorgestrel,Warfarin,The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Warfarin.,increase,risk
Levonorgestrel,Ximelagatran,The risk or severity of adverse effects can be increased when Levonorgestrel is combined with Ximelagatran.,increase,risk
Levonorgestrel,Zaleplon,The metabolism of Levonorgestrel can be increased when combined with Zaleplon.,increase,no risk
Levonorgestrel,Zimelidine,The metabolism of Levonorgestrel can be decreased when combined with Zimelidine.,decrease,no risk
Levonorgestrel,Ziprasidone,The metabolism of Levonorgestrel can be decreased when combined with Ziprasidone.,decrease,no risk
Norepinephrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Gallamine triethiodide.,increase,risk
Norepinephrine,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Norepinephrine.,increase,risk
Norepinephrine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Norepinephrine.,increase,no risk
Norepinephrine,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Norepinephrine.,increase,risk
Norepinephrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Norepinephrine.,decrease,no risk
Norepinephrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Glycopyrronium.,increase,risk
Norepinephrine,Grepafloxacin,The serum concentration of Norepinephrine can be increased when it is combined with Grepafloxacin.,increase,no risk
Norepinephrine,Guanabenz,Norepinephrine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Norepinephrine,Guanadrel,Norepinephrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Norepinephrine,Guanethidine,Norepinephrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Norepinephrine,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Norepinephrine.,increase,risk
Norepinephrine,Guanidine,The serum concentration of Norepinephrine can be increased when it is combined with Guanidine.,increase,no risk
Norepinephrine,Guanoxan,Norepinephrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Norepinephrine,Halothane,Halothane may increase the arrhythmogenic activities of Norepinephrine.,increase,no risk
Norepinephrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Hexocyclium.,increase,risk
Norepinephrine,Histamine,The serum concentration of Histamine can be increased when it is combined with Norepinephrine.,increase,no risk
Norepinephrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Homatropine methylbromide.,increase,risk
Norepinephrine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Norepinephrine.,increase,risk
Norepinephrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Norepinephrine.,increase,risk
Norepinephrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydralazine,Norepinephrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Norepinephrine,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Hydrochlorothiazide.,increase,risk
Norepinephrine,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Norepinephrine.,increase,risk
Norepinephrine,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Norepinephrine is combined with Hydroflumethiazide.,increase,risk
Norepinephrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Hyoscyamine.,increase,risk
Norepinephrine,Ketamine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Ketamine.,increase,risk
Norepinephrine,Ketoprofen,The risk or severity of hypertension can be increased when Norepinephrine is combined with Ketoprofen.,increase,risk
Norepinephrine,Ketorolac,The risk or severity of hypertension can be increased when Norepinephrine is combined with Ketorolac.,increase,risk
Norepinephrine,Ketotifen,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Ketotifen.,increase,no risk
Norepinephrine,Olanzapine,The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Norepinephrine,Olmesartan,Norepinephrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Norepinephrine,Olodaterol,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Olodaterol.,increase,risk
Norepinephrine,Opicapone,The metabolism of Norepinephrine can be decreased when combined with Opicapone.,decrease,no risk
Norepinephrine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Norepinephrine.,increase,no risk
Norepinephrine,Orphenadrine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Orphenadrine.,increase,risk
Norepinephrine,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Norepinephrine is combined with Ouabain.,increase,risk
Norepinephrine,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Norepinephrine.,increase,no risk
Norepinephrine,Oxaprozin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Oxaprozin.,increase,risk
Norepinephrine,Oxatomide,The therapeutic efficacy of Norepinephrine can be increased when used in combination with Oxatomide.,increase,no risk
Norepinephrine,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Norepinephrine.,decrease,no risk
Norepinephrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Norepinephrine is combined with Oxtriphylline.,increase,risk
Norepinephrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Oxybutynin.,increase,risk
Norepinephrine,Oxymetazoline,Norepinephrine may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Norepinephrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Norepinephrine is combined with Oxyphenbutazone.,increase,risk
Norepinephrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Norepinephrine is combined with Oxyphencyclimine.,increase,risk
Norepinephrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Norepinephrine.,increase,risk
Norepinephrine,Oxytocin,The risk or severity of hypertension can be increased when Norepinephrine is combined with Oxytocin.,increase,risk
Cidofovir,Gabapentin enacarbil,Cidofovir may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadobenic acid,Cidofovir may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadodiamide,Cidofovir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadofosveset trisodium,Cidofovir may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadopentetic acid,Cidofovir may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadoteric acid,Cidofovir may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cidofovir,Gadoteridol,Cidofovir may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cidofovir,Ganciclovir,Cidofovir may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cidofovir,Gemcitabine,Cidofovir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cidofovir,Gemfibrozil,Cidofovir may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cidofovir,Gentamicin,Cidofovir may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cidofovir,Gimeracil,Cidofovir may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cidofovir,Givosiran,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Givosiran.,increase,risk
Cidofovir,Glipizide,Cidofovir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cidofovir,Glyburide,The excretion of Cidofovir can be decreased when combined with Glyburide.,decrease,no risk
Cidofovir,Glycerol phenylbutyrate,Cidofovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cidofovir,Golodirsen,Cidofovir may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cidofovir,Goserelin,Cidofovir may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cidofovir,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Cidofovir.,decrease,no risk
Cidofovir,Guanethidine,Cidofovir may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cidofovir,Guanfacine,Cidofovir may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cidofovir,Haloperidol,Cidofovir may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cidofovir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Cidofovir.,decrease,no risk
Cidofovir,Hydralazine,Cidofovir may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cidofovir,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Hydrochlorothiazide.,increase,risk
Cidofovir,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cidofovir,Hydromorphone,Cidofovir may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cidofovir,Hydroxocobalamin,Cidofovir may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cidofovir,Hydroxyethyl Starch,Cidofovir may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cidofovir,Kanamycin,Cidofovir may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cidofovir,Ketamine,Cidofovir may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cidofovir,Ketazolam,Cidofovir may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cidofovir,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Ketoprofen.,increase,risk
Cidofovir,Ketorolac,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Ketorolac.,increase,risk
Cidofovir,Octinoxate,Cidofovir may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cidofovir,Ofloxacin,The excretion of Cidofovir can be decreased when combined with Ofloxacin.,decrease,no risk
Cidofovir,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Olsalazine.,increase,risk
Cidofovir,Opium,Cidofovir may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cidofovir,Oseltamivir,Cidofovir may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cidofovir,Oxacillin,Cidofovir may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cidofovir,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cidofovir.,increase,risk
Cidofovir,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Oxaprozin.,increase,risk
Cidofovir,Oxazepam,Cidofovir may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cidofovir,Oxybenzone,Cidofovir may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cidofovir,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Oxyphenbutazone.,increase,risk
Cidofovir,Oxyquinoline,Cidofovir may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cidofovir,Oxytetracycline,The excretion of Cidofovir can be decreased when combined with Oxytetracycline.,decrease,no risk
Cidofovir,Quetiapine,Cidofovir may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cidofovir,Quinethazone,Quinethazone may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cidofovir,Quinidine,Cidofovir may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cidofovir,Vaborbactam,Cidofovir may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cidofovir,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Cidofovir.,increase,no risk
Cidofovir,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Valaciclovir.,increase,risk
Cidofovir,Valbenazine,Cidofovir may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cidofovir,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Valdecoxib.,increase,risk
Cidofovir,Valganciclovir,Cidofovir may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cidofovir,Valproic acid,The excretion of Cidofovir can be decreased when combined with Valproic acid.,decrease,no risk
Cidofovir,Vancomycin,Cidofovir may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cidofovir,Varenicline,Cidofovir may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cidofovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Cidofovir.,decrease,no risk
Cidofovir,Venlafaxine,Cidofovir may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cidofovir,Verapamil,Cidofovir may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cidofovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cidofovir.,decrease,no risk
Cidofovir,Vilanterol,Cidofovir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cidofovir,Viloxazine,Cidofovir may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cidofovir,Vortioxetine,Cidofovir may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cidofovir,Warfarin,Cidofovir may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cidofovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Cidofovir.,decrease,no risk
Cidofovir,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Cidofovir.,decrease,no risk
Cidofovir,Zaleplon,Cidofovir may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cidofovir,Zanamivir,Cidofovir may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cidofovir,Zidovudine,The excretion of Zidovudine can be decreased when combined with Cidofovir.,decrease,no risk
Cidofovir,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cidofovir is combined with Zoledronic acid.,increase,risk
Cidofovir,Zonisamide,Zonisamide may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Mirtazapine,Benzylpenicilloyl polylysine,Mirtazapine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Mirtazapine,Bepridil,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Bepridil.,increase,risk
Mirtazapine,Berotralstat,The metabolism of Mirtazapine can be decreased when combined with Berotralstat.,decrease,no risk
Mirtazapine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Mirtazapine.,decrease,no risk
Mirtazapine,Betaxolol,The metabolism of Mirtazapine can be decreased when combined with Betaxolol.,decrease,no risk
Mirtazapine,Bethanidine,Mirtazapine may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Mirtazapine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Bilastine,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Bilastine.,increase,risk
Mirtazapine,Bimekizumab,The metabolism of Mirtazapine can be increased when combined with Bimekizumab.,increase,no risk
Mirtazapine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Biperiden,The metabolism of Mirtazapine can be decreased when combined with Biperiden.,decrease,no risk
Mirtazapine,Bisoprolol,Mirtazapine may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Mirtazapine,Boceprevir,The metabolism of Mirtazapine can be decreased when combined with Boceprevir.,decrease,no risk
Mirtazapine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Bosentan,Mirtazapine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mirtazapine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Botulinum toxin type A,Botulinum toxin type A may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Bretylium,Mirtazapine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mirtazapine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Brexpiprazole,Brexpiprazole may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Bromazepam,Bromazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Mirtazapine.,increase,risk
Mirtazapine,Bumadizone,The risk or severity of hypertension can be increased when Mirtazapine is combined with Bumadizone.,increase,risk
Mirtazapine,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Buprenorphine,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mirtazapine,Bupropion,Bupropion may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Buserelin,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Buserelin.,increase,risk
Mirtazapine,Buspirone,Buspirone may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Busulfan,The metabolism of Busulfan can be decreased when combined with Mirtazapine.,decrease,no risk
Mirtazapine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Butorphanol,Butorphanol may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Butriptyline,Butriptyline may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Gadobenic acid.,increase,risk
Mirtazapine,Galantamine,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Galantamine.,increase,risk
Mirtazapine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Mirtazapine is combined with Ganaxolone.",increase,risk
Mirtazapine,Gatifloxacin,The metabolism of Mirtazapine can be decreased when combined with Gatifloxacin.,decrease,no risk
Mirtazapine,Gefitinib,The metabolism of Mirtazapine can be decreased when combined with Gefitinib.,decrease,no risk
Mirtazapine,Gemfibrozil,The metabolism of Mirtazapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Mirtazapine,Gemifloxacin,The metabolism of Mirtazapine can be decreased when combined with Gemifloxacin.,decrease,no risk
Mirtazapine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Mirtazapine.,increase,no risk
Mirtazapine,Gilteritinib,The therapeutic efficacy of Mirtazapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Mirtazapine,Givosiran,The serum concentration of Mirtazapine can be increased when it is combined with Givosiran.,increase,no risk
Mirtazapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Glasdegib.,increase,risk
Mirtazapine,Glofitamab,The serum concentration of Mirtazapine can be increased when it is combined with Glofitamab.,increase,no risk
Mirtazapine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Glycerol phenylbutyrate,The metabolism of Mirtazapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mirtazapine,Golimumab,The metabolism of Mirtazapine can be increased when combined with Golimumab.,increase,no risk
Mirtazapine,Goserelin,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Goserelin.,increase,risk
Mirtazapine,Granisetron,Granisetron may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Grepafloxacin.,increase,risk
Mirtazapine,Guanabenz,Mirtazapine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Mirtazapine,Guanadrel,Mirtazapine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Mirtazapine,Guanethidine,Mirtazapine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Mirtazapine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Guanoxan,Mirtazapine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Mirtazapine,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Halofantrine,The metabolism of Mirtazapine can be decreased when combined with Halofantrine.,decrease,no risk
Mirtazapine,Haloperidol,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Haloperidol.,increase,risk
Mirtazapine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Histrelin,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Histrelin.,increase,risk
Mirtazapine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Mirtazapine.,decrease,no risk
Mirtazapine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Mirtazapine.,decrease,no risk
Mirtazapine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Mirtazapine.,decrease,no risk
Mirtazapine,Hydralazine,Mirtazapine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Mirtazapine,Hydrochlorothiazide,Mirtazapine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Mirtazapine,Hydrocodone,Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mirtazapine,Hydroflumethiazide,Mirtazapine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Mirtazapine,Hydromorphone,Hydromorphone may increase the serotonergic activities of Mirtazapine.,increase,no risk
Mirtazapine,Hydroxychloroquine,The metabolism of Mirtazapine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Mirtazapine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Mirtazapine is combined with Hydroxyzine.,increase,risk
Mirtazapine,Hyoscyamine,Mirtazapine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mirtazapine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.,increase,no risk
Mirtazapine,Ketoconazole,The metabolism of Mirtazapine can be decreased when combined with Ketoconazole.,decrease,no risk
Mirtazapine,Ketoprofen,The risk or severity of hypertension can be increased when Mirtazapine is combined with Ketoprofen.,increase,risk
Mirtazapine,Ketorolac,The risk or severity of hypertension can be increased when Mirtazapine is combined with Ketorolac.,increase,risk
Meprobamate,Gabapentin,The risk or severity of CNS depression can be increased when Meprobamate is combined with Gabapentin.,increase,risk
Meprobamate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Meprobamate is combined with Gabapentin enacarbil.,increase,risk
Meprobamate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Meprobamate is combined with Gallamine triethiodide.,increase,risk
Meprobamate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Meprobamate is combined with Ganaxolone.",increase,risk
Meprobamate,Gepirone,The risk or severity of CNS depression can be increased when Meprobamate is combined with Gepirone.,increase,risk
Meprobamate,Glutethimide,The risk or severity of CNS depression can be increased when Meprobamate is combined with Glutethimide.,increase,risk
Meprobamate,Granisetron,The risk or severity of CNS depression can be increased when Meprobamate is combined with Granisetron.,increase,risk
Meprobamate,Guanfacine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Guanfacine.,increase,risk
Meprobamate,Halazepam,The risk or severity of CNS depression can be increased when Meprobamate is combined with Halazepam.,increase,risk
Meprobamate,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Meprobamate.,increase,risk
Meprobamate,Halothane,The risk or severity of CNS depression can be increased when Meprobamate is combined with Halothane.,increase,risk
Meprobamate,Hexafluronium,The risk or severity of CNS depression can be increased when Meprobamate is combined with Hexafluronium.,increase,risk
Meprobamate,Hydrocodone,Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Meprobamate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Meprobamate.,increase,risk
Meprobamate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Meprobamate.,increase,no risk
Meprobamate,Ketamine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Ketamine.,increase,risk
Meprobamate,Ketazolam,The risk or severity of CNS depression can be increased when Meprobamate is combined with Ketazolam.,increase,risk
Meprobamate,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Meprobamate.,increase,risk
Meprobamate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Meprobamate is combined with Oliceridine.",increase,risk
Meprobamate,Ondansetron,The risk or severity of CNS depression can be increased when Meprobamate is combined with Ondansetron.,increase,risk
Meprobamate,Opium,The risk or severity of CNS depression can be increased when Meprobamate is combined with Opium.,increase,risk
Meprobamate,Orphenadrine,Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Meprobamate,Oxazepam,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxazepam.,increase,risk
Meprobamate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxcarbazepine.,increase,risk
Meprobamate,Oxitriptan,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxitriptan.,increase,risk
Meprobamate,Oxprenolol,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxprenolol.,increase,risk
Meprobamate,Oxybuprocaine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxybuprocaine.,increase,risk
Meprobamate,Oxycodone,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxycodone.,increase,risk
Meprobamate,Oxymorphone,The risk or severity of CNS depression can be increased when Meprobamate is combined with Oxymorphone.,increase,risk
Meprobamate,Quazepam,The risk or severity of CNS depression can be increased when Meprobamate is combined with Quazepam.,increase,risk
Meprobamate,Quetiapine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Quetiapine.,increase,risk
Meprobamate,Quinine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Quinine.,increase,risk
Meprobamate,Quinupramine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Quinupramine.,increase,risk
Meprobamate,Urethane,The risk or severity of CNS depression can be increased when Meprobamate is combined with Urethane.,increase,risk
Meprobamate,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Meprobamate.,increase,risk
Meprobamate,Vecuronium,The risk or severity of CNS depression can be increased when Meprobamate is combined with Vecuronium.,increase,risk
Meprobamate,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Meprobamate.,increase,risk
Meprobamate,Vigabatrin,The risk or severity of CNS depression can be increased when Meprobamate is combined with Vigabatrin.,increase,risk
Meprobamate,Vilazodone,The risk or severity of CNS depression can be increased when Meprobamate is combined with Vilazodone.,increase,risk
Meprobamate,Viloxazine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Viloxazine.,increase,risk
Meprobamate,Vortioxetine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Vortioxetine.,increase,risk
Meprobamate,Yohimbine,The therapeutic efficacy of Meprobamate can be increased when used in combination with Yohimbine.,increase,no risk
Meprobamate,Zaleplon,The risk or severity of CNS depression can be increased when Meprobamate is combined with Zaleplon.,increase,risk
Meprobamate,Ziconotide,The risk or severity of CNS depression can be increased when Meprobamate is combined with Ziconotide.,increase,risk
Meprobamate,Zimelidine,The risk or severity of adverse effects can be increased when Meprobamate is combined with Zimelidine.,increase,risk
Meprobamate,Ziprasidone,The risk or severity of adverse effects can be increased when Meprobamate is combined with Ziprasidone.,increase,risk
Meprobamate,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Meprobamate.,increase,risk
Meprobamate,Zolpidem,Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Meprobamate,Zonisamide,The risk or severity of CNS depression can be increased when Meprobamate is combined with Zonisamide.,increase,risk
Meprobamate,Zopiclone,The risk or severity of adverse effects can be increased when Meprobamate is combined with Zopiclone.,increase,risk
Meprobamate,Zotepine,The risk or severity of CNS depression can be increased when Meprobamate is combined with Zotepine.,increase,risk
Meprobamate,Zuclopenthixol,The risk or severity of CNS depression can be increased when Meprobamate is combined with Zuclopenthixol.,increase,risk
Meprobamate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Meprobamate.,increase,risk
Thiethylperazine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Thiethylperazine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Thiethylperazine.,increase,no risk
Thiethylperazine,Bisoxatin,Thiethylperazine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Bleomycin,Bleomycin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Brexanolone,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Brexanolone.,increase,risk
Thiethylperazine,Brexpiprazole,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Brexpiprazole.,increase,risk
Thiethylperazine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Thiethylperazine.,increase,no risk
Thiethylperazine,Brivaracetam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Brivaracetam.,increase,risk
Thiethylperazine,Bromazepam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Bromazepam.,increase,risk
Thiethylperazine,Bromocriptine,The risk or severity of adverse effects can be increased when Bromocriptine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiethylperazine,Bromperidol,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Bromperidol.,increase,risk
Thiethylperazine,Brompheniramine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Brompheniramine.,increase,risk
Thiethylperazine,Budesonide,Thiethylperazine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Bumadizone,Bumadizone may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Bumetanide,Bumetanide may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiethylperazine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Buprenorphine,Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Thiethylperazine,Bupropion,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Bupropion.,increase,risk
Thiethylperazine,Buspirone,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Buspirone.,increase,risk
Thiethylperazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Butaperazine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Butaperazine.,increase,risk
Thiethylperazine,Butobarbital,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Butobarbital.,increase,risk
Thiethylperazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Butorphanol.,increase,risk
Thiethylperazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Thiethylperazine.,increase,no risk
Thiethylperazine,Gabapentin,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Gabapentin.,increase,risk
Thiethylperazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Gabapentin enacarbil.,increase,risk
Thiethylperazine,Gadobenic acid,Thiethylperazine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gadofosveset trisodium,Thiethylperazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gadopentetic acid,Thiethylperazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gadoteric acid,Thiethylperazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gadoteridol,Thiethylperazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Gallamine triethiodide.,increase,risk
Thiethylperazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Thiethylperazine is combined with Ganaxolone.",increase,risk
Thiethylperazine,Ganciclovir,Thiethylperazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gemcitabine,Thiethylperazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gemfibrozil,Thiethylperazine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gentamicin,Thiethylperazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gepirone,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Gepirone.,increase,risk
Thiethylperazine,Gimeracil,Thiethylperazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Givosiran,Givosiran may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Glutethimide,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Glutethimide.,increase,risk
Thiethylperazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Glycerol phenylbutyrate,Thiethylperazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Golodirsen,Thiethylperazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Goserelin,Goserelin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Granisetron,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Granisetron.,increase,risk
Thiethylperazine,Guanethidine,Thiethylperazine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Guanfacine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Guanfacine.,increase,risk
Thiethylperazine,Halazepam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Halazepam.,increase,risk
Thiethylperazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Halothane,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Halothane.,increase,risk
Thiethylperazine,Hexafluronium,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Hexafluronium.,increase,risk
Thiethylperazine,Hydralazine,Thiethylperazine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiethylperazine,Hydrocodone,Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Thiethylperazine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiethylperazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Hydromorphone.,increase,risk
Thiethylperazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Thiethylperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Thiethylperazine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Hydroxyethyl Starch,Thiethylperazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Thiethylperazine.,increase,no risk
Thiethylperazine,Hyoscyamine,Thiethylperazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Thiethylperazine,Kanamycin,Thiethylperazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Ketamine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Ketamine.,increase,risk
Thiethylperazine,Ketazolam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Ketazolam.,increase,risk
Thiethylperazine,Ketoprofen,Ketoprofen may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Ketorolac,Ketorolac may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Octinoxate,Thiethylperazine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Thiethylperazine is combined with Oliceridine.",increase,risk
Thiethylperazine,Olsalazine,Olsalazine may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Ondansetron,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Ondansetron.,increase,risk
Thiethylperazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Opium.,increase,risk
Thiethylperazine,Orphenadrine,Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Thiethylperazine,Oseltamivir,Oseltamivir may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Oxacillin,Thiethylperazine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Oxaprozin,Oxaprozin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Oxazepam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Oxazepam.,increase,risk
Thiethylperazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Oxcarbazepine.,increase,risk
Thiethylperazine,Oxitriptan,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Oxitriptan.,increase,risk
Thiethylperazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Thiethylperazine.,increase,no risk
Thiethylperazine,Oxybenzone,Thiethylperazine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Oxybuprocaine.,increase,risk
Thiethylperazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Oxycodone.,increase,risk
Thiethylperazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Thiethylperazine is combined with Oxymorphone.,increase,risk
Thiethylperazine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Oxyquinoline,Thiethylperazine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Quazepam,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Quazepam.,increase,risk
Thiethylperazine,Quetiapine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Quetiapine.,increase,risk
Thiethylperazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Thiethylperazine.,decrease,no risk
Thiethylperazine,Quinethazone,Quinethazone may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Thiethylperazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Thiethylperazine.,increase,no risk
Thiethylperazine,Urethane,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Urethane.,increase,risk
Thiethylperazine,Vaborbactam,Thiethylperazine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Valaciclovir,Valaciclovir may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Valbenazine,Thiethylperazine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Valdecoxib,Valdecoxib may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Valganciclovir,Thiethylperazine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Valproate bismuth,Thiethylperazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Thiethylperazine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Vancomycin,Thiethylperazine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Varenicline,Thiethylperazine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Vecuronium,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Vecuronium.,increase,risk
Thiethylperazine,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Verapamil,Thiethylperazine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Vigabatrin,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Vigabatrin.,increase,risk
Thiethylperazine,Vilanterol,Thiethylperazine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Viloxazine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Viloxazine.,increase,risk
Thiethylperazine,Vincristine,Thiethylperazine may increase the neurotoxic activities of Vincristine.,increase,no risk
Thiethylperazine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Thiethylperazine.,increase,no risk
Thiethylperazine,Viomycin,Thiethylperazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Thiethylperazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Warfarin,Thiethylperazine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Yohimbine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Yohimbine.,increase,risk
Thiethylperazine,Zaleplon,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Zaleplon.,increase,risk
Thiethylperazine,Zanamivir,Thiethylperazine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Thiethylperazine,Ziconotide,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Ziconotide.,increase,risk
Thiethylperazine,Zimelidine,The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Zimelidine.,increase,risk
Thiethylperazine,Ziprasidone,The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Ziprasidone.,increase,risk
Thiethylperazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Thiethylperazine.,increase,risk
Thiethylperazine,Zolpidem,Thiethylperazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Thiethylperazine,Zonisamide,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Zonisamide.,increase,risk
Thiethylperazine,Zopiclone,The risk or severity of adverse effects can be increased when Thiethylperazine is combined with Zopiclone.,increase,risk
Thiethylperazine,Zotepine,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Zotepine.,increase,risk
Thiethylperazine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Zuclopenthixol.,increase,risk
Thiethylperazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Thiethylperazine.,increase,risk
Timolol,Bacitracin,Bacitracin may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Baclofen,The risk or severity of adverse effects can be increased when Baclofen is combined with Timolol.,increase,risk
Timolol,Balsalazide,Balsalazide may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Baricitinib,Timolol may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Timolol,Bedaquiline,The risk or severity of QTc prolongation can be increased when Timolol is combined with Bedaquiline.,increase,risk
Timolol,Belzutifan,The metabolism of Belzutifan can be decreased when combined with Timolol.,decrease,no risk
Timolol,Bemiparin,The risk or severity of hyperkalemia can be increased when Timolol is combined with Bemiparin.,increase,risk
Timolol,Benazepril,Timolol may increase the hypotensive activities of Benazepril.,increase,no risk
Timolol,Bendroflumethiazide,The therapeutic efficacy of Timolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Timolol,Benorilate,Benorilate may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Benoxaprofen,Benoxaprofen may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Benserazide,Timolol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Timolol,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Timolol.,increase,risk
Timolol,Benznidazole,Timolol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Timolol,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Timolol.,decrease,no risk
Timolol,Benzphetamine,The therapeutic efficacy of Timolol can be decreased when used in combination with Benzphetamine.,decrease,no risk
Timolol,Benzthiazide,The therapeutic efficacy of Timolol can be increased when used in combination with Benzthiazide.,increase,no risk
Timolol,Benzydamine,Benzydamine may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Timolol.,decrease,no risk
Timolol,Bepotastine,Timolol may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Timolol,Bepridil,The risk or severity of adverse effects can be increased when Bepridil is combined with Timolol.,increase,risk
Timolol,Beractant,Timolol may increase the bradycardic activities of Beractant.,increase,no risk
Timolol,Berotralstat,The metabolism of Timolol can be decreased when combined with Berotralstat.,decrease,no risk
Timolol,Betaine,Betaine may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Betaxolol,The risk or severity of adverse effects can be increased when Timolol is combined with Betaxolol.,increase,risk
Timolol,Bethanechol,The risk or severity of adverse effects can be increased when Timolol is combined with Bethanechol.,increase,risk
Timolol,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Timolol.,decrease,no risk
Timolol,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Timolol.,increase,no risk
Timolol,Bicalutamide,The metabolism of Timolol can be decreased when combined with Bicalutamide.,decrease,no risk
Timolol,Bicisate,Timolol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Timolol,Bilastine,The risk or severity of QTc prolongation can be increased when Timolol is combined with Bilastine.,increase,risk
Timolol,Bimatoprost,Timolol may increase the hypotensive activities of Bimatoprost.,increase,no risk
Timolol,Bimekizumab,The metabolism of Timolol can be increased when combined with Bimekizumab.,increase,no risk
Timolol,Bioallethrin,Timolol may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Timolol,Biperiden,The metabolism of Timolol can be decreased when combined with Biperiden.,decrease,no risk
Timolol,Bismuth subgallate,Timolol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Timolol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Timolol.,increase,risk
Timolol,Bisoxatin,Timolol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Timolol,Bleomycin,Bleomycin may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Bortezomib,The metabolism of Timolol can be decreased when combined with Bortezomib.,decrease,no risk
Timolol,Bosentan,Timolol may increase the hypotensive activities of Bosentan.,increase,no risk
Timolol,Bouteloua gracilis pollen,The risk of a hypersensitivity reaction to Bouteloua gracilis pollen is increased when it is combined with Timolol.,increase,risk
Timolol,Bretylium,Timolol may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Timolol,Brexpiprazole,Timolol may increase the orthostatic hypotensive activities of Brexpiprazole.,increase,no risk
Timolol,Brimonidine,Brimonidine may increase the antihypertensive activities of Timolol.,increase,no risk
Timolol,Brivaracetam,Timolol may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Timolol,Bromazepam,Timolol may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Timolol,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Timolol.,increase,no risk
Timolol,Bromotheophylline,The risk or severity of adverse effects can be increased when Timolol is combined with Bromotheophylline.,increase,risk
Timolol,Brompheniramine,The risk or severity of QTc prolongation can be increased when Timolol is combined with Brompheniramine.,increase,risk
Timolol,Bromus secalinus pollen,The risk of a hypersensitivity reaction to Bromus secalinus pollen is increased when it is combined with Timolol.,increase,risk
Timolol,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Timolol.,increase,risk
Timolol,Budesonide,Timolol may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Timolol,Bumadizone,Bumadizone may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Bumetanide,Bumetanide may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Timolol,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Timolol.,increase,no risk
Timolol,Buprenorphine,The metabolism of Timolol can be decreased when combined with Buprenorphine.,decrease,no risk
Timolol,Bupropion,The metabolism of Timolol can be decreased when combined with Bupropion.,decrease,no risk
Timolol,Buserelin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Buserelin.,increase,risk
Timolol,Buspirone,Buspirone may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Butabarbital,Butabarbital may increase the hypotensive activities of Timolol.,increase,no risk
Timolol,Butalbital,Butalbital may increase the hypotensive activities of Timolol.,increase,no risk
Timolol,Butaperazine,The serum concentration of Timolol can be increased when it is combined with Butaperazine.,increase,no risk
Timolol,Butriptyline,Butriptyline may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Gabapentin enacarbil,Timolol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Timolol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Timolol is combined with Gadobenic acid.,increase,risk
Timolol,Gadodiamide,Gadodiamide may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Gadofosveset trisodium,Timolol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Timolol,Gadopentetic acid,Timolol may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Timolol,Gadoteric acid,Timolol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Timolol,Gadoteridol,Timolol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Timolol,Galantamine,Galantamine may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Gallamine triethiodide,Gallamine triethiodide may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Ganciclovir,Timolol may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Timolol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Gatifloxacin.,increase,risk
Timolol,Gefitinib,The metabolism of Timolol can be decreased when combined with Gefitinib.,decrease,no risk
Timolol,Gemcitabine,Timolol may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Timolol,Gemfibrozil,The metabolism of Timolol can be decreased when combined with Gemfibrozil.,decrease,no risk
Timolol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Gemifloxacin.,increase,risk
Timolol,Gentamicin,Timolol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Timolol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Timolol.,increase,risk
Timolol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Timolol is combined with Gilteritinib.,increase,risk
Timolol,Gimeracil,Timolol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Timolol,Ginkgo biloba,Ginkgo biloba may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Givosiran,The serum concentration of Timolol can be increased when it is combined with Givosiran.,increase,no risk
Timolol,Glasdegib,The risk or severity of QTc prolongation can be increased when Timolol is combined with Glasdegib.,increase,risk
Timolol,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Timolol.,increase,no risk
Timolol,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Timolol.,increase,no risk
Timolol,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Timolol.,increase,no risk
Timolol,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Timolol.,increase,no risk
Timolol,Glofitamab,The serum concentration of Timolol can be increased when it is combined with Glofitamab.,increase,no risk
Timolol,Glucagon,The therapeutic efficacy of Timolol can be decreased when used in combination with Glucagon.,decrease,no risk
Timolol,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Timolol.,increase,no risk
Timolol,Glycerol phenylbutyrate,The metabolism of Timolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Timolol,Glycol salicylate,Glycol salicylate may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Timolol.,increase,no risk
Timolol,Golimumab,The metabolism of Timolol can be increased when combined with Golimumab.,increase,no risk
Timolol,Golodirsen,Timolol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Timolol,Goserelin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Goserelin.,increase,risk
Timolol,Granisetron,The risk or severity of QTc prolongation can be increased when Timolol is combined with Granisetron.,increase,risk
Timolol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Grepafloxacin.,increase,risk
Timolol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Timolol.,decrease,no risk
Timolol,Guanadrel,Guanadrel may increase the hypotensive activities of Timolol.,increase,no risk
Timolol,Guanethidine,The risk or severity of adverse effects can be increased when Timolol is combined with Guanethidine.,increase,risk
Timolol,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Timolol.,decrease,no risk
Timolol,Guanoxan,Timolol may increase the hypotensive activities of Guanoxan.,increase,no risk
Timolol,Halofantrine,The metabolism of Timolol can be decreased when combined with Halofantrine.,decrease,no risk
Timolol,Haloperidol,The risk or severity of QTc prolongation can be increased when Timolol is combined with Haloperidol.,increase,risk
Timolol,Halothane,Halothane may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Heparin,The risk or severity of hyperkalemia can be increased when Timolol is combined with Heparin.,increase,risk
Timolol,Hexafluronium,Hexafluronium may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Histrelin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Histrelin.,increase,risk
Timolol,Holcus lanatus pollen,The risk of a hypersensitivity reaction to Holcus lanatus pollen is increased when it is combined with Timolol.,increase,risk
Timolol,Huperzine A,Huperzine A may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Hydralazine,Timolol may increase the hypotensive activities of Hydralazine.,increase,no risk
Timolol,Hydroflumethiazide,The therapeutic efficacy of Timolol can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Timolol,Hydromorphone,Hydromorphone may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Hydroxychloroquine,The metabolism of Timolol can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Timolol,Hydroxyethyl Starch,Timolol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Timolol,Hydroxyurea,The metabolism of Timolol can be decreased when combined with Hydroxyurea.,decrease,no risk
Timolol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Timolol is combined with Hydroxyzine.,increase,risk
Timolol,Hyoscyamine,Timolol may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Timolol,Kanamycin,Timolol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Timolol,Ketamine,Ketamine may increase the bradycardic activities of Timolol.,increase,no risk
Timolol,Ketazolam,Timolol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Timolol,Ketoconazole,The metabolism of Timolol can be decreased when combined with Ketoconazole.,decrease,no risk
Timolol,Ketoprofen,Ketoprofen may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Ketorolac,Ketorolac may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Koeleria macrantha pollen,The risk of a hypersensitivity reaction to Koeleria macrantha pollen is increased when it is combined with Timolol.,increase,risk
Timolol,Obinutuzumab,Timolol may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Timolol,Octinoxate,Timolol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Timolol,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Timolol.,increase,no risk
Timolol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Timolol is combined with Ofloxacin.,increase,risk
Timolol,Olanzapine,Timolol may increase the orthostatic hypotensive activities of Olanzapine.,increase,no risk
Timolol,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Timolol.,decrease,no risk
Timolol,Olmesartan,Olmesartan may increase the hypotensive activities of Timolol.,increase,no risk
Timolol,Olodaterol,Timolol may decrease the bronchodilatory activities of Olodaterol.,decrease,no risk
Timolol,Olsalazine,Olsalazine may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Omeprazole,The metabolism of Timolol can be decreased when combined with Omeprazole.,decrease,no risk
Timolol,Ondansetron,The risk or severity of QTc prolongation can be increased when Timolol is combined with Ondansetron.,increase,risk
Timolol,Opicapone,The risk or severity of adverse effects can be increased when Timolol is combined with Opicapone.,increase,risk
Timolol,Opium,Timolol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Timolol,Orciprenaline,Timolol may decrease the bronchodilatory activities of Orciprenaline.,decrease,no risk
Timolol,Oritavancin,The metabolism of Timolol can be decreased when combined with Oritavancin.,decrease,no risk
Timolol,Orphenadrine,The metabolism of Timolol can be decreased when combined with Orphenadrine.,decrease,no risk
Timolol,Oseltamivir,Oseltamivir may decrease the excretion rate of Timolol which could result in a higher serum level.,decrease,no risk
Timolol,Osilodrostat,The metabolism of Timolol can be decreased when combined with Osilodrostat.,decrease,no risk
Timolol,Ospemifene,The metabolism of Timolol can be decreased when combined with Ospemifene.,decrease,no risk
Timolol,Ouabain,Timolol may increase the bradycardic activities of Ouabain.,increase,no risk
Timolol,Oxacillin,Timolol may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Timolol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Timolol.,increase,risk
Timolol,Oxamniquine,The metabolism of Timolol can be decreased when combined with Oxamniquine.,decrease,no risk
Timolol,Oxaprozin,Oxaprozin may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Oxatomide,The risk or severity of QTc prolongation can be increased when Timolol is combined with Oxatomide.,increase,risk
Timolol,Oxazepam,Timolol may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Timolol,Oxcarbazepine,The metabolism of Timolol can be decreased when combined with Oxcarbazepine.,decrease,no risk
Timolol,Oxprenolol,The risk or severity of adverse effects can be increased when Timolol is combined with Oxprenolol.,increase,risk
Timolol,Oxtriphylline,The risk or severity of adverse effects can be increased when Timolol is combined with Oxtriphylline.,increase,risk
Timolol,Oxybenzone,Timolol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Timolol,Oxybutynin,The metabolism of Timolol can be decreased when combined with Oxybutynin.,decrease,no risk
Timolol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Timolol.,decrease,no risk
Timolol,Oxymetazoline,The risk or severity of cardiovascular complications can be increased when Timolol is combined with Oxymetazoline.,increase,risk
Timolol,Oxymetholone,The metabolism of Timolol can be decreased when combined with Oxymetholone.,decrease,no risk
Timolol,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Timolol.,decrease,no risk
Timolol,Oxyphenbutazone,Oxyphenbutazone may decrease the antihypertensive activities of Timolol.,decrease,no risk
Timolol,Oxyquinoline,Timolol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Timolol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Timolol.,increase,risk
Timolol,Quetiapine,Quetiapine may increase the hypotensive activities of Timolol.,increase,no risk
Timolol,Quinapril,Timolol may increase the hypotensive activities of Quinapril.,increase,no risk
Timolol,Quinethazone,Quinethazone may increase the excretion rate of Timolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Timolol,Quinidine,The risk or severity of bradycardia can be increased when Quinidine is combined with Timolol.,increase,risk
Timolol,Quinine,The metabolism of Timolol can be decreased when combined with Quinine.,decrease,no risk
Treprostinil,Berotralstat,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Berotralstat.,increase,risk
Treprostinil,Betamethasone,The metabolism of Treprostinil can be increased when combined with Betamethasone.,increase,no risk
Treprostinil,Betaxolol,Treprostinil may increase the hypotensive activities of Betaxolol.,increase,no risk
Treprostinil,Bethanidine,Treprostinil may increase the hypotensive activities of Bethanidine.,increase,no risk
Treprostinil,Betrixaban,The risk or severity of bleeding can be increased when Treprostinil is combined with Betrixaban.,increase,risk
Treprostinil,Bexarotene,The metabolism of Treprostinil can be decreased when combined with Bexarotene.,decrease,no risk
Treprostinil,Bezafibrate,The metabolism of Treprostinil can be decreased when combined with Bezafibrate.,decrease,no risk
Treprostinil,Bilastine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Bilastine.,increase,risk
Treprostinil,Bimatoprost,Treprostinil may increase the hypotensive activities of Bimatoprost.,increase,no risk
Treprostinil,Bimekizumab,The metabolism of Treprostinil can be increased when combined with Bimekizumab.,increase,no risk
Treprostinil,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Treprostinil is combined with Bismuth subsalicylate.,increase,risk
Treprostinil,Bisoprolol,Treprostinil may increase the hypotensive activities of Bisoprolol.,increase,no risk
Treprostinil,Bivalirudin,The risk or severity of bleeding can be increased when Treprostinil is combined with Bivalirudin.,increase,risk
Treprostinil,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Treprostinil.,increase,risk
Treprostinil,Bosentan,Treprostinil may increase the hypotensive activities of Bosentan.,increase,no risk
Treprostinil,Bosutinib,The metabolism of Treprostinil can be decreased when combined with Bosutinib.,decrease,no risk
Treprostinil,Bretylium,Treprostinil may increase the hypotensive activities of Bretylium.,increase,no risk
Treprostinil,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Brimonidine,Brimonidine may increase the antihypertensive activities of Treprostinil.,increase,no risk
Treprostinil,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Brompheniramine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Brompheniramine.,increase,risk
Treprostinil,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Treprostinil.,increase,risk
Treprostinil,Bumadizone,The risk or severity of bleeding can be increased when Treprostinil is combined with Bumadizone.,increase,risk
Treprostinil,Bumetanide,Bumetanide may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Bupivacaine,Bupivacaine may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Bupropion,The metabolism of Bupropion can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Buserelin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Buserelin.,increase,risk
Treprostinil,Buspirone,Buspirone may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Butriptyline,Butriptyline may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Gadobenic acid.,increase,risk
Treprostinil,Galantamine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Galantamine.,increase,risk
Treprostinil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Gatifloxacin.,increase,risk
Treprostinil,Gemfibrozil,The serum concentration of Treprostinil can be increased when it is combined with Gemfibrozil.,increase,no risk
Treprostinil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Gemifloxacin.,increase,risk
Treprostinil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Treprostinil.,increase,risk
Treprostinil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Gilteritinib.,increase,risk
Treprostinil,Ginkgo biloba,The metabolism of Treprostinil can be decreased when combined with Ginkgo biloba.,decrease,no risk
Treprostinil,Glasdegib,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Glasdegib.,increase,risk
Treprostinil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Glimepiride,The metabolism of Treprostinil can be decreased when combined with Glimepiride.,decrease,no risk
Treprostinil,Glipizide,The metabolism of Glipizide can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Glofitamab,The serum concentration of Treprostinil can be increased when it is combined with Glofitamab.,increase,no risk
Treprostinil,Glyburide,The metabolism of Treprostinil can be decreased when combined with Glyburide.,decrease,no risk
Treprostinil,Glycol salicylate,The risk or severity of bleeding can be increased when Treprostinil is combined with Glycol salicylate.,increase,risk
Treprostinil,Golimumab,The metabolism of Treprostinil can be increased when combined with Golimumab.,increase,no risk
Treprostinil,Goserelin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Goserelin.,increase,risk
Treprostinil,Granisetron,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Granisetron.,increase,risk
Treprostinil,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Grepafloxacin.,increase,risk
Treprostinil,Guanabenz,Treprostinil may increase the hypotensive activities of Guanabenz.,increase,no risk
Treprostinil,Guanadrel,Treprostinil may increase the hypotensive activities of Guanadrel.,increase,no risk
Treprostinil,Guanethidine,Treprostinil may increase the hypotensive activities of Guanethidine.,increase,no risk
Treprostinil,Guanfacine,Treprostinil may increase the hypotensive activities of Guanfacine.,increase,no risk
Treprostinil,Guanoxan,Treprostinil may increase the hypotensive activities of Guanoxan.,increase,no risk
Treprostinil,Halofantrine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Halofantrine.,increase,risk
Treprostinil,Haloperidol,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Haloperidol.,increase,risk
Treprostinil,Halothane,Halothane may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Heparin,The risk or severity of bleeding can be increased when Treprostinil is combined with Heparin.,increase,risk
Treprostinil,Histrelin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Histrelin.,increase,risk
Treprostinil,Hydralazine,Treprostinil may increase the hypotensive activities of Hydralazine.,increase,no risk
Treprostinil,Hydrochlorothiazide,The therapeutic efficacy of Treprostinil can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Treprostinil,Hydrocortisone,The metabolism of Treprostinil can be increased when combined with Hydrocortisone.,increase,no risk
Treprostinil,Hydroflumethiazide,The therapeutic efficacy of Treprostinil can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Treprostinil,Hydromorphone,The metabolism of Treprostinil can be decreased when combined with Hydromorphone.,decrease,no risk
Treprostinil,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Hydroxyzine.,increase,risk
Treprostinil,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Hyoscyamine.,increase,risk
Treprostinil,Ketamine,The metabolism of Ketamine can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Ketoconazole,The metabolism of Treprostinil can be decreased when combined with Ketoconazole.,decrease,no risk
Treprostinil,Ketoprofen,The risk or severity of bleeding can be increased when Treprostinil is combined with Ketoprofen.,increase,risk
Treprostinil,Ketorolac,The risk or severity of bleeding can be increased when Treprostinil is combined with Ketorolac.,increase,risk
Treprostinil,Obinutuzumab,Treprostinil may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Treprostinil,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Treprostinil.,increase,risk
Treprostinil,Ofloxacin,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ofloxacin.,increase,risk
Treprostinil,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Treprostinil.,increase,risk
Treprostinil,Olmesartan,Treprostinil may increase the hypotensive activities of Olmesartan.,increase,no risk
Treprostinil,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Olsalazine,The risk or severity of bleeding can be increased when Treprostinil is combined with Olsalazine.,increase,risk
Treprostinil,Omaveloxolone,The serum concentration of Treprostinil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Treprostinil,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Ondansetron,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ondansetron.,increase,risk
Treprostinil,Opicapone,Opicapone may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Oritavancin,The metabolism of Treprostinil can be decreased when combined with Oritavancin.,decrease,no risk
Treprostinil,Orphenadrine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Orphenadrine.,increase,risk
Treprostinil,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Treprostinil.,increase,risk
Treprostinil,Oxandrolone,The metabolism of Treprostinil can be decreased when combined with Oxandrolone.,decrease,no risk
Treprostinil,Oxaprozin,The risk or severity of bleeding can be increased when Treprostinil is combined with Oxaprozin.,increase,risk
Treprostinil,Oxatomide,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Oxatomide.,increase,risk
Treprostinil,Oxprenolol,Treprostinil may increase the hypotensive activities of Oxprenolol.,increase,no risk
Treprostinil,Oxybutynin,The metabolism of Treprostinil can be decreased when combined with Oxybutynin.,decrease,no risk
Treprostinil,Oxymetazoline,The therapeutic efficacy of Treprostinil can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Treprostinil,Oxyphenbutazone,The risk or severity of bleeding can be increased when Treprostinil is combined with Oxyphenbutazone.,increase,risk
Treprostinil,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Treprostinil.,increase,risk
Treprostinil,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Quetiapine,Quetiapine may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Quinapril,Treprostinil may increase the hypotensive activities of Quinapril.,increase,no risk
Treprostinil,Quinidine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Quinidine.,increase,risk
Treprostinil,Quinine,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Quinine.,increase,risk
Treprostinil,Quinupramine,Quinupramine may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Quizartinib,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Quizartinib.,increase,risk
Treprostinil,Udenafil,Udenafil may increase the antihypertensive activities of Treprostinil.,increase,no risk
Treprostinil,Unoprostone,Treprostinil may increase the hypotensive activities of Unoprostone.,increase,no risk
Treprostinil,Urokinase,The risk or severity of adverse effects can be increased when Urokinase is combined with Treprostinil.,increase,risk
Treprostinil,Vadadustat,The serum concentration of Treprostinil can be increased when it is combined with Vadadustat.,increase,no risk
Treprostinil,Valdecoxib,The risk or severity of bleeding can be increased when Treprostinil is combined with Valdecoxib.,increase,risk
Treprostinil,Valproic acid,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Valproic acid.,increase,risk
Treprostinil,Valsartan,Treprostinil may increase the hypotensive activities of Valsartan.,increase,no risk
Treprostinil,Vandetanib,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vandetanib.,increase,risk
Treprostinil,Vardenafil,Vardenafil may increase the antihypertensive activities of Treprostinil.,increase,no risk
Treprostinil,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Treprostinil.,increase,risk
Treprostinil,Verapamil,Verapamil may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Vericiguat,Vericiguat may increase the hypotensive activities of Treprostinil.,increase,no risk
Treprostinil,Vernakalant,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vernakalant.,increase,risk
Treprostinil,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Treprostinil.,increase,risk
Treprostinil,Vilazodone,Vilazodone may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Vorapaxar,Treprostinil may increase the antiplatelet activities of Vorapaxar.,increase,no risk
Treprostinil,Voriconazole,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Voriconazole.,increase,risk
Treprostinil,Vorinostat,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Vorinostat.,increase,risk
Treprostinil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Warfarin,The risk or severity of bleeding can be increased when Treprostinil is combined with Warfarin.,increase,risk
Treprostinil,Xamoterol,Xamoterol may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Ximelagatran,The risk or severity of bleeding can be increased when Treprostinil is combined with Ximelagatran.,increase,risk
Treprostinil,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Yohimbine,Yohimbine may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Zafirlukast,The metabolism of Treprostinil can be decreased when combined with Zafirlukast.,decrease,no risk
Treprostinil,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Zileuton,The metabolism of Zileuton can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Ziprasidone,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Ziprasidone.,increase,risk
Treprostinil,Zofenopril,Treprostinil may increase the hypotensive activities of Zofenopril.,increase,no risk
Treprostinil,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Treprostinil.,decrease,no risk
Treprostinil,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Zonisamide,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Zonisamide.,increase,risk
Treprostinil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Treprostinil.,decrease,no risk
Treprostinil,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Treprostinil is combined with Zuclopenthixol.,increase,risk
Colestipol,Ketoprofen,Colestipol can cause a decrease in the absorption of Ketoprofen resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Ketorolac,Colestipol can cause a decrease in the absorption of Ketorolac resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Obeticholic acid,Colestipol can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Odevixibat,The therapeutic efficacy of Odevixibat can be decreased when used in combination with Colestipol.,decrease,no risk
Colestipol,Omadacycline,Colestipol can cause a decrease in the absorption of Omadacycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Ouabain,Colestipol can cause a decrease in the absorption of Ouabain resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Oxaprozin,Colestipol can cause a decrease in the absorption of Oxaprozin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Oxyphenbutazone,Colestipol can cause a decrease in the absorption of Oxyphenbutazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Oxytetracycline,Colestipol can cause a decrease in the absorption of Oxytetracycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Quinethazone,Colestipol can cause a decrease in the absorption of Quinethazone resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Udenafil,Colestipol can cause a decrease in the absorption of Udenafil resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Ursodeoxycholic acid,Colestipol can cause a decrease in the absorption of Ursodeoxycholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Valdecoxib,Colestipol can cause a decrease in the absorption of Valdecoxib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Vancomycin,The therapeutic efficacy of Vancomycin can be decreased when used in combination with Colestipol.,decrease,no risk
Colestipol,Vemurafenib,Colestipol can cause a decrease in the absorption of Vemurafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Vitamin D,The serum concentration of Vitamin D can be decreased when it is combined with Colestipol.,decrease,no risk
Colestipol,Warfarin,Colestipol can cause a decrease in the absorption of Warfarin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Colestipol,Zonisamide,Colestipol can cause a decrease in the absorption of Zonisamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Trihexyphenidyl,Galantamine,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Galantamine.,decrease,no risk
Trihexyphenidyl,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Gallamine triethiodide.,increase,risk
Trihexyphenidyl,Ginkgo biloba,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Trihexyphenidyl,Glucagon,Trihexyphenidyl may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Trihexyphenidyl,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Trihexyphenidyl.,decrease,no risk
Trihexyphenidyl,Glycopyrronium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Glycopyrronium.,increase,risk
Trihexyphenidyl,Guanabenz,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Guanabenz.,increase,risk
Trihexyphenidyl,Guanfacine,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Guanfacine.,increase,risk
Trihexyphenidyl,Haloperidol,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Haloperidol.,decrease,no risk
Trihexyphenidyl,Hexafluronium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hexafluronium.,increase,risk
Trihexyphenidyl,Hexocyclium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hexocyclium.,increase,risk
Trihexyphenidyl,Homatropine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Homatropine.,increase,risk
Trihexyphenidyl,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Homatropine methylbromide.,increase,risk
Trihexyphenidyl,Huperzine A,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Huperzine A.,decrease,no risk
Trihexyphenidyl,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Trihexyphenidyl.,increase,no risk
Trihexyphenidyl,Hydrocodone,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hydrocodone.,increase,risk
Trihexyphenidyl,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Trihexyphenidyl.,increase,no risk
Trihexyphenidyl,Hydromorphone,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hydromorphone.,increase,risk
Trihexyphenidyl,Hyoscyamine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Hyoscyamine.,increase,risk
Trihexyphenidyl,Ketamine,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ketamine.,decrease,no risk
Trihexyphenidyl,Olanzapine,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Olanzapine.,decrease,no risk
Trihexyphenidyl,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Trihexyphenidyl is combined with Oliceridine.",increase,risk
Trihexyphenidyl,Olodaterol,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Olodaterol.,increase,risk
Trihexyphenidyl,Opium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Opium.,increase,risk
Trihexyphenidyl,Orciprenaline,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Orciprenaline.,increase,risk
Trihexyphenidyl,Orphenadrine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Orphenadrine.,increase,risk
Trihexyphenidyl,Oxybutynin,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxybutynin.,increase,risk
Trihexyphenidyl,Oxycodone,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxycodone.,increase,risk
Trihexyphenidyl,Oxymetazoline,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Oxymetazoline.,increase,risk
Trihexyphenidyl,Oxymorphone,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxymorphone.,increase,risk
Trihexyphenidyl,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxyphencyclimine.,increase,risk
Trihexyphenidyl,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Trihexyphenidyl.,decrease,no risk
Trihexyphenidyl,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Trihexyphenidyl.,increase,risk
Trihexyphenidyl,Quetiapine,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Quetiapine.,decrease,no risk
Trihexyphenidyl,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Trihexyphenidyl.,increase,no risk
Trihexyphenidyl,Quinidine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Quinidine.,increase,risk
Trihexyphenidyl,Quinupramine,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Quinupramine.,increase,risk
Trihexyphenidyl,Umeclidinium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Umeclidinium.,increase,risk
Trihexyphenidyl,Vecuronium,The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Vecuronium.,increase,risk
Trihexyphenidyl,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Trihexyphenidyl.,increase,risk
Trihexyphenidyl,Vilanterol,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Vilanterol.,increase,risk
Trihexyphenidyl,Xamoterol,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Xamoterol.,increase,risk
Trihexyphenidyl,Xylometazoline,The risk or severity of Tachycardia can be increased when Trihexyphenidyl is combined with Xylometazoline.,increase,risk
Trihexyphenidyl,Ziprasidone,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Ziprasidone.,decrease,no risk
Trihexyphenidyl,Zotepine,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Zotepine.,decrease,no risk
Trihexyphenidyl,Zuclopenthixol,The therapeutic efficacy of Trihexyphenidyl can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Palonosetron,Berotralstat,The metabolism of Palonosetron can be decreased when combined with Berotralstat.,decrease,no risk
Palonosetron,Betaxolol,The metabolism of Palonosetron can be decreased when combined with Betaxolol.,decrease,no risk
Palonosetron,Bicisate,Palonosetron may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Palonosetron,Bimekizumab,The metabolism of Palonosetron can be increased when combined with Bimekizumab.,increase,no risk
Palonosetron,Biperiden,The metabolism of Palonosetron can be decreased when combined with Biperiden.,decrease,no risk
Palonosetron,Bismuth subgallate,Palonosetron may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Palonosetron,Bisoprolol,Palonosetron may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Palonosetron,Bisoxatin,Palonosetron may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Palonosetron,Bleomycin,Bleomycin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Boceprevir,The metabolism of Palonosetron can be decreased when combined with Boceprevir.,decrease,no risk
Palonosetron,Bortezomib,The metabolism of Palonosetron can be decreased when combined with Bortezomib.,decrease,no risk
Palonosetron,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Palonosetron.,increase,risk
Palonosetron,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Palonosetron.,increase,risk
Palonosetron,Brexanolone,The risk or severity of CNS depression can be increased when Palonosetron is combined with Brexanolone.,increase,risk
Palonosetron,Brexpiprazole,The risk or severity of CNS depression can be increased when Palonosetron is combined with Brexpiprazole.,increase,risk
Palonosetron,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.,increase,no risk
Palonosetron,Brivaracetam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Brivaracetam.,increase,risk
Palonosetron,Bromazepam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Bromazepam.,increase,risk
Palonosetron,Bromocriptine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Bromocriptine.,increase,risk
Palonosetron,Bromotheophylline,Bromotheophylline may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palonosetron,Bromperidol,The risk or severity of CNS depression can be increased when Palonosetron is combined with Bromperidol.,increase,risk
Palonosetron,Brompheniramine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Brompheniramine.,increase,risk
Palonosetron,Budesonide,Palonosetron may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Palonosetron,Bumadizone,Bumadizone may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Bumetanide,Bumetanide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palonosetron,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Palonosetron.,increase,risk
Palonosetron,Buprenorphine,Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Palonosetron,Bupropion,The metabolism of Palonosetron can be decreased when combined with Bupropion.,decrease,no risk
Palonosetron,Buspirone,The risk or severity of CNS depression can be increased when Palonosetron is combined with Buspirone.,increase,risk
Palonosetron,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Palonosetron.,increase,risk
Palonosetron,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Palonosetron.,increase,risk
Palonosetron,Butaperazine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Butaperazine.,increase,risk
Palonosetron,Butobarbital,The risk or severity of CNS depression can be increased when Palonosetron is combined with Butobarbital.,increase,risk
Palonosetron,Butorphanol,The risk or severity of CNS depression can be increased when Palonosetron is combined with Butorphanol.,increase,risk
Palonosetron,Butriptyline,The risk or severity of CNS depression can be increased when Palonosetron is combined with Butriptyline.,increase,risk
Palonosetron,Gabapentin,The risk or severity of CNS depression can be increased when Palonosetron is combined with Gabapentin.,increase,risk
Palonosetron,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Palonosetron is combined with Gabapentin enacarbil.,increase,risk
Palonosetron,Gadobenic acid,Palonosetron may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Palonosetron,Gadodiamide,Gadodiamide may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Gadofosveset trisodium,Palonosetron may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Palonosetron,Gadopentetic acid,Palonosetron may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Palonosetron,Gadoteric acid,Palonosetron may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Palonosetron,Gadoteridol,Palonosetron may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Palonosetron,Galantamine,The metabolism of Galantamine can be decreased when combined with Palonosetron.,decrease,no risk
Palonosetron,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Palonosetron is combined with Gallamine triethiodide.,increase,risk
Palonosetron,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Palonosetron is combined with Ganaxolone.",increase,risk
Palonosetron,Ganciclovir,Palonosetron may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Palonosetron,Gefitinib,The metabolism of Palonosetron can be decreased when combined with Gefitinib.,decrease,no risk
Palonosetron,Gemcitabine,Palonosetron may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Palonosetron,Gemfibrozil,Palonosetron may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Palonosetron,Gentamicin,Palonosetron may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Palonosetron,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Palonosetron.,increase,risk
Palonosetron,Gilteritinib,The therapeutic efficacy of Palonosetron can be decreased when used in combination with Gilteritinib.,decrease,no risk
Palonosetron,Gimeracil,Palonosetron may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Palonosetron,Givosiran,The serum concentration of Palonosetron can be increased when it is combined with Givosiran.,increase,no risk
Palonosetron,Glipizide,Palonosetron may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Palonosetron,Glofitamab,The serum concentration of Palonosetron can be increased when it is combined with Glofitamab.,increase,no risk
Palonosetron,Glutethimide,The risk or severity of CNS depression can be increased when Palonosetron is combined with Glutethimide.,increase,risk
Palonosetron,Glycerol phenylbutyrate,The metabolism of Palonosetron can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Palonosetron,Golimumab,The metabolism of Palonosetron can be increased when combined with Golimumab.,increase,no risk
Palonosetron,Golodirsen,Palonosetron may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Palonosetron,Goserelin,Goserelin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Granisetron,The risk or severity of CNS depression can be increased when Palonosetron is combined with Granisetron.,increase,risk
Palonosetron,Guanethidine,Palonosetron may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Palonosetron,Guanfacine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Guanfacine.,increase,risk
Palonosetron,Halazepam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Halazepam.,increase,risk
Palonosetron,Halofantrine,The metabolism of Palonosetron can be decreased when combined with Halofantrine.,decrease,no risk
Palonosetron,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Palonosetron.,increase,risk
Palonosetron,Halothane,The risk or severity of CNS depression can be increased when Palonosetron is combined with Halothane.,increase,risk
Palonosetron,Hexafluronium,The risk or severity of CNS depression can be increased when Palonosetron is combined with Hexafluronium.,increase,risk
Palonosetron,Hydralazine,Palonosetron may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Palonosetron,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palonosetron,Hydrocodone,Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Palonosetron,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palonosetron,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Palonosetron.,increase,risk
Palonosetron,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Hydroxychloroquine,The metabolism of Palonosetron can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Palonosetron,Hydroxyethyl Starch,Palonosetron may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Palonosetron,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Palonosetron.,increase,no risk
Palonosetron,Kanamycin,Palonosetron may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Palonosetron,Ketamine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Ketamine.,increase,risk
Palonosetron,Ketazolam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Ketazolam.,increase,risk
Palonosetron,Ketoconazole,The metabolism of Palonosetron can be decreased when combined with Ketoconazole.,decrease,no risk
Palonosetron,Ketoprofen,Ketoprofen may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Ketorolac,Ketorolac may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Octinoxate,Palonosetron may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Palonosetron,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Palonosetron.,increase,risk
Palonosetron,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Palonosetron is combined with Oliceridine.",increase,risk
Palonosetron,Olsalazine,Olsalazine may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Omaveloxolone,The serum concentration of Palonosetron can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Palonosetron,Ondansetron,The risk or severity of CNS depression can be increased when Palonosetron is combined with Ondansetron.,increase,risk
Palonosetron,Opium,The risk or severity of CNS depression can be increased when Palonosetron is combined with Opium.,increase,risk
Palonosetron,Oritavancin,The metabolism of Palonosetron can be decreased when combined with Oritavancin.,decrease,no risk
Palonosetron,Orphenadrine,Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Palonosetron,Oseltamivir,Oseltamivir may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Osilodrostat,The metabolism of Palonosetron can be decreased when combined with Osilodrostat.,decrease,no risk
Palonosetron,Ospemifene,The metabolism of Palonosetron can be decreased when combined with Ospemifene.,decrease,no risk
Palonosetron,Oxacillin,Palonosetron may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Palonosetron,Oxamniquine,The metabolism of Palonosetron can be decreased when combined with Oxamniquine.,decrease,no risk
Palonosetron,Oxaprozin,Oxaprozin may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Oxazepam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxazepam.,increase,risk
Palonosetron,Oxcarbazepine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxcarbazepine.,increase,risk
Palonosetron,Oxitriptan,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxitriptan.,increase,risk
Palonosetron,Oxprenolol,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxprenolol.,increase,risk
Palonosetron,Oxybenzone,Palonosetron may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Palonosetron,Oxybuprocaine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxybuprocaine.,increase,risk
Palonosetron,Oxybutynin,The metabolism of Palonosetron can be decreased when combined with Oxybutynin.,decrease,no risk
Palonosetron,Oxycodone,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxycodone.,increase,risk
Palonosetron,Oxymorphone,The risk or severity of CNS depression can be increased when Palonosetron is combined with Oxymorphone.,increase,risk
Palonosetron,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Palonosetron which could result in a higher serum level.,decrease,no risk
Palonosetron,Oxyquinoline,Palonosetron may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Palonosetron,Quazepam,The risk or severity of CNS depression can be increased when Palonosetron is combined with Quazepam.,increase,risk
Palonosetron,Quetiapine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Quetiapine.,increase,risk
Palonosetron,Quinethazone,Quinethazone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Palonosetron,Quinidine,The metabolism of Palonosetron can be decreased when combined with Quinidine.,decrease,no risk
Palonosetron,Quinine,The metabolism of Palonosetron can be decreased when combined with Quinine.,decrease,no risk
Palonosetron,Quinupramine,The risk or severity of CNS depression can be increased when Palonosetron is combined with Quinupramine.,increase,risk
Dydrogesterone,Omadacycline,The serum concentration of Dydrogesterone can be decreased when it is combined with Omadacycline.,decrease,no risk
Dydrogesterone,Omaveloxolone,The serum concentration of Dydrogesterone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dydrogesterone,Oxytetracycline,The serum concentration of Dydrogesterone can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Dydrogesterone,Ulipristal,The therapeutic efficacy of Dydrogesterone can be decreased when used in combination with Ulipristal.,decrease,no risk
Dydrogesterone,Urokinase,Dydrogesterone may decrease the anticoagulant activities of Urokinase.,decrease,no risk
Dydrogesterone,Vadadustat,The serum concentration of Dydrogesterone can be increased when it is combined with Vadadustat.,increase,no risk
Dydrogesterone,Venetoclax,The metabolism of Dydrogesterone can be decreased when combined with Venetoclax.,decrease,no risk
Dydrogesterone,Verapamil,The metabolism of Dydrogesterone can be decreased when combined with Verapamil.,decrease,no risk
Dydrogesterone,Viloxazine,The metabolism of Dydrogesterone can be decreased when combined with Viloxazine.,decrease,no risk
Dydrogesterone,Vorapaxar,Dydrogesterone may decrease the anticoagulant activities of Vorapaxar.,decrease,no risk
Dydrogesterone,Voriconazole,The metabolism of Dydrogesterone can be decreased when combined with Voriconazole.,decrease,no risk
Dydrogesterone,Warfarin,Dydrogesterone may decrease the anticoagulant activities of Warfarin.,decrease,no risk
Dydrogesterone,Ximelagatran,Dydrogesterone may decrease the anticoagulant activities of Ximelagatran.,decrease,no risk
Dydrogesterone,Zimelidine,The metabolism of Dydrogesterone can be decreased when combined with Zimelidine.,decrease,no risk
Dydrogesterone,Ziprasidone,The metabolism of Dydrogesterone can be decreased when combined with Ziprasidone.,decrease,no risk
Mexiletine,Galantamine,The metabolism of Galantamine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Gatifloxacin,The metabolism of Mexiletine can be decreased when combined with Gatifloxacin.,decrease,no risk
Mexiletine,Gefitinib,The metabolism of Mexiletine can be decreased when combined with Gefitinib.,decrease,no risk
Mexiletine,Gemfibrozil,The metabolism of Mexiletine can be decreased when combined with Gemfibrozil.,decrease,no risk
Mexiletine,Gemifloxacin,The metabolism of Mexiletine can be decreased when combined with Gemifloxacin.,decrease,no risk
Mexiletine,Givosiran,The serum concentration of Mexiletine can be increased when it is combined with Givosiran.,increase,no risk
Mexiletine,Glofitamab,The serum concentration of Mexiletine can be increased when it is combined with Glofitamab.,increase,no risk
Mexiletine,Glycerol phenylbutyrate,The metabolism of Mexiletine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mexiletine,Golimumab,The metabolism of Mexiletine can be increased when combined with Golimumab.,increase,no risk
Mexiletine,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Halofantrine,The metabolism of Mexiletine can be decreased when combined with Halofantrine.,decrease,no risk
Mexiletine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Mexiletine.,increase,no risk
Mexiletine,Halothane,The metabolism of Halothane can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Hydrocortisone,The metabolism of Mexiletine can be increased when combined with Hydrocortisone.,increase,no risk
Mexiletine,Hydroxychloroquine,The metabolism of Mexiletine can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Mexiletine,Hydroxyzine,The metabolism of Mexiletine can be decreased when combined with Hydroxyzine.,decrease,no risk
Mexiletine,Hyoscyamine,Mexiletine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Mexiletine,Ketamine,The metabolism of Ketamine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Ketoconazole,The metabolism of Mexiletine can be decreased when combined with Ketoconazole.,decrease,no risk
Mexiletine,Obeticholic acid,The metabolism of Mexiletine can be decreased when combined with Obeticholic acid.,decrease,no risk
Mexiletine,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Omaveloxolone,The serum concentration of Mexiletine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Mexiletine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Opium,The metabolism of Opium can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Oritavancin,The metabolism of Mexiletine can be decreased when combined with Oritavancin.,decrease,no risk
Mexiletine,Orphenadrine,The metabolism of Mexiletine can be decreased when combined with Orphenadrine.,decrease,no risk
Mexiletine,Osilodrostat,The metabolism of Mexiletine can be decreased when combined with Osilodrostat.,decrease,no risk
Mexiletine,Osimertinib,The serum concentration of Mexiletine can be decreased when it is combined with Osimertinib.,decrease,no risk
Mexiletine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Oxamniquine,The metabolism of Mexiletine can be decreased when combined with Oxamniquine.,decrease,no risk
Mexiletine,Oxprenolol,Mexiletine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Mexiletine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Oxybutynin,The metabolism of Mexiletine can be decreased when combined with Oxybutynin.,decrease,no risk
Mexiletine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Quinidine,Mexiletine may increase the arrhythmogenic activities of Quinidine.,increase,no risk
Mexiletine,Quinine,The metabolism of Mexiletine can be decreased when combined with Quinine.,decrease,no risk
Mexiletine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Vadadustat,The serum concentration of Mexiletine can be decreased when it is combined with Vadadustat.,decrease,no risk
Mexiletine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Valproic acid,The metabolism of Mexiletine can be decreased when combined with Valproic acid.,decrease,no risk
Mexiletine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Vemurafenib,The serum concentration of Mexiletine can be increased when it is combined with Vemurafenib.,increase,no risk
Mexiletine,Venetoclax,The metabolism of Mexiletine can be decreased when combined with Venetoclax.,decrease,no risk
Mexiletine,Venlafaxine,The metabolism of Mexiletine can be decreased when combined with Venlafaxine.,decrease,no risk
Mexiletine,Verapamil,Mexiletine may increase the arrhythmogenic activities of Verapamil.,increase,no risk
Mexiletine,Vernakalant,Mexiletine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Mexiletine,Vilazodone,The metabolism of Mexiletine can be decreased when combined with Vilazodone.,decrease,no risk
Mexiletine,Viloxazine,The metabolism of Mexiletine can be decreased when combined with Viloxazine.,decrease,no risk
Mexiletine,Vinblastine,The metabolism of Mexiletine can be decreased when combined with Vinblastine.,decrease,no risk
Mexiletine,Vinorelbine,The metabolism of Mexiletine can be decreased when combined with Vinorelbine.,decrease,no risk
Mexiletine,Voriconazole,The metabolism of Mexiletine can be decreased when combined with Voriconazole.,decrease,no risk
Mexiletine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Warfarin,The metabolism of Warfarin can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Xylometazoline,Mexiletine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Mexiletine,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Ziconotide,Mexiletine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Mexiletine,Zileuton,The metabolism of Zileuton can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Zimelidine,The metabolism of Mexiletine can be decreased when combined with Zimelidine.,decrease,no risk
Mexiletine,Ziprasidone,The metabolism of Mexiletine can be decreased when combined with Ziprasidone.,decrease,no risk
Mexiletine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Zonisamide,Mexiletine may increase the arrhythmogenic activities of Zonisamide.,increase,no risk
Mexiletine,Zotepine,The metabolism of Zotepine can be decreased when combined with Mexiletine.,decrease,no risk
Mexiletine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Mexiletine.,decrease,no risk
Dexrazoxane,Bicisate,Dexrazoxane may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bimekizumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Bimekizumab.,increase,risk
Dexrazoxane,Bismuth subgallate,Dexrazoxane may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bisoprolol,Dexrazoxane may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bisoxatin,Dexrazoxane may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Blinatumomab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Blinatumomab.,increase,risk
Dexrazoxane,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Dexrazoxane.",decrease,no risk
Dexrazoxane,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Bosutinib,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Bosutinib.,increase,risk
Dexrazoxane,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Brentuximab vedotin.,increase,risk
Dexrazoxane,Brivaracetam,Dexrazoxane may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Brodalumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Brodalumab.,increase,risk
Dexrazoxane,Bromazepam,Dexrazoxane may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bromotheophylline,Bromotheophylline may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexrazoxane,Budesonide,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Budesonide.,increase,risk
Dexrazoxane,Bumadizone,Bumadizone may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Bumetanide,Bumetanide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexrazoxane,Bupropion,Dexrazoxane may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Buspirone,Dexrazoxane may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Busulfan,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Busulfan.,increase,risk
Dexrazoxane,Butabarbital,Butabarbital may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gabapentin enacarbil,Dexrazoxane may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadobenic acid,Dexrazoxane may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadodiamide,Gadodiamide may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadofosveset trisodium,Dexrazoxane may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadopentetic acid,Dexrazoxane may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadoteric acid,Dexrazoxane may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gadoteridol,Dexrazoxane may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ganciclovir,Dexrazoxane may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gemcitabine,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Gemcitabine.,increase,risk
Dexrazoxane,Gemfibrozil,Dexrazoxane may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Gentamicin,Dexrazoxane may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Gimeracil,Dexrazoxane may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Givosiran,Givosiran may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Glatiramer,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Glatiramer.,increase,risk
Dexrazoxane,Glipizide,Dexrazoxane may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Glycerol phenylbutyrate,Dexrazoxane may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Golimumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Golimumab.,increase,risk
Dexrazoxane,Golodirsen,Dexrazoxane may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Goserelin,Goserelin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Guanethidine,Dexrazoxane may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Guanfacine,Dexrazoxane may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Guselkumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Guselkumab.,increase,risk
Dexrazoxane,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Haloperidol,Dexrazoxane may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Hydralazine,Dexrazoxane may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexrazoxane,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Hydrocortisone acetate.,increase,risk
Dexrazoxane,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Hydrocortisone butyrate.,increase,risk
Dexrazoxane,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Hydrocortisone succinate.,increase,risk
Dexrazoxane,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexrazoxane,Hydromorphone,Hydromorphone may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Hydroxychloroquine.,increase,risk
Dexrazoxane,Hydroxyethyl Starch,Dexrazoxane may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Hydroxyurea,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Hydroxyurea.,increase,risk
Dexrazoxane,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Kanamycin,Dexrazoxane may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ketamine,Dexrazoxane may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ketazolam,Dexrazoxane may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ketoprofen,Ketoprofen may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ketorolac,Ketorolac may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Obinutuzumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Obinutuzumab.,increase,risk
Dexrazoxane,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Dexrazoxane.,increase,no risk
Dexrazoxane,Octinoxate,Dexrazoxane may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ofatumumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Ofatumumab.,increase,risk
Dexrazoxane,Olaparib,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Olaparib.,increase,risk
Dexrazoxane,Olsalazine,Olsalazine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Opium,Dexrazoxane may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oseltamivir,Oseltamivir may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxacillin,Dexrazoxane may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxaliplatin,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Oxaliplatin.,increase,risk
Dexrazoxane,Oxaprozin,Oxaprozin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxazepam,Dexrazoxane may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxybenzone,Dexrazoxane may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Oxyquinoline,Dexrazoxane may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ozanimod,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Ozanimod.,increase,risk
Dexrazoxane,Quetiapine,Dexrazoxane may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Quinethazone,Quinethazone may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Dexrazoxane,Quinidine,Dexrazoxane may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Upadacitinib,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Upadacitinib.,increase,risk
Dexrazoxane,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Vaborbactam,Dexrazoxane may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Valaciclovir,Valaciclovir may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Valbenazine,Dexrazoxane may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Valdecoxib,Valdecoxib may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Valganciclovir,Dexrazoxane may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Vancomycin,Dexrazoxane may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Varenicline,Dexrazoxane may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Vedolizumab,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vedolizumab.,increase,risk
Dexrazoxane,Venlafaxine,Venlafaxine may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Verapamil,Dexrazoxane may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dexrazoxane.,decrease,no risk
Dexrazoxane,Vilanterol,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vilanterol.,increase,risk
Dexrazoxane,Viloxazine,Dexrazoxane may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Vinblastine,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vinblastine.,increase,risk
Dexrazoxane,Vincristine,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vincristine.,increase,risk
Dexrazoxane,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Voclosporin,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Voclosporin.,increase,risk
Dexrazoxane,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Vorinostat,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Vorinostat.,increase,risk
Dexrazoxane,Vortioxetine,Dexrazoxane may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Warfarin,Dexrazoxane may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Dexrazoxane.,increase,risk
Dexrazoxane,Zaleplon,Dexrazoxane may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Zanamivir,Dexrazoxane may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Dexrazoxane,Zidovudine,The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Zidovudine.,increase,risk
Dexrazoxane,Zonisamide,Zonisamide may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amlodipine,Budesonide,The metabolism of Amlodipine can be increased when combined with Budesonide.,increase,no risk
Amlodipine,Bumadizone,Bumadizone may decrease the antihypertensive activities of Amlodipine.,decrease,no risk
Amlodipine,Bumetanide,The risk or severity of adverse effects can be increased when Amlodipine is combined with Bumetanide.,increase,risk
Amlodipine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Amlodipine.,increase,risk
Amlodipine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Bupropion,The metabolism of Bupropion can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Buspirone,Buspirone may decrease the antihypertensive activities of Amlodipine.,decrease,no risk
Amlodipine,Butabarbital,Butabarbital may increase the hypotensive activities of Amlodipine.,increase,no risk
Amlodipine,Butalbital,The metabolism of Amlodipine can be increased when combined with Butalbital.,increase,no risk
Amlodipine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Amlodipine.,decrease,no risk
Amlodipine,Galantamine,Amlodipine may increase the bradycardic activities of Galantamine.,increase,no risk
Amlodipine,Gallamine triethiodide,Amlodipine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Amlodipine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Glipizide,The metabolism of Glipizide can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Glofitamab,The serum concentration of Amlodipine can be increased when it is combined with Glofitamab.,increase,no risk
Amlodipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Amlodipine.,decrease,no risk
Amlodipine,Glyburide,The metabolism of Glyburide can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Amlodipine.,decrease,no risk
Amlodipine,Glymidine,The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Glymidine.,increase,risk
Amlodipine,Griseofulvin,The metabolism of Amlodipine can be increased when combined with Griseofulvin.,increase,no risk
Amlodipine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Amlodipine.,decrease,no risk
Amlodipine,Guanadrel,Guanadrel may increase the hypotensive activities of Amlodipine.,increase,no risk
Amlodipine,Guanethidine,Amlodipine may increase the hypotensive activities of Guanethidine.,increase,no risk
Amlodipine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Amlodipine.,decrease,no risk
Amlodipine,Guanoxan,Amlodipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Amlodipine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Amlodipine.,increase,no risk
Amlodipine,Halothane,The metabolism of Halothane can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Heparin,The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Heparin.,increase,risk
Amlodipine,Hydralazine,Amlodipine may increase the hypotensive activities of Hydralazine.,increase,no risk
Amlodipine,Hydrocortamate,The metabolism of Amlodipine can be increased when combined with Hydrocortamate.,increase,no risk
Amlodipine,Hydrocortisone,The metabolism of Amlodipine can be increased when combined with Hydrocortisone.,increase,no risk
Amlodipine,Hydrocortisone acetate,The metabolism of Amlodipine can be increased when combined with Hydrocortisone acetate.,increase,no risk
Amlodipine,Hydrocortisone butyrate,The metabolism of Amlodipine can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Amlodipine,Hydrocortisone succinate,The metabolism of Amlodipine can be increased when combined with Hydrocortisone succinate.,increase,no risk
Amlodipine,Hydroflumethiazide,The therapeutic efficacy of Amlodipine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Amlodipine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Amlodipine.,decrease,no risk
Amlodipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Amlodipine.,increase,risk
Amlodipine,Hyoscyamine,Amlodipine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Tacrine,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Ganciclovir.",increase,risk
Tacrine,Gatifloxacin,The metabolism of Tacrine can be decreased when combined with Gatifloxacin.,decrease,no risk
Tacrine,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Gemfibrozil.",increase,risk
Tacrine,Gemifloxacin,The metabolism of Tacrine can be decreased when combined with Gemifloxacin.,decrease,no risk
Tacrine,Givosiran,The serum concentration of Tacrine can be increased when it is combined with Givosiran.,increase,no risk
Tacrine,Glofitamab,The serum concentration of Tacrine can be increased when it is combined with Glofitamab.,increase,no risk
Tacrine,Glycopyrronium,The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Golimumab,The metabolism of Tacrine can be increased when combined with Golimumab.,increase,no risk
Tacrine,Grepafloxacin,The metabolism of Tacrine can be decreased when combined with Grepafloxacin.,decrease,no risk
Tacrine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Hexocyclium,The therapeutic efficacy of Hexocyclium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Homatropine methylbromide,The therapeutic efficacy of Homatropine methylbromide can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Hydrocortisone,The therapeutic efficacy of Tacrine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Tacrine,Hydrocortisone acetate,The therapeutic efficacy of Tacrine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Tacrine,Hydrocortisone butyrate,The therapeutic efficacy of Tacrine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Tacrine,Hydrocortisone cypionate,The therapeutic efficacy of Tacrine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Tacrine,Hydrocortisone succinate,The therapeutic efficacy of Tacrine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Tacrine,Hyoscyamine,The therapeutic efficacy of Hyoscyamine can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Ketoconazole,The metabolism of Tacrine can be decreased when combined with Ketoconazole.,decrease,no risk
Tacrine,Obeticholic acid,The metabolism of Tacrine can be decreased when combined with Obeticholic acid.,decrease,no risk
Tacrine,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Ofloxacin.",increase,risk
Tacrine,Olanzapine,The metabolism of Tacrine can be decreased when combined with Olanzapine.,decrease,no risk
Tacrine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Orphenadrine,The metabolism of Tacrine can be decreased when combined with Orphenadrine.,decrease,no risk
Tacrine,Osilodrostat,The metabolism of Tacrine can be decreased when combined with Osilodrostat.,decrease,no risk
Tacrine,Osimertinib,The serum concentration of Tacrine can be decreased when it is combined with Osimertinib.,decrease,no risk
Tacrine,Oxprenolol,Tacrine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Tacrine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Oxybuprocaine,Tacrine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Tacrine,Oxybutynin,The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Oxyphencyclimine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Oxyphenonium,The therapeutic efficacy of Oxyphenonium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Quetiapine,The therapeutic efficacy of Quetiapine can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Quinidine,The metabolism of Tacrine can be decreased when combined with Quinidine.,decrease,no risk
Tacrine,Quinine,The metabolism of Quinine can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Ubidecarenone.",increase,risk
Tacrine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Valproic acid,The metabolism of Tacrine can be decreased when combined with Valproic acid.,decrease,no risk
Tacrine,Vamorolone,The therapeutic efficacy of Tacrine can be decreased when used in combination with Vamorolone.,decrease,no risk
Tacrine,Varenicline,The risk or severity of adverse effects can be increased when Tacrine is combined with Varenicline.,increase,risk
Tacrine,Vecuronium,The therapeutic efficacy of Vecuronium can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Vemurafenib,The serum concentration of Tacrine can be increased when it is combined with Vemurafenib.,increase,no risk
Tacrine,Verapamil,The metabolism of Verapamil can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Viloxazine,The metabolism of Tacrine can be decreased when combined with Viloxazine.,decrease,no risk
Tacrine,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Vincristine.",increase,risk
Tacrine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Warfarin,The metabolism of Warfarin can be decreased when combined with Tacrine.,decrease,no risk
Tacrine,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Zidovudine.",increase,risk
Tacrine,Zileuton,The metabolism of Tacrine can be decreased when combined with Zileuton.,decrease,no risk
Tacrine,Ziprasidone,The therapeutic efficacy of Ziprasidone can be decreased when used in combination with Tacrine.,decrease,no risk
Tacrine,Zolmitriptan,The metabolism of Tacrine can be decreased when combined with Zolmitriptan.,decrease,no risk
Tacrine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Tacrine.,decrease,no risk
Oxyphencyclimine,Galantamine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Galantamine.,decrease,no risk
Oxyphencyclimine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Gallamine triethiodide.,increase,risk
Oxyphencyclimine,Ginkgo biloba,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Oxyphencyclimine,Glucagon,Oxyphencyclimine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Oxyphencyclimine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Oxyphencyclimine,Glycopyrronium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Glycopyrronium.,increase,risk
Oxyphencyclimine,Guanabenz,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Guanabenz.,increase,risk
Oxyphencyclimine,Guanfacine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Guanfacine.,increase,risk
Oxyphencyclimine,Hexafluronium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexafluronium.,increase,risk
Oxyphencyclimine,Hexocyclium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hexocyclium.,increase,risk
Oxyphencyclimine,Homatropine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Homatropine.,increase,risk
Oxyphencyclimine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Homatropine methylbromide.,increase,risk
Oxyphencyclimine,Huperzine A,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Huperzine A.,decrease,no risk
Oxyphencyclimine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Oxyphencyclimine,Hydrocodone,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hydrocodone.,increase,risk
Oxyphencyclimine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Oxyphencyclimine,Hydromorphone,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hydromorphone.,increase,risk
Oxyphencyclimine,Hyoscyamine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Hyoscyamine.,increase,risk
Oxyphencyclimine,Ketamine,The therapeutic efficacy of Oxyphencyclimine can be decreased when used in combination with Ketamine.,decrease,no risk
Oxyphencyclimine,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Oxyphencyclimine.,increase,risk
Oxyphencyclimine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Oxyphencyclimine is combined with Oliceridine.",increase,risk
Oxyphencyclimine,Olodaterol,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Olodaterol.,increase,risk
Oxyphencyclimine,Opium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Opium.,increase,risk
Oxyphencyclimine,Orciprenaline,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Orciprenaline.,increase,risk
Oxyphencyclimine,Orphenadrine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Orphenadrine.,increase,risk
Oxyphencyclimine,Oxybutynin,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Oxybutynin.,increase,risk
Oxyphencyclimine,Oxycodone,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Oxycodone.,increase,risk
Oxyphencyclimine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Oxymetazoline.,increase,risk
Oxyphencyclimine,Oxymorphone,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Oxymorphone.,increase,risk
Oxyphencyclimine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Oxyphencyclimine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxyphencyclimine.,increase,risk
Oxyphencyclimine,Quetiapine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quetiapine.,increase,risk
Oxyphencyclimine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Oxyphencyclimine,Quinidine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quinidine.,increase,risk
Oxyphencyclimine,Quinupramine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Quinupramine.,increase,risk
Oxyphencyclimine,Umeclidinium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Umeclidinium.,increase,risk
Oxyphencyclimine,Vecuronium,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Vecuronium.,increase,risk
Oxyphencyclimine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Oxyphencyclimine.,increase,risk
Oxyphencyclimine,Vilanterol,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Vilanterol.,increase,risk
Oxyphencyclimine,Xamoterol,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Xamoterol.,increase,risk
Oxyphencyclimine,Xylometazoline,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Xylometazoline.,increase,risk
Oxyphencyclimine,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Oxyphencyclimine.,increase,risk
Triamterene,Betaxolol,The metabolism of Triamterene can be decreased when combined with Betaxolol.,decrease,no risk
Triamterene,Bethanidine,Triamterene may increase the hypotensive activities of Bethanidine.,increase,no risk
Triamterene,Bicisate,Triamterene may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bimekizumab,The metabolism of Triamterene can be increased when combined with Bimekizumab.,increase,no risk
Triamterene,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Triamterene.,decrease,no risk
Triamterene,Bisacodyl,The risk or severity of dehydration can be increased when Triamterene is combined with Bisacodyl.,increase,risk
Triamterene,Bismuth subgallate,Triamterene may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bisoprolol,Triamterene may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bisoxatin,The risk or severity of dehydration can be increased when Triamterene is combined with Bisoxatin.,increase,risk
Triamterene,Bleomycin,Triamterene may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bortezomib,The metabolism of Triamterene can be decreased when combined with Bortezomib.,decrease,no risk
Triamterene,Bosentan,Triamterene may increase the hypotensive activities of Bosentan.,increase,no risk
Triamterene,Bretylium,The risk or severity of adverse effects can be increased when Triamterene is combined with Bretylium.,increase,risk
Triamterene,Brivaracetam,Triamterene may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bromazepam,Triamterene may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bromocriptine,The risk or severity of adverse effects can be increased when Triamterene is combined with Bromocriptine.,increase,risk
Triamterene,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Triamterene.,decrease,no risk
Triamterene,Budesonide,Triamterene may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Bumadizone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Bumadizone is combined with Triamterene.",increase,risk
Triamterene,Bumetanide,The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Bumetanide.,increase,risk
Triamterene,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Triamterene.,increase,risk
Triamterene,Buprenorphine,The therapeutic efficacy of Triamterene can be decreased when used in combination with Buprenorphine.,decrease,no risk
Triamterene,Bupropion,Triamterene may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Buspirone,Triamterene may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Butabarbital,Butabarbital may increase the hypotensive activities of Triamterene.,increase,no risk
Triamterene,Butalbital,Butalbital may increase the hypotensive activities of Triamterene.,increase,no risk
Triamterene,Butorphanol,The therapeutic efficacy of Triamterene can be decreased when used in combination with Butorphanol.,decrease,no risk
Triamterene,Gabapentin enacarbil,Triamterene may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadobenic acid,Triamterene may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadodiamide,Triamterene may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadofosveset trisodium,Triamterene may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadopentetic acid,Triamterene may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadoteric acid,Triamterene may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gadoteridol,Triamterene may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Ganciclovir,Triamterene may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gatifloxacin,The metabolism of Triamterene can be decreased when combined with Gatifloxacin.,decrease,no risk
Triamterene,Gemcitabine,Triamterene may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gemfibrozil,Triamterene may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Gemifloxacin,The metabolism of Triamterene can be decreased when combined with Gemifloxacin.,decrease,no risk
Triamterene,Gentamicin,Triamterene may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Triamterene,Gimeracil,Triamterene may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Givosiran,The serum concentration of Triamterene can be increased when it is combined with Givosiran.,increase,no risk
Triamterene,Glipizide,Triamterene may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Glofitamab,The serum concentration of Triamterene can be increased when it is combined with Glofitamab.,increase,no risk
Triamterene,Gluconic Acid,The risk or severity of dehydration can be increased when Triamterene is combined with Gluconic Acid.,increase,risk
Triamterene,Glycerin,The risk or severity of dehydration can be increased when Triamterene is combined with Glycerin.,increase,risk
Triamterene,Glycerol phenylbutyrate,Triamterene may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Glycol salicylate,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Glycol salicylate is combined with Triamterene.",increase,risk
Triamterene,Golimumab,The metabolism of Triamterene can be increased when combined with Golimumab.,increase,no risk
Triamterene,Golodirsen,Triamterene may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Goserelin,Triamterene may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Grepafloxacin,The metabolism of Triamterene can be decreased when combined with Grepafloxacin.,decrease,no risk
Triamterene,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Triamterene.,decrease,no risk
Triamterene,Guanadrel,Triamterene may increase the hypotensive activities of Guanadrel.,increase,no risk
Triamterene,Guanethidine,Triamterene may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Guanfacine,Triamterene may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Guanoxan,Triamterene may increase the hypotensive activities of Guanoxan.,increase,no risk
Triamterene,Haloperidol,Triamterene may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Halothane,The risk or severity of adverse effects can be increased when Triamterene is combined with Halothane.,increase,risk
Triamterene,Heparin,The risk or severity of hyperkalemia can be increased when Triamterene is combined with Heparin.,increase,risk
Triamterene,Hydralazine,Triamterene may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Hydrocodone,The therapeutic efficacy of Triamterene can be decreased when used in combination with Hydrocodone.,decrease,no risk
Triamterene,Hydroflumethiazide,The risk or severity of adverse effects can be increased when Triamterene is combined with Hydroflumethiazide.,increase,risk
Triamterene,Hydromorphone,Triamterene may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Hydroxocobalamin,Triamterene may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Hydroxyethyl Starch,Triamterene may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Kanamycin,Triamterene may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Triamterene,Ketamine,Triamterene may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Ketazolam,Triamterene may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Ketoconazole,The metabolism of Triamterene can be decreased when combined with Ketoconazole.,decrease,no risk
Triamterene,Ketoprofen,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketoprofen is combined with Triamterene.",increase,risk
Triamterene,Ketorolac,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Triamterene.",increase,risk
Triamterene,Obeticholic acid,The metabolism of Triamterene can be decreased when combined with Obeticholic acid.,decrease,no risk
Triamterene,Obinutuzumab,The risk or severity of adverse effects can be increased when Triamterene is combined with Obinutuzumab.,increase,risk
Triamterene,Octinoxate,Triamterene may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Olanzapine,The metabolism of Triamterene can be decreased when combined with Olanzapine.,decrease,no risk
Triamterene,Oliceridine,The therapeutic efficacy of Triamterene can be decreased when used in combination with Oliceridine.,decrease,no risk
Triamterene,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Triamterene.,increase,risk
Triamterene,Olsalazine,The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Olsalazine.,increase,risk
Triamterene,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Triamterene.,decrease,no risk
Triamterene,Opicapone,The risk or severity of adverse effects can be increased when Triamterene is combined with Opicapone.,increase,risk
Triamterene,Opium,Triamterene may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Orphenadrine,The metabolism of Triamterene can be decreased when combined with Orphenadrine.,decrease,no risk
Triamterene,Oseltamivir,Triamterene may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Osilodrostat,The metabolism of Triamterene can be decreased when combined with Osilodrostat.,decrease,no risk
Triamterene,Osimertinib,The serum concentration of Triamterene can be decreased when it is combined with Osimertinib.,decrease,no risk
Triamterene,Ouabain,Triamterene may decrease the excretion rate of Ouabain which could result in a higher serum level.,decrease,no risk
Triamterene,Oxacillin,Triamterene may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Triamterene.,increase,risk
Triamterene,Oxaprozin,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxaprozin is combined with Triamterene.",increase,risk
Triamterene,Oxazepam,Triamterene may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Oxprenolol,The risk or severity of adverse effects can be increased when Triamterene is combined with Oxprenolol.,increase,risk
Triamterene,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Triamterene.,decrease,no risk
Triamterene,Oxybenzone,Triamterene may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Triamterene,Oxycodone,The therapeutic efficacy of Triamterene can be decreased when used in combination with Oxycodone.,decrease,no risk
Triamterene,Oxymorphone,The therapeutic efficacy of Triamterene can be decreased when used in combination with Oxymorphone.,decrease,no risk
Triamterene,Oxyphenbutazone,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Oxyphenbutazone is combined with Triamterene.",increase,risk
Triamterene,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Triamterene is combined with Oxyphenisatin acetate.,increase,risk
Triamterene,Oxyquinoline,Triamterene may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valrubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Benzocaine.,increase,risk
Valrubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Benzyl alcohol.,increase,risk
Valrubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Bupivacaine.,increase,risk
Valrubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Butacaine.,increase,risk
Valrubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Butamben.,increase,risk
Valrubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Oxetacaine.,increase,risk
Valrubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Valrubicin is combined with Oxybuprocaine.,increase,risk
Rauwolfia serpentina root,Glycol salicylate,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Rauwolfia serpentina root,Guanabenz,Guanabenz may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Guanadrel,Guanadrel may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Guanethidine,Guanethidine may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Guanfacine,Guanfacine may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Guanoxan,Rauwolfia serpentina root may increase the hypotensive activities of Guanoxan.,increase,no risk
Rauwolfia serpentina root,Halothane,Halothane may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Hydralazine,Hydralazine may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Hydrochlorothiazide,The therapeutic efficacy of Rauwolfia serpentina root can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Rauwolfia serpentina root,Hydroflumethiazide,The therapeutic efficacy of Rauwolfia serpentina root can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Rauwolfia serpentina root,Ketoprofen,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Ketoprofen.,decrease,no risk
Rauwolfia serpentina root,Ketorolac,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Ketorolac.,decrease,no risk
Rauwolfia serpentina root,Obinutuzumab,Rauwolfia serpentina root may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Rauwolfia serpentina root,Olanzapine,Olanzapine may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Olmesartan,Olmesartan may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Olodaterol,Olodaterol may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Opicapone,Opicapone may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Oxaprozin,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Oxaprozin.,decrease,no risk
Rauwolfia serpentina root,Oxprenolol,Oxprenolol may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Oxymetazoline,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Rauwolfia serpentina root,Oxyphenbutazone,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Rauwolfia serpentina root,Quetiapine,Quetiapine may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Quinapril,Quinapril may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Quinidine,Quinidine may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Quinine,Quinine may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Quinupramine,Quinupramine may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Udenafil,Udenafil may increase the antihypertensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Unoprostone,Unoprostone may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Valdecoxib,The therapeutic efficacy of Rauwolfia serpentina root can be decreased when used in combination with Valdecoxib.,decrease,no risk
Rauwolfia serpentina root,Valsartan,Valsartan may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Vardenafil,Vardenafil may increase the antihypertensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Verapamil,Verapamil may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Vericiguat,Vericiguat may increase the hypotensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Vilanterol,Vilanterol may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Vilazodone,Vilazodone may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Xamoterol,Xamoterol may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Yohimbine,Yohimbine may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Rauwolfia serpentina root.,increase,no risk
Rauwolfia serpentina root,Zofenopril,Rauwolfia serpentina root may increase the hypotensive activities of Zofenopril.,increase,no risk
Rauwolfia serpentina root,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Rauwolfia serpentina root,Zuclopenthixol,Zuclopenthixol may decrease the antihypertensive activities of Rauwolfia serpentina root.,decrease,no risk
Procyclidine,Galantamine,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Galantamine.,decrease,no risk
Procyclidine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Procyclidine is combined with Gallamine triethiodide.,increase,risk
Procyclidine,Ginkgo biloba,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Procyclidine,Glucagon,Procyclidine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Procyclidine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Procyclidine.,decrease,no risk
Procyclidine,Glycopyrronium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Glycopyrronium.,increase,risk
Procyclidine,Guanabenz,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Guanabenz.,increase,risk
Procyclidine,Guanfacine,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Guanfacine.,increase,risk
Procyclidine,Haloperidol,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Haloperidol.,decrease,no risk
Procyclidine,Hexafluronium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Hexafluronium.,increase,risk
Procyclidine,Hexocyclium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Hexocyclium.,increase,risk
Procyclidine,Homatropine,The risk or severity of adverse effects can be increased when Procyclidine is combined with Homatropine.,increase,risk
Procyclidine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Procyclidine is combined with Homatropine methylbromide.,increase,risk
Procyclidine,Huperzine A,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Huperzine A.,decrease,no risk
Procyclidine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Procyclidine.,increase,no risk
Procyclidine,Hydrocodone,The risk or severity of adverse effects can be increased when Procyclidine is combined with Hydrocodone.,increase,risk
Procyclidine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Procyclidine.,increase,no risk
Procyclidine,Hydromorphone,The risk or severity of adverse effects can be increased when Procyclidine is combined with Hydromorphone.,increase,risk
Procyclidine,Hyoscyamine,The risk or severity of adverse effects can be increased when Procyclidine is combined with Hyoscyamine.,increase,risk
Procyclidine,Ketamine,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Ketamine.,decrease,no risk
Procyclidine,Olanzapine,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Olanzapine.,decrease,no risk
Procyclidine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Procyclidine is combined with Oliceridine.",increase,risk
Procyclidine,Olodaterol,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Olodaterol.,increase,risk
Procyclidine,Opium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Opium.,increase,risk
Procyclidine,Orciprenaline,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Orciprenaline.,increase,risk
Procyclidine,Orphenadrine,The risk or severity of adverse effects can be increased when Procyclidine is combined with Orphenadrine.,increase,risk
Procyclidine,Oxybutynin,The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxybutynin.,increase,risk
Procyclidine,Oxycodone,The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxycodone.,increase,risk
Procyclidine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Oxymetazoline.,increase,risk
Procyclidine,Oxymorphone,The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxymorphone.,increase,risk
Procyclidine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Procyclidine.,increase,risk
Procyclidine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Procyclidine.,decrease,no risk
Procyclidine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Procyclidine.,increase,risk
Procyclidine,Quetiapine,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Quetiapine.,decrease,no risk
Procyclidine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Procyclidine.,increase,no risk
Procyclidine,Quinidine,The risk or severity of adverse effects can be increased when Procyclidine is combined with Quinidine.,increase,risk
Procyclidine,Quinupramine,The risk or severity of adverse effects can be increased when Procyclidine is combined with Quinupramine.,increase,risk
Procyclidine,Umeclidinium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Umeclidinium.,increase,risk
Procyclidine,Vecuronium,The risk or severity of adverse effects can be increased when Procyclidine is combined with Vecuronium.,increase,risk
Procyclidine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Procyclidine.,increase,risk
Procyclidine,Vilanterol,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Vilanterol.,increase,risk
Procyclidine,Xamoterol,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Xamoterol.,increase,risk
Procyclidine,Xylometazoline,The risk or severity of Tachycardia can be increased when Procyclidine is combined with Xylometazoline.,increase,risk
Procyclidine,Ziprasidone,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Procyclidine,Zotepine,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Zotepine.,decrease,no risk
Procyclidine,Zuclopenthixol,The therapeutic efficacy of Procyclidine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Phenylephrine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Gallamine triethiodide.,increase,risk
Phenylephrine,Ginkgo biloba,The metabolism of Phenylephrine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Phenylephrine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Phenylephrine.,decrease,no risk
Phenylephrine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Glycopyrronium.,increase,risk
Phenylephrine,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Guanabenz,The metabolism of Guanabenz can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Guanadrel,Phenylephrine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Phenylephrine,Guanethidine,Phenylephrine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Phenylephrine,Guanfacine,Phenylephrine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Phenylephrine,Guanoxan,Phenylephrine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Phenylephrine,Halazepam,The risk or severity of hypertension can be decreased when Halazepam is combined with Phenylephrine.,decrease,risk
Phenylephrine,Halcinonide,The risk or severity of hypertension can be increased when Halcinonide is combined with Phenylephrine.,increase,risk
Phenylephrine,Haloperidol,The metabolism of Haloperidol can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Halothane,The risk or severity of hypertension can be increased when Phenylephrine is combined with Halothane.,increase,risk
Phenylephrine,Hexocyclium,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Hexocyclium.,increase,risk
Phenylephrine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Homatropine methylbromide.,increase,risk
Phenylephrine,Hyaluronidase,The risk or severity of adverse effects can be increased when Hyaluronidase is combined with Phenylephrine.,increase,risk
Phenylephrine,Hyaluronidase (human recombinant),The risk or severity of adverse effects can be increased when Hyaluronidase (human recombinant) is combined with Phenylephrine.,increase,risk
Phenylephrine,Hyaluronidase (ovine),The risk or severity of adverse effects can be increased when Hyaluronidase (ovine) is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydralazine,Phenylephrine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Phenylephrine,Hydrochlorothiazide,Phenylephrine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Phenylephrine,Hydrocortisone,The risk or severity of hypertension can be increased when Hydrocortisone is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone acetate,The risk or severity of hypertension can be increased when Hydrocortisone acetate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone butyrate,The risk or severity of hypertension can be increased when Hydrocortisone butyrate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone cypionate,The risk or severity of hypertension can be increased when Hydrocortisone cypionate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone probutate,The risk or severity of hypertension can be increased when Hydrocortisone probutate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone succinate,The risk or severity of hypertension can be increased when Hydrocortisone succinate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydrocortisone valerate,The risk or severity of hypertension can be increased when Hydrocortisone valerate is combined with Phenylephrine.,increase,risk
Phenylephrine,Hydroflumethiazide,Phenylephrine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Phenylephrine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Hyoscyamine.,increase,risk
Phenylephrine,Ketamine,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Ketamine.,increase,risk
Phenylephrine,Ketazolam,The risk or severity of hypertension can be decreased when Ketazolam is combined with Phenylephrine.,decrease,risk
Phenylephrine,Ketoprofen,The risk or severity of hypertension can be increased when Phenylephrine is combined with Ketoprofen.,increase,risk
Phenylephrine,Olanzapine,The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Olanzapine.,decrease,no risk
Phenylephrine,Olmesartan,Phenylephrine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Phenylephrine,Olodaterol,The risk or severity of hypertension can be increased when Phenylephrine is combined with Olodaterol.,increase,risk
Phenylephrine,Ondansetron,The metabolism of Ondansetron can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Orciprenaline,The risk or severity of hypertension can be increased when Phenylephrine is combined with Orciprenaline.,increase,risk
Phenylephrine,Orphenadrine,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Orphenadrine.,increase,risk
Phenylephrine,Oxaprozin,The risk or severity of hypertension can be increased when Phenylephrine is combined with Oxaprozin.,increase,risk
Phenylephrine,Oxazepam,The risk or severity of hypertension can be decreased when Oxazepam is combined with Phenylephrine.,decrease,risk
Phenylephrine,Oxprenolol,The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Phenylephrine,Oxtriphylline,The risk or severity of adverse effects can be increased when Phenylephrine is combined with Oxtriphylline.,increase,risk
Phenylephrine,Oxybutynin,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Oxybutynin.,increase,risk
Phenylephrine,Oxymetazoline,The absorption of Phenylephrine can be decreased when combined with Oxymetazoline.,decrease,no risk
Phenylephrine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Phenylephrine is combined with Oxyphenbutazone.,increase,risk
Phenylephrine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Phenylephrine.,increase,risk
Phenylephrine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phenylephrine.,increase,risk
Phenylephrine,Oxytocin,The risk or severity of hypertension can be increased when Oxytocin is combined with Phenylephrine.,increase,risk
Phenylephrine,Quazepam,The risk or severity of hypertension can be decreased when Quazepam is combined with Phenylephrine.,decrease,risk
Phenylephrine,Quetiapine,The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Quetiapine.,decrease,no risk
Phenylephrine,Quinapril,Phenylephrine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Phenylephrine,Quinidine,The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Quinidine.,decrease,no risk
Phenylephrine,Quinine,The metabolism of Quinine can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Quinupramine,Quinupramine may increase the vasopressor activities of Phenylephrine.,increase,no risk
Phenylephrine,Udenafil,The risk or severity of hypertension can be decreased when Udenafil is combined with Phenylephrine.,decrease,risk
Phenylephrine,Ulobetasol,The risk or severity of hypertension can be increased when Ulobetasol is combined with Phenylephrine.,increase,risk
Phenylephrine,Umeclidinium,The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Umeclidinium.,increase,risk
Phenylephrine,Valdecoxib,The risk or severity of hypertension can be increased when Phenylephrine is combined with Valdecoxib.,increase,risk
Phenylephrine,Valsartan,Phenylephrine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Phenylephrine,Vamorolone,The risk or severity of hypertension can be increased when Vamorolone is combined with Phenylephrine.,increase,risk
Phenylephrine,Vardenafil,The risk or severity of hypertension can be decreased when Vardenafil is combined with Phenylephrine.,decrease,risk
Phenylephrine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Phenylephrine.,increase,no risk
Phenylephrine,Verapamil,The risk or severity of hypertension can be decreased when Verapamil is combined with Phenylephrine.,decrease,risk
Phenylephrine,Vilanterol,The risk or severity of hypertension can be increased when Phenylephrine is combined with Vilanterol.,increase,risk
Phenylephrine,Vilazodone,The risk or severity of hypertension can be increased when Phenylephrine is combined with Vilazodone.,increase,risk
Phenylephrine,Vortioxetine,The risk or severity of hypertension can be increased when Phenylephrine is combined with Vortioxetine.,increase,risk
Phenylephrine,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Warfarin,The metabolism of Warfarin can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Xamoterol,The risk or severity of hypertension can be increased when Phenylephrine is combined with Xamoterol.,increase,risk
Phenylephrine,Xylometazoline,The risk or severity of hypertension can be decreased when Xylometazoline is combined with Phenylephrine.,decrease,risk
Phenylephrine,Yohimbine,The risk or severity of hypertension can be increased when Phenylephrine is combined with Yohimbine.,increase,risk
Phenylephrine,Ziconotide,The risk or severity of hypertension can be decreased when Ziconotide is combined with Phenylephrine.,decrease,risk
Phenylephrine,Zileuton,The metabolism of Zileuton can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Zimelidine,The metabolism of Phenylephrine can be decreased when combined with Zimelidine.,decrease,no risk
Phenylephrine,Ziprasidone,The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Phenylephrine,Zofenopril,Phenylephrine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Phenylephrine,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Zolpidem,The metabolism of Zolpidem can be increased when combined with Phenylephrine.,increase,no risk
Phenylephrine,Zonisamide,The risk or severity of hypertension can be decreased when Zonisamide is combined with Phenylephrine.,decrease,risk
Phenylephrine,Zotepine,The metabolism of Zotepine can be increased when combined with Phenylephrine.,increase,no risk
Carbimazole,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ganciclovir.",increase,risk
Carbimazole,Gefitinib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Gefitinib.,decrease,no risk
Carbimazole,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Gemfibrozil.",increase,risk
Carbimazole,Gilteritinib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Gilteritinib.,decrease,no risk
Carbimazole,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Carbimazole.,decrease,no risk
Carbimazole,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Carbimazole.,decrease,no risk
Carbimazole,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Carbimazole.,decrease,no risk
Carbimazole,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Carbimazole.,decrease,no risk
Carbimazole,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Carbimazole.,decrease,no risk
Carbimazole,Heparin,Carbimazole may increase the anticoagulant activities of Heparin.,increase,no risk
Carbimazole,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ofloxacin.",increase,risk
Carbimazole,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Carbimazole.,increase,risk
Carbimazole,Osimertinib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Osimertinib.,decrease,no risk
Carbimazole,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Carbimazole.,increase,no risk
Carbimazole,Oxtriphylline,Carbimazole may decrease the excretion rate of Oxtriphylline which could result in a higher serum level.,decrease,no risk
Carbimazole,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Carbimazole.,increase,risk
Carbimazole,Quinupramine,The risk or severity of Cardiac Arrhythmia can be increased when Carbimazole is combined with Quinupramine.,increase,risk
Carbimazole,Quizartinib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Quizartinib.,decrease,no risk
Carbimazole,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Ubidecarenone.",increase,risk
Carbimazole,Urokinase,Carbimazole may increase the anticoagulant activities of Urokinase.,increase,no risk
Carbimazole,Vandetanib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Vandetanib.,decrease,no risk
Carbimazole,Vemurafenib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Vemurafenib.,decrease,no risk
Carbimazole,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Vincristine.",increase,risk
Carbimazole,Vorapaxar,Carbimazole may increase the anticoagulant activities of Vorapaxar.,increase,no risk
Carbimazole,Warfarin,Carbimazole may increase the anticoagulant activities of Warfarin.,increase,no risk
Carbimazole,Ximelagatran,Carbimazole may increase the anticoagulant activities of Ximelagatran.,increase,no risk
Carbimazole,Zanubrutinib,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Carbimazole,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Zidovudine.",increase,risk
Carbimazole,Zimelidine,The therapeutic efficacy of Carbimazole can be decreased when used in combination with Zimelidine.,decrease,no risk
Digoxin,Bacitracin,Bacitracin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Baclofen,Baclofen may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Balsalazide,Balsalazide may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Baricitinib,Baricitinib may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Digoxin.,increase,risk
Digoxin,Bedaquiline,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bedaquiline.,increase,risk
Digoxin,Belantamab mafodotin,Digoxin may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Digoxin,Belinostat,The serum concentration of Digoxin can be increased when it is combined with Belinostat.,increase,no risk
Digoxin,Belumosudil,Belumosudil may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bemiparin,The risk or severity of hyperkalemia can be increased when Digoxin is combined with Bemiparin.,increase,risk
Digoxin,Bempedoic acid,The excretion of Digoxin can be decreased when combined with Bempedoic acid.,decrease,no risk
Digoxin,Benazepril,The risk or severity of hyperkalemia can be increased when Digoxin is combined with Benazepril.,increase,risk
Digoxin,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Bendroflumethiazide,Bendroflumethiazide may increase the hypokalemic activities of Digoxin.,increase,no risk
Digoxin,Benorilate,Benorilate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benserazide,Benserazide may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benzatropine,Benzatropine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benznidazole,Benznidazole may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benzthiazide,Benzthiazide may increase the hypokalemic activities of Digoxin.,increase,no risk
Digoxin,Benzydamine,Benzydamine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Digoxin.,decrease,no risk
Digoxin,Bepotastine,Bepotastine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bepridil,Digoxin may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Digoxin,Beractant,Digoxin may increase the bradycardic activities of Beractant.,increase,no risk
Digoxin,Berotralstat,The serum concentration of Digoxin can be increased when it is combined with Berotralstat.,increase,no risk
Digoxin,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Digoxin.,increase,risk
Digoxin,Betamethasone phosphate,The risk or severity of adverse effects can be increased when Betamethasone phosphate is combined with Digoxin.,increase,risk
Digoxin,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Digoxin.,increase,no risk
Digoxin,Betrixaban,The serum concentration of Digoxin can be increased when it is combined with Betrixaban.,increase,no risk
Digoxin,Bevacizumab,Digoxin may decrease the cardiotoxic activities of Bevacizumab.,decrease,no risk
Digoxin,Bezafibrate,The excretion of Digoxin can be decreased when combined with Bezafibrate.,decrease,no risk
Digoxin,Bicisate,Bicisate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bilastine,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Bilastine.,increase,risk
Digoxin,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Bioallethrin,Digoxin may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Digoxin,Bismuth subgallate,Bismuth subgallate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bismuth subnitrate,The serum concentration of Digoxin can be decreased when it is combined with Bismuth subnitrate.,decrease,no risk
Digoxin,Bismuth subsalicylate,The serum concentration of Digoxin can be decreased when it is combined with Bismuth subsalicylate.,decrease,no risk
Digoxin,Bisoprolol,The therapeutic efficacy of Digoxin can be increased when used in combination with Bisoprolol.,increase,no risk
Digoxin,Bisoxatin,Bisoxatin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bleomycin,Bleomycin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bortezomib,The serum concentration of Digoxin can be increased when it is combined with Bortezomib.,increase,no risk
Digoxin,Bosentan,Bosentan may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Botulinum toxin type A,The risk or severity of Cardiac Arrhythmia can be increased when Botulinum toxin type A is combined with Digoxin.,increase,risk
Digoxin,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Bretylium,Digoxin may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Digoxin,Brimonidine,Brimonidine may increase the bradycardic activities of Digoxin.,increase,no risk
Digoxin,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Brivaracetam,Brivaracetam may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bromazepam,Bromazepam may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Digoxin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Digoxin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Brompheniramine.,increase,risk
Digoxin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Digoxin.,increase,risk
Digoxin,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Digoxin.,increase,risk
Digoxin,Bumadizone,Bumadizone may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Bumetanide,The risk or severity of adverse effects can be increased when Bumetanide is combined with Digoxin.,increase,risk
Digoxin,Bupropion,Bupropion may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Buserelin,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Buserelin.,increase,risk
Digoxin,Buspirone,Buspirone may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Busulfan,Digoxin may decrease the cardiotoxic activities of Busulfan.,decrease,no risk
Digoxin,Butabarbital,Butabarbital may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Butriptyline,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Butriptyline.,increase,risk
Digoxin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadodiamide,Gadodiamide may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadoteridol,Gadoteridol may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Digoxin.,decrease,no risk
Digoxin,Galantamine,Digoxin may increase the bradycardic activities of Galantamine.,increase,no risk
Digoxin,Gallamine triethiodide,The risk or severity of Cardiac Arrhythmia can be increased when Gallamine triethiodide is combined with Digoxin.,increase,risk
Digoxin,Ganciclovir,Ganciclovir may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Gatifloxacin.,increase,risk
Digoxin,Gemcitabine,Gemcitabine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Gemifloxacin.,increase,risk
Digoxin,Gentamicin,The serum concentration of Digoxin can be increased when it is combined with Gentamicin.,increase,no risk
Digoxin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Digoxin.,increase,risk
Digoxin,Gilteritinib,The serum concentration of Digoxin can be increased when it is combined with Gilteritinib.,increase,no risk
Digoxin,Gimeracil,Gimeracil may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Givosiran,Givosiran may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glasdegib,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Glasdegib.,increase,risk
Digoxin,Glecaprevir,Glecaprevir may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glimepiride,Glimepiride may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glipizide,Glipizide may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glyburide,Glyburide may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glycine,The risk or severity of adverse effects can be increased when Glycine is combined with Digoxin.,increase,risk
Digoxin,Glycol salicylate,Glycol salicylate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Glycopyrronium,The serum concentration of Digoxin can be increased when it is combined with Glycopyrronium.,increase,no risk
Digoxin,Glycyrrhizic acid,Digoxin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Digoxin,Golodirsen,Golodirsen may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Goserelin,Goserelin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Granisetron,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Granisetron.,increase,risk
Digoxin,Grazoprevir,The serum concentration of Digoxin can be increased when it is combined with Grazoprevir.,increase,no risk
Digoxin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Grepafloxacin.,increase,risk
Digoxin,Guanethidine,Guanethidine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Guanfacine,Guanfacine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Halcinonide,The risk or severity of adverse effects can be increased when Halcinonide is combined with Digoxin.,increase,risk
Digoxin,Halofantrine,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Halofantrine.,increase,risk
Digoxin,Haloperidol,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Haloperidol.,increase,risk
Digoxin,Heparin,The risk or severity of hyperkalemia can be increased when Digoxin is combined with Heparin.,increase,risk
Digoxin,Histrelin,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Histrelin.,increase,risk
Digoxin,Hydralazine,Hydralazine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Hydrochlorothiazide,Hydrochlorothiazide may increase the hypokalemic activities of Digoxin.,increase,no risk
Digoxin,Hydrocortisone,The risk or severity of adverse effects can be increased when Hydrocortisone is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Hydrocortisone acetate is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Hydrocortisone butyrate is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone cypionate,The risk or severity of adverse effects can be increased when Hydrocortisone cypionate is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone probutate,The risk or severity of adverse effects can be increased when Hydrocortisone probutate is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Hydrocortisone succinate is combined with Digoxin.,increase,risk
Digoxin,Hydrocortisone valerate,The risk or severity of adverse effects can be increased when Hydrocortisone valerate is combined with Digoxin.,increase,risk
Digoxin,Hydroflumethiazide,Hydroflumethiazide may increase the hypokalemic activities of Digoxin.,increase,no risk
Digoxin,Hydromorphone,Hydromorphone may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Hydrotalcite,The serum concentration of Digoxin can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Digoxin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Hydroxychloroquine,The serum concentration of Digoxin can be increased when it is combined with Hydroxychloroquine.,increase,no risk
Digoxin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Hydroxyzine.,increase,risk
Digoxin,Hyoscyamine,Digoxin may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Digoxin,Kanamycin,Kanamycin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Kaolin,The serum concentration of Digoxin can be decreased when it is combined with Kaolin.,decrease,no risk
Digoxin,Ketamine,Ketamine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Ketazolam,Ketazolam may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Ketoconazole,The serum concentration of Digoxin can be increased when it is combined with Ketoconazole.,increase,no risk
Digoxin,Ketoprofen,Ketoprofen may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Ketorolac,Ketorolac may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Octinoxate,Octinoxate may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Octreotide,The serum concentration of Digoxin can be decreased when it is combined with Octreotide.,decrease,no risk
Digoxin,Ofloxacin,Digoxin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Digoxin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Digoxin.,increase,risk
Digoxin,Olodaterol,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Olodaterol.,increase,risk
Digoxin,Olsalazine,Olsalazine may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Omadacycline,Omadacycline can cause an increase in the absorption of Digoxin resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Digoxin,Ombitasvir,The serum concentration of Digoxin can be increased when it is combined with Ombitasvir.,increase,no risk
Digoxin,Omeprazole,The serum concentration of Digoxin can be increased when it is combined with Omeprazole.,increase,no risk
Digoxin,Ondansetron,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Ondansetron.,increase,risk
Digoxin,Opium,Opium may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Orphenadrine.,increase,risk
Digoxin,Oseltamivir,Oseltamivir may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Digoxin.,increase,no risk
Digoxin,Ouabain,The excretion of Ouabain can be decreased when combined with Digoxin.,decrease,no risk
Digoxin,Oxacillin,Oxacillin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Digoxin.,increase,risk
Digoxin,Oxaprozin,Oxaprozin may decrease the excretion rate of Digoxin which could result in a higher serum level.,decrease,no risk
Digoxin,Oxatomide,The risk or severity of QTc prolongation can be increased when Digoxin is combined with Oxatomide.,increase,risk
Sulpiride,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Sulpiride.,increase,risk
Sulpiride,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Sulpiride.,increase,risk
Sulpiride,Butaperazine,Butaperazine may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Butobarbital,The risk or severity of CNS depression can be increased when Sulpiride is combined with Butobarbital.,increase,risk
Sulpiride,Butorphanol,The risk or severity of CNS depression can be increased when Sulpiride is combined with Butorphanol.,increase,risk
Sulpiride,Butriptyline,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Butriptyline.,increase,risk
Sulpiride,Butylscopolamine,Butylscopolamine may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Gabapentin,The risk or severity of CNS depression can be increased when Sulpiride is combined with Gabapentin.,increase,risk
Sulpiride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Sulpiride is combined with Gabapentin enacarbil.,increase,risk
Sulpiride,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Gadobenic acid.,increase,risk
Sulpiride,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Sulpiride.,increase,risk
Sulpiride,Gallamine triethiodide,Gallamine triethiodide may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Sulpiride is combined with Ganaxolone.",increase,risk
Sulpiride,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Sulpiride.,increase,risk
Sulpiride,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Gemifloxacin.,increase,risk
Sulpiride,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sulpiride.,increase,risk
Sulpiride,Gilteritinib,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Gilteritinib.,increase,risk
Sulpiride,Glasdegib,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Glasdegib.,increase,risk
Sulpiride,Glutethimide,The risk or severity of CNS depression can be increased when Sulpiride is combined with Glutethimide.,increase,risk
Sulpiride,Glycopyrronium,Glycopyrronium may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Sulpiride.,increase,risk
Sulpiride,Granisetron,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Granisetron.,increase,risk
Sulpiride,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Grepafloxacin.,increase,risk
Sulpiride,Guanfacine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Guanfacine.,increase,risk
Sulpiride,Halazepam,The risk or severity of CNS depression can be increased when Sulpiride is combined with Halazepam.,increase,risk
Sulpiride,Halofantrine,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Halofantrine.,increase,risk
Sulpiride,Haloperidol,Haloperidol may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Halothane,The risk or severity of CNS depression can be increased when Sulpiride is combined with Halothane.,increase,risk
Sulpiride,Hexafluronium,The risk or severity of CNS depression can be increased when Sulpiride is combined with Hexafluronium.,increase,risk
Sulpiride,Hexocyclium,Hexocyclium may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Sulpiride.,increase,risk
Sulpiride,Homatropine methylbromide,Homatropine methylbromide may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Hydrochlorothiazide,The risk or severity of orthostatic hypotension can be increased when Hydrochlorothiazide is combined with Sulpiride.,increase,risk
Sulpiride,Hydrocodone,Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Sulpiride,Hydrocortisone,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Sulpiride,Hydrocortisone acetate,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Sulpiride,Hydrocortisone butyrate,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Sulpiride,Hydrocortisone cypionate,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Sulpiride,Hydrocortisone succinate,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Sulpiride,Hydroflumethiazide,The risk or severity of orthostatic hypotension can be increased when Hydroflumethiazide is combined with Sulpiride.,increase,risk
Sulpiride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Sulpiride.,increase,risk
Sulpiride,Hydrotalcite,The therapeutic efficacy of Sulpiride can be increased when used in combination with Hydrotalcite.,increase,no risk
Sulpiride,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Sulpiride.,increase,risk
Sulpiride,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Hydroxyzine.,increase,risk
Sulpiride,Hyoscyamine,Hyoscyamine may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Ketamine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Ketamine.,increase,risk
Sulpiride,Ketazolam,The risk or severity of CNS depression can be increased when Sulpiride is combined with Ketazolam.,increase,risk
Sulpiride,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Sulpiride.,increase,risk
Sulpiride,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Sulpiride.,increase,risk
Sulpiride,Ofloxacin,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Ofloxacin.,increase,risk
Sulpiride,Olanzapine,Olanzapine may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sulpiride is combined with Oliceridine.",increase,risk
Sulpiride,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Sulpiride.,increase,risk
Sulpiride,Omeprazole,The therapeutic efficacy of Sulpiride can be increased when used in combination with Omeprazole.,increase,no risk
Sulpiride,Ondansetron,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Ondansetron.,increase,risk
Sulpiride,Opium,The risk or severity of CNS depression can be increased when Sulpiride is combined with Opium.,increase,risk
Sulpiride,Orphenadrine,Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Sulpiride,Ouabain,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Ouabain.,increase,risk
Sulpiride,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sulpiride.,increase,risk
Sulpiride,Oxatomide,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Oxatomide.,increase,risk
Sulpiride,Oxazepam,The risk or severity of CNS depression can be increased when Sulpiride is combined with Oxazepam.,increase,risk
Sulpiride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Oxcarbazepine.,increase,risk
Sulpiride,Oxitriptan,The risk or severity of CNS depression can be increased when Sulpiride is combined with Oxitriptan.,increase,risk
Sulpiride,Oxprenolol,Sulpiride may increase the bradycardic activities of Oxprenolol.,increase,no risk
Sulpiride,Oxybuprocaine,Sulpiride may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Sulpiride,Oxybutynin,Oxybutynin may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Oxycodone,The risk or severity of CNS depression can be increased when Sulpiride is combined with Oxycodone.,increase,risk
Sulpiride,Oxymorphone,The risk or severity of CNS depression can be increased when Sulpiride is combined with Oxymorphone.,increase,risk
Sulpiride,Oxyphencyclimine,Oxyphencyclimine may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Oxyphenonium,Oxyphenonium may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sulpiride.,increase,risk
Sulpiride,Quazepam,The risk or severity of CNS depression can be increased when Sulpiride is combined with Quazepam.,increase,risk
Sulpiride,Quetiapine,Quetiapine may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Sulpiride.,decrease,no risk
Sulpiride,Quinethazone,The risk or severity of orthostatic hypotension can be increased when Quinethazone is combined with Sulpiride.,increase,risk
Sulpiride,Quinidine,Quinidine may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Quinine,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Quinine.,increase,risk
Sulpiride,Quinupramine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Quinupramine.,increase,risk
Sulpiride,Quizartinib,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Quizartinib.,increase,risk
Sulpiride,Umeclidinium,Umeclidinium may increase the anticholinergic activities of Sulpiride.,increase,no risk
Sulpiride,Urethane,The risk or severity of CNS depression can be increased when Sulpiride is combined with Urethane.,increase,risk
Sulpiride,Valproate bismuth,Sulpiride may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Sulpiride,Valproic acid,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Valproic acid.,increase,risk
Sulpiride,Vamorolone,The therapeutic efficacy of Sulpiride can be decreased when used in combination with Vamorolone.,decrease,no risk
Sulpiride,Vandetanib,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Vandetanib.,increase,risk
Sulpiride,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Sulpiride.,increase,risk
Sulpiride,Varenicline,The risk or severity of adverse effects can be increased when Sulpiride is combined with Varenicline.,increase,risk
Sulpiride,Vecuronium,The risk or severity of CNS depression can be increased when Sulpiride is combined with Vecuronium.,increase,risk
Sulpiride,Vemurafenib,The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Vemurafenib.,increase,risk
Sulpiride,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Sulpiride.,increase,risk
Sulpiride,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Sulpiride.,increase,risk
Sulpiride,Vigabatrin,The risk or severity of CNS depression can be increased when Sulpiride is combined with Vigabatrin.,increase,risk
Sulpiride,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sulpiride.,increase,risk
Sulpiride,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Sulpiride.,increase,risk
Sulpiride,Viloxazine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Viloxazine.,increase,risk
Sulpiride,Vincristine,Sulpiride may increase the neurotoxic activities of Vincristine.,increase,no risk
Sulpiride,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Sulpiride.,increase,no risk
Sulpiride,Viomycin,Sulpiride may increase the neurotoxic activities of Viomycin.,increase,no risk
Sulpiride,Vonoprazan,The therapeutic efficacy of Sulpiride can be increased when used in combination with Vonoprazan.,increase,no risk
Sulpiride,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Sulpiride.,increase,risk
Sulpiride,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Sulpiride.,increase,risk
Sulpiride,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sulpiride.,increase,risk
Sulpiride,Warfarin,The risk or severity of adverse effects can be increased when Sulpiride is combined with Warfarin.,increase,risk
Sulpiride,Yohimbine,The risk or severity of CNS depression can be increased when Sulpiride is combined with Yohimbine.,increase,risk
Sulpiride,Zaleplon,The risk or severity of CNS depression can be increased when Sulpiride is combined with Zaleplon.,increase,risk
Sulpiride,Ziconotide,The risk or severity of CNS depression can be increased when Sulpiride is combined with Ziconotide.,increase,risk
Sulpiride,Zimelidine,The risk or severity of adverse effects can be increased when Sulpiride is combined with Zimelidine.,increase,risk
Sulpiride,Ziprasidone,Ziprasidone may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sulpiride.,increase,risk
Sulpiride,Zolpidem,Sulpiride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Sulpiride,Zonisamide,The risk or severity of CNS depression can be increased when Sulpiride is combined with Zonisamide.,increase,risk
Sulpiride,Zopiclone,The risk or severity of adverse effects can be increased when Sulpiride is combined with Zopiclone.,increase,risk
Sulpiride,Zotepine,Zotepine may increase the antipsychotic activities of Sulpiride.,increase,no risk
Sulpiride,Zuclopenthixol,Zuclopenthixol may increase the antipsychotic activities of Sulpiride.,increase,no risk
Profenamine,Galantamine,The therapeutic efficacy of Profenamine can be decreased when used in combination with Galantamine.,decrease,no risk
Profenamine,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Profenamine is combined with Gallamine triethiodide.,increase,risk
Profenamine,Ginkgo biloba,The therapeutic efficacy of Profenamine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Profenamine,Glucagon,Profenamine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Profenamine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Glycopyrronium,The risk or severity of adverse effects can be increased when Profenamine is combined with Glycopyrronium.,increase,risk
Profenamine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Haloperidol,The therapeutic efficacy of Profenamine can be decreased when used in combination with Haloperidol.,decrease,no risk
Profenamine,Hexafluronium,The risk or severity of adverse effects can be increased when Profenamine is combined with Hexafluronium.,increase,risk
Profenamine,Hexocyclium,The risk or severity of adverse effects can be increased when Profenamine is combined with Hexocyclium.,increase,risk
Profenamine,Homatropine,The risk or severity of adverse effects can be increased when Profenamine is combined with Homatropine.,increase,risk
Profenamine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Profenamine is combined with Homatropine methylbromide.,increase,risk
Profenamine,Huperzine A,The therapeutic efficacy of Profenamine can be decreased when used in combination with Huperzine A.,decrease,no risk
Profenamine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Profenamine.,increase,no risk
Profenamine,Hydrocodone,The risk or severity of adverse effects can be increased when Profenamine is combined with Hydrocodone.,increase,risk
Profenamine,Hydrocortisone,The therapeutic efficacy of Profenamine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Profenamine,Hydrocortisone acetate,The therapeutic efficacy of Profenamine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Profenamine,Hydrocortisone butyrate,The therapeutic efficacy of Profenamine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Profenamine,Hydrocortisone cypionate,The therapeutic efficacy of Profenamine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Profenamine,Hydrocortisone succinate,The therapeutic efficacy of Profenamine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Profenamine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Profenamine.,increase,no risk
Profenamine,Hydromorphone,The risk or severity of adverse effects can be increased when Profenamine is combined with Hydromorphone.,increase,risk
Profenamine,Hyoscyamine,The risk or severity of adverse effects can be increased when Profenamine is combined with Hyoscyamine.,increase,risk
Profenamine,Ketamine,The therapeutic efficacy of Profenamine can be decreased when used in combination with Ketamine.,decrease,no risk
Profenamine,Olanzapine,The therapeutic efficacy of Profenamine can be decreased when used in combination with Olanzapine.,decrease,no risk
Profenamine,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Profenamine is combined with Oliceridine.",increase,risk
Profenamine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Opium,The risk or severity of adverse effects can be increased when Profenamine is combined with Opium.,increase,risk
Profenamine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Orphenadrine,The risk or severity of adverse effects can be increased when Profenamine is combined with Orphenadrine.,increase,risk
Profenamine,Oxprenolol,Profenamine may increase the bradycardic activities of Oxprenolol.,increase,no risk
Profenamine,Oxybuprocaine,Profenamine may increase the neuromuscular blocking activities of Oxybuprocaine.,increase,no risk
Profenamine,Oxybutynin,The risk or severity of adverse effects can be increased when Profenamine is combined with Oxybutynin.,increase,risk
Profenamine,Oxycodone,The risk or severity of adverse effects can be increased when Profenamine is combined with Oxycodone.,increase,risk
Profenamine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Oxymorphone,The risk or severity of adverse effects can be increased when Profenamine is combined with Oxymorphone.,increase,risk
Profenamine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Profenamine.,increase,risk
Profenamine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Profenamine.,increase,risk
Profenamine,Quetiapine,The therapeutic efficacy of Profenamine can be decreased when used in combination with Quetiapine.,decrease,no risk
Profenamine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Profenamine.,increase,no risk
Profenamine,Quinidine,The risk or severity of adverse effects can be increased when Profenamine is combined with Quinidine.,increase,risk
Profenamine,Quinupramine,The risk or severity of adverse effects can be increased when Profenamine is combined with Quinupramine.,increase,risk
Profenamine,Umeclidinium,The risk or severity of adverse effects can be increased when Profenamine is combined with Umeclidinium.,increase,risk
Profenamine,Vamorolone,The therapeutic efficacy of Profenamine can be decreased when used in combination with Vamorolone.,decrease,no risk
Profenamine,Varenicline,The risk or severity of adverse effects can be increased when Profenamine is combined with Varenicline.,increase,risk
Profenamine,Vecuronium,The risk or severity of adverse effects can be increased when Profenamine is combined with Vecuronium.,increase,risk
Profenamine,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Profenamine.,increase,risk
Profenamine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Profenamine.,decrease,no risk
Profenamine,Ziprasidone,The therapeutic efficacy of Profenamine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Profenamine,Zotepine,The therapeutic efficacy of Profenamine can be decreased when used in combination with Zotepine.,decrease,no risk
Profenamine,Zuclopenthixol,The therapeutic efficacy of Profenamine can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Nimodipine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Nimodipine.,increase,risk
Nimodipine,Bumadizone,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Bumadizone.,decrease,no risk
Nimodipine,Bumetanide,The risk or severity of adverse effects can be increased when Nimodipine is combined with Bumetanide.,increase,risk
Nimodipine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nimodipine.,increase,risk
Nimodipine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Nimodipine.,increase,risk
Nimodipine,Buspirone,Buspirone may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Nimodipine,Butabarbital,Butabarbital may increase the hypotensive activities of Nimodipine.,increase,no risk
Nimodipine,Butalbital,Butalbital may increase the hypotensive activities of Nimodipine.,increase,no risk
Nimodipine,Butriptyline,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Butriptyline.,increase,risk
Nimodipine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Gadobenic acid.,increase,risk
Nimodipine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Nimodipine.,increase,risk
Nimodipine,Gallamine triethiodide,Nimodipine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Nimodipine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Nimodipine.,increase,risk
Nimodipine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Gemifloxacin.,increase,risk
Nimodipine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Nimodipine.,increase,risk
Nimodipine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Gilteritinib.,increase,risk
Nimodipine,Glasdegib,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Glasdegib.,increase,risk
Nimodipine,Gliclazide,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Gliclazide.,increase,risk
Nimodipine,Glimepiride,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glimepiride.,increase,risk
Nimodipine,Glipizide,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glipizide.,increase,risk
Nimodipine,Gliquidone,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Gliquidone.,increase,risk
Nimodipine,Glofitamab,The serum concentration of Nimodipine can be increased when it is combined with Glofitamab.,increase,no risk
Nimodipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nimodipine.,decrease,no risk
Nimodipine,Glyburide,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glyburide.,increase,risk
Nimodipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Nimodipine.,decrease,no risk
Nimodipine,Glycol salicylate,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Nimodipine,Glymidine,The risk or severity of hypoglycemia can be increased when Nimodipine is combined with Glymidine.,increase,risk
Nimodipine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nimodipine.,increase,risk
Nimodipine,Granisetron,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Granisetron.,increase,risk
Nimodipine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Grepafloxacin.,increase,risk
Nimodipine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Nimodipine,Guanadrel,Guanadrel may increase the hypotensive activities of Nimodipine.,increase,no risk
Nimodipine,Guanethidine,Nimodipine may increase the hypotensive activities of Guanethidine.,increase,no risk
Nimodipine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Nimodipine,Guanoxan,Nimodipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Nimodipine,Halofantrine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Halofantrine.,increase,risk
Nimodipine,Haloperidol,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Haloperidol.,increase,risk
Nimodipine,Halothane,Halothane may decrease the antihypertensive activities of Nimodipine.,decrease,no risk
Nimodipine,Heparin,The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Heparin.,increase,risk
Nimodipine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Nimodipine.,increase,risk
Nimodipine,Hydralazine,Nimodipine may increase the hypotensive activities of Hydralazine.,increase,no risk
Nimodipine,Hydrochlorothiazide,The therapeutic efficacy of Nimodipine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Nimodipine,Hydroflumethiazide,The therapeutic efficacy of Nimodipine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Nimodipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Nimodipine.,increase,risk
Nimodipine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Nimodipine.,increase,risk
Nimodipine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Hydroxyzine.,increase,risk
Nimodipine,Hyoscyamine,Nimodipine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Nimodipine,Ketoconazole,The metabolism of Nimodipine can be decreased when combined with Ketoconazole.,decrease,no risk
Nimodipine,Ketoprofen,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Nimodipine,Ketorolac,The therapeutic efficacy of Nimodipine can be decreased when used in combination with Ketorolac.,decrease,no risk
Beclomethasone dipropionate,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Betaine,The therapeutic efficacy of Betaine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Betamethasone,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Betamethasone.,increase,risk
Beclomethasone dipropionate,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Bexagliflozin.,increase,risk
Beclomethasone dipropionate,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Bimekizumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Bimekizumab.,increase,risk
Beclomethasone dipropionate,Binimetinib,Beclomethasone dipropionate may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Blinatumomab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Blinatumomab.,increase,risk
Beclomethasone dipropionate,Boceprevir,The metabolism of Beclomethasone dipropionate can be decreased when combined with Boceprevir.,decrease,no risk
Beclomethasone dipropionate,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Beclomethasone dipropionate.",decrease,no risk
Beclomethasone dipropionate,Bortezomib,The metabolism of Bortezomib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Bosentan,The excretion of Bosentan can be decreased when combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Bosutinib,The metabolism of Bosutinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Brigatinib,The metabolism of Brigatinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Brodalumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Brodalumab.,increase,risk
Beclomethasone dipropionate,Bromocriptine,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Bromocriptine.,increase,risk
Beclomethasone dipropionate,Budesonide,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Budesonide.,increase,risk
Beclomethasone dipropionate,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Bumadizone.,increase,risk
Beclomethasone dipropionate,Bumetanide,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Bumetanide.,increase,risk
Beclomethasone dipropionate,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Buspirone,The metabolism of Buspirone can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Busulfan,The metabolism of Busulfan can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Gatifloxacin,The risk or severity of tendinopathy can be increased when Beclomethasone dipropionate is combined with Gatifloxacin.,increase,risk
Beclomethasone dipropionate,Gefitinib,Beclomethasone dipropionate may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Gemcitabine,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Gemcitabine.,increase,risk
Beclomethasone dipropionate,Gemifloxacin,The risk or severity of tendinopathy can be increased when Beclomethasone dipropionate is combined with Gemifloxacin.,increase,risk
Beclomethasone dipropionate,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Gestrinone,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Gestrinone.,increase,no risk
Beclomethasone dipropionate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Glasdegib,Beclomethasone dipropionate may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Glatiramer,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Glatiramer.,increase,risk
Beclomethasone dipropionate,Glecaprevir,Beclomethasone dipropionate may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Gliclazide,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Gliclazide.,increase,risk
Beclomethasone dipropionate,Glimepiride,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Glimepiride.,increase,risk
Beclomethasone dipropionate,Glipizide,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Glipizide.,increase,risk
Beclomethasone dipropionate,Gliquidone,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Gliquidone.,increase,risk
Beclomethasone dipropionate,Glofitamab,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Glofitamab.,increase,no risk
Beclomethasone dipropionate,Glyburide,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Glyburide.,increase,risk
Beclomethasone dipropionate,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Glycol salicylate.,increase,risk
Beclomethasone dipropionate,Glymidine,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Glymidine.,increase,risk
Beclomethasone dipropionate,Golimumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Golimumab.,increase,risk
Beclomethasone dipropionate,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Grepafloxacin,The risk or severity of tendinopathy can be increased when Beclomethasone dipropionate is combined with Grepafloxacin.,increase,risk
Beclomethasone dipropionate,Guselkumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Guselkumab.,increase,risk
Beclomethasone dipropionate,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Halofantrine,The metabolism of Halofantrine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Beclomethasone dipropionate is combined with Hydrochlorothiazide.,increase,risk
Beclomethasone dipropionate,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydrocortisone acetate.,increase,risk
Beclomethasone dipropionate,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydrocortisone butyrate.,increase,risk
Beclomethasone dipropionate,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydrocortisone succinate.,increase,risk
Beclomethasone dipropionate,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Beclomethasone dipropionate is combined with Hydroflumethiazide.,increase,risk
Beclomethasone dipropionate,Hydrotalcite,The bioavailability of Beclomethasone dipropionate can be decreased when combined with Hydrotalcite.,decrease,no risk
Beclomethasone dipropionate,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydroxychloroquine.,increase,risk
Beclomethasone dipropionate,Hydroxyprogesterone caproate,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Beclomethasone dipropionate,Hydroxyurea,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Hydroxyurea.,increase,risk
Beclomethasone dipropionate,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Ketoconazole,The metabolism of Beclomethasone dipropionate can be decreased when combined with Ketoconazole.,decrease,no risk
Beclomethasone dipropionate,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Ketoprofen.,increase,risk
Beclomethasone dipropionate,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Ketorolac.,increase,risk
Beclomethasone dipropionate,Obinutuzumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Obinutuzumab.,increase,risk
Beclomethasone dipropionate,Ocrelizumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ocrelizumab.,increase,risk
Beclomethasone dipropionate,Ofatumumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Ofatumumab.,increase,risk
Beclomethasone dipropionate,Ofloxacin,The risk or severity of tendinopathy can be increased when Beclomethasone dipropionate is combined with Ofloxacin.,increase,risk
Beclomethasone dipropionate,Olaparib,The metabolism of Olaparib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Olodaterol,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Olodaterol.,increase,risk
Beclomethasone dipropionate,Omaveloxolone,The serum concentration of Beclomethasone dipropionate can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Beclomethasone dipropionate,Ombitasvir,Beclomethasone dipropionate may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Ondansetron,The metabolism of Ondansetron can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Orciprenaline,The risk or severity of hypokalemia can be increased when Beclomethasone dipropionate is combined with Orciprenaline.,increase,risk
Beclomethasone dipropionate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Ouabain,The excretion of Ouabain can be decreased when combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Oxaliplatin,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Oxaliplatin.,increase,risk
Beclomethasone dipropionate,Oxandrolone,The risk or severity of fluid retention can be increased when Beclomethasone dipropionate is combined with Oxandrolone.,increase,risk
Beclomethasone dipropionate,Oxaprozin,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Oxaprozin.,increase,risk
Beclomethasone dipropionate,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Oxycodone,The metabolism of Oxycodone can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Oxymetazoline,The absorption of Beclomethasone dipropionate can be decreased when combined with Oxymetazoline.,decrease,no risk
Beclomethasone dipropionate,Oxymetholone,The risk or severity of fluid retention can be increased when Beclomethasone dipropionate is combined with Oxymetholone.,increase,risk
Beclomethasone dipropionate,Oxyphenbutazone,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Oxyphenbutazone.,increase,risk
Beclomethasone dipropionate,Ozanimod,Beclomethasone dipropionate may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Quetiapine,The metabolism of Quetiapine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Quinethazone,Beclomethasone dipropionate may increase the hypokalemic activities of Quinethazone.,increase,no risk
Beclomethasone dipropionate,Quinidine,The metabolism of Quinidine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Quinine,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Quinine.,increase,risk
Beclomethasone dipropionate,Quizartinib,The metabolism of Quizartinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Udenafil,The metabolism of Udenafil can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Ulipristal,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Ulipristal.,increase,no risk
Beclomethasone dipropionate,Upadacitinib,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Upadacitinib.,increase,risk
Beclomethasone dipropionate,Vadadustat,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Vadadustat.,increase,no risk
Beclomethasone dipropionate,Valbenazine,The metabolism of Valbenazine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Valdecoxib,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Valdecoxib.,increase,risk
Beclomethasone dipropionate,Valsartan,The excretion of Valsartan can be decreased when combined with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vardenafil,The metabolism of Vardenafil can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Vecuronium,The risk or severity of myopathy and weakness can be increased when Vecuronium is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Vedolizumab,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Vedolizumab.,increase,risk
Beclomethasone dipropionate,Velpatasvir,Beclomethasone dipropionate may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Venetoclax,The metabolism of Venetoclax can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Verapamil,The metabolism of Beclomethasone dipropionate can be decreased when combined with Verapamil.,decrease,no risk
Beclomethasone dipropionate,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Vilanterol,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Vilanterol.,increase,risk
Beclomethasone dipropionate,Vildagliptin,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Vildagliptin.,increase,risk
Beclomethasone dipropionate,Viloxazine,The metabolism of Beclomethasone dipropionate can be decreased when combined with Viloxazine.,decrease,no risk
Beclomethasone dipropionate,Vinblastine,The metabolism of Vinblastine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vincristine,The metabolism of Vincristine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vindesine,The metabolism of Vindesine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vinflunine,The metabolism of Vinflunine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vitamin D,The therapeutic efficacy of Vitamin D can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Beclomethasone dipropionate,Voclosporin,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Voclosporin.,increase,risk
Beclomethasone dipropionate,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Voriconazole,The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Voriconazole.,increase,no risk
Beclomethasone dipropionate,Vorinostat,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Vorinostat.,increase,risk
Beclomethasone dipropionate,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Voxilaprevir,Beclomethasone dipropionate may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Beclomethasone dipropionate,Warfarin,Beclomethasone dipropionate may increase the anticoagulant activities of Warfarin.,increase,no risk
Beclomethasone dipropionate,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Beclomethasone dipropionate.,increase,risk
Beclomethasone dipropionate,Zaleplon,The metabolism of Zaleplon can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zidovudine,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Zidovudine.,increase,risk
Beclomethasone dipropionate,Zimelidine,The metabolism of Beclomethasone dipropionate can be decreased when combined with Zimelidine.,decrease,no risk
Beclomethasone dipropionate,Ziprasidone,The metabolism of Beclomethasone dipropionate can be decreased when combined with Ziprasidone.,decrease,no risk
Beclomethasone dipropionate,Zolpidem,The metabolism of Zolpidem can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zonisamide,The metabolism of Zonisamide can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Beclomethasone dipropionate,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Beclomethasone dipropionate.,decrease,no risk
Carisoprodol,Gabapentin,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin.,increase,risk
Carisoprodol,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gabapentin enacarbil.,increase,risk
Carisoprodol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gallamine triethiodide.,increase,risk
Carisoprodol,Ganaxolone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ganaxolone.,increase,risk
Carisoprodol,Gemfibrozil,The metabolism of Carisoprodol can be decreased when combined with Gemfibrozil.,decrease,no risk
Carisoprodol,Gepirone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Gepirone.,increase,risk
Carisoprodol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Carisoprodol.,decrease,no risk
Carisoprodol,Glofitamab,The serum concentration of Carisoprodol can be increased when it is combined with Glofitamab.,increase,no risk
Carisoprodol,Glutethimide,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Glutethimide.,increase,risk
Carisoprodol,Glyburide,The metabolism of Glyburide can be decreased when combined with Carisoprodol.,decrease,no risk
Carisoprodol,Golimumab,The metabolism of Carisoprodol can be increased when combined with Golimumab.,increase,no risk
Carisoprodol,Granisetron,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Granisetron.,increase,risk
Carisoprodol,Guanfacine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Guanfacine.,increase,risk
Carisoprodol,Halazepam,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Halazepam.,increase,risk
Carisoprodol,Haloperidol,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Haloperidol.,increase,risk
Carisoprodol,Halothane,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Halothane.,increase,risk
Carisoprodol,Hexafluronium,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Hexafluronium.,increase,risk
Carisoprodol,Hydrocodone,Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Carisoprodol,Hydromorphone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Hydromorphone.,increase,risk
Carisoprodol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carisoprodol.,increase,no risk
Carisoprodol,Ketamine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ketamine.,increase,risk
Carisoprodol,Ketazolam,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ketazolam.,increase,risk
Carisoprodol,Olanzapine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Olanzapine.,increase,risk
Carisoprodol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Carisoprodol is combined with Oliceridine.",increase,risk
Carisoprodol,Omeprazole,The metabolism of Carisoprodol can be decreased when combined with Omeprazole.,decrease,no risk
Carisoprodol,Ondansetron,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ondansetron.,increase,risk
Carisoprodol,Opium,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Opium.,increase,risk
Carisoprodol,Oritavancin,The metabolism of Carisoprodol can be decreased when combined with Oritavancin.,decrease,no risk
Carisoprodol,Orphenadrine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Orphenadrine.,increase,risk
Carisoprodol,Osilodrostat,The metabolism of Carisoprodol can be decreased when combined with Osilodrostat.,decrease,no risk
Carisoprodol,Oxazepam,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxazepam.,increase,risk
Carisoprodol,Oxcarbazepine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxcarbazepine.,increase,risk
Carisoprodol,Oxitriptan,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxitriptan.,increase,risk
Carisoprodol,Oxprenolol,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxprenolol.,increase,risk
Carisoprodol,Oxybuprocaine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxybuprocaine.,increase,risk
Carisoprodol,Oxycodone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxycodone.,increase,risk
Carisoprodol,Oxymorphone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Oxymorphone.,increase,risk
Carisoprodol,Quazepam,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quazepam.,increase,risk
Carisoprodol,Quetiapine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quetiapine.,increase,risk
Carisoprodol,Quinine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quinine.,increase,risk
Carisoprodol,Quinupramine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Quinupramine.,increase,risk
Carisoprodol,Urethane,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Urethane.,increase,risk
Carisoprodol,Valproic acid,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Valproic acid.,increase,risk
Carisoprodol,Vecuronium,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vecuronium.,increase,risk
Carisoprodol,Venlafaxine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Venlafaxine.,increase,risk
Carisoprodol,Vigabatrin,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vigabatrin.,increase,risk
Carisoprodol,Vilazodone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vilazodone.,increase,risk
Carisoprodol,Viloxazine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Viloxazine.,increase,risk
Carisoprodol,Vonoprazan,The metabolism of Carisoprodol can be decreased when combined with Vonoprazan.,decrease,no risk
Carisoprodol,Voriconazole,The metabolism of Carisoprodol can be decreased when combined with Voriconazole.,decrease,no risk
Carisoprodol,Vortioxetine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Vortioxetine.,increase,risk
Carisoprodol,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Carisoprodol.,decrease,no risk
Carisoprodol,Yohimbine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Yohimbine.,increase,risk
Carisoprodol,Zafirlukast,The metabolism of Carisoprodol can be decreased when combined with Zafirlukast.,decrease,no risk
Carisoprodol,Zaleplon,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zaleplon.,increase,risk
Carisoprodol,Ziconotide,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ziconotide.,increase,risk
Carisoprodol,Zimelidine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zimelidine.,increase,risk
Carisoprodol,Ziprasidone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ziprasidone.,increase,risk
Carisoprodol,Zolmitriptan,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zolmitriptan.,increase,risk
Carisoprodol,Zolpidem,Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Carisoprodol,Zonisamide,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zonisamide.,increase,risk
Carisoprodol,Zopiclone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zopiclone.,increase,risk
Carisoprodol,Zotepine,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zotepine.,increase,risk
Carisoprodol,Zuclopenthixol,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zuclopenthixol.,increase,risk
Carisoprodol,Zuranolone,The risk or severity of adverse effects can be increased when Carisoprodol is combined with Zuranolone.,increase,risk
Progesterone,Binimetinib,Progesterone may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Progesterone,Biperiden,The metabolism of Progesterone can be decreased when combined with Biperiden.,decrease,no risk
Progesterone,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Boceprevir,The serum concentration of Progesterone can be increased when it is combined with Boceprevir.,increase,no risk
Progesterone,Bortezomib,The metabolism of Progesterone can be decreased when combined with Bortezomib.,decrease,no risk
Progesterone,Bosentan,The serum concentration of Progesterone can be decreased when it is combined with Bosentan.,decrease,no risk
Progesterone,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Brexanolone,The metabolism of Progesterone can be increased when combined with Brexanolone.,increase,no risk
Progesterone,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Brigatinib,Progesterone may decrease the excretion rate of Brigatinib which could result in a higher serum level.,decrease,no risk
Progesterone,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Brivaracetam,The metabolism of Progesterone can be increased when combined with Brivaracetam.,increase,no risk
Progesterone,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Bupivacaine,The metabolism of Progesterone can be decreased when combined with Bupivacaine.,decrease,no risk
Progesterone,Buprenorphine,The metabolism of Progesterone can be decreased when combined with Buprenorphine.,decrease,no risk
Progesterone,Bupropion,The metabolism of Progesterone can be decreased when combined with Bupropion.,decrease,no risk
Progesterone,Buspirone,The metabolism of Buspirone can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Butalbital,The metabolism of Progesterone can be increased when combined with Butalbital.,increase,no risk
Progesterone,Gabapentin,The metabolism of Progesterone can be increased when combined with Gabapentin.,increase,no risk
Progesterone,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Galantamine,The metabolism of Galantamine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ganaxolone,The metabolism of Progesterone can be increased when combined with Ganaxolone.,increase,no risk
Progesterone,Ganciclovir,The risk or severity of adverse effects can be increased when Progesterone is combined with Ganciclovir.,increase,risk
Progesterone,Gefitinib,Progesterone may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Progesterone,Gemfibrozil,The metabolism of Progesterone can be decreased when combined with Gemfibrozil.,decrease,no risk
Progesterone,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Ginkgo biloba,The metabolism of Progesterone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Progesterone,Givosiran,The serum concentration of Progesterone can be increased when it is combined with Givosiran.,increase,no risk
Progesterone,Glasdegib,Progesterone may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Progesterone,Glecaprevir,Progesterone may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Progesterone,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Glofitamab,The serum concentration of Progesterone can be increased when it is combined with Glofitamab.,increase,no risk
Progesterone,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Glycerol phenylbutyrate,The metabolism of Progesterone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Progesterone,Glycyrrhizic acid,Progesterone may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Progesterone,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Golimumab,The metabolism of Progesterone can be increased when combined with Golimumab.,increase,no risk
Progesterone,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Griseofulvin,The metabolism of Progesterone can be increased when combined with Griseofulvin.,increase,no risk
Progesterone,Guanfacine,The risk or severity of adverse effects can be increased when Progesterone is combined with Guanfacine.,increase,risk
Progesterone,Halofantrine,The metabolism of Progesterone can be decreased when combined with Halofantrine.,decrease,no risk
Progesterone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Halothane,The metabolism of Halothane can be increased when combined with Progesterone.,increase,no risk
Progesterone,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Hetacillin,The therapeutic efficacy of Progesterone can be decreased when used in combination with Hetacillin.,decrease,no risk
Progesterone,Histamine,The serum concentration of Histamine can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Human C1-esterase inhibitor,The risk or severity of thromboembolism can be increased when Progesterone is combined with Human C1-esterase inhibitor.,increase,risk
Progesterone,Hydrocortamate,The metabolism of Progesterone can be increased when combined with Hydrocortamate.,increase,no risk
Progesterone,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Hydroxychloroquine,The metabolism of Progesterone can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Progesterone,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ketamine,The metabolism of Ketamine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ketoconazole,The metabolism of Progesterone can be decreased when combined with Ketoconazole.,decrease,no risk
Progesterone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Obeticholic acid,The risk or severity of adverse effects can be increased when Progesterone is combined with Obeticholic acid.,increase,risk
Progesterone,Ofloxacin,Progesterone may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Progesterone,Olanzapine,The metabolism of Progesterone can be decreased when combined with Olanzapine.,decrease,no risk
Progesterone,Olaparib,The metabolism of Olaparib can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Progesterone.,decrease,no risk
Progesterone,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Progesterone.,increase,risk
Progesterone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Olutasidenib,The metabolism of Progesterone can be increased when combined with Olutasidenib.,increase,no risk
Progesterone,Omadacycline,The serum concentration of Progesterone can be decreased when it is combined with Omadacycline.,decrease,no risk
Progesterone,Omaveloxolone,The therapeutic efficacy of Progesterone can be decreased when used in combination with Omaveloxolone.,decrease,no risk
Progesterone,Ombitasvir,Progesterone may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Progesterone,Omeprazole,The metabolism of Progesterone can be decreased when combined with Omeprazole.,decrease,no risk
Progesterone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Opium,The metabolism of Opium can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Oritavancin,The metabolism of Progesterone can be increased when combined with Oritavancin.,increase,no risk
Progesterone,Orphenadrine,The metabolism of Progesterone can be decreased when combined with Orphenadrine.,decrease,no risk
Progesterone,Osilodrostat,The metabolism of Progesterone can be decreased when combined with Osilodrostat.,decrease,no risk
Progesterone,Osimertinib,Progesterone may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Progesterone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ouabain,The excretion of Ouabain can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Oxacillin,The therapeutic efficacy of Progesterone can be decreased when used in combination with Oxacillin.,decrease,no risk
Progesterone,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Oxamniquine,The metabolism of Progesterone can be decreased when combined with Oxamniquine.,decrease,no risk
Progesterone,Oxandrolone,The metabolism of Progesterone can be decreased when combined with Oxandrolone.,decrease,no risk
Progesterone,Oxcarbazepine,The metabolism of Progesterone can be increased when combined with Oxcarbazepine.,increase,no risk
Progesterone,Oxprenolol,The metabolism of Progesterone can be decreased when combined with Oxprenolol.,decrease,no risk
Progesterone,Oxybutynin,The metabolism of Progesterone can be decreased when combined with Oxybutynin.,decrease,no risk
Progesterone,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Oxytetracycline,The serum concentration of Progesterone can be decreased when it is combined with Oxytetracycline.,decrease,no risk
Progesterone,Ozanimod,Progesterone may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Progesterone,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Quinidine,The metabolism of Quinidine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Quinine,The metabolism of Progesterone can be decreased when combined with Quinine.,decrease,no risk
Progesterone,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Udenafil,The metabolism of Udenafil can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Ulipristal,The therapeutic efficacy of Progesterone can be decreased when used in combination with Ulipristal.,decrease,no risk
Progesterone,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Ursodeoxycholic acid,Progesterone may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Progesterone,Vadadustat,The serum concentration of Progesterone can be increased when it is combined with Vadadustat.,increase,no risk
Progesterone,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Valproic acid,The metabolism of Progesterone can be increased when combined with Valproic acid.,increase,no risk
Progesterone,Valsartan,The metabolism of Progesterone can be decreased when combined with Valsartan.,decrease,no risk
Progesterone,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Progesterone.,increase,no risk
Progesterone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Varenicline,The excretion of Varenicline can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Velpatasvir,Progesterone may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Progesterone,Vemurafenib,Progesterone may decrease the excretion rate of Vemurafenib which could result in a higher serum level.,decrease,no risk
Progesterone,Venetoclax,The metabolism of Progesterone can be decreased when combined with Venetoclax.,decrease,no risk
Progesterone,Venlafaxine,The metabolism of Progesterone can be decreased when combined with Venlafaxine.,decrease,no risk
Progesterone,Verapamil,The metabolism of Progesterone can be decreased when combined with Verapamil.,decrease,no risk
Progesterone,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Vigabatrin,The metabolism of Progesterone can be increased when combined with Vigabatrin.,increase,no risk
Progesterone,Vilazodone,The metabolism of Progesterone can be decreased when combined with Vilazodone.,decrease,no risk
Progesterone,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Viloxazine,The metabolism of Progesterone can be decreased when combined with Viloxazine.,decrease,no risk
Progesterone,Vinblastine,Progesterone may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Progesterone,Vincristine,The metabolism of Vincristine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Vinorelbine,The metabolism of Progesterone can be decreased when combined with Vinorelbine.,decrease,no risk
Progesterone,Vitamin E,The metabolism of Progesterone can be increased when combined with Vitamin E.,increase,no risk
Progesterone,Vonoprazan,The metabolism of Progesterone can be decreased when combined with Vonoprazan.,decrease,no risk
Progesterone,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Voriconazole,The metabolism of Progesterone can be decreased when combined with Voriconazole.,decrease,no risk
Progesterone,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Voxilaprevir,Progesterone may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Progesterone,Warfarin,The metabolism of Warfarin can be increased when combined with Progesterone.,increase,no risk
Progesterone,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Progesterone.,decrease,no risk
Progesterone,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Zafirlukast,The metabolism of Progesterone can be decreased when combined with Zafirlukast.,decrease,no risk
Progesterone,Zaleplon,The metabolism of Progesterone can be increased when combined with Zaleplon.,increase,no risk
Progesterone,Zavegepant,The serum concentration of Zavegepant can be decreased when it is combined with Progesterone.,decrease,no risk
Progesterone,Zidovudine,Progesterone may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Progesterone,Zileuton,The metabolism of Zileuton can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Zimelidine,The metabolism of Progesterone can be decreased when combined with Zimelidine.,decrease,no risk
Progesterone,Ziprasidone,The metabolism of Progesterone can be decreased when combined with Ziprasidone.,decrease,no risk
Progesterone,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Zonisamide,The metabolism of Progesterone can be increased when combined with Zonisamide.,increase,no risk
Progesterone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Progesterone.,decrease,no risk
Progesterone,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Progesterone.,decrease,no risk
Phenylpropanolamine,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Gallamine triethiodide.,increase,risk
Phenylpropanolamine,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Glycopyrronium,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Glycopyrronium.,increase,risk
Phenylpropanolamine,Guanabenz,Phenylpropanolamine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Phenylpropanolamine,Guanadrel,Phenylpropanolamine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Phenylpropanolamine,Guanethidine,The risk or severity of Cardiac Arrhythmia can be increased when Phenylpropanolamine is combined with Guanethidine.,increase,risk
Phenylpropanolamine,Guanfacine,Phenylpropanolamine may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Phenylpropanolamine,Guanoxan,Phenylpropanolamine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Phenylpropanolamine,Halothane,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Halothane.,increase,risk
Phenylpropanolamine,Hexocyclium,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Hexocyclium.,increase,risk
Phenylpropanolamine,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Homatropine methylbromide.,increase,risk
Phenylpropanolamine,Hydralazine,Phenylpropanolamine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Phenylpropanolamine,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Phenylpropanolamine is combined with Hydrochlorothiazide.,increase,risk
Phenylpropanolamine,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Phenylpropanolamine is combined with Hydroflumethiazide.,increase,risk
Phenylpropanolamine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Hyoscyamine,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Hyoscyamine.,increase,risk
Phenylpropanolamine,Ketamine,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Ketamine.,increase,risk
Phenylpropanolamine,Ketoprofen,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Ketoprofen.,increase,risk
Phenylpropanolamine,Ketorolac,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Ketorolac.,increase,risk
Phenylpropanolamine,Olanzapine,The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Olanzapine.,decrease,no risk
Phenylpropanolamine,Olmesartan,Phenylpropanolamine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Phenylpropanolamine,Olodaterol,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Olodaterol.,increase,risk
Phenylpropanolamine,Orciprenaline,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Orciprenaline.,increase,risk
Phenylpropanolamine,Orphenadrine,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Orphenadrine.,increase,risk
Phenylpropanolamine,Oxaprozin,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Oxaprozin.,increase,risk
Phenylpropanolamine,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Oxtriphylline,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Oxtriphylline.,increase,risk
Phenylpropanolamine,Oxybutynin,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Oxybutynin.,increase,risk
Phenylpropanolamine,Oxymetazoline,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Oxymetazoline.,increase,risk
Phenylpropanolamine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Oxyphenbutazone.,increase,risk
Phenylpropanolamine,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Oxytocin,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Oxytocin.,increase,risk
Phenylpropanolamine,Quetiapine,The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Quetiapine.,decrease,no risk
Phenylpropanolamine,Quinapril,Phenylpropanolamine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Phenylpropanolamine,Quinethazone,Phenylpropanolamine may increase the hypokalemic activities of Quinethazone.,increase,no risk
Phenylpropanolamine,Quinidine,The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Quinidine.,decrease,no risk
Phenylpropanolamine,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Umeclidinium,The risk or severity of Tachycardia can be increased when Phenylpropanolamine is combined with Umeclidinium.,increase,risk
Phenylpropanolamine,Valdecoxib,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Valdecoxib.,increase,risk
Phenylpropanolamine,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Valsartan,Phenylpropanolamine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Phenylpropanolamine,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Phenylpropanolamine.,increase,risk
Phenylpropanolamine,Venlafaxine,Venlafaxine may increase the tachycardic activities of Phenylpropanolamine.,increase,no risk
Phenylpropanolamine,Verapamil,The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Verapamil.,decrease,no risk
Phenylpropanolamine,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Vilanterol,The risk or severity of adverse effects can be increased when Phenylpropanolamine is combined with Vilanterol.,increase,risk
Phenylpropanolamine,Vilazodone,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Vilazodone.,increase,risk
Phenylpropanolamine,Vortioxetine,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Vortioxetine.,increase,risk
Phenylpropanolamine,Xamoterol,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Xamoterol.,increase,risk
Phenylpropanolamine,Xylometazoline,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Xylometazoline.,increase,risk
Phenylpropanolamine,Yohimbine,The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Yohimbine.,increase,risk
Phenylpropanolamine,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Ziprasidone,The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Ziprasidone.,decrease,no risk
Phenylpropanolamine,Zofenopril,Phenylpropanolamine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Phenylpropanolamine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Phenylpropanolamine.,decrease,no risk
Phenylpropanolamine,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Phenylpropanolamine.,decrease,no risk
Sorafenib,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Sorafenib.,increase,risk
Sorafenib,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Sorafenib.,increase,risk
Sorafenib,Bacitracin,Bacitracin may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Baclofen,Baclofen may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Balsalazide,Balsalazide may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Baricitinib,The risk or severity of adverse effects can be increased when Sorafenib is combined with Baricitinib.,increase,risk
Sorafenib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Sorafenib.,increase,risk
Sorafenib,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Sorafenib.,increase,risk
Sorafenib,Beclomethasone dipropionate,The metabolism of Sorafenib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Sorafenib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Bedaquiline.,increase,risk
Sorafenib,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Belatacept,The risk or severity of adverse effects can be increased when Sorafenib is combined with Belatacept.,increase,risk
Sorafenib,Belimumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Belimumab.,increase,risk
Sorafenib,Belinostat,The metabolism of Belinostat can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Belumosudil,The risk or severity of adverse effects can be increased when Sorafenib is combined with Belumosudil.,increase,risk
Sorafenib,Belzutifan,The serum concentration of Sorafenib can be decreased when it is combined with Belzutifan.,decrease,no risk
Sorafenib,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Sorafenib.,increase,risk
Sorafenib,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Benorilate,Benorilate may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Benserazide,Sorafenib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Sorafenib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Sorafenib.,increase,risk
Sorafenib,Benznidazole,Sorafenib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Sorafenib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Benzocaine.,increase,risk
Sorafenib,Benzthiazide,Benzthiazide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Benzydamine,Benzydamine may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Benzyl alcohol.,increase,risk
Sorafenib,Bepotastine,Sorafenib may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Sorafenib,Bepridil,The risk or severity of QTc prolongation can be increased when Bepridil is combined with Sorafenib.,increase,risk
Sorafenib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Betamethasone,The metabolism of Sorafenib can be increased when combined with Betamethasone.,increase,no risk
Sorafenib,Betamethasone phosphate,The metabolism of Sorafenib can be increased when combined with Betamethasone phosphate.,increase,no risk
Sorafenib,Betaxolol,The metabolism of Sorafenib can be decreased when combined with Betaxolol.,decrease,no risk
Sorafenib,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Sorafenib.,increase,risk
Sorafenib,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Bexarotene,The metabolism of Sorafenib can be increased when combined with Bexarotene.,increase,no risk
Sorafenib,Bezafibrate,The metabolism of Sorafenib can be decreased when combined with Bezafibrate.,decrease,no risk
Sorafenib,Bicalutamide,The metabolism of Sorafenib can be decreased when combined with Bicalutamide.,decrease,no risk
Sorafenib,Bicisate,Sorafenib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Sorafenib,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Bifonazole,The metabolism of Sorafenib can be decreased when combined with Bifonazole.,decrease,no risk
Sorafenib,Bilastine,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Bilastine.,increase,risk
Sorafenib,Bimekizumab,The metabolism of Sorafenib can be increased when combined with Bimekizumab.,increase,no risk
Sorafenib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bismuth subgallate,Sorafenib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Sorafenib,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bisoxatin,Sorafenib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Sorafenib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Sorafenib.,increase,risk
Sorafenib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Sorafenib.,increase,risk
Sorafenib,Blinatumomab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Blinatumomab.,increase,risk
Sorafenib,Boceprevir,The metabolism of Sorafenib can be decreased when combined with Boceprevir.,decrease,no risk
Sorafenib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Sorafenib.",decrease,no risk
Sorafenib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bosentan,The metabolism of Sorafenib can be increased when combined with Bosentan.,increase,no risk
Sorafenib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Bretylium,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Bretylium.,increase,risk
Sorafenib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Brivaracetam,Sorafenib may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Sorafenib,Brodalumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Brodalumab.,increase,risk
Sorafenib,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Bromotheophylline,Bromotheophylline may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Brompheniramine.,increase,risk
Sorafenib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Sorafenib.,increase,risk
Sorafenib,Budesonide,The metabolism of Sorafenib can be increased when combined with Budesonide.,increase,no risk
Sorafenib,Bumadizone,Bumadizone may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Bumetanide,Bumetanide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Bupivacaine.,increase,risk
Sorafenib,Buprenorphine,The metabolism of Sorafenib can be decreased when combined with Buprenorphine.,decrease,no risk
Sorafenib,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Buserelin,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Buserelin.,increase,risk
Sorafenib,Buspirone,The metabolism of Sorafenib can be decreased when combined with Buspirone.,decrease,no risk
Sorafenib,Busulfan,The risk or severity of adverse effects can be increased when Sorafenib is combined with Busulfan.,increase,risk
Sorafenib,Butabarbital,Butabarbital may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Butacaine,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Butacaine.,increase,risk
Sorafenib,Butalbital,The metabolism of Sorafenib can be increased when combined with Butalbital.,increase,no risk
Sorafenib,Butamben,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Butamben.,increase,risk
Sorafenib,Butriptyline,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Butriptyline.,increase,risk
Sorafenib,Gabapentin enacarbil,Sorafenib may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Sorafenib,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Gadobenic acid.,increase,risk
Sorafenib,Gadodiamide,Gadodiamide may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Gadofosveset trisodium,Sorafenib may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Sorafenib,Gadopentetic acid,Sorafenib may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Sorafenib,Gadoteric acid,Sorafenib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Sorafenib,Gadoteridol,Sorafenib may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Sorafenib,Galantamine,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Galantamine.,increase,risk
Sorafenib,Ganciclovir,Sorafenib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Sorafenib,Gatifloxacin,The metabolism of Sorafenib can be decreased when combined with Gatifloxacin.,decrease,no risk
Sorafenib,Gefitinib,The metabolism of Sorafenib can be decreased when combined with Gefitinib.,decrease,no risk
Sorafenib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Gemfibrozil,The metabolism of Sorafenib can be decreased when combined with Gemfibrozil.,decrease,no risk
Sorafenib,Gemifloxacin,The metabolism of Sorafenib can be decreased when combined with Gemifloxacin.,decrease,no risk
Sorafenib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Sorafenib.,increase,risk
Sorafenib,Gentamicin,Sorafenib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Sorafenib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Gilteritinib,The metabolism of Sorafenib can be decreased when combined with Gilteritinib.,decrease,no risk
Sorafenib,Gimeracil,Sorafenib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Sorafenib,Ginkgo biloba,The metabolism of Sorafenib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sorafenib,Givosiran,The serum concentration of Sorafenib can be increased when it is combined with Givosiran.,increase,no risk
Sorafenib,Glasdegib,The risk or severity of QTc prolongation can be increased when Glasdegib is combined with Sorafenib.,increase,risk
Sorafenib,Glatiramer,The risk or severity of adverse effects can be increased when Sorafenib is combined with Glatiramer.,increase,risk
Sorafenib,Glecaprevir,The metabolism of Sorafenib can be decreased when combined with Glecaprevir.,decrease,no risk
Sorafenib,Glipizide,The metabolism of Glipizide can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Glofitamab,The serum concentration of Sorafenib can be increased when it is combined with Glofitamab.,increase,no risk
Sorafenib,Glyburide,The metabolism of Sorafenib can be decreased when combined with Glyburide.,decrease,no risk
Sorafenib,Glycerol phenylbutyrate,The metabolism of Sorafenib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Sorafenib,Golimumab,The metabolism of Sorafenib can be increased when combined with Golimumab.,increase,no risk
Sorafenib,Golodirsen,Sorafenib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Sorafenib,Goserelin,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Goserelin.,increase,risk
Sorafenib,Granisetron,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Granisetron.,increase,risk
Sorafenib,Grapefruit,The serum concentration of Sorafenib can be increased when it is combined with Grapefruit.,increase,no risk
Sorafenib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Sorafenib.,increase,risk
Sorafenib,Griseofulvin,The metabolism of Sorafenib can be increased when combined with Griseofulvin.,increase,no risk
Sorafenib,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Guanethidine,Sorafenib may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Sorafenib,Guanfacine,Sorafenib may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Sorafenib,Guselkumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Guselkumab.,increase,risk
Sorafenib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Sorafenib.,increase,risk
Sorafenib,Haloperidol,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Haloperidol.,increase,risk
Sorafenib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Sorafenib.,increase,risk
Sorafenib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Histrelin,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Histrelin.,increase,risk
Sorafenib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Sorafenib.,increase,risk
Sorafenib,Hydralazine,The serum concentration of Sorafenib can be increased when it is combined with Hydralazine.,increase,no risk
Sorafenib,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Hydrocortamate,The metabolism of Sorafenib can be increased when combined with Hydrocortamate.,increase,no risk
Sorafenib,Hydrocortisone,The metabolism of Sorafenib can be increased when combined with Hydrocortisone.,increase,no risk
Sorafenib,Hydrocortisone acetate,The metabolism of Sorafenib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Sorafenib,Hydrocortisone butyrate,The metabolism of Sorafenib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Sorafenib,Hydrocortisone cypionate,The metabolism of Sorafenib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Sorafenib,Hydrocortisone phosphate,The metabolism of Sorafenib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Sorafenib,Hydrocortisone succinate,The metabolism of Sorafenib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Sorafenib,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Sorafenib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Sorafenib,Hydromorphone,Hydromorphone may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Sorafenib is combined with Hydroxychloroquine.,increase,risk
Sorafenib,Hydroxyethyl Starch,Sorafenib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Sorafenib,Hydroxyprogesterone caproate,The metabolism of Sorafenib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Sorafenib,Hydroxyurea,The risk or severity of adverse effects can be increased when Sorafenib is combined with Hydroxyurea.,increase,risk
Sorafenib,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Hydroxyzine.,increase,risk
Sorafenib,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Hyoscyamine.,increase,risk
Sorafenib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Sorafenib.,decrease,no risk
Sorafenib,Kanamycin,Sorafenib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Sorafenib,Ketamine,The metabolism of Ketamine can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Ketazolam,The serum concentration of Sorafenib can be increased when it is combined with Ketazolam.,increase,no risk
Sorafenib,Ketoconazole,The metabolism of Sorafenib can be decreased when combined with Ketoconazole.,decrease,no risk
Sorafenib,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Obeticholic acid,The metabolism of Sorafenib can be decreased when combined with Obeticholic acid.,decrease,no risk
Sorafenib,Obinutuzumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Obinutuzumab.,increase,risk
Sorafenib,Ocrelizumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Ocrelizumab.,increase,risk
Sorafenib,Octinoxate,Sorafenib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Sorafenib,Octreotide,The serum concentration of Sorafenib can be increased when it is combined with Octreotide.,increase,no risk
Sorafenib,Ofatumumab,The risk or severity of adverse effects can be increased when Sorafenib is combined with Ofatumumab.,increase,risk
Sorafenib,Ofloxacin,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Ofloxacin.,increase,risk
Sorafenib,Olanzapine,The metabolism of Sorafenib can be decreased when combined with Olanzapine.,decrease,no risk
Sorafenib,Olaparib,The metabolism of Sorafenib can be decreased when combined with Olaparib.,decrease,no risk
Sorafenib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Olsalazine,Olsalazine may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Olutasidenib,The metabolism of Sorafenib can be increased when combined with Olutasidenib.,increase,no risk
Sorafenib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Omaveloxolone,The serum concentration of Sorafenib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sorafenib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Sorafenib.,increase,no risk
Sorafenib,Ondansetron,The metabolism of Sorafenib can be decreased when combined with Ondansetron.,decrease,no risk
Sorafenib,Opium,Sorafenib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Sorafenib,Oritavancin,The metabolism of Sorafenib can be increased when combined with Oritavancin.,increase,no risk
Sorafenib,Orphenadrine,The metabolism of Sorafenib can be decreased when combined with Orphenadrine.,decrease,no risk
Sorafenib,Oseltamivir,Oseltamivir may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Osilodrostat,The metabolism of Sorafenib can be decreased when combined with Osilodrostat.,decrease,no risk
Sorafenib,Osimertinib,The serum concentration of Sorafenib can be decreased when it is combined with Osimertinib.,decrease,no risk
Sorafenib,Oxacillin,Sorafenib may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Sorafenib,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sorafenib.,increase,risk
Sorafenib,Oxaprozin,Oxaprozin may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Oxatomide,The risk or severity of QTc prolongation can be increased when Sorafenib is combined with Oxatomide.,increase,risk
Sorafenib,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Oxcarbazepine,The metabolism of Sorafenib can be increased when combined with Oxcarbazepine.,increase,no risk
Sorafenib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Oxetacaine.,increase,risk
Sorafenib,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Sorafenib.,decrease,no risk
Sorafenib,Oxybenzone,Sorafenib may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Sorafenib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sorafenib is combined with Oxybuprocaine.,increase,risk
Sorafenib,Oxybutynin,The serum concentration of Sorafenib can be increased when it is combined with Oxybutynin.,increase,no risk
Sorafenib,Oxycodone,The metabolism of Sorafenib can be decreased when combined with Oxycodone.,decrease,no risk
Sorafenib,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Sorafenib which could result in a higher serum level.,decrease,no risk
Sorafenib,Oxyquinoline,Sorafenib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Sorafenib,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Sorafenib.,increase,risk
Sorafenib,Ozanimod,The risk or severity of adverse effects can be increased when Sorafenib is combined with Ozanimod.,increase,risk
Zoledronic acid,Gentamicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Givosiran,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Glycol salicylate is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Human calcitonin,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Hydrochlorothiazide,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrochlorothiazide is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Hydrotalcite,The serum concentration of Zoledronic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Zoledronic acid,Kanamycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Olsalazine,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Oxyphenbutazone is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Valaciclovir,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Valdecoxib is combined with Zoledronic acid.,increase,risk
Zoledronic acid,Vancomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Vancomycin is combined with Zoledronic acid.,increase,risk
Griseofulvin,Olaparib,The metabolism of Olaparib can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Griseofulvin.,decrease,no risk
Griseofulvin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Quinidine,The metabolism of Quinidine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vincristine,The metabolism of Vincristine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vindesine,The metabolism of Vindesine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Warfarin,The metabolism of Warfarin can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Griseofulvin.,increase,no risk
Griseofulvin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Griseofulvin.,decrease,no risk
Nisoldipine,Benazepril,Nisoldipine may increase the hypotensive activities of Benazepril.,increase,no risk
Nisoldipine,Bendroflumethiazide,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Nisoldipine,Benorilate,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Benorilate.,decrease,no risk
Nisoldipine,Benoxaprofen,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Benoxaprofen.,decrease,no risk
Nisoldipine,Benserazide,Nisoldipine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Nisoldipine,Benzatropine,Benzatropine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Benznidazole,Nisoldipine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Nisoldipine,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Benzthiazide,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Benzthiazide.,increase,no risk
Nisoldipine,Benzydamine,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Benzydamine.,decrease,no risk
Nisoldipine,Bepotastine,Nisoldipine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Bepridil,Nisoldipine may increase the arrhythmogenic activities of Bepridil.,increase,no risk
Nisoldipine,Beractant,Nisoldipine may increase the bradycardic activities of Beractant.,increase,no risk
Nisoldipine,Berotralstat,The metabolism of Nisoldipine can be decreased when combined with Berotralstat.,decrease,no risk
Nisoldipine,Betamethasone,The metabolism of Nisoldipine can be increased when combined with Betamethasone.,increase,no risk
Nisoldipine,Betamethasone phosphate,The metabolism of Nisoldipine can be increased when combined with Betamethasone phosphate.,increase,no risk
Nisoldipine,Betaxolol,Betaxolol may increase the arrhythmogenic activities of Nisoldipine.,increase,no risk
Nisoldipine,Bethanidine,Bethanidine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Bexagliflozin.,increase,risk
Nisoldipine,Bicisate,Nisoldipine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nisoldipine,Bifonazole,The therapeutic efficacy of Bifonazole can be increased when used in combination with Nisoldipine.,increase,no risk
Nisoldipine,Bimatoprost,Nisoldipine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Nisoldipine,Bimekizumab,The metabolism of Nisoldipine can be increased when combined with Bimekizumab.,increase,no risk
Nisoldipine,Bioallethrin,Nisoldipine may increase the arrhythmogenic activities of Bioallethrin.,increase,no risk
Nisoldipine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Nisoldipine.,decrease,no risk
Nisoldipine,Bismuth subgallate,Nisoldipine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nisoldipine,Bisoprolol,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Bisoprolol.,increase,no risk
Nisoldipine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Nisoldipine.,decrease,no risk
Nisoldipine,Bleomycin,Bleomycin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Boceprevir,The serum concentration of Nisoldipine can be increased when it is combined with Boceprevir.,increase,no risk
Nisoldipine,Bosentan,Nisoldipine may increase the hypotensive activities of Bosentan.,increase,no risk
Nisoldipine,Bretylium,Nisoldipine may increase the arrhythmogenic activities of Bretylium.,increase,no risk
Nisoldipine,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Brimonidine,Brimonidine may increase the antihypertensive activities of Nisoldipine.,increase,no risk
Nisoldipine,Brivaracetam,Nisoldipine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nisoldipine,Bromazepam,Nisoldipine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Nisoldipine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Bromocriptine.,increase,risk
Nisoldipine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nisoldipine,Budesonide,The metabolism of Nisoldipine can be increased when combined with Budesonide.,increase,no risk
Nisoldipine,Bumadizone,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Bumadizone.,decrease,no risk
Nisoldipine,Bumetanide,Bumetanide may increase the excretion rate of Nisoldipine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nisoldipine,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Nisoldipine.,increase,risk
Nisoldipine,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Bupropion,Nisoldipine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nisoldipine,Buspirone,Buspirone may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Butabarbital,Butabarbital may increase the hypotensive activities of Nisoldipine.,increase,no risk
Nisoldipine,Butalbital,Butalbital may increase the hypotensive activities of Nisoldipine.,increase,no risk
Nisoldipine,Butriptyline,Butriptyline may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Gabapentin enacarbil,Nisoldipine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadobenic acid,Nisoldipine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadodiamide,Gadodiamide may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadofosveset trisodium,Nisoldipine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadopentetic acid,Nisoldipine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadoteric acid,Nisoldipine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gadoteridol,Nisoldipine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nisoldipine,Galantamine,Nisoldipine may increase the bradycardic activities of Galantamine.,increase,no risk
Nisoldipine,Gallamine triethiodide,Nisoldipine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Nisoldipine,Ganciclovir,Nisoldipine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gefitinib,The metabolism of Nisoldipine can be decreased when combined with Gefitinib.,decrease,no risk
Nisoldipine,Gemcitabine,Nisoldipine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gemfibrozil,Nisoldipine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gentamicin,Nisoldipine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gimeracil,Nisoldipine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nisoldipine,Givosiran,Givosiran may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Gliclazide,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Gliclazide.,increase,risk
Nisoldipine,Glimepiride,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glimepiride.,increase,risk
Nisoldipine,Glipizide,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glipizide.,increase,risk
Nisoldipine,Gliquidone,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Gliquidone.,increase,risk
Nisoldipine,Glofitamab,The serum concentration of Nisoldipine can be increased when it is combined with Glofitamab.,increase,no risk
Nisoldipine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nisoldipine.,decrease,no risk
Nisoldipine,Glyburide,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glyburide.,increase,risk
Nisoldipine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Nisoldipine.,decrease,no risk
Nisoldipine,Glycerol phenylbutyrate,Nisoldipine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nisoldipine,Glycol salicylate,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Nisoldipine,Glymidine,The risk or severity of hypoglycemia can be increased when Nisoldipine is combined with Glymidine.,increase,risk
Nisoldipine,Golimumab,The metabolism of Nisoldipine can be increased when combined with Golimumab.,increase,no risk
Nisoldipine,Golodirsen,Nisoldipine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nisoldipine,Goserelin,Goserelin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Guanadrel,Guanadrel may increase the hypotensive activities of Nisoldipine.,increase,no risk
Nisoldipine,Guanethidine,Nisoldipine may increase the hypotensive activities of Guanethidine.,increase,no risk
Nisoldipine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Guanoxan,Nisoldipine may increase the hypotensive activities of Guanoxan.,increase,no risk
Nisoldipine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nisoldipine.,increase,no risk
Nisoldipine,Halothane,Halothane may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Heparin,The risk or severity of hyperkalemia can be increased when Nisoldipine is combined with Heparin.,increase,risk
Nisoldipine,Hydralazine,Nisoldipine may increase the hypotensive activities of Hydralazine.,increase,no risk
Nisoldipine,Hydrochlorothiazide,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Nisoldipine,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydroflumethiazide,The therapeutic efficacy of Nisoldipine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Nisoldipine,Hydromorphone,Hydromorphone may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Nisoldipine.,increase,risk
Nisoldipine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Hydroxyethyl Starch,Nisoldipine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nisoldipine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Hyoscyamine,Nisoldipine may increase the arrhythmogenic activities of Hyoscyamine.,increase,no risk
Nisoldipine,Kanamycin,Nisoldipine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nisoldipine,Ketamine,Nisoldipine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Ketazolam,Nisoldipine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nisoldipine,Ketoconazole,The metabolism of Nisoldipine can be decreased when combined with Ketoconazole.,decrease,no risk
Nisoldipine,Ketoprofen,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Nisoldipine,Ketorolac,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Ketorolac.,decrease,no risk
Nisoldipine,Obinutuzumab,Nisoldipine may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Nisoldipine,Octinoxate,Nisoldipine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nisoldipine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nisoldipine.,increase,no risk
Nisoldipine,Olanzapine,The risk or severity of hypotension can be increased when Olanzapine is combined with Nisoldipine.,increase,risk
Nisoldipine,Olaparib,The metabolism of Olaparib can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Olmesartan,Olmesartan may increase the hypotensive activities of Nisoldipine.,increase,no risk
Nisoldipine,Olodaterol,Olodaterol may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Olsalazine,Olsalazine may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Olutasidenib,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Olutasidenib.,decrease,no risk
Nisoldipine,Omaveloxolone,The serum concentration of Nisoldipine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nisoldipine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Opicapone,The risk or severity of adverse effects can be increased when Nisoldipine is combined with Opicapone.,increase,risk
Nisoldipine,Opium,Nisoldipine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Nisoldipine,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Nisoldipine.,decrease,no risk
Nisoldipine,Oseltamivir,Oseltamivir may decrease the excretion rate of Nisoldipine which could result in a higher serum level.,decrease,no risk
Nisoldipine,Osilodrostat,The metabolism of Nisoldipine can be decreased when combined with Osilodrostat.,decrease,no risk
Nisoldipine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Nisoldipine.,increase,no risk
Nisoldipine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Nisoldipine.,increase,no risk
Nisoldipine,Oxacillin,Nisoldipine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Nisoldipine,Oxaprozin,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Nisoldipine,Oxazepam,Nisoldipine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Nisoldipine,Oxcarbazepine,The metabolism of Nisoldipine can be increased when combined with Oxcarbazepine.,increase,no risk
Nisoldipine,Oxprenolol,Nisoldipine may increase the arrhythmogenic activities of Oxprenolol.,increase,no risk
Nisoldipine,Oxybenzone,Nisoldipine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Nisoldipine,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Nisoldipine.,decrease,no risk
Nisoldipine,Oxymetazoline,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Nisoldipine,Oxyphenbutazone,The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Nisoldipine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Nisoldipine.,decrease,no risk
Nisoldipine,Oxyquinoline,Nisoldipine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Eszopiclone,Benznidazole,Eszopiclone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Eszopiclone,Benzocaine,The risk or severity of CNS depression can be increased when Benzocaine is combined with Eszopiclone.,increase,risk
Eszopiclone,Benzphetamine,The risk or severity of CNS depression can be increased when Benzphetamine is combined with Eszopiclone.,increase,risk
Eszopiclone,Benzthiazide,Benzthiazide may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Eszopiclone,Benzydamine,Benzydamine may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,decrease,no risk
Eszopiclone,Benzyl alcohol,The risk or severity of CNS depression can be increased when Benzyl alcohol is combined with Eszopiclone.,increase,risk
Eszopiclone,Bepotastine,Eszopiclone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Eszopiclone,Berotralstat,The metabolism of Eszopiclone can be decreased when combined with Berotralstat.,decrease,no risk
Eszopiclone,Betamethasone,The serum concentration of Eszopiclone can be decreased when it is combined with Betamethasone.,decrease,no risk
Eszopiclone,Bexarotene,The serum concentration of Eszopiclone can be decreased when it is combined with Bexarotene.,decrease,no risk
Eszopiclone,Bezafibrate,The metabolism of Eszopiclone can be decreased when combined with Bezafibrate.,decrease,no risk
Eszopiclone,Bicalutamide,The metabolism of Eszopiclone can be decreased when combined with Bicalutamide.,decrease,no risk
Eszopiclone,Bicisate,Eszopiclone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Eszopiclone,Bifonazole,The metabolism of Eszopiclone can be decreased when combined with Bifonazole.,decrease,no risk
Eszopiclone,Bimekizumab,The metabolism of Eszopiclone can be increased when combined with Bimekizumab.,increase,no risk
Eszopiclone,Bismuth subgallate,Eszopiclone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Eszopiclone,Bisoprolol,Eszopiclone may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Eszopiclone,Bisoxatin,Eszopiclone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Eszopiclone,Bleomycin,Bleomycin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,decrease,no risk
Eszopiclone,Boceprevir,The serum concentration of Eszopiclone can be increased when it is combined with Boceprevir.,increase,no risk
Eszopiclone,Bosentan,The serum concentration of Eszopiclone can be decreased when it is combined with Bosentan.,decrease,no risk
Eszopiclone,Bosutinib,The metabolism of Eszopiclone can be decreased when combined with Bosutinib.,decrease,no risk
Eszopiclone,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Eszopiclone.,increase,risk
Eszopiclone,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Eszopiclone.,increase,risk
Eszopiclone,Brentuximab vedotin,The metabolism of Eszopiclone can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Eszopiclone,Brexanolone,The risk or severity of CNS depression can be increased when Brexanolone is combined with Eszopiclone.,increase,risk
Eszopiclone,Brexpiprazole,The risk or severity of CNS depression can be increased when Brexpiprazole is combined with Eszopiclone.,increase,risk
Eszopiclone,Brigatinib,The serum concentration of Eszopiclone can be decreased when it is combined with Brigatinib.,decrease,no risk
Eszopiclone,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Eszopiclone.,increase,no risk
Eszopiclone,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Eszopiclone.,increase,risk
Eszopiclone,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Eszopiclone.,increase,risk
Eszopiclone,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Eszopiclone.,increase,risk
Eszopiclone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Eszopiclone,Bromperidol,The risk or severity of CNS depression can be increased when Bromperidol is combined with Eszopiclone.,increase,risk
Eszopiclone,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Eszopiclone.,increase,risk
Eszopiclone,Budesonide,The serum concentration of Eszopiclone can be decreased when it is combined with Budesonide.,decrease,no risk
Eszopiclone,Bumadizone,Bumadizone may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,decrease,no risk
Eszopiclone,Bumetanide,Bumetanide may increase the excretion rate of Eszopiclone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Eszopiclone,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Eszopiclone.,increase,risk
Eszopiclone,Buprenorphine,Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Eszopiclone,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Eszopiclone.,increase,risk
Eszopiclone,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Eszopiclone.,increase,risk
Eszopiclone,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Eszopiclone.,increase,risk
Eszopiclone,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Eszopiclone.,increase,risk
Eszopiclone,Butaperazine,The risk or severity of CNS depression can be increased when Butaperazine is combined with Eszopiclone.,increase,risk
Eszopiclone,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Eszopiclone.,increase,risk
Eszopiclone,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Eszopiclone.,increase,risk
Eszopiclone,Butriptyline,The risk or severity of CNS depression can be increased when Butriptyline is combined with Eszopiclone.,increase,risk
Eszopiclone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Eszopiclone.,increase,risk
Eszopiclone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Eszopiclone.,increase,risk
Eszopiclone,Gadobenic acid,Eszopiclone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gadodiamide,Gadodiamide may decrease the excretion rate of Eszopiclone which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gadofosveset trisodium,Eszopiclone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gadopentetic acid,Eszopiclone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gadoteric acid,Eszopiclone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gadoteridol,Eszopiclone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Eszopiclone.,increase,risk
Eszopiclone,Ganaxolone,The risk or severity of CNS depression can be increased when Ganaxolone is combined with Eszopiclone.,increase,risk
Eszopiclone,Ganciclovir,Eszopiclone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gemcitabine,Eszopiclone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Eszopiclone,Gemfibrozil,The metabolism of Eszopiclone can be decreased when combined with Gemfibrozil.,decrease,no risk
Alprazolam,Benzthiazide,Benzthiazide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alprazolam,Benzydamine,Benzydamine may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Benzyl alcohol,The risk or severity of CNS depression can be increased when Alprazolam is combined with Benzyl alcohol.,increase,risk
Alprazolam,Bepotastine,Alprazolam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Alprazolam,Berotralstat,The metabolism of Alprazolam can be decreased when combined with Berotralstat.,decrease,no risk
Alprazolam,Betamethasone,The metabolism of Alprazolam can be increased when combined with Betamethasone.,increase,no risk
Alprazolam,Betamethasone phosphate,The metabolism of Alprazolam can be increased when combined with Betamethasone phosphate.,increase,no risk
Alprazolam,Bicalutamide,The metabolism of Alprazolam can be decreased when combined with Bicalutamide.,decrease,no risk
Alprazolam,Bicisate,Alprazolam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Alprazolam,Bifonazole,The metabolism of Alprazolam can be decreased when combined with Bifonazole.,decrease,no risk
Alprazolam,Bimekizumab,The metabolism of Alprazolam can be increased when combined with Bimekizumab.,increase,no risk
Alprazolam,Bismuth subgallate,Alprazolam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Alprazolam,Bisoprolol,Alprazolam may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Alprazolam,Bisoxatin,Alprazolam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Alprazolam,Bleomycin,Bleomycin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Boceprevir,The metabolism of Alprazolam can be decreased when combined with Boceprevir.,decrease,no risk
Alprazolam,Bosutinib,The metabolism of Alprazolam can be decreased when combined with Bosutinib.,decrease,no risk
Alprazolam,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Alprazolam.,increase,risk
Alprazolam,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Alprazolam.,increase,risk
Alprazolam,Brentuximab vedotin,The metabolism of Alprazolam can be decreased when combined with Brentuximab vedotin.,decrease,no risk
Alprazolam,Brexanolone,The risk or severity of CNS depression can be increased when Alprazolam is combined with Brexanolone.,increase,risk
Alprazolam,Brexpiprazole,The risk or severity of CNS depression can be increased when Alprazolam is combined with Brexpiprazole.,increase,risk
Alprazolam,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.,increase,no risk
Alprazolam,Brivaracetam,The risk or severity of CNS depression can be increased when Alprazolam is combined with Brivaracetam.,increase,risk
Alprazolam,Bromazepam,The risk or severity of CNS depression can be increased when Alprazolam is combined with Bromazepam.,increase,risk
Alprazolam,Bromocriptine,The metabolism of Alprazolam can be decreased when combined with Bromocriptine.,decrease,no risk
Alprazolam,Bromotheophylline,The therapeutic efficacy of Alprazolam can be decreased when used in combination with Bromotheophylline.,decrease,no risk
Alprazolam,Bromperidol,The risk or severity of CNS depression can be increased when Alprazolam is combined with Bromperidol.,increase,risk
Alprazolam,Brompheniramine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Brompheniramine.,increase,risk
Alprazolam,Budesonide,The metabolism of Alprazolam can be increased when combined with Budesonide.,increase,no risk
Alprazolam,Bumadizone,Bumadizone may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Bumetanide,Bumetanide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alprazolam,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Alprazolam.,increase,risk
Alprazolam,Buprenorphine,Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Alprazolam,Bupropion,The risk or severity of CNS depression can be increased when Alprazolam is combined with Bupropion.,increase,risk
Alprazolam,Buspirone,The risk or severity of CNS depression can be increased when Alprazolam is combined with Buspirone.,increase,risk
Alprazolam,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Alprazolam.,increase,risk
Alprazolam,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Alprazolam.,increase,risk
Alprazolam,Butaperazine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Butaperazine.,increase,risk
Alprazolam,Butobarbital,The risk or severity of CNS depression can be increased when Alprazolam is combined with Butobarbital.,increase,risk
Alprazolam,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Alprazolam.,increase,risk
Alprazolam,Butriptyline,The risk or severity of CNS depression can be increased when Alprazolam is combined with Butriptyline.,increase,risk
Alprazolam,Gabapentin,The risk or severity of CNS depression can be increased when Alprazolam is combined with Gabapentin.,increase,risk
Alprazolam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Alprazolam is combined with Gabapentin enacarbil.,increase,risk
Alprazolam,Gadobenic acid,Alprazolam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Alprazolam,Gadodiamide,Gadodiamide may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Gadofosveset trisodium,Alprazolam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Alprazolam,Gadopentetic acid,Alprazolam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Alprazolam,Gadoteric acid,Alprazolam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Alprazolam,Gadoteridol,Alprazolam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Alprazolam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Alprazolam is combined with Gallamine triethiodide.,increase,risk
Alprazolam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Alprazolam is combined with Ganaxolone.",increase,risk
Alprazolam,Ganciclovir,Alprazolam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Alprazolam,Gefitinib,The metabolism of Alprazolam can be decreased when combined with Gefitinib.,decrease,no risk
Alprazolam,Gemcitabine,Alprazolam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Alprazolam,Gemfibrozil,Alprazolam may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Alprazolam,Gentamicin,Alprazolam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Alprazolam,Gepirone,The risk or severity of CNS depression can be increased when Alprazolam is combined with Gepirone.,increase,risk
Alprazolam,Gimeracil,Alprazolam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Alprazolam,Givosiran,Givosiran may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Glipizide,Alprazolam may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Alprazolam,Glofitamab,The serum concentration of Alprazolam can be increased when it is combined with Glofitamab.,increase,no risk
Alprazolam,Glutethimide,The risk or severity of CNS depression can be increased when Alprazolam is combined with Glutethimide.,increase,risk
Alprazolam,Glyburide,The metabolism of Alprazolam can be decreased when combined with Glyburide.,decrease,no risk
Alprazolam,Glycerol phenylbutyrate,Alprazolam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Alprazolam,Golimumab,The metabolism of Alprazolam can be increased when combined with Golimumab.,increase,no risk
Alprazolam,Golodirsen,Alprazolam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Alprazolam,Goserelin,Goserelin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Granisetron,The risk or severity of CNS depression can be increased when Alprazolam is combined with Granisetron.,increase,risk
Alprazolam,Guanethidine,Alprazolam may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Alprazolam,Guanfacine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Guanfacine.,increase,risk
Alprazolam,Halazepam,The risk or severity of CNS depression can be increased when Alprazolam is combined with Halazepam.,increase,risk
Alprazolam,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Haloperidol,The metabolism of Alprazolam can be decreased when combined with Haloperidol.,decrease,no risk
Alprazolam,Halothane,The risk or severity of CNS depression can be increased when Alprazolam is combined with Halothane.,increase,risk
Alprazolam,Hexafluronium,The risk or severity of CNS depression can be increased when Alprazolam is combined with Hexafluronium.,increase,risk
Alprazolam,Hydralazine,The metabolism of Alprazolam can be decreased when combined with Hydralazine.,decrease,no risk
Alprazolam,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alprazolam,Hydrocodone,Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Alprazolam,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alprazolam,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alprazolam.,increase,risk
Alprazolam,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Hydroxyethyl Starch,Alprazolam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Alprazolam,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Alprazolam.,increase,no risk
Alprazolam,Kanamycin,Alprazolam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Alprazolam,Ketamine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Ketamine.,increase,risk
Alprazolam,Ketazolam,The metabolism of Alprazolam can be decreased when combined with Ketazolam.,decrease,no risk
Alprazolam,Ketoconazole,The serum concentration of Alprazolam can be increased when it is combined with Ketoconazole.,increase,no risk
Alprazolam,Ketoprofen,Ketoprofen may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Ketorolac,Ketorolac may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Octinoxate,Alprazolam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Alprazolam,Octreotide,The metabolism of Alprazolam can be decreased when combined with Octreotide.,decrease,no risk
Alprazolam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Alprazolam.,increase,risk
Alprazolam,Olaparib,The metabolism of Alprazolam can be decreased when combined with Olaparib.,decrease,no risk
Alprazolam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Alprazolam is combined with Oliceridine.",increase,risk
Alprazolam,Olsalazine,Olsalazine may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Olutasidenib,The therapeutic efficacy of Alprazolam can be decreased when used in combination with Olutasidenib.,decrease,no risk
Alprazolam,Omaveloxolone,The serum concentration of Alprazolam can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Alprazolam,Ondansetron,The risk or severity of CNS depression can be increased when Alprazolam is combined with Ondansetron.,increase,risk
Alprazolam,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Alprazolam.,increase,risk
Alprazolam,Orphenadrine,The metabolism of Alprazolam can be decreased when combined with Orphenadrine.,decrease,no risk
Alprazolam,Oseltamivir,Oseltamivir may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Osilodrostat,The metabolism of Alprazolam can be decreased when combined with Osilodrostat.,decrease,no risk
Alprazolam,Oxacillin,Alprazolam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Alprazolam,Oxaprozin,Oxaprozin may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Oxazepam,The risk or severity of CNS depression can be increased when Alprazolam is combined with Oxazepam.,increase,risk
Alprazolam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Oxcarbazepine.,increase,risk
Alprazolam,Oxetacaine,The metabolism of Alprazolam can be decreased when combined with Oxetacaine.,decrease,no risk
Alprazolam,Oxitriptan,The risk or severity of CNS depression can be increased when Alprazolam is combined with Oxitriptan.,increase,risk
Alprazolam,Oxprenolol,The risk or severity of CNS depression can be increased when Alprazolam is combined with Oxprenolol.,increase,risk
Alprazolam,Oxtriphylline,The therapeutic efficacy of Alprazolam can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Alprazolam,Oxybenzone,Alprazolam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Alprazolam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Oxybuprocaine.,increase,risk
Alprazolam,Oxybutynin,The metabolism of Alprazolam can be decreased when combined with Oxybutynin.,decrease,no risk
Alprazolam,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Alprazolam.,increase,risk
Alprazolam,Oxymetholone,The metabolism of Alprazolam can be decreased when combined with Oxymetholone.,decrease,no risk
Alprazolam,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Alprazolam.,increase,risk
Alprazolam,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Oxyquinoline,Alprazolam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Alprazolam,Quazepam,The risk or severity of CNS depression can be increased when Alprazolam is combined with Quazepam.,increase,risk
Alprazolam,Quetiapine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Quetiapine.,increase,risk
Alprazolam,Quinethazone,Quinethazone may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alprazolam,Quinidine,The metabolism of Alprazolam can be decreased when combined with Quinidine.,decrease,no risk
Alprazolam,Quinine,The metabolism of Alprazolam can be decreased when combined with Quinine.,decrease,no risk
Alprazolam,Quinupramine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Quinupramine.,increase,risk
Alprazolam,Quinupristin,The metabolism of Alprazolam can be decreased when combined with Quinupristin.,decrease,no risk
Alprazolam,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Udenafil,The metabolism of Udenafil can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Urethane,The risk or severity of CNS depression can be increased when Alprazolam is combined with Urethane.,increase,risk
Alprazolam,Vaborbactam,Alprazolam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Alprazolam,Vadadustat,The serum concentration of Alprazolam can be increased when it is combined with Vadadustat.,increase,no risk
Alprazolam,Valaciclovir,Valaciclovir may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Valbenazine,Alprazolam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Alprazolam,Valdecoxib,Valdecoxib may decrease the excretion rate of Alprazolam which could result in a higher serum level.,decrease,no risk
Alprazolam,Valganciclovir,Alprazolam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Alprazolam,Valproic acid,The metabolism of Alprazolam can be decreased when combined with Valproic acid.,decrease,no risk
Alprazolam,Vancomycin,Alprazolam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Alprazolam,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Varenicline,Alprazolam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Alprazolam,Vecuronium,The risk or severity of CNS depression can be increased when Alprazolam is combined with Vecuronium.,increase,risk
Alprazolam,Venetoclax,The metabolism of Alprazolam can be decreased when combined with Venetoclax.,decrease,no risk
Alprazolam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Alprazolam.,increase,risk
Alprazolam,Verapamil,The metabolism of Alprazolam can be decreased when combined with Verapamil.,decrease,no risk
Alprazolam,Vigabatrin,The risk or severity of CNS depression can be increased when Alprazolam is combined with Vigabatrin.,increase,risk
Alprazolam,Vilanterol,Alprazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Alprazolam,Vilazodone,The risk or severity of CNS depression can be increased when Alprazolam is combined with Vilazodone.,increase,risk
Alprazolam,Viloxazine,The metabolism of Alprazolam can be decreased when combined with Viloxazine.,decrease,no risk
Alprazolam,Vinblastine,The metabolism of Alprazolam can be decreased when combined with Vinblastine.,decrease,no risk
Alprazolam,Vincristine,The metabolism of Vincristine can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Alprazolam.,decrease,no risk
Alprazolam,Voriconazole,The metabolism of Alprazolam can be decreased when combined with Voriconazole.,decrease,no risk
Alprazolam,Vortioxetine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Vortioxetine.,increase,risk
Alprazolam,Warfarin,Alprazolam may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Alprazolam,Yohimbine,The therapeutic efficacy of Alprazolam can be increased when used in combination with Yohimbine.,increase,no risk
Alprazolam,Zafirlukast,The metabolism of Alprazolam can be decreased when combined with Zafirlukast.,decrease,no risk
Alprazolam,Zaleplon,The risk or severity of CNS depression can be increased when Alprazolam is combined with Zaleplon.,increase,risk
Alprazolam,Zanamivir,Alprazolam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Alprazolam,Ziconotide,The risk or severity of CNS depression can be increased when Alprazolam is combined with Ziconotide.,increase,risk
Alprazolam,Zimelidine,The metabolism of Alprazolam can be decreased when combined with Zimelidine.,decrease,no risk
Alprazolam,Ziprasidone,The metabolism of Alprazolam can be decreased when combined with Ziprasidone.,decrease,no risk
Alprazolam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Alprazolam.,increase,risk
Alprazolam,Zolpidem,Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Alprazolam,Zonisamide,The risk or severity of CNS depression can be increased when Alprazolam is combined with Zonisamide.,increase,risk
Alprazolam,Zopiclone,The risk or severity of adverse effects can be increased when Alprazolam is combined with Zopiclone.,increase,risk
Alprazolam,Zotepine,The risk or severity of CNS depression can be increased when Alprazolam is combined with Zotepine.,increase,risk
Alprazolam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Alprazolam is combined with Zuclopenthixol.,increase,risk
Alprazolam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Alprazolam.,increase,risk
Dexbrompheniramine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ofloxacin.,increase,risk
Dexbrompheniramine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dexbrompheniramine is combined with Oliceridine.",increase,risk
Dexbrompheniramine,Olodaterol,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Olodaterol.,increase,risk
Dexbrompheniramine,Ondansetron,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Ondansetron.,increase,risk
Dexbrompheniramine,Opium,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Opium.,increase,risk
Dexbrompheniramine,Orphenadrine,Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dexbrompheniramine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Oxatomide,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Oxatomide.,increase,risk
Dexbrompheniramine,Oxazepam,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxazepam.,increase,risk
Dexbrompheniramine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxcarbazepine.,increase,risk
Dexbrompheniramine,Oxitriptan,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxitriptan.,increase,risk
Dexbrompheniramine,Oxprenolol,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxprenolol.,increase,risk
Dexbrompheniramine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxybuprocaine.,increase,risk
Dexbrompheniramine,Oxycodone,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxycodone.,increase,risk
Dexbrompheniramine,Oxymorphone,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Oxymorphone.,increase,risk
Dexbrompheniramine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Quazepam,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Quazepam.,increase,risk
Dexbrompheniramine,Quetiapine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Quetiapine.,increase,risk
Dexbrompheniramine,Quinidine,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Quinidine.,increase,risk
Dexbrompheniramine,Quinine,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Quinine.,increase,risk
Dexbrompheniramine,Quinupramine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Quinupramine.,increase,risk
Dexbrompheniramine,Quizartinib,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Quizartinib.,increase,risk
Dexbrompheniramine,Urethane,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Urethane.,increase,risk
Dexbrompheniramine,Valproic acid,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Valproic acid.,increase,risk
Dexbrompheniramine,Vandetanib,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vandetanib.,increase,risk
Dexbrompheniramine,Vardenafil,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vardenafil.,increase,risk
Dexbrompheniramine,Vecuronium,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Vecuronium.,increase,risk
Dexbrompheniramine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Vernakalant,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vernakalant.,increase,risk
Dexbrompheniramine,Vigabatrin,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Vigabatrin.,increase,risk
Dexbrompheniramine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Vilazodone,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Vilazodone.,increase,risk
Dexbrompheniramine,Viloxazine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Viloxazine.,increase,risk
Dexbrompheniramine,Voriconazole,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Voriconazole.,increase,risk
Dexbrompheniramine,Vorinostat,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Vorinostat.,increase,risk
Dexbrompheniramine,Vortioxetine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Vortioxetine.,increase,risk
Dexbrompheniramine,Yohimbine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Yohimbine.,increase,risk
Dexbrompheniramine,Zaleplon,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Zaleplon.,increase,risk
Dexbrompheniramine,Ziconotide,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Ziconotide.,increase,risk
Dexbrompheniramine,Zimelidine,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zimelidine.,increase,risk
Dexbrompheniramine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Ziprasidone.,increase,risk
Dexbrompheniramine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dexbrompheniramine.,increase,risk
Dexbrompheniramine,Zolpidem,Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dexbrompheniramine,Zonisamide,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Zonisamide.,increase,risk
Dexbrompheniramine,Zopiclone,The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Zopiclone.,increase,risk
Dexbrompheniramine,Zotepine,The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Zotepine.,increase,risk
Dexbrompheniramine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Zuclopenthixol.,increase,risk
Dexbrompheniramine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dexbrompheniramine.,increase,risk
Ardeparin,Gemcitabine,The risk or severity of bleeding can be increased when Ardeparin is combined with Gemcitabine.,increase,risk
Ardeparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Ardeparin is combined with Gemtuzumab ozogamicin.,increase,risk
Ardeparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Ardeparin.,decrease,no risk
Ardeparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Ardeparin.,increase,risk
Ardeparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Ardeparin.,increase,no risk
Ardeparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Ardeparin.,increase,risk
Ardeparin,Hemin,Hemin may increase the anticoagulant activities of Ardeparin.,increase,no risk
Ardeparin,Heparin,The risk or severity of bleeding can be increased when Ardeparin is combined with Heparin.,increase,risk
Ardeparin,Hydrochlorothiazide,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Ardeparin,Hydroflumethiazide,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Ardeparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Ardeparin,Hydroxyurea,The risk or severity of bleeding can be increased when Ardeparin is combined with Hydroxyurea.,increase,risk
Ardeparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Ardeparin.,decrease,no risk
Ardeparin,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Ketoconazole.,increase,risk
Ardeparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Ardeparin.,increase,risk
Ardeparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ardeparin.,increase,risk
Ardeparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Ardeparin is combined with Obeticholic acid.,increase,risk
Ardeparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Ardeparin is combined with Obinutuzumab.,increase,risk
Ardeparin,Olaparib,The risk or severity of bleeding can be increased when Ardeparin is combined with Olaparib.,increase,risk
Ardeparin,Olive oil,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Olive oil.,decrease,no risk
Ardeparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Olmesartan.,increase,risk
Ardeparin,Olsalazine,The risk or severity of bleeding can be increased when Ardeparin is combined with Olsalazine.,increase,risk
Ardeparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ardeparin is combined with Omacetaxine mepesuccinate.,increase,risk
Ardeparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Ardeparin.,increase,no risk
Ardeparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Ardeparin.,increase,risk
Ardeparin,Omega-3-carboxylic acids,The therapeutic efficacy of Ardeparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Ardeparin,Oritavancin,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Ardeparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Ardeparin.,increase,risk
Ardeparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Ardeparin.,increase,risk
Ardeparin,Oxprenolol,The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Oxprenolol.,increase,risk
Ardeparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Ardeparin.,increase,risk
Ardeparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Ardeparin.,increase,risk
Ardeparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Ardeparin.,decrease,no risk
Ardeparin,Quinidine,The therapeutic efficacy of Ardeparin can be increased when used in combination with Quinidine.,increase,no risk
Ardeparin,Quinine,The therapeutic efficacy of Ardeparin can be increased when used in combination with Quinine.,increase,no risk
Ardeparin,Ulipristal,The therapeutic efficacy of Ardeparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Ardeparin,Urokinase,Urokinase may increase the anticoagulant activities of Ardeparin.,increase,no risk
Ardeparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Ardeparin is combined with Ursodeoxycholic acid.,increase,risk
Ardeparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Ardeparin.,increase,risk
Ardeparin,Valsartan,The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Valsartan.,increase,risk
Ardeparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Ardeparin.,decrease,no risk
Ardeparin,Venlafaxine,The risk or severity of bleeding can be increased when Ardeparin is combined with Venlafaxine.,increase,risk
Ardeparin,Vinblastine,The risk or severity of bleeding can be increased when Ardeparin is combined with Vinblastine.,increase,risk
Ardeparin,Vindesine,The risk or severity of bleeding can be increased when Ardeparin is combined with Vindesine.,increase,risk
Ardeparin,Vinorelbine,The risk or severity of bleeding can be increased when Ardeparin is combined with Vinorelbine.,increase,risk
Ardeparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Ardeparin.,increase,no risk
Ardeparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Ardeparin.,decrease,no risk
Ardeparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Ardeparin.,increase,risk
Ardeparin,Vorinostat,The risk or severity of bleeding can be increased when Ardeparin is combined with Vorinostat.,increase,risk
Ardeparin,Warfarin,The risk or severity of bleeding can be increased when Ardeparin is combined with Warfarin.,increase,risk
Ardeparin,Ximelagatran,The risk or severity of bleeding can be increased when Ardeparin is combined with Ximelagatran.,increase,risk
Ardeparin,Zidovudine,The risk or severity of bleeding can be increased when Ardeparin is combined with Zidovudine.,increase,risk
Ardeparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Ardeparin.,increase,risk
Ardeparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Ardeparin.,increase,risk
Ardeparin,Zonisamide,The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Zonisamide.,increase,risk
Loxapine,Gabapentin,The risk or severity of CNS depression can be increased when Loxapine is combined with Gabapentin.,increase,risk
Loxapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Loxapine is combined with Gabapentin enacarbil.,increase,risk
Loxapine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Loxapine is combined with Gallamine triethiodide.,increase,risk
Loxapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Loxapine is combined with Ganaxolone.",increase,risk
Loxapine,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Loxapine.,increase,risk
Loxapine,Gilteritinib,The therapeutic efficacy of Loxapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Loxapine,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Glutethimide,The risk or severity of CNS depression can be increased when Loxapine is combined with Glutethimide.,increase,risk
Loxapine,Granisetron,The risk or severity of CNS depression can be increased when Loxapine is combined with Granisetron.,increase,risk
Loxapine,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Guanfacine,The risk or severity of CNS depression can be increased when Loxapine is combined with Guanfacine.,increase,risk
Loxapine,Halazepam,The risk or severity of CNS depression can be increased when Loxapine is combined with Halazepam.,increase,risk
Loxapine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Loxapine.,increase,risk
Loxapine,Halothane,The risk or severity of CNS depression can be increased when Loxapine is combined with Halothane.,increase,risk
Loxapine,Hexafluronium,The risk or severity of CNS depression can be increased when Loxapine is combined with Hexafluronium.,increase,risk
Loxapine,Hydrocodone,Loxapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Loxapine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Loxapine.,increase,risk
Loxapine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Loxapine.,increase,no risk
Loxapine,Ketamine,The risk or severity of CNS depression can be increased when Loxapine is combined with Ketamine.,increase,risk
Loxapine,Ketazolam,The risk or severity of CNS depression can be increased when Loxapine is combined with Ketazolam.,increase,risk
Loxapine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Loxapine.,increase,risk
Loxapine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Loxapine is combined with Oliceridine.",increase,risk
Loxapine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Omalizumab,The therapeutic efficacy of Omalizumab can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Ondansetron,The risk or severity of CNS depression can be increased when Loxapine is combined with Ondansetron.,increase,risk
Loxapine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Opium,The risk or severity of CNS depression can be increased when Loxapine is combined with Opium.,increase,risk
Loxapine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Orphenadrine,Loxapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Loxapine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Oxazepam,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxazepam.,increase,risk
Loxapine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxcarbazepine.,increase,risk
Loxapine,Oxitriptan,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxitriptan.,increase,risk
Loxapine,Oxprenolol,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxprenolol.,increase,risk
Loxapine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxybuprocaine.,increase,risk
Loxapine,Oxycodone,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxycodone.,increase,risk
Loxapine,Oxymorphone,The risk or severity of CNS depression can be increased when Loxapine is combined with Oxymorphone.,increase,risk
Loxapine,Quazepam,The risk or severity of CNS depression can be increased when Loxapine is combined with Quazepam.,increase,risk
Loxapine,Quetiapine,The risk or severity of CNS depression can be increased when Loxapine is combined with Quetiapine.,increase,risk
Loxapine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Quinine,The risk or severity of CNS depression can be increased when Loxapine is combined with Quinine.,increase,risk
Loxapine,Quinupramine,The risk or severity of CNS depression can be increased when Loxapine is combined with Quinupramine.,increase,risk
Loxapine,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Umeclidinium,The therapeutic efficacy of Umeclidinium can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Urethane,The risk or severity of CNS depression can be increased when Loxapine is combined with Urethane.,increase,risk
Loxapine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Loxapine is combined with Valproate bismuth.,increase,risk
Loxapine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Loxapine.,increase,risk
Loxapine,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vecuronium,The risk or severity of CNS depression can be increased when Loxapine is combined with Vecuronium.,increase,risk
Loxapine,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Loxapine is combined with Venlafaxine.,increase,risk
Loxapine,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vigabatrin,The risk or severity of CNS depression can be increased when Loxapine is combined with Vigabatrin.,increase,risk
Loxapine,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Loxapine.,increase,risk
Loxapine,Viloxazine,The risk or severity of CNS depression can be increased when Loxapine is combined with Viloxazine.,increase,risk
Loxapine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vincristine,The excretion of Vincristine can be decreased when combined with Loxapine.,decrease,no risk
Loxapine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Loxapine.,increase,no risk
Loxapine,Viomycin,Loxapine may increase the neurotoxic activities of Viomycin.,increase,no risk
Loxapine,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Loxapine.,increase,risk
Loxapine,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Loxapine.,increase,no risk
Loxapine,Warfarin,The risk or severity of adverse effects can be increased when Loxapine is combined with Warfarin.,increase,risk
Loxapine,Yohimbine,The risk or severity of CNS depression can be increased when Loxapine is combined with Yohimbine.,increase,risk
Loxapine,Zafirlukast,The therapeutic efficacy of Zafirlukast can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Zaleplon,The risk or severity of CNS depression can be increased when Loxapine is combined with Zaleplon.,increase,risk
Loxapine,Ziconotide,The risk or severity of CNS depression can be increased when Loxapine is combined with Ziconotide.,increase,risk
Loxapine,Zileuton,The therapeutic efficacy of Zileuton can be decreased when used in combination with Loxapine.,decrease,no risk
Loxapine,Zimelidine,The risk or severity of adverse effects can be increased when Loxapine is combined with Zimelidine.,increase,risk
Loxapine,Ziprasidone,The risk or severity of adverse effects can be increased when Loxapine is combined with Ziprasidone.,increase,risk
Loxapine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Loxapine.,increase,risk
Loxapine,Zolpidem,Loxapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Loxapine,Zonisamide,The risk or severity of CNS depression can be increased when Loxapine is combined with Zonisamide.,increase,risk
Loxapine,Zopiclone,The risk or severity of adverse effects can be increased when Loxapine is combined with Zopiclone.,increase,risk
Loxapine,Zotepine,The risk or severity of CNS depression can be increased when Loxapine is combined with Zotepine.,increase,risk
Loxapine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Loxapine is combined with Zuclopenthixol.,increase,risk
Loxapine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Loxapine.,increase,risk
Remoxipride,Gabapentin,The risk or severity of CNS depression can be increased when Remoxipride is combined with Gabapentin.,increase,risk
Remoxipride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Remoxipride is combined with Gabapentin enacarbil.,increase,risk
Remoxipride,Galantamine,The metabolism of Galantamine can be decreased when combined with Remoxipride.,decrease,no risk
Remoxipride,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Remoxipride is combined with Gallamine triethiodide.,increase,risk
Remoxipride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Remoxipride is combined with Ganaxolone.",increase,risk
Remoxipride,Gefitinib,The metabolism of Remoxipride can be decreased when combined with Gefitinib.,decrease,no risk
Remoxipride,Gepirone,The risk or severity of CNS depression can be increased when Remoxipride is combined with Gepirone.,increase,risk
Remoxipride,Givosiran,The serum concentration of Remoxipride can be increased when it is combined with Givosiran.,increase,no risk
Remoxipride,Glutethimide,The risk or severity of CNS depression can be increased when Remoxipride is combined with Glutethimide.,increase,risk
Remoxipride,Glycerol phenylbutyrate,The metabolism of Remoxipride can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Remoxipride,Golimumab,The metabolism of Remoxipride can be increased when combined with Golimumab.,increase,no risk
Remoxipride,Granisetron,The risk or severity of CNS depression can be increased when Remoxipride is combined with Granisetron.,increase,risk
Remoxipride,Guanfacine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Guanfacine.,increase,risk
Remoxipride,Halazepam,The risk or severity of CNS depression can be increased when Remoxipride is combined with Halazepam.,increase,risk
Remoxipride,Halofantrine,The metabolism of Remoxipride can be decreased when combined with Halofantrine.,decrease,no risk
Remoxipride,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Remoxipride.,increase,risk
Remoxipride,Halothane,The risk or severity of CNS depression can be increased when Remoxipride is combined with Halothane.,increase,risk
Remoxipride,Hexafluronium,The risk or severity of CNS depression can be increased when Remoxipride is combined with Hexafluronium.,increase,risk
Remoxipride,Hydrocodone,Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Remoxipride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Remoxipride.,increase,risk
Remoxipride,Hydroxychloroquine,The metabolism of Remoxipride can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Remoxipride,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remoxipride.,increase,no risk
Remoxipride,Ketamine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Ketamine.,increase,risk
Remoxipride,Ketazolam,The risk or severity of CNS depression can be increased when Remoxipride is combined with Ketazolam.,increase,risk
Remoxipride,Ketoconazole,The metabolism of Remoxipride can be decreased when combined with Ketoconazole.,decrease,no risk
Remoxipride,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Remoxipride.,increase,risk
Remoxipride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Remoxipride is combined with Oliceridine.",increase,risk
Remoxipride,Ondansetron,The risk or severity of CNS depression can be increased when Remoxipride is combined with Ondansetron.,increase,risk
Remoxipride,Opium,The risk or severity of CNS depression can be increased when Remoxipride is combined with Opium.,increase,risk
Remoxipride,Oritavancin,The metabolism of Remoxipride can be decreased when combined with Oritavancin.,decrease,no risk
Remoxipride,Orphenadrine,Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Remoxipride,Osilodrostat,The metabolism of Remoxipride can be decreased when combined with Osilodrostat.,decrease,no risk
Remoxipride,Ospemifene,The metabolism of Remoxipride can be decreased when combined with Ospemifene.,decrease,no risk
Remoxipride,Oxamniquine,The metabolism of Remoxipride can be decreased when combined with Oxamniquine.,decrease,no risk
Remoxipride,Oxazepam,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxazepam.,increase,risk
Remoxipride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxcarbazepine.,increase,risk
Remoxipride,Oxitriptan,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxitriptan.,increase,risk
Remoxipride,Oxprenolol,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxprenolol.,increase,risk
Remoxipride,Oxybuprocaine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxybuprocaine.,increase,risk
Remoxipride,Oxybutynin,The metabolism of Remoxipride can be decreased when combined with Oxybutynin.,decrease,no risk
Remoxipride,Oxycodone,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxycodone.,increase,risk
Remoxipride,Oxymorphone,The risk or severity of CNS depression can be increased when Remoxipride is combined with Oxymorphone.,increase,risk
Remoxipride,Quazepam,The risk or severity of CNS depression can be increased when Remoxipride is combined with Quazepam.,increase,risk
Remoxipride,Quetiapine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Quetiapine.,increase,risk
Remoxipride,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Remoxipride.,decrease,no risk
Remoxipride,Quinidine,The metabolism of Remoxipride can be decreased when combined with Quinidine.,decrease,no risk
Remoxipride,Quinine,The metabolism of Remoxipride can be decreased when combined with Quinine.,decrease,no risk
Remoxipride,Quinupramine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Quinupramine.,increase,risk
Remoxipride,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Remoxipride.,decrease,no risk
Remoxipride,Urethane,The risk or severity of CNS depression can be increased when Remoxipride is combined with Urethane.,increase,risk
Remoxipride,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Remoxipride.,decrease,no risk
Remoxipride,Valproate bismuth,Remoxipride may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Remoxipride,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Remoxipride.,increase,risk
Remoxipride,Vecuronium,The risk or severity of CNS depression can be increased when Remoxipride is combined with Vecuronium.,increase,risk
Remoxipride,Vemurafenib,The metabolism of Remoxipride can be decreased when combined with Vemurafenib.,decrease,no risk
Remoxipride,Venlafaxine,The metabolism of Remoxipride can be decreased when combined with Venlafaxine.,decrease,no risk
Remoxipride,Verapamil,The metabolism of Remoxipride can be decreased when combined with Verapamil.,decrease,no risk
Remoxipride,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Remoxipride.,decrease,no risk
Remoxipride,Vigabatrin,The risk or severity of CNS depression can be increased when Remoxipride is combined with Vigabatrin.,increase,risk
Remoxipride,Vilazodone,The metabolism of Remoxipride can be decreased when combined with Vilazodone.,decrease,no risk
Remoxipride,Viloxazine,The metabolism of Remoxipride can be decreased when combined with Viloxazine.,decrease,no risk
Remoxipride,Vinblastine,The metabolism of Remoxipride can be decreased when combined with Vinblastine.,decrease,no risk
Remoxipride,Vincristine,Remoxipride may increase the neurotoxic activities of Vincristine.,increase,no risk
Remoxipride,Vinorelbine,The metabolism of Remoxipride can be decreased when combined with Vinorelbine.,decrease,no risk
Remoxipride,Viomycin,Remoxipride may increase the neurotoxic activities of Viomycin.,increase,no risk
Remoxipride,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Remoxipride.,increase,risk
Remoxipride,Yohimbine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Yohimbine.,increase,risk
Remoxipride,Zaleplon,The risk or severity of CNS depression can be increased when Remoxipride is combined with Zaleplon.,increase,risk
Remoxipride,Ziconotide,The risk or severity of CNS depression can be increased when Remoxipride is combined with Ziconotide.,increase,risk
Remoxipride,Zimelidine,The risk or severity of adverse effects can be increased when Remoxipride is combined with Zimelidine.,increase,risk
Remoxipride,Ziprasidone,The risk or severity of adverse effects can be increased when Remoxipride is combined with Ziprasidone.,increase,risk
Remoxipride,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Remoxipride.,increase,risk
Remoxipride,Zolpidem,Remoxipride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Remoxipride,Zonisamide,The risk or severity of CNS depression can be increased when Remoxipride is combined with Zonisamide.,increase,risk
Remoxipride,Zopiclone,The risk or severity of adverse effects can be increased when Remoxipride is combined with Zopiclone.,increase,risk
Remoxipride,Zotepine,The risk or severity of CNS depression can be increased when Remoxipride is combined with Zotepine.,increase,risk
Remoxipride,Zuclopenthixol,The risk or severity of CNS depression can be increased when Remoxipride is combined with Zuclopenthixol.,increase,risk
Remoxipride,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Remoxipride.,increase,risk
Mupirocin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Benzocaine.,increase,risk
Mupirocin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Benzyl alcohol.,increase,risk
Mupirocin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Bupivacaine.,increase,risk
Mupirocin,Butacaine,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Butacaine.,increase,risk
Mupirocin,Butamben,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Butamben.,increase,risk
Mupirocin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Oxetacaine.,increase,risk
Mupirocin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mupirocin is combined with Oxybuprocaine.,increase,risk
Mupirocin,Oxymetazoline,The absorption of Mupirocin can be decreased when combined with Oxymetazoline.,decrease,no risk
Mupirocin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mupirocin.,decrease,no risk
Mupirocin,Warfarin,The risk or severity of bleeding can be increased when Mupirocin is combined with Warfarin.,increase,risk
Carbachol,Betaine,The risk or severity of adverse effects can be increased when Betaine is combined with Carbamoylcholine.,increase,risk
Carbachol,Betaxolol,The risk or severity of adverse effects can be increased when Betaxolol is combined with Carbamoylcholine.,increase,risk
Carbachol,Bisoprolol,The risk or severity of adverse effects can be increased when Bisoprolol is combined with Carbamoylcholine.,increase,risk
Carbachol,Galantamine,The risk or severity of adverse effects can be increased when Galantamine is combined with Carbamoylcholine.,increase,risk
Carbachol,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Carbamoylcholine.,increase,risk
Carbachol,Gentamicin,The therapeutic efficacy of Carbamoylcholine can be decreased when used in combination with Gentamicin.,decrease,no risk
Carbachol,Ginkgo biloba,The risk or severity of adverse effects can be increased when Ginkgo biloba is combined with Carbamoylcholine.,increase,risk
Carbachol,Hexafluronium,The risk or severity of adverse effects can be increased when Hexafluronium is combined with Carbamoylcholine.,increase,risk
Carbachol,Huperzine A,The risk or severity of adverse effects can be increased when Huperzine A is combined with Carbamoylcholine.,increase,risk
Carbachol,Kanamycin,The therapeutic efficacy of Carbamoylcholine can be decreased when used in combination with Kanamycin.,decrease,no risk
Carbachol,Ketamine,The risk or severity of adverse effects can be increased when Ketamine is combined with Carbamoylcholine.,increase,risk
Carbachol,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Carbamoylcholine.,increase,risk
Rosiglitazone,Balsalazide,Balsalazide may increase the hypoglycemic activities of Rosiglitazone.,increase,no risk
Rosiglitazone,Baricitinib,Rosiglitazone may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Beclomethasone dipropionate,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Belantamab mafodotin,Rosiglitazone may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Bendroflumethiazide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Rosiglitazone,Benorilate,Benorilate may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benserazide,Rosiglitazone may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benzatropine,Benzatropine may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benznidazole,Rosiglitazone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Benzthiazide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Benzthiazide.,decrease,no risk
Rosiglitazone,Benzydamine,Benzydamine may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Bepotastine,Rosiglitazone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Berotralstat,The metabolism of Rosiglitazone can be decreased when combined with Berotralstat.,decrease,no risk
Rosiglitazone,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Betaxolol,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Betaxolol.,increase,no risk
Rosiglitazone,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Rosiglitazone.,increase,no risk
Rosiglitazone,Bexarotene,The metabolism of Rosiglitazone can be decreased when combined with Bexarotene.,decrease,no risk
Rosiglitazone,Bezafibrate,The metabolism of Rosiglitazone can be decreased when combined with Bezafibrate.,decrease,no risk
Rosiglitazone,Bicisate,Rosiglitazone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bifonazole,The metabolism of Rosiglitazone can be decreased when combined with Bifonazole.,decrease,no risk
Rosiglitazone,Bimekizumab,The metabolism of Rosiglitazone can be increased when combined with Bimekizumab.,increase,no risk
Rosiglitazone,Bismuth subgallate,Rosiglitazone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Rosiglitazone.,increase,no risk
Rosiglitazone,Bisoprolol,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Bisoprolol.,increase,no risk
Rosiglitazone,Bisoxatin,Rosiglitazone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bleomycin,Bleomycin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Boceprevir,The metabolism of Rosiglitazone can be decreased when combined with Boceprevir.,decrease,no risk
Rosiglitazone,Bortezomib,The metabolism of Rosiglitazone can be decreased when combined with Bortezomib.,decrease,no risk
Rosiglitazone,Bosentan,Bosentan may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bosutinib,The metabolism of Rosiglitazone can be decreased when combined with Bosutinib.,decrease,no risk
Rosiglitazone,Brexpiprazole,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Rosiglitazone,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Rosiglitazone.,increase,no risk
Rosiglitazone,Brivaracetam,Rosiglitazone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bromazepam,The metabolism of Rosiglitazone can be decreased when combined with Bromazepam.,decrease,no risk
Rosiglitazone,Bromocriptine,The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Bromocriptine.,increase,risk
Rosiglitazone,Bromotheophylline,Bromotheophylline may increase the excretion rate of Rosiglitazone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rosiglitazone,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Bumadizone,Bumadizone may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Bumetanide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Bumetanide.,decrease,no risk
Rosiglitazone,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Bupropion,Rosiglitazone may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Buserelin,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Buserelin.,decrease,no risk
Rosiglitazone,Buspirone,Rosiglitazone may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Butabarbital,Butabarbital may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Rosiglitazone.,decrease,no risk
Rosiglitazone,Gabapentin enacarbil,Rosiglitazone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadobenic acid,Rosiglitazone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadodiamide,Gadodiamide may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadofosveset trisodium,Rosiglitazone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadopentetic acid,Rosiglitazone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadoteric acid,Rosiglitazone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadoteridol,Rosiglitazone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Ganciclovir,Rosiglitazone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gatifloxacin,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Gatifloxacin.,increase,no risk
Rosiglitazone,Gefapixant,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Gefapixant.,increase,no risk
Rosiglitazone,Gemcitabine,Rosiglitazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gemfibrozil,The metabolism of Rosiglitazone can be decreased when combined with Gemfibrozil.,decrease,no risk
Rosiglitazone,Gemifloxacin,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Gemifloxacin.,increase,no risk
Rosiglitazone,Gentamicin,Rosiglitazone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Gimeracil,Rosiglitazone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Ginkgo biloba,The metabolism of Rosiglitazone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Rosiglitazone,Givosiran,Givosiran may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Glecaprevir,The excretion of Glecaprevir can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Rosiglitazone.,increase,no risk
Rosiglitazone,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Rosiglitazone.,increase,no risk
Rosiglitazone,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Rosiglitazone.,increase,no risk
Rosiglitazone,Glofitamab,The serum concentration of Rosiglitazone can be increased when it is combined with Glofitamab.,increase,no risk
Rosiglitazone,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Rosiglitazone.,increase,no risk
Rosiglitazone,Glycerin,The metabolism of Rosiglitazone can be increased when combined with Glycerin.,increase,no risk
Rosiglitazone,Glycerol phenylbutyrate,Rosiglitazone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Glycyrrhizic acid,Rosiglitazone may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Glymidine,The risk or severity of hypoglycemia can be increased when Rosiglitazone is combined with Glymidine.,increase,risk
Rosiglitazone,Golimumab,The metabolism of Rosiglitazone can be increased when combined with Golimumab.,increase,no risk
Rosiglitazone,Golodirsen,Rosiglitazone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Goserelin,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Goserelin.,decrease,no risk
Rosiglitazone,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Grepafloxacin,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Grepafloxacin.,increase,no risk
Rosiglitazone,Guanethidine,Rosiglitazone may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Guanfacine,Rosiglitazone may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rosiglitazone.,increase,no risk
Rosiglitazone,Halothane,The metabolism of Halothane can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Histrelin,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Histrelin.,decrease,no risk
Rosiglitazone,Hydralazine,Rosiglitazone may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Hydrochlorothiazide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Rosiglitazone,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Rosiglitazone.,increase,risk
Rosiglitazone,Hydroflumethiazide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Rosiglitazone,Hydromorphone,Hydromorphone may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Hydroxychloroquine,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Rosiglitazone,Hydroxyethyl Starch,Rosiglitazone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Hydroxyprogesterone caproate,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Rosiglitazone,Kanamycin,Rosiglitazone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Ketamine,The metabolism of Ketamine can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Ketazolam,Rosiglitazone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Ketoconazole,The metabolism of Rosiglitazone can be decreased when combined with Ketoconazole.,decrease,no risk
Rosiglitazone,Ketoprofen,Ketoprofen may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Ketotifen,The risk or severity of thrombocytopenia can be increased when Rosiglitazone is combined with Ketotifen.,increase,risk
Rosiglitazone,Octinoxate,Rosiglitazone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Octreotide,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Octreotide.,decrease,no risk
Rosiglitazone,Ofloxacin,The therapeutic efficacy of Rosiglitazone can be increased when used in combination with Ofloxacin.,increase,no risk
Rosiglitazone,Olanzapine,The therapeutic efficacy of Rosiglitazone can be decreased when used in combination with Olanzapine.,decrease,no risk
Rosiglitazone,Olmesartan,Olmesartan may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.,decrease,no risk
Rosiglitazone,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Olsalazine,Olsalazine may increase the hypoglycemic activities of Rosiglitazone.,increase,no risk
Rosiglitazone,Omaveloxolone,The serum concentration of Rosiglitazone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Rosiglitazone,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Rosiglitazone.,decrease,no risk
Rosiglitazone,Opium,Rosiglitazone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pramipexole,Bismuth subgallate,Pramipexole may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Pramipexole,Bisoprolol,The risk or severity of adverse effects can be increased when Pramipexole is combined with Bisoprolol.,increase,risk
Pramipexole,Bisoxatin,Pramipexole may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Pramipexole,Bleomycin,Bleomycin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Bosentan,Pramipexole may increase the hypotensive activities of Bosentan.,increase,no risk
Pramipexole,Botulinum toxin type A,Botulinum toxin type A may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Botulinum toxin type B,Botulinum toxin type B may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Bretylium,The risk or severity of adverse effects can be increased when Pramipexole is combined with Bretylium.,increase,risk
Pramipexole,Brexanolone,Brexanolone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Brexpiprazole,Brexpiprazole may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Brivaracetam,Brivaracetam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Bromazepam,Bromazepam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Bromocriptine,Bromocriptine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Bromotheophylline,Bromotheophylline may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pramipexole,Bromperidol,Bromperidol may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Brompheniramine,Brompheniramine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Budesonide,Pramipexole may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Pramipexole,Bumadizone,Bumadizone may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Bumetanide,Bumetanide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pramipexole,Bupivacaine,Bupivacaine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Buprenorphine,Buprenorphine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Bupropion,The excretion of Pramipexole can be decreased when combined with Bupropion.,decrease,no risk
Pramipexole,Buspirone,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Buspirone.,decrease,no risk
Pramipexole,Butabarbital,Butabarbital may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Butalbital,Butalbital may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Butaperazine,Butaperazine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Butobarbital,Butobarbital may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Butorphanol,Butorphanol may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Butriptyline,Butriptyline may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Gabapentin,Gabapentin may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Gabapentin enacarbil,Gabapentin enacarbil may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Gadobenic acid,Pramipexole may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Pramipexole,Gadodiamide,Gadodiamide may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Gadofosveset trisodium,Pramipexole may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pramipexole,Gadopentetic acid,Pramipexole may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Pramipexole,Gadoteric acid,Pramipexole may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pramipexole,Gadoteridol,Pramipexole may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Pramipexole,Gallamine triethiodide,Gallamine triethiodide may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Ganaxolone,Ganaxolone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Ganciclovir,The risk or severity of adverse effects can be increased when Ganciclovir is combined with Pramipexole.,increase,risk
Pramipexole,Gemcitabine,Pramipexole may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Pramipexole,Gemfibrozil,Pramipexole may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Pramipexole,Gentamicin,Pramipexole may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pramipexole,Gepirone,Gepirone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Gilteritinib,The risk or severity of adverse effects can be increased when Gilteritinib is combined with Pramipexole.,increase,risk
Pramipexole,Gimeracil,Pramipexole may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pramipexole,Givosiran,Givosiran may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Glipizide,Pramipexole may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Pramipexole,Glutethimide,Glutethimide may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Glycerol phenylbutyrate,Pramipexole may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pramipexole,Golodirsen,Pramipexole may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pramipexole,Goserelin,Goserelin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Granisetron,Granisetron may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Grepafloxacin,The serum concentration of Pramipexole can be increased when it is combined with Grepafloxacin.,increase,no risk
Pramipexole,Guanabenz,Pramipexole may increase the hypotensive activities of Guanabenz.,increase,no risk
Pramipexole,Guanadrel,Pramipexole may increase the hypotensive activities of Guanadrel.,increase,no risk
Pramipexole,Guanethidine,Pramipexole may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Pramipexole,Guanfacine,Guanfacine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Guanidine,The serum concentration of Pramipexole can be increased when it is combined with Guanidine.,increase,no risk
Pramipexole,Guanoxan,Pramipexole may increase the hypotensive activities of Guanoxan.,increase,no risk
Pramipexole,Halazepam,Halazepam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Haloperidol,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Haloperidol.,decrease,no risk
Pramipexole,Halothane,Halothane may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Hexafluronium,Hexafluronium may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Histamine,The serum concentration of Pramipexole can be increased when it is combined with Histamine.,increase,no risk
Pramipexole,Hydralazine,The risk or severity of adverse effects can be increased when Pramipexole is combined with Hydralazine.,increase,risk
Pramipexole,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pramipexole,Hydrocodone,Hydrocodone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pramipexole,Hydromorphone,Hydromorphone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Hydroxyethyl Starch,Pramipexole may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pramipexole,Hydroxyzine,Hydroxyzine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Kanamycin,Pramipexole may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pramipexole,Ketamine,Ketamine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Ketazolam,Ketazolam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Ketoprofen,Ketoprofen may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Ketorolac,Ketorolac may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Obinutuzumab,The risk or severity of adverse effects can be increased when Pramipexole is combined with Obinutuzumab.,increase,risk
Pramipexole,Octinoxate,Pramipexole may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pramipexole,Olanzapine,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Olanzapine.,decrease,no risk
Pramipexole,Oliceridine,Oliceridine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Pramipexole.,increase,risk
Pramipexole,Olsalazine,Olsalazine may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Ondansetron,Ondansetron may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Opicapone,The risk or severity of adverse effects can be increased when Pramipexole is combined with Opicapone.,increase,risk
Pramipexole,Opium,Opium may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Orphenadrine,Orphenadrine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oseltamivir,Oseltamivir may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Oxacillin,Pramipexole may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Pramipexole,Oxaprozin,Oxaprozin may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Oxazepam,Oxazepam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxcarbazepine,Oxcarbazepine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxitriptan,Oxitriptan may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxprenolol,Oxprenolol may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxybenzone,Pramipexole may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Pramipexole,Oxybuprocaine,Oxybuprocaine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxycodone,Oxycodone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxymorphone,Oxymorphone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Oxyquinoline,Pramipexole may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pramipexole,Quazepam,Quazepam may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Quetiapine,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Quetiapine.,decrease,no risk
Pramipexole,Quinagolide,The risk or severity of adverse effects can be decreased when Pramipexole is combined with Quinagolide.,decrease,risk
Pramipexole,Quinapril,The risk or severity of adverse effects can be increased when Pramipexole is combined with Quinapril.,increase,risk
Pramipexole,Quinethazone,Quinethazone may increase the excretion rate of Pramipexole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pramipexole,Quinidine,Pramipexole may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pramipexole,Quinine,Quinine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Quinupramine,Quinupramine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Pramipexole.,increase,risk
Pramipexole,Urethane,Urethane may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Vaborbactam,Pramipexole may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pramipexole,Valaciclovir,Valaciclovir may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Valbenazine,Pramipexole may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pramipexole,Valdecoxib,Valdecoxib may decrease the excretion rate of Pramipexole which could result in a higher serum level.,decrease,no risk
Pramipexole,Valganciclovir,Pramipexole may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Pramipexole,Valproic acid,Valproic acid may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Pramipexole.,increase,risk
Pramipexole,Vancomycin,Pramipexole may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pramipexole,Vandetanib,The serum concentration of Pramipexole can be increased when it is combined with Vandetanib.,increase,no risk
Pramipexole,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Pramipexole.,increase,risk
Pramipexole,Varenicline,The serum concentration of Pramipexole can be increased when it is combined with Varenicline.,increase,no risk
Pramipexole,Vecuronium,Vecuronium may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Venlafaxine,Venlafaxine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Pramipexole.,increase,risk
Pramipexole,Vericiguat,The risk or severity of adverse effects can be increased when Pramipexole is combined with Vericiguat.,increase,risk
Pramipexole,Vigabatrin,Vigabatrin may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Vilanterol,Pramipexole may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Pramipexole,Vilazodone,Vilazodone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Viloxazine,Viloxazine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Vortioxetine,Vortioxetine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Warfarin,Pramipexole may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pramipexole,Yohimbine,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Yohimbine.,decrease,no risk
Pramipexole,Zaleplon,Zaleplon may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zanamivir,Pramipexole may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Pramipexole,Ziconotide,Ziconotide may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zimelidine,Zimelidine may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Ziprasidone,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Ziprasidone.,decrease,no risk
Pramipexole,Zofenopril,Pramipexole may increase the hypotensive activities of Zofenopril.,increase,no risk
Pramipexole,Zolmitriptan,Zolmitriptan may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zolpidem,Zolpidem may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zonisamide,Zonisamide may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zopiclone,Zopiclone may increase the sedative activities of Pramipexole.,increase,no risk
Pramipexole,Zotepine,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Zotepine.,decrease,no risk
Pramipexole,Zuclopenthixol,The therapeutic efficacy of Pramipexole can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Pramipexole,Zuranolone,Zuranolone may increase the sedative activities of Pramipexole.,increase,no risk
Acetohexamide,Gatifloxacin,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Gatifloxacin.,increase,no risk
Acetohexamide,Gefapixant,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Gefapixant.,increase,no risk
Acetohexamide,Gemfibrozil,The metabolism of Acetohexamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Acetohexamide,Gemifloxacin,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Gemifloxacin.,increase,no risk
Acetohexamide,Gestrinone,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Gestrinone.,decrease,no risk
Acetohexamide,Ginkgo biloba,The metabolism of Acetohexamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Acetohexamide,Gliclazide,The risk or severity of hypoglycemia can be increased when Gliclazide is combined with Acetohexamide.,increase,risk
Acetohexamide,Glimepiride,The risk or severity of hypoglycemia can be increased when Glimepiride is combined with Acetohexamide.,increase,risk
Acetohexamide,Glipizide,The risk or severity of hypoglycemia can be increased when Glipizide is combined with Acetohexamide.,increase,risk
Acetohexamide,Gliquidone,The risk or severity of hypoglycemia can be increased when Acetohexamide is combined with Gliquidone.,increase,risk
Acetohexamide,Glofitamab,The serum concentration of Acetohexamide can be increased when it is combined with Glofitamab.,increase,no risk
Acetohexamide,Glyburide,The risk or severity of hypoglycemia can be increased when Glyburide is combined with Acetohexamide.,increase,risk
Acetohexamide,Glycol salicylate,The protein binding of Acetohexamide can be decreased when combined with Glycol salicylate.,decrease,no risk
Acetohexamide,Glymidine,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Glymidine.,increase,no risk
Acetohexamide,Golimumab,The metabolism of Acetohexamide can be increased when combined with Golimumab.,increase,no risk
Acetohexamide,Goserelin,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Goserelin.,decrease,no risk
Acetohexamide,Grepafloxacin,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Grepafloxacin.,increase,no risk
Acetohexamide,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Acetohexamide.,increase,risk
Acetohexamide,Haloperidol,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Haloperidol.,decrease,no risk
Acetohexamide,Halothane,The metabolism of Halothane can be decreased when combined with Acetohexamide.,decrease,no risk
Acetohexamide,Histrelin,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Histrelin.,decrease,no risk
Acetohexamide,Hydrochlorothiazide,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Acetohexamide,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Acetohexamide.,increase,risk
Acetohexamide,Hydroflumethiazide,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Acetohexamide,Hydromorphone,The metabolism of Acetohexamide can be decreased when combined with Hydromorphone.,decrease,no risk
Acetohexamide,Hydroxychloroquine,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Acetohexamide,Hydroxyprogesterone caproate,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Acetohexamide,Ketamine,The metabolism of Ketamine can be decreased when combined with Acetohexamide.,decrease,no risk
Acetohexamide,Ketoprofen,The protein binding of Acetohexamide can be decreased when combined with Ketoprofen.,decrease,no risk
Acetohexamide,Ketorolac,The protein binding of Acetohexamide can be decreased when combined with Ketorolac.,decrease,no risk
Acetohexamide,Ketotifen,The risk or severity of thrombocytopenia can be increased when Acetohexamide is combined with Ketotifen.,increase,risk
Acetohexamide,Octreotide,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Octreotide.,decrease,no risk
Acetohexamide,Ofloxacin,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Ofloxacin.,increase,no risk
Acetohexamide,Olanzapine,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Olanzapine.,decrease,no risk
Acetohexamide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Acetohexamide.,decrease,no risk
Acetohexamide,Olsalazine,Olsalazine may increase the hypoglycemic activities of Acetohexamide.,increase,no risk
Acetohexamide,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Acetohexamide.,decrease,no risk
Acetohexamide,Oritavancin,The metabolism of Acetohexamide can be decreased when combined with Oritavancin.,decrease,no risk
Acetohexamide,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Acetohexamide.,decrease,no risk
Acetohexamide,Oxandrolone,The metabolism of Acetohexamide can be decreased when combined with Oxandrolone.,decrease,no risk
Acetohexamide,Oxaprozin,The protein binding of Acetohexamide can be decreased when combined with Oxaprozin.,decrease,no risk
Acetohexamide,Oxprenolol,The therapeutic efficacy of Acetohexamide can be increased when used in combination with Oxprenolol.,increase,no risk
Acetohexamide,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Acetohexamide.,increase,no risk
Acetohexamide,Oxyphenbutazone,The protein binding of Acetohexamide can be decreased when combined with Oxyphenbutazone.,decrease,no risk
Acetohexamide,Quetiapine,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Quetiapine.,decrease,no risk
Acetohexamide,Quinestrol,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Quinestrol.,decrease,no risk
Acetohexamide,Quinethazone,The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Quinethazone.,decrease,no risk
Acetohexamide,Quinidine,The metabolism of Acetohexamide can be decreased when combined with Quinidine.,decrease,no risk
Acetohexamide,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Acetohexamide.,increase,risk
Acetohexamide,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Acetohexamide.,decrease,no risk
Ampicillin,Gabapentin enacarbil,Ampicillin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadobenic acid,Ampicillin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadodiamide,Gadodiamide may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadofosveset trisodium,Ampicillin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadopentetic acid,Ampicillin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadoteric acid,Ampicillin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ampicillin,Gadoteridol,Ampicillin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ampicillin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Ampicillin.,increase,no risk
Ampicillin,Ganciclovir,Ampicillin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ampicillin,Gatifloxacin,The serum concentration of Gatifloxacin can be increased when it is combined with Ampicillin.,increase,no risk
Ampicillin,Gemcitabine,Ampicillin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ampicillin,Gemfibrozil,Ampicillin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ampicillin,Gemifloxacin,The serum concentration of Gemifloxacin can be increased when it is combined with Ampicillin.,increase,no risk
Ampicillin,Gentamicin,Ampicillin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ampicillin,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Ampicillin.,decrease,no risk
Ampicillin,Gimeracil,Ampicillin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ampicillin,Givosiran,Givosiran may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Glipizide,Ampicillin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ampicillin,Glycerol phenylbutyrate,Ampicillin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ampicillin,Golodirsen,Ampicillin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ampicillin,Goserelin,Goserelin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Ampicillin.,increase,no risk
Ampicillin,Guanethidine,Ampicillin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ampicillin,Guanfacine,Ampicillin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ampicillin,Haloperidol,Ampicillin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ampicillin,Hydralazine,Ampicillin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ampicillin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ampicillin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ampicillin,Hydromorphone,Hydromorphone may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Hydroxychloroquine,Hydroxychloroquine can cause a decrease in the absorption of Ampicillin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ampicillin,Hydroxyethyl Starch,Ampicillin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ampicillin,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Ampicillin.,decrease,no risk
Ampicillin,Kanamycin,Ampicillin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ampicillin,Ketamine,Ampicillin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ampicillin,Ketazolam,Ampicillin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ampicillin,Ketoprofen,Ketoprofen may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Ketorolac,Ketorolac may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Octinoxate,Ampicillin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ampicillin,Ofloxacin,The serum concentration of Ofloxacin can be increased when it is combined with Ampicillin.,increase,no risk
Ampicillin,Olsalazine,Olsalazine may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Omadacycline,The therapeutic efficacy of Ampicillin can be decreased when used in combination with Omadacycline.,decrease,no risk
Ampicillin,Opium,Ampicillin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ampicillin,Oseltamivir,Oseltamivir may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxacillin,Ampicillin may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxaprozin,Oxaprozin may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxazepam,Ampicillin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ampicillin is combined with Oxetacaine.,increase,risk
Ampicillin,Oxybenzone,Ampicillin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ampicillin is combined with Oxybuprocaine.,increase,risk
Ampicillin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxyquinoline,Ampicillin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ampicillin,Oxytetracycline,The therapeutic efficacy of Ampicillin can be decreased when used in combination with Oxytetracycline.,decrease,no risk
Ampicillin,Quetiapine,Ampicillin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ampicillin,Quinethazone,Quinethazone may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ampicillin,Quinidine,Ampicillin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ampicillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Ampicillin.,decrease,no risk
Ampicillin,Vaborbactam,Ampicillin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ampicillin,Valaciclovir,Valaciclovir may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Valbenazine,Ampicillin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ampicillin,Valdecoxib,Valdecoxib may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Valganciclovir,Ampicillin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ampicillin,Vancomycin,Ampicillin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ampicillin,Varenicline,Ampicillin may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ampicillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Ampicillin.,increase,no risk
Ampicillin,Venlafaxine,Venlafaxine may decrease the excretion rate of Ampicillin which could result in a higher serum level.,decrease,no risk
Ampicillin,Verapamil,Ampicillin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ampicillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ampicillin.,decrease,no risk
Ampicillin,Vilanterol,Ampicillin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ampicillin,Viloxazine,Ampicillin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ampicillin,Vortioxetine,Ampicillin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ampicillin,Warfarin,Ampicillin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ampicillin,Zaleplon,Ampicillin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ampicillin,Zanamivir,Ampicillin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ampicillin,Zonisamide,Zonisamide may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Metocurine iodide,Gabapentin,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Gabapentin.,increase,risk
Metocurine iodide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Gabapentin enacarbil.,increase,risk
Metocurine iodide,Galantamine,The therapeutic efficacy of Metocurine iodide can be decreased when used in combination with Galantamine.,decrease,no risk
Metocurine iodide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Gallamine triethiodide.,increase,risk
Metocurine iodide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Metocurine iodide is combined with Ganaxolone.",increase,risk
Metocurine iodide,Gentamicin,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Gentamicin.,increase,no risk
Metocurine iodide,Gepirone,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Gepirone.,increase,risk
Metocurine iodide,Ginkgo biloba,The therapeutic efficacy of Metocurine iodide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Metocurine iodide,Glutethimide,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Glutethimide.,increase,risk
Metocurine iodide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Metocurine iodide.,decrease,no risk
Metocurine iodide,Glycopyrronium,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Glycopyrronium.,increase,risk
Metocurine iodide,Granisetron,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Granisetron.,increase,risk
Metocurine iodide,Guanfacine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Guanfacine.,increase,risk
Metocurine iodide,Halazepam,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Halazepam.,increase,risk
Metocurine iodide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Halothane,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Halothane.,increase,risk
Metocurine iodide,Hetacillin,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Hetacillin.,increase,no risk
Metocurine iodide,Hexafluronium,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Hexafluronium.,increase,risk
Metocurine iodide,Hexocyclium,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Hexocyclium.,increase,risk
Metocurine iodide,Homatropine,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Homatropine.,increase,risk
Metocurine iodide,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Homatropine methylbromide.,increase,risk
Metocurine iodide,Huperzine A,The therapeutic efficacy of Metocurine iodide can be decreased when used in combination with Huperzine A.,decrease,no risk
Metocurine iodide,Hydrochlorothiazide,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Metocurine iodide,Hydrocodone,Metocurine iodide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Metocurine iodide,Hydrocortisone,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Hydrocortisone.,increase,risk
Metocurine iodide,Hydrocortisone acetate,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Hydrocortisone acetate.,increase,risk
Metocurine iodide,Hydrocortisone butyrate,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Hydrocortisone butyrate.,increase,risk
Metocurine iodide,Hydrocortisone cypionate,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Hydrocortisone cypionate.,increase,risk
Metocurine iodide,Hydrocortisone succinate,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Hydrocortisone succinate.,increase,risk
Metocurine iodide,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Metocurine iodide.,increase,no risk
Metocurine iodide,Hydromorphone,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Hydromorphone.,increase,risk
Metocurine iodide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Metocurine iodide.,increase,no risk
Metocurine iodide,Hyoscyamine,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Hyoscyamine.,increase,risk
Metocurine iodide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Metocurine iodide is combined with Oliceridine.",increase,risk
Metocurine iodide,Ondansetron,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Ondansetron.,increase,risk
Metocurine iodide,Opium,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Opium.,increase,risk
Metocurine iodide,Orphenadrine,Metocurine iodide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Metocurine iodide,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Metocurine iodide is combined with Ouabain.,increase,risk
Metocurine iodide,Oxacillin,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Oxacillin.,increase,no risk
Metocurine iodide,Oxazepam,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Oxazepam.,increase,risk
Metocurine iodide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Oxcarbazepine.,increase,risk
Metocurine iodide,Oxitriptan,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Oxitriptan.,increase,risk
Metocurine iodide,Oxprenolol,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Oxprenolol.,increase,risk
Metocurine iodide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Oxybuprocaine.,increase,risk
Metocurine iodide,Oxybutynin,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Oxybutynin.,increase,risk
Metocurine iodide,Oxycodone,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Oxycodone.,increase,risk
Metocurine iodide,Oxymorphone,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Oxymorphone.,increase,risk
Metocurine iodide,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Metocurine iodide.,decrease,no risk
Metocurine iodide,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Oxytetracycline,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Oxytetracycline.,increase,no risk
Metocurine iodide,Quazepam,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Quazepam.,increase,risk
Metocurine iodide,Quetiapine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Quetiapine.,increase,risk
Metocurine iodide,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Metocurine iodide.,increase,no risk
Metocurine iodide,Quinidine,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Quinidine.,increase,no risk
Metocurine iodide,Quinine,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Quinine.,increase,no risk
Metocurine iodide,Quinupramine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Quinupramine.,increase,risk
Metocurine iodide,Umeclidinium,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Umeclidinium.,increase,risk
Metocurine iodide,Urethane,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Urethane.,increase,risk
Metocurine iodide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Vamorolone,The risk or severity of myopathy and weakness can be increased when Metocurine iodide is combined with Vamorolone.,increase,risk
Metocurine iodide,Vancomycin,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Vancomycin.,increase,no risk
Metocurine iodide,Vecuronium,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Vecuronium.,increase,risk
Metocurine iodide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Verapamil,Verapamil may increase the neuromuscular blocking activities of Metocurine iodide.,increase,no risk
Metocurine iodide,Vigabatrin,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Vigabatrin.,increase,risk
Metocurine iodide,Vilazodone,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Vilazodone.,increase,risk
Metocurine iodide,Viloxazine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Viloxazine.,increase,risk
Metocurine iodide,Viomycin,The therapeutic efficacy of Metocurine iodide can be increased when used in combination with Viomycin.,increase,no risk
Metocurine iodide,Vortioxetine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Vortioxetine.,increase,risk
Metocurine iodide,Xylometazoline,Xylometazoline may increase the neuromuscular blocking activities of Metocurine iodide.,increase,no risk
Metocurine iodide,Yohimbine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Yohimbine.,increase,risk
Metocurine iodide,Zaleplon,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Zaleplon.,increase,risk
Metocurine iodide,Ziconotide,Ziconotide may increase the neuromuscular blocking activities of Metocurine iodide.,increase,no risk
Metocurine iodide,Zimelidine,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Zimelidine.,increase,risk
Metocurine iodide,Ziprasidone,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Ziprasidone.,increase,risk
Metocurine iodide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Metocurine iodide.,increase,risk
Metocurine iodide,Zolpidem,Metocurine iodide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Metocurine iodide,Zonisamide,Zonisamide may increase the neuromuscular blocking activities of Metocurine iodide.,increase,no risk
Metocurine iodide,Zopiclone,The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Zopiclone.,increase,risk
Metocurine iodide,Zotepine,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Zotepine.,increase,risk
Metocurine iodide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Zuclopenthixol.,increase,risk
Phenoxymethylpenicillin,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Phenoxymethylpenicillin.,decrease,no risk
Phenoxymethylpenicillin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Phenoxymethylpenicillin.,increase,no risk
Phenoxymethylpenicillin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Phenoxymethylpenicillin.,decrease,no risk
Phenoxymethylpenicillin,Warfarin,Phenoxymethylpenicillin may increase the anticoagulant activities of Warfarin.,increase,no risk
Secobarbital,Belladonna,The risk or severity of adverse effects can be increased when Secobarbital is combined with Belladonna.,increase,risk
Secobarbital,Benazepril,Secobarbital may increase the hypotensive activities of Benazepril.,increase,no risk
Secobarbital,Bendroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Secobarbital is combined with Bendroflumethiazide.,increase,risk
Secobarbital,Benorilate,Benorilate may decrease the excretion rate of Secobarbital which could result in a higher serum level.,decrease,no risk
Secobarbital,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Secobarbital which could result in a higher serum level.,decrease,no risk
Secobarbital,Benperidol,The risk or severity of CNS depression can be increased when Secobarbital is combined with Benperidol.,increase,risk
Secobarbital,Benserazide,Secobarbital may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Secobarbital,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Secobarbital.,increase,risk
Secobarbital,Benzhydrocodone,The risk or severity of adverse effects can be increased when Secobarbital is combined with Benzhydrocodone.,increase,risk
Secobarbital,Benznidazole,Secobarbital may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Secobarbital,Benzocaine,The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Benzocaine.,increase,risk
Secobarbital,Benzphetamine,The risk or severity of CNS depression can be increased when Secobarbital is combined with Benzphetamine.,increase,risk
Secobarbital,Benzthiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Secobarbital is combined with Benzthiazide.,increase,risk
Secobarbital,Benzydamine,Benzydamine may decrease the excretion rate of Secobarbital which could result in a higher serum level.,decrease,no risk
Secobarbital,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Benzyl alcohol.,increase,risk
Secobarbital,Bepotastine,Secobarbital may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Secobarbital,Bepridil,Secobarbital may increase the hypotensive activities of Bepridil.,increase,no risk
Secobarbital,Betaine,The therapeutic efficacy of Secobarbital can be decreased when used in combination with Betaine.,decrease,no risk
Secobarbital,Betaxolol,Secobarbital may increase the hypotensive activities of Betaxolol.,increase,no risk
Secobarbital,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Bicisate,Secobarbital may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Secobarbital,Binimetinib,The metabolism of Binimetinib can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Biperiden,The risk or severity of adverse effects can be increased when Secobarbital is combined with Biperiden.,increase,risk
Secobarbital,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Secobarbital.,decrease,no risk
Secobarbital,Bismuth subgallate,Secobarbital may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Secobarbital,Bisoprolol,Secobarbital may increase the hypotensive activities of Bisoprolol.,increase,no risk
Secobarbital,Bisoxatin,Secobarbital may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Secobarbital,Bleomycin,Bleomycin may decrease the excretion rate of Secobarbital which could result in a higher serum level.,decrease,no risk
Secobarbital,Borage oil,The therapeutic efficacy of Secobarbital can be decreased when used in combination with Borage oil.,decrease,no risk
Secobarbital,Bortezomib,The metabolism of Bortezomib can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Bosutinib,The metabolism of Bosutinib can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Secobarbital is combined with Botulinum toxin type A.,increase,risk
Secobarbital,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Secobarbital is combined with Botulinum toxin type B.,increase,risk
Secobarbital,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Bretylium,Secobarbital may increase the hypotensive activities of Bretylium.,increase,no risk
Secobarbital,Brexanolone,The risk or severity of CNS depression can be increased when Secobarbital is combined with Brexanolone.,increase,risk
Secobarbital,Brexpiprazole,The risk or severity of CNS depression can be increased when Secobarbital is combined with Brexpiprazole.,increase,risk
Secobarbital,Brigatinib,The metabolism of Brigatinib can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Secobarbital.,increase,no risk
Secobarbital,Brivaracetam,The risk or severity of CNS depression can be increased when Secobarbital is combined with Brivaracetam.,increase,risk
Secobarbital,Bromazepam,The risk or severity of CNS depression can be increased when Secobarbital is combined with Bromazepam.,increase,risk
Secobarbital,Bromocriptine,Secobarbital may increase the hypotensive activities of Bromocriptine.,increase,no risk
Secobarbital,Bromotheophylline,The serum concentration of Bromotheophylline can be decreased when it is combined with Secobarbital.,decrease,no risk
Secobarbital,Bromperidol,The risk or severity of CNS depression can be increased when Secobarbital is combined with Bromperidol.,increase,risk
Secobarbital,Brompheniramine,The risk or severity of CNS depression can be increased when Secobarbital is combined with Brompheniramine.,increase,risk
Secobarbital,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Secobarbital.,increase,risk
Secobarbital,Budesonide,Secobarbital may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Secobarbital,Bumadizone,Bumadizone may decrease the excretion rate of Secobarbital which could result in a higher serum level.,decrease,no risk
Secobarbital,Bumetanide,Secobarbital may increase the hypotensive activities of Bumetanide.,increase,no risk
Secobarbital,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Bupivacaine.,increase,risk
Secobarbital,Buprenorphine,Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Secobarbital,Bupropion,The risk or severity of CNS depression can be increased when Secobarbital is combined with Bupropion.,increase,risk
Secobarbital,Buspirone,The risk or severity of CNS depression can be increased when Secobarbital is combined with Buspirone.,increase,risk
Secobarbital,Busulfan,The metabolism of Busulfan can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Secobarbital.,increase,risk
Secobarbital,Butacaine,The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Butacaine.,increase,risk
Secobarbital,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Secobarbital.,increase,risk
Secobarbital,Butamben,The risk or severity of methemoglobinemia can be increased when Secobarbital is combined with Butamben.,increase,risk
Secobarbital,Butaperazine,The risk or severity of CNS depression can be increased when Secobarbital is combined with Butaperazine.,increase,risk
Secobarbital,Butobarbital,The risk or severity of CNS depression can be increased when Secobarbital is combined with Butobarbital.,increase,risk
Secobarbital,Butorphanol,The risk or severity of adverse effects can be increased when Secobarbital is combined with Butorphanol.,increase,risk
Secobarbital,Butriptyline,The metabolism of Butriptyline can be increased when combined with Secobarbital.,increase,no risk
Secobarbital,Butylscopolamine,The risk or severity of adverse effects can be increased when Secobarbital is combined with Butylscopolamine.,increase,risk
Promazine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Promazine.,increase,no risk
Promazine,Balsalazide,The risk or severity of hypertension can be increased when Promazine is combined with Balsalazide.,increase,risk
Promazine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Promazine is combined with Bedaquiline.,increase,risk
Promazine,Belinostat,The metabolism of Promazine can be increased when combined with Belinostat.,increase,no risk
Promazine,Belladonna,The risk or severity of adverse effects can be increased when Promazine is combined with Belladonna.,increase,risk
Promazine,Benazepril,Promazine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Promazine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Promazine.,decrease,no risk
Promazine,Bendroflumethiazide,Promazine may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Promazine,Benorilate,The risk or severity of hypertension can be increased when Promazine is combined with Benorilate.,increase,risk
Promazine,Benoxaprofen,The risk or severity of hypertension can be increased when Promazine is combined with Benoxaprofen.,increase,risk
Promazine,Benperidol,The risk or severity of CNS depression can be increased when Promazine is combined with Benperidol.,increase,risk
Promazine,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Benzatropine,The risk or severity of adverse effects can be increased when Promazine is combined with Benzatropine.,increase,risk
Promazine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Promazine is combined with Benzhydrocodone.,increase,risk
Promazine,Benzocaine,The risk or severity of CNS depression can be increased when Promazine is combined with Benzocaine.,increase,risk
Promazine,Benzphetamine,Benzphetamine may decrease the sedative activities of Promazine.,decrease,no risk
Promazine,Benzthiazide,The serum concentration of Benzthiazide can be increased when it is combined with Promazine.,increase,no risk
Promazine,Benzydamine,The risk or severity of hypertension can be increased when Promazine is combined with Benzydamine.,increase,risk
Promazine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Promazine is combined with Benzyl alcohol.,increase,risk
Promazine,Benzylpenicilloyl polylysine,Promazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Promazine,Bepridil,The risk or severity of QTc prolongation can be increased when Promazine is combined with Bepridil.,increase,risk
Promazine,Berotralstat,The metabolism of Promazine can be decreased when combined with Berotralstat.,decrease,no risk
Promazine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Betaine,The therapeutic efficacy of Promazine can be decreased when used in combination with Betaine.,decrease,no risk
Promazine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Promazine.,increase,no risk
Promazine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Bexarotene,The metabolism of Promazine can be decreased when combined with Bexarotene.,decrease,no risk
Promazine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Promazine.,increase,risk
Promazine,Bimekizumab,The metabolism of Promazine can be increased when combined with Bimekizumab.,increase,no risk
Promazine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Promazine.,decrease,no risk
Promazine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Bismuth subcitrate potassium,Promazine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Promazine,Bismuth subgallate,Promazine may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Promazine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Promazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Promazine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Promazine.,increase,no risk
Promazine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Boceprevir,The metabolism of Promazine can be decreased when combined with Boceprevir.,decrease,no risk
Promazine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Promazine.,decrease,no risk
Promazine,Bosentan,The metabolism of Promazine can be increased when combined with Bosentan.,increase,no risk
Promazine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Promazine is combined with Botulinum toxin type A.,increase,risk
Promazine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Promazine is combined with Botulinum toxin type B.,increase,risk
Promazine,Bretylium,Promazine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Promazine,Brexanolone,The risk or severity of CNS depression can be increased when Promazine is combined with Brexanolone.,increase,risk
Promazine,Brexpiprazole,"Promazine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Promazine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Promazine.,increase,no risk
Promazine,Brivaracetam,The risk or severity of CNS depression can be increased when Promazine is combined with Brivaracetam.,increase,risk
Promazine,Bromazepam,The risk or severity of CNS depression can be increased when Promazine is combined with Bromazepam.,increase,risk
Promazine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Promazine.,decrease,no risk
Promazine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Promazine.,decrease,no risk
Promazine,Bromperidol,The risk or severity of CNS depression can be increased when Promazine is combined with Bromperidol.,increase,risk
Promazine,Brompheniramine,The risk or severity of CNS depression can be increased when Promazine is combined with Brompheniramine.,increase,risk
Promazine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Promazine.,increase,risk
Promazine,Bumadizone,The risk or severity of hypertension can be increased when Promazine is combined with Bumadizone.,increase,risk
Promazine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Promazine.,increase,risk
Promazine,Buprenorphine,Promazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Promazine,Bupropion,The metabolism of Promazine can be decreased when combined with Bupropion.,decrease,no risk
Promazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Promazine.,increase,risk
Promazine,Buspirone,The risk or severity of CNS depression can be increased when Promazine is combined with Buspirone.,increase,risk
Promazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Promazine.,increase,risk
Promazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Promazine.,increase,risk
Promazine,Butaperazine,The risk or severity of CNS depression can be increased when Promazine is combined with Butaperazine.,increase,risk
Promazine,Butobarbital,The risk or severity of CNS depression can be increased when Promazine is combined with Butobarbital.,increase,risk
Promazine,Butorphanol,The risk or severity of adverse effects can be increased when Promazine is combined with Butorphanol.,increase,risk
Promazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Promazine.,increase,no risk
Promazine,Butylscopolamine,The risk or severity of adverse effects can be increased when Promazine is combined with Butylscopolamine.,increase,risk
Spironolactone,Bretylium,Spironolactone may increase the hypotensive activities of Bretylium.,increase,no risk
Spironolactone,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Spironolactone.,decrease,no risk
Spironolactone,Brimonidine,Brimonidine may increase the antihypertensive activities of Spironolactone.,increase,no risk
Spironolactone,Brivaracetam,Spironolactone may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Bromazepam,Spironolactone may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Bromfenac,The risk or severity of hyperkalemia can be increased when Bromfenac is combined with Spironolactone.,increase,risk
Spironolactone,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Spironolactone.,decrease,no risk
Spironolactone,Budesonide,Spironolactone may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Bufexamac,The risk or severity of hyperkalemia can be increased when Bufexamac is combined with Spironolactone.,increase,risk
Spironolactone,Bumadizone,The risk or severity of hyperkalemia can be increased when Bumadizone is combined with Spironolactone.,increase,risk
Spironolactone,Bumetanide,Spironolactone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Spironolactone.,increase,risk
Spironolactone,Buprenorphine,The risk or severity of orthostatic hypotension can be increased when Buprenorphine is combined with Spironolactone.,increase,risk
Spironolactone,Bupropion,Spironolactone may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Buspirone,Spironolactone may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Butabarbital,The risk or severity of orthostatic hypotension can be increased when Butabarbital is combined with Spironolactone.,increase,risk
Spironolactone,Butalbital,The risk or severity of orthostatic hypotension can be increased when Butalbital is combined with Spironolactone.,increase,risk
Spironolactone,Butorphanol,The risk or severity of orthostatic hypotension can be increased when Butorphanol is combined with Spironolactone.,increase,risk
Spironolactone,Butriptyline,Butriptyline may decrease the antihypertensive activities of Spironolactone.,decrease,no risk
Spironolactone,Gabapentin enacarbil,Spironolactone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadobenic acid,Spironolactone may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadodiamide,Spironolactone may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadofosveset trisodium,Spironolactone may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadopentetic acid,Spironolactone may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadoteric acid,Spironolactone may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gadoteridol,Spironolactone may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gallamine triethiodide,Spironolactone may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Spironolactone,Ganciclovir,Spironolactone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gemcitabine,Spironolactone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gemfibrozil,Spironolactone may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gimeracil,Spironolactone may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Glipizide,Spironolactone may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Gluconic Acid,The risk or severity of dehydration can be increased when Spironolactone is combined with Gluconic Acid.,increase,risk
Spironolactone,Glycerin,The risk or severity of dehydration can be increased when Spironolactone is combined with Glycerin.,increase,risk
Spironolactone,Glycerol phenylbutyrate,Spironolactone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Glycol salicylate,The therapeutic efficacy of Spironolactone can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Spironolactone,Golodirsen,Spironolactone may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Goserelin,Spironolactone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Spironolactone.,decrease,no risk
Spironolactone,Guanadrel,Guanadrel may increase the hypotensive activities of Spironolactone.,increase,no risk
Spironolactone,Guanethidine,Spironolactone may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Spironolactone.,decrease,no risk
Spironolactone,Guanoxan,Spironolactone may increase the hypotensive activities of Guanoxan.,increase,no risk
Spironolactone,Haloperidol,Spironolactone may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Halothane,Halothane may decrease the antihypertensive activities of Spironolactone.,decrease,no risk
Spironolactone,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Spironolactone.,increase,risk
Spironolactone,Hydralazine,Spironolactone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Hydrocodone,The risk or severity of orthostatic hypotension can be increased when Hydrocodone is combined with Spironolactone.,increase,risk
Spironolactone,Hydroflumethiazide,The therapeutic efficacy of Spironolactone can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Spironolactone,Hydromorphone,The risk or severity of orthostatic hypotension can be increased when Hydromorphone is combined with Spironolactone.,increase,risk
Spironolactone,Hydroxocobalamin,Spironolactone may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Hydroxyethyl Starch,Spironolactone may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Ketamine,Spironolactone may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Ketazolam,Spironolactone may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Spironolactone.,increase,risk
Spironolactone,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Spironolactone.,increase,risk
Spironolactone,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Spironolactone.,increase,risk
Spironolactone,Obinutuzumab,Spironolactone may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Spironolactone,Octinoxate,Spironolactone may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Spironolactone.,increase,risk
Spironolactone,Oliceridine,The therapeutic efficacy of Spironolactone can be decreased when used in combination with Oliceridine.,decrease,no risk
Spironolactone,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Spironolactone.,increase,risk
Spironolactone,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Spironolactone.,decrease,no risk
Spironolactone,Opicapone,The risk or severity of adverse effects can be increased when Spironolactone is combined with Opicapone.,increase,risk
Spironolactone,Opium,The risk or severity of orthostatic hypotension can be increased when Opium is combined with Spironolactone.,increase,risk
Spironolactone,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Spironolactone.,decrease,no risk
Spironolactone,Oseltamivir,Spironolactone may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Ouabain,Spironolactone may decrease the excretion rate of Ouabain which could result in a higher serum level.,decrease,no risk
Spironolactone,Oxacillin,Spironolactone may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Spironolactone.,increase,risk
Spironolactone,Oxazepam,Spironolactone may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Spironolactone.,increase,risk
Spironolactone,Oxybenzone,Spironolactone may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Oxycodone,The risk or severity of orthostatic hypotension can be increased when Oxycodone is combined with Spironolactone.,increase,risk
Spironolactone,Oxymetazoline,The therapeutic efficacy of Spironolactone can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Spironolactone,Oxymorphone,The risk or severity of orthostatic hypotension can be increased when Oxymorphone is combined with Spironolactone.,increase,risk
Spironolactone,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Spironolactone.,increase,risk
Spironolactone,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Spironolactone is combined with Oxyphenisatin acetate.,increase,risk
Spironolactone,Oxyquinoline,Spironolactone may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Quetiapine,Quetiapine may increase the hypotensive activities of Spironolactone.,increase,no risk
Spironolactone,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Spironolactone.,increase,risk
Spironolactone,Quinidine,Spironolactone may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Spironolactone,Quinine,Quinine may increase the hypotensive activities of Spironolactone.,increase,no risk
Spironolactone,Quinupramine,Quinupramine may decrease the antihypertensive activities of Spironolactone.,decrease,no risk
Methylphenidate,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Guanabenz,Methylphenidate may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Methylphenidate,Guanadrel,Methylphenidate may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Methylphenidate,Guanethidine,Methylphenidate may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Methylphenidate,Guanfacine,Methylphenidate may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Methylphenidate,Guanoxan,Methylphenidate may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Methylphenidate,Haloperidol,The risk or severity of adverse effects can be increased when Haloperidol is combined with Methylphenidate.,increase,risk
Methylphenidate,Halothane,Methylphenidate may increase the hypertensive activities of Halothane.,increase,no risk
Methylphenidate,Hydralazine,Methylphenidate may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Methylphenidate,Hydrochlorothiazide,Methylphenidate may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Methylphenidate,Hydroflumethiazide,Methylphenidate may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Methylphenidate,Hydrotalcite,Hydrotalcite can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Methylphenidate,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Methylphenidate.,increase,risk
Methylphenidate,Ketoprofen,The risk or severity of hypertension can be increased when Methylphenidate is combined with Ketoprofen.,increase,risk
Methylphenidate,Ketorolac,The risk or severity of hypertension can be increased when Methylphenidate is combined with Ketorolac.,increase,risk
Methylphenidate,Olanzapine,The therapeutic efficacy of Methylphenidate can be decreased when used in combination with Olanzapine.,decrease,no risk
Methylphenidate,Olmesartan,Methylphenidate may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Methylphenidate,Olodaterol,The risk or severity of hypertension can be increased when Methylphenidate is combined with Olodaterol.,increase,risk
Methylphenidate,Omeprazole,Omeprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Methylphenidate,Opicapone,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Opicapone.,increase,risk
Methylphenidate,Orciprenaline,The risk or severity of hypertension can be increased when Methylphenidate is combined with Orciprenaline.,increase,risk
Methylphenidate,Orphenadrine,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Orphenadrine.,increase,risk
Methylphenidate,Oxaprozin,The risk or severity of hypertension can be increased when Methylphenidate is combined with Oxaprozin.,increase,risk
Methylphenidate,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Oxprenolol,Methylphenidate may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Methylphenidate,Oxymetazoline,The risk or severity of hypertension can be increased when Methylphenidate is combined with Oxymetazoline.,increase,risk
Methylphenidate,Oxyphenbutazone,The risk or severity of hypertension can be increased when Methylphenidate is combined with Oxyphenbutazone.,increase,risk
Methylphenidate,Quetiapine,The risk or severity of adverse effects can be increased when Quetiapine is combined with Methylphenidate.,increase,risk
Methylphenidate,Quinapril,Methylphenidate may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Methylphenidate,Quinidine,The risk or severity of hypertension can be increased when Methylphenidate is combined with Quinidine.,increase,risk
Methylphenidate,Quinupramine,The risk or severity of adverse effects can be increased when Methylphenidate is combined with Quinupramine.,increase,risk
Methylphenidate,Valdecoxib,The risk or severity of hypertension can be increased when Methylphenidate is combined with Valdecoxib.,increase,risk
Methylphenidate,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Valsartan,Methylphenidate may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Methylphenidate,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Vilanterol,The risk or severity of hypertension can be increased when Methylphenidate is combined with Vilanterol.,increase,risk
Methylphenidate,Vilazodone,The risk or severity of hypertension can be increased when Methylphenidate is combined with Vilazodone.,increase,risk
Methylphenidate,Vonoprazan,Vonoprazan can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects.,increase,no risk
Methylphenidate,Vortioxetine,The risk or severity of hypertension can be increased when Methylphenidate is combined with Vortioxetine.,increase,risk
Methylphenidate,Warfarin,The metabolism of Warfarin can be decreased when combined with Methylphenidate.,decrease,no risk
Methylphenidate,Xamoterol,The risk or severity of hypertension can be increased when Methylphenidate is combined with Xamoterol.,increase,risk
Methylphenidate,Xylometazoline,The risk or severity of hypertension can be increased when Methylphenidate is combined with Xylometazoline.,increase,risk
Methylphenidate,Yohimbine,The risk or severity of hypertension can be increased when Methylphenidate is combined with Yohimbine.,increase,risk
Methylphenidate,Zaleplon,The therapeutic efficacy of Zaleplon can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Methylphenidate.,increase,risk
Methylphenidate,Zofenopril,Methylphenidate may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Methylphenidate,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Methylphenidate.,increase,risk
Methylphenidate,Zonisamide,The therapeutic efficacy of Zonisamide can be decreased when used in combination with Methylphenidate.,decrease,no risk
Methylphenidate,Zotepine,The risk or severity of adverse effects can be increased when Zotepine is combined with Methylphenidate.,increase,risk
Methylphenidate,Zuclopenthixol,The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Methylphenidate.,increase,risk
Methocarbamol,Gabapentin,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Gabapentin.,increase,risk
Methocarbamol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Gabapentin enacarbil.,increase,risk
Methocarbamol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Gallamine triethiodide.,increase,risk
Methocarbamol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methocarbamol is combined with Ganaxolone.",increase,risk
Methocarbamol,Gepirone,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Gepirone.,increase,risk
Methocarbamol,Glutethimide,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Glutethimide.,increase,risk
Methocarbamol,Granisetron,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Granisetron.,increase,risk
Methocarbamol,Guanfacine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Guanfacine.,increase,risk
Methocarbamol,Halazepam,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Halazepam.,increase,risk
Methocarbamol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methocarbamol.,increase,risk
Methocarbamol,Halothane,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Halothane.,increase,risk
Methocarbamol,Hexafluronium,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Hexafluronium.,increase,risk
Methocarbamol,Hydrocodone,Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methocarbamol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Methocarbamol.,increase,risk
Methocarbamol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methocarbamol.,increase,no risk
Methocarbamol,Ketamine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Ketamine.,increase,risk
Methocarbamol,Ketazolam,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Ketazolam.,increase,risk
Methocarbamol,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Methocarbamol.,increase,risk
Methocarbamol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methocarbamol is combined with Oliceridine.",increase,risk
Methocarbamol,Ondansetron,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Ondansetron.,increase,risk
Methocarbamol,Opium,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Opium.,increase,risk
Methocarbamol,Orphenadrine,Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methocarbamol,Oxazepam,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxazepam.,increase,risk
Methocarbamol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxcarbazepine.,increase,risk
Methocarbamol,Oxitriptan,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxitriptan.,increase,risk
Methocarbamol,Oxprenolol,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxprenolol.,increase,risk
Methocarbamol,Oxybuprocaine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxybuprocaine.,increase,risk
Methocarbamol,Oxycodone,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxycodone.,increase,risk
Methocarbamol,Oxymorphone,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Oxymorphone.,increase,risk
Methocarbamol,Quazepam,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Quazepam.,increase,risk
Methocarbamol,Quetiapine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Quetiapine.,increase,risk
Methocarbamol,Quinine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Quinine.,increase,risk
Methocarbamol,Quinupramine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Quinupramine.,increase,risk
Methocarbamol,Urethane,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Urethane.,increase,risk
Methocarbamol,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Methocarbamol.,increase,risk
Methocarbamol,Vecuronium,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Vecuronium.,increase,risk
Methocarbamol,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Methocarbamol.,increase,risk
Methocarbamol,Vigabatrin,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Vigabatrin.,increase,risk
Methocarbamol,Vilazodone,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Vilazodone.,increase,risk
Methocarbamol,Viloxazine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Viloxazine.,increase,risk
Methocarbamol,Vortioxetine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Vortioxetine.,increase,risk
Methocarbamol,Yohimbine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Yohimbine.,increase,risk
Methocarbamol,Zaleplon,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Zaleplon.,increase,risk
Methocarbamol,Ziconotide,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Ziconotide.,increase,risk
Methocarbamol,Zimelidine,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Zimelidine.,increase,risk
Methocarbamol,Ziprasidone,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ziprasidone.,increase,risk
Methocarbamol,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Methocarbamol.,increase,risk
Methocarbamol,Zolpidem,Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Methocarbamol,Zonisamide,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Zonisamide.,increase,risk
Methocarbamol,Zopiclone,The risk or severity of adverse effects can be increased when Methocarbamol is combined with Zopiclone.,increase,risk
Methocarbamol,Zotepine,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Zotepine.,increase,risk
Methocarbamol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Methocarbamol is combined with Zuclopenthixol.,increase,risk
Methocarbamol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Methocarbamol.,increase,risk
Zolpidem,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Budesonide,The metabolism of Zolpidem can be increased when combined with Budesonide.,increase,no risk
Zolpidem,Bupivacaine,Bupivacaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Buprenorphine,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Zolpidem,Bupropion,Bupropion may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Buspirone,Buspirone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butorphanol,Butorphanol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Butriptyline,Butriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Galantamine,The metabolism of Galantamine can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Gatifloxacin,The metabolism of Zolpidem can be decreased when combined with Gatifloxacin.,decrease,no risk
Zolpidem,Gefitinib,The metabolism of Zolpidem can be decreased when combined with Gefitinib.,decrease,no risk
Zolpidem,Gemfibrozil,The metabolism of Zolpidem can be decreased when combined with Gemfibrozil.,decrease,no risk
Zolpidem,Gemifloxacin,The metabolism of Zolpidem can be decreased when combined with Gemifloxacin.,decrease,no risk
Zolpidem,Gepirone,Gepirone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ginkgo biloba,The metabolism of Zolpidem can be decreased when combined with Ginkgo biloba.,decrease,no risk
Zolpidem,Givosiran,The serum concentration of Zolpidem can be increased when it is combined with Givosiran.,increase,no risk
Zolpidem,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Glimepiride,The metabolism of Zolpidem can be decreased when combined with Glimepiride.,decrease,no risk
Zolpidem,Glipizide,The metabolism of Glipizide can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Glofitamab,The serum concentration of Zolpidem can be increased when it is combined with Glofitamab.,increase,no risk
Zolpidem,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Glyburide,The metabolism of Glyburide can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Glycerol phenylbutyrate,The metabolism of Zolpidem can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Zolpidem,Golimumab,The metabolism of Zolpidem can be increased when combined with Golimumab.,increase,no risk
Zolpidem,Granisetron,Granisetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Grepafloxacin,The metabolism of Zolpidem can be decreased when combined with Grepafloxacin.,decrease,no risk
Zolpidem,Griseofulvin,The metabolism of Zolpidem can be increased when combined with Griseofulvin.,increase,no risk
Zolpidem,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Halazepam,Halazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Halofantrine,The metabolism of Zolpidem can be decreased when combined with Halofantrine.,decrease,no risk
Zolpidem,Haloperidol,Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Hydrocodone,Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Zolpidem,Hydrocortamate,The metabolism of Zolpidem can be increased when combined with Hydrocortamate.,increase,no risk
Zolpidem,Hydrocortisone,The metabolism of Zolpidem can be increased when combined with Hydrocortisone.,increase,no risk
Zolpidem,Hydrocortisone acetate,The metabolism of Zolpidem can be increased when combined with Hydrocortisone acetate.,increase,no risk
Zolpidem,Hydrocortisone butyrate,The metabolism of Zolpidem can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Zolpidem,Hydrocortisone succinate,The metabolism of Zolpidem can be increased when combined with Hydrocortisone succinate.,increase,no risk
Zolpidem,Hydromorphone,Hydromorphone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Hydroxychloroquine,The metabolism of Zolpidem can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Zolpidem,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ketazolam,Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ketoconazole,The metabolism of Zolpidem can be decreased when combined with Ketoconazole.,decrease,no risk
Zolpidem,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Obeticholic acid,The metabolism of Zolpidem can be decreased when combined with Obeticholic acid.,decrease,no risk
Zolpidem,Olanzapine,Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Zolpidem is combined with Oliceridine.",increase,risk
Zolpidem,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Olutasidenib,The metabolism of Zolpidem can be increased when combined with Olutasidenib.,increase,no risk
Zolpidem,Omaveloxolone,The serum concentration of Zolpidem can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Zolpidem,Omeprazole,The metabolism of Zolpidem can be decreased when combined with Omeprazole.,decrease,no risk
Zolpidem,Ondansetron,Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Opium,Opium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oritavancin,The metabolism of Zolpidem can be decreased when combined with Oritavancin.,decrease,no risk
Zolpidem,Orphenadrine,Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Osilodrostat,The metabolism of Zolpidem can be decreased when combined with Osilodrostat.,decrease,no risk
Zolpidem,Osimertinib,The serum concentration of Zolpidem can be decreased when it is combined with Osimertinib.,decrease,no risk
Zolpidem,Ospemifene,The metabolism of Zolpidem can be decreased when combined with Ospemifene.,decrease,no risk
Zolpidem,Oxamniquine,The metabolism of Zolpidem can be decreased when combined with Oxamniquine.,decrease,no risk
Zolpidem,Oxandrolone,The metabolism of Zolpidem can be decreased when combined with Oxandrolone.,decrease,no risk
Zolpidem,Oxazepam,Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxcarbazepine,Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxitriptan,Oxitriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxprenolol,Oxprenolol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Oxybuprocaine,Oxybuprocaine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxybutynin,The metabolism of Zolpidem can be decreased when combined with Oxybutynin.,decrease,no risk
Zolpidem,Oxycodone,Oxycodone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Oxymorphone,Oxymorphone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Quazepam,Quazepam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Quetiapine,Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Quinidine,The metabolism of Zolpidem can be decreased when combined with Quinidine.,decrease,no risk
Zolpidem,Quinine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Quinupramine,Quinupramine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Urethane,Urethane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Vadadustat,The serum concentration of Zolpidem can be increased when it is combined with Vadadustat.,increase,no risk
Zolpidem,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Valdecoxib,The metabolism of Zolpidem can be decreased when combined with Valdecoxib.,decrease,no risk
Zolpidem,Valproic acid,Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Valsartan,The metabolism of Zolpidem can be decreased when combined with Valsartan.,decrease,no risk
Zolpidem,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Vecuronium,Vecuronium may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Vemurafenib,The serum concentration of Zolpidem can be increased when it is combined with Vemurafenib.,increase,no risk
Zolpidem,Venetoclax,The metabolism of Zolpidem can be decreased when combined with Venetoclax.,decrease,no risk
Zolpidem,Venlafaxine,Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Verapamil,The metabolism of Zolpidem can be decreased when combined with Verapamil.,decrease,no risk
Zolpidem,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Vigabatrin,Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Vilazodone,Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Viloxazine,Viloxazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Vinblastine,The metabolism of Zolpidem can be increased when combined with Vinblastine.,increase,no risk
Zolpidem,Vinorelbine,The metabolism of Zolpidem can be decreased when combined with Vinorelbine.,decrease,no risk
Zolpidem,Vitamin E,The metabolism of Zolpidem can be increased when combined with Vitamin E.,increase,no risk
Zolpidem,Vonoprazan,The metabolism of Zolpidem can be decreased when combined with Vonoprazan.,decrease,no risk
Zolpidem,Voriconazole,The metabolism of Zolpidem can be decreased when combined with Voriconazole.,decrease,no risk
Zolpidem,Vortioxetine,Vortioxetine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Warfarin,The metabolism of Warfarin can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Yohimbine,Yohimbine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zafirlukast,The metabolism of Zolpidem can be decreased when combined with Zafirlukast.,decrease,no risk
Zolpidem,Zaleplon,Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ziconotide,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Zolpidem.,decrease,no risk
Zolpidem,Zileuton,The metabolism of Zolpidem can be decreased when combined with Zileuton.,decrease,no risk
Zolpidem,Zimelidine,Zimelidine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Ziprasidone,Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zolmitriptan,Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zonisamide,Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zopiclone,Zopiclone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zotepine,Zotepine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zuclopenthixol,Zuclopenthixol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Zolpidem,Zuranolone,Zuranolone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Famciclovir,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Famciclovir.,decrease,no risk
Famciclovir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Famciclovir.,decrease,no risk
Triprolidine,Gabapentin,The risk or severity of CNS depression can be increased when Triprolidine is combined with Gabapentin.,increase,risk
Triprolidine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Triprolidine is combined with Gabapentin enacarbil.,increase,risk
Triprolidine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Gadobenic acid.,increase,risk
Triprolidine,Galantamine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Galantamine.,increase,risk
Triprolidine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Triprolidine is combined with Gallamine triethiodide.,increase,risk
Triprolidine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Triprolidine is combined with Ganaxolone.",increase,risk
Triprolidine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Gatifloxacin.,increase,risk
Triprolidine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Gemifloxacin.,increase,risk
Triprolidine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Triprolidine.,increase,risk
Triprolidine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Gilteritinib.,increase,risk
Triprolidine,Glasdegib,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Glasdegib.,increase,risk
Triprolidine,Glutethimide,The risk or severity of CNS depression can be increased when Triprolidine is combined with Glutethimide.,increase,risk
Triprolidine,Goserelin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Goserelin.,increase,risk
Triprolidine,Granisetron,The risk or severity of CNS depression can be increased when Triprolidine is combined with Granisetron.,increase,risk
Triprolidine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Grepafloxacin.,increase,risk
Triprolidine,Guanfacine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Guanfacine.,increase,risk
Triprolidine,Halazepam,The risk or severity of CNS depression can be increased when Triprolidine is combined with Halazepam.,increase,risk
Triprolidine,Halofantrine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Halofantrine.,increase,risk
Triprolidine,Haloperidol,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Haloperidol.,increase,risk
Triprolidine,Halothane,The risk or severity of CNS depression can be increased when Triprolidine is combined with Halothane.,increase,risk
Triprolidine,Hexafluronium,The risk or severity of CNS depression can be increased when Triprolidine is combined with Hexafluronium.,increase,risk
Triprolidine,Histrelin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Histrelin.,increase,risk
Triprolidine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Hydrochlorothiazide.,increase,risk
Triprolidine,Hydrocodone,Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Triprolidine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Triprolidine.,increase,risk
Triprolidine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Hydroxychloroquine.,increase,risk
Triprolidine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Hydroxyzine.,increase,risk
Triprolidine,Hyoscyamine,Triprolidine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Triprolidine,Ketamine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Ketamine.,increase,risk
Triprolidine,Ketazolam,The risk or severity of CNS depression can be increased when Triprolidine is combined with Ketazolam.,increase,risk
Triprolidine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ketoconazole.,increase,risk
Triprolidine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Triprolidine.,increase,risk
Triprolidine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ofloxacin.,increase,risk
Triprolidine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Triprolidine.,increase,risk
Triprolidine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Triprolidine is combined with Oliceridine.",increase,risk
Triprolidine,Olodaterol,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Olodaterol.,increase,risk
Triprolidine,Ondansetron,The risk or severity of CNS depression can be increased when Triprolidine is combined with Ondansetron.,increase,risk
Triprolidine,Opium,The risk or severity of CNS depression can be increased when Triprolidine is combined with Opium.,increase,risk
Triprolidine,Orphenadrine,Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Triprolidine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Triprolidine.,increase,risk
Triprolidine,Oxatomide,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Oxatomide.,increase,risk
Triprolidine,Oxazepam,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxazepam.,increase,risk
Triprolidine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxcarbazepine.,increase,risk
Triprolidine,Oxitriptan,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxitriptan.,increase,risk
Triprolidine,Oxprenolol,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxprenolol.,increase,risk
Triprolidine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxybuprocaine.,increase,risk
Triprolidine,Oxycodone,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxycodone.,increase,risk
Triprolidine,Oxymorphone,The risk or severity of CNS depression can be increased when Triprolidine is combined with Oxymorphone.,increase,risk
Triprolidine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Triprolidine.,increase,risk
Triprolidine,Quazepam,The risk or severity of CNS depression can be increased when Triprolidine is combined with Quazepam.,increase,risk
Triprolidine,Quetiapine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Quetiapine.,increase,risk
Triprolidine,Quinidine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Quinidine.,increase,risk
Triprolidine,Quinine,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Quinine.,increase,risk
Triprolidine,Quinupramine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Quinupramine.,increase,risk
Triprolidine,Quizartinib,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Quizartinib.,increase,risk
Triprolidine,Urethane,The risk or severity of CNS depression can be increased when Triprolidine is combined with Urethane.,increase,risk
Triprolidine,Valproic acid,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Valproic acid.,increase,risk
Triprolidine,Vandetanib,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vandetanib.,increase,risk
Triprolidine,Vardenafil,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vardenafil.,increase,risk
Triprolidine,Vecuronium,The risk or severity of CNS depression can be increased when Triprolidine is combined with Vecuronium.,increase,risk
Triprolidine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Triprolidine.,increase,risk
Triprolidine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Triprolidine.,increase,risk
Triprolidine,Vernakalant,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vernakalant.,increase,risk
Triprolidine,Vigabatrin,The risk or severity of CNS depression can be increased when Triprolidine is combined with Vigabatrin.,increase,risk
Triprolidine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Triprolidine.,increase,risk
Triprolidine,Vilazodone,The risk or severity of CNS depression can be increased when Triprolidine is combined with Vilazodone.,increase,risk
Triprolidine,Viloxazine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Viloxazine.,increase,risk
Triprolidine,Voriconazole,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Voriconazole.,increase,risk
Triprolidine,Vorinostat,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Vorinostat.,increase,risk
Triprolidine,Vortioxetine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Vortioxetine.,increase,risk
Triprolidine,Yohimbine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Yohimbine.,increase,risk
Triprolidine,Zaleplon,The risk or severity of CNS depression can be increased when Triprolidine is combined with Zaleplon.,increase,risk
Triprolidine,Ziconotide,The risk or severity of CNS depression can be increased when Triprolidine is combined with Ziconotide.,increase,risk
Triprolidine,Zimelidine,The risk or severity of adverse effects can be increased when Triprolidine is combined with Zimelidine.,increase,risk
Triprolidine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Ziprasidone.,increase,risk
Triprolidine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Triprolidine.,increase,risk
Triprolidine,Zolpidem,Triprolidine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Triprolidine,Zonisamide,The risk or severity of CNS depression can be increased when Triprolidine is combined with Zonisamide.,increase,risk
Triprolidine,Zopiclone,The risk or severity of adverse effects can be increased when Triprolidine is combined with Zopiclone.,increase,risk
Triprolidine,Zotepine,The risk or severity of CNS depression can be increased when Triprolidine is combined with Zotepine.,increase,risk
Triprolidine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Zuclopenthixol.,increase,risk
Triprolidine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Triprolidine.,increase,risk
Streptozocin,Gemcitabine,The risk or severity of adverse effects can be increased when Streptozocin is combined with Gemcitabine.,increase,risk
Streptozocin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Streptozocin.,increase,risk
Streptozocin,Glatiramer,The risk or severity of adverse effects can be increased when Streptozocin is combined with Glatiramer.,increase,risk
Streptozocin,Golimumab,The risk or severity of adverse effects can be increased when Streptozocin is combined with Golimumab.,increase,risk
Streptozocin,Guselkumab,The risk or severity of adverse effects can be increased when Streptozocin is combined with Guselkumab.,increase,risk
Streptozocin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Streptozocin.,increase,risk
Streptozocin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Streptozocin.,increase,risk
Streptozocin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Streptozocin.,increase,risk
Streptozocin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Streptozocin is combined with Hydrocortisone acetate.,increase,risk
Streptozocin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Streptozocin is combined with Hydrocortisone butyrate.,increase,risk
Streptozocin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Streptozocin is combined with Hydrocortisone succinate.,increase,risk
Streptozocin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Streptozocin.,increase,risk
Streptozocin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Streptozocin is combined with Hydroxychloroquine.,increase,risk
Streptozocin,Hydroxyurea,The risk or severity of adverse effects can be increased when Streptozocin is combined with Hydroxyurea.,increase,risk
Streptozocin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Obinutuzumab,The risk or severity of adverse effects can be increased when Streptozocin is combined with Obinutuzumab.,increase,risk
Streptozocin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Streptozocin.,increase,no risk
Streptozocin,Ofatumumab,The risk or severity of adverse effects can be increased when Streptozocin is combined with Ofatumumab.,increase,risk
Streptozocin,Olaparib,The risk or severity of adverse effects can be increased when Streptozocin is combined with Olaparib.,increase,risk
Streptozocin,Oxaliplatin,The risk or severity of adverse effects can be increased when Streptozocin is combined with Oxaliplatin.,increase,risk
Streptozocin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Streptozocin is combined with Oxetacaine.,increase,risk
Streptozocin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Streptozocin is combined with Oxybuprocaine.,increase,risk
Streptozocin,Ozanimod,The risk or severity of adverse effects can be increased when Streptozocin is combined with Ozanimod.,increase,risk
Streptozocin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Streptozocin.,increase,risk
Streptozocin,Upadacitinib,The risk or severity of adverse effects can be increased when Streptozocin is combined with Upadacitinib.,increase,risk
Streptozocin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Streptozocin.,increase,risk
Streptozocin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Streptozocin.,increase,risk
Streptozocin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Vedolizumab,The risk or severity of adverse effects can be increased when Streptozocin is combined with Vedolizumab.,increase,risk
Streptozocin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Streptozocin.,decrease,no risk
Streptozocin,Vilanterol,The risk or severity of adverse effects can be increased when Streptozocin is combined with Vilanterol.,increase,risk
Streptozocin,Vinblastine,The risk or severity of adverse effects can be increased when Streptozocin is combined with Vinblastine.,increase,risk
Streptozocin,Vincristine,The risk or severity of adverse effects can be increased when Streptozocin is combined with Vincristine.,increase,risk
Streptozocin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Streptozocin.,increase,risk
Streptozocin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Streptozocin.,increase,risk
Streptozocin,Voclosporin,The risk or severity of adverse effects can be increased when Streptozocin is combined with Voclosporin.,increase,risk
Streptozocin,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Streptozocin.,increase,risk
Streptozocin,Vorinostat,The risk or severity of adverse effects can be increased when Streptozocin is combined with Vorinostat.,increase,risk
Streptozocin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Streptozocin.,increase,risk
Streptozocin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Streptozocin.,increase,risk
Streptozocin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Streptozocin.,increase,risk
Streptozocin,Zidovudine,The risk or severity of adverse effects can be increased when Streptozocin is combined with Zidovudine.,increase,risk
Carboprost tromethamine,Oxytocin,Carboprost tromethamine may increase the uterotonic activities of Oxytocin.,increase,no risk
Cefpiramide,Gabapentin enacarbil,Cefpiramide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadobenic acid,Cefpiramide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadodiamide,Cefpiramide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadofosveset trisodium,Cefpiramide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadopentetic acid,Cefpiramide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadoteric acid,Cefpiramide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gadoteridol,Cefpiramide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Cefpiramide,Ganciclovir,Cefpiramide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gemcitabine,Cefpiramide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gemfibrozil,Cefpiramide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gentamicin,Cefpiramide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Gimeracil,Cefpiramide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Cefpiramide,Givosiran,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Givosiran.,increase,risk
Cefpiramide,Glipizide,Cefpiramide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cefpiramide,Glycerol phenylbutyrate,Cefpiramide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Cefpiramide,Golodirsen,Cefpiramide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Cefpiramide,Goserelin,Cefpiramide may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Guanethidine,Cefpiramide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Guanfacine,Cefpiramide may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Haloperidol,Cefpiramide may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Cefpiramide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Cefpiramide.,decrease,no risk
Cefpiramide,Hydralazine,Cefpiramide may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Hydrochlorothiazide.,increase,risk
Cefpiramide,Hydromorphone,Cefpiramide may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Cefpiramide,Hydroxocobalamin,Cefpiramide may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Hydroxyethyl Starch,Cefpiramide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Cefpiramide,Kanamycin,Cefpiramide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Ketamine,Cefpiramide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Ketazolam,Cefpiramide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Cefpiramide,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Ketoprofen.,increase,risk
Cefpiramide,Ketorolac,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Ketorolac.,increase,risk
Cefpiramide,Octinoxate,Cefpiramide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Cefpiramide,Olsalazine,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Olsalazine.,increase,risk
Cefpiramide,Opium,Cefpiramide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Cefpiramide,Oseltamivir,Cefpiramide may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Cefpiramide,Oxacillin,Cefpiramide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Cefpiramide.,increase,risk
Cefpiramide,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Oxaprozin.,increase,risk
Cefpiramide,Oxazepam,Cefpiramide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Cefpiramide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cefpiramide is combined with Oxetacaine.,increase,risk
Cefpiramide,Oxybenzone,Cefpiramide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Cefpiramide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cefpiramide is combined with Oxybuprocaine.,increase,risk
Cefpiramide,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Oxyphenbutazone.,increase,risk
Cefpiramide,Oxyquinoline,Cefpiramide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Cefpiramide,Quetiapine,Cefpiramide may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Quinidine,Cefpiramide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefpiramide.,decrease,no risk
Cefpiramide,Vaborbactam,Cefpiramide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Cefpiramide,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Valaciclovir.,increase,risk
Cefpiramide,Valbenazine,Cefpiramide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Cefpiramide is combined with Valdecoxib.,increase,risk
Cefpiramide,Valganciclovir,Cefpiramide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Cefpiramide,Vancomycin,Cefpiramide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Varenicline,Cefpiramide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Cefpiramide,Venlafaxine,Cefpiramide may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Verapamil,Cefpiramide may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Cefpiramide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cefpiramide.,decrease,no risk
Cefpiramide,Vilanterol,Cefpiramide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Cefpiramide,Viloxazine,Cefpiramide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefpiramide.,decrease,no risk
Cefpiramide,Vortioxetine,Cefpiramide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Cefpiramide,Warfarin,Cefpiramide may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Cefpiramide,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Cefpiramide.,decrease,no risk
Cefpiramide,Zaleplon,Cefpiramide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Cefpiramide,Zanamivir,Cefpiramide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Cefpiramide,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cefpiramide is combined with Zoledronic acid.,increase,risk
Cefpiramide,Zonisamide,Cefpiramide may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Lindane,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Lindane.,increase,risk
Lindane,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Lindane.,increase,risk
Trifluridine,Bisoprolol,Trifluridine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Trifluridine,Bisoxatin,Trifluridine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Trifluridine,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Trifluridine.,increase,risk
Trifluridine,Blinatumomab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Blinatumomab.,increase,risk
Trifluridine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Trifluridine.",decrease,no risk
Trifluridine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Trifluridine.,increase,risk
Trifluridine,Bosutinib,The risk or severity of adverse effects can be increased when Trifluridine is combined with Bosutinib.,increase,risk
Trifluridine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Trifluridine is combined with Brentuximab vedotin.,increase,risk
Trifluridine,Brivaracetam,Trifluridine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Trifluridine,Brodalumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Brodalumab.,increase,risk
Trifluridine,Bromazepam,Trifluridine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Trifluridine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trifluridine,Budesonide,The risk or severity of adverse effects can be increased when Trifluridine is combined with Budesonide.,increase,risk
Trifluridine,Bumadizone,Bumadizone may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Bumetanide,The excretion of Trifluridine can be decreased when combined with Bumetanide.,decrease,no risk
Trifluridine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Bupivacaine.,increase,risk
Trifluridine,Bupropion,Trifluridine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Trifluridine,Buspirone,Trifluridine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Trifluridine,Busulfan,The risk or severity of adverse effects can be increased when Trifluridine is combined with Busulfan.,increase,risk
Trifluridine,Butabarbital,Butabarbital may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Butacaine,The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Butacaine.,increase,risk
Trifluridine,Butamben,The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Butamben.,increase,risk
Trifluridine,Gabapentin enacarbil,Trifluridine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadobenic acid,Trifluridine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadodiamide,Gadodiamide may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadofosveset trisodium,Trifluridine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadopentetic acid,Trifluridine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadoteric acid,Trifluridine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Trifluridine,Gadoteridol,Trifluridine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Trifluridine,Ganciclovir,The excretion of Trifluridine can be decreased when combined with Ganciclovir.,decrease,no risk
Trifluridine,Gemcitabine,The risk or severity of adverse effects can be increased when Trifluridine is combined with Gemcitabine.,increase,risk
Trifluridine,Gemfibrozil,The excretion of Trifluridine can be decreased when combined with Gemfibrozil.,decrease,no risk
Trifluridine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Trifluridine.,increase,risk
Trifluridine,Gentamicin,Trifluridine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Trifluridine,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Gimeracil,Trifluridine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Trifluridine,Givosiran,Givosiran may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Glatiramer,The risk or severity of adverse effects can be increased when Trifluridine is combined with Glatiramer.,increase,risk
Trifluridine,Glipizide,Trifluridine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Trifluridine,Glyburide,The excretion of Trifluridine can be decreased when combined with Glyburide.,decrease,no risk
Trifluridine,Glycerol phenylbutyrate,Trifluridine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Trifluridine,Golimumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Golimumab.,increase,risk
Trifluridine,Golodirsen,Trifluridine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Trifluridine,Goserelin,Goserelin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Trifluridine.,decrease,no risk
Trifluridine,Guanethidine,Trifluridine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Trifluridine,Guanfacine,Trifluridine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Trifluridine,Guanidine,The excretion of Trifluridine can be decreased when combined with Guanidine.,decrease,no risk
Trifluridine,Guselkumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Guselkumab.,increase,risk
Trifluridine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Haloperidol,Trifluridine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Trifluridine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Trifluridine.,increase,risk
Trifluridine,Hydralazine,Trifluridine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Trifluridine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trifluridine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Trifluridine is combined with Hydrocortisone acetate.,increase,risk
Trifluridine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Trifluridine is combined with Hydrocortisone butyrate.,increase,risk
Trifluridine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Trifluridine is combined with Hydrocortisone succinate.,increase,risk
Trifluridine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trifluridine,Hydromorphone,Hydromorphone may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Trifluridine is combined with Hydroxychloroquine.,increase,risk
Trifluridine,Hydroxyethyl Starch,Trifluridine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Trifluridine,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Hydroxyurea,The risk or severity of adverse effects can be increased when Trifluridine is combined with Hydroxyurea.,increase,risk
Trifluridine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Kanamycin,Trifluridine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Trifluridine,Ketamine,Trifluridine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Trifluridine,Ketazolam,Trifluridine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Trifluridine,Ketoprofen,The excretion of Trifluridine can be decreased when combined with Ketoprofen.,decrease,no risk
Trifluridine,Ketorolac,Ketorolac may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Obinutuzumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Obinutuzumab.,increase,risk
Trifluridine,Ocrelizumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Ocrelizumab.,increase,risk
Trifluridine,Octinoxate,Trifluridine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Trifluridine,Ofatumumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Ofatumumab.,increase,risk
Trifluridine,Ofloxacin,The excretion of Trifluridine can be decreased when combined with Ofloxacin.,decrease,no risk
Trifluridine,Olaparib,The risk or severity of adverse effects can be increased when Trifluridine is combined with Olaparib.,increase,risk
Trifluridine,Olsalazine,Olsalazine may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Opium,Trifluridine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Trifluridine,Oseltamivir,Oseltamivir may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Ouabain,The excretion of Trifluridine can be decreased when combined with Ouabain.,decrease,no risk
Trifluridine,Oxacillin,Trifluridine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxaliplatin,The risk or severity of adverse effects can be increased when Trifluridine is combined with Oxaliplatin.,increase,risk
Trifluridine,Oxaprozin,Oxaprozin may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxazepam,Trifluridine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Oxetacaine.,increase,risk
Trifluridine,Oxybenzone,Trifluridine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Trifluridine is combined with Oxybuprocaine.,increase,risk
Trifluridine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxyquinoline,Trifluridine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Trifluridine,Oxytetracycline,The excretion of Trifluridine can be decreased when combined with Oxytetracycline.,decrease,no risk
Trifluridine,Ozanimod,The risk or severity of adverse effects can be increased when Trifluridine is combined with Ozanimod.,increase,risk
Trifluridine,Quetiapine,Trifluridine may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Trifluridine,Quinethazone,Quinethazone may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trifluridine,Quinidine,Trifluridine may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Trifluridine,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Trifluridine.,increase,risk
Trifluridine,Ulipristal,The therapeutic efficacy of Ulipristal can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Upadacitinib,The risk or severity of adverse effects can be increased when Trifluridine is combined with Upadacitinib.,increase,risk
Trifluridine,Vaborbactam,Trifluridine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Trifluridine,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Trifluridine.,increase,no risk
Trifluridine,Valaciclovir,Valaciclovir may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Valbenazine,Trifluridine may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Trifluridine,Valdecoxib,Valdecoxib may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Valganciclovir,Trifluridine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Trifluridine,Valproic acid,The excretion of Trifluridine can be decreased when combined with Valproic acid.,decrease,no risk
Trifluridine,Vancomycin,Trifluridine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Trifluridine,Varenicline,Trifluridine may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Trifluridine,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Trifluridine.,increase,risk
Trifluridine,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Vedolizumab,The risk or severity of adverse effects can be increased when Trifluridine is combined with Vedolizumab.,increase,risk
Trifluridine,Venlafaxine,Venlafaxine may decrease the excretion rate of Trifluridine which could result in a higher serum level.,decrease,no risk
Trifluridine,Verapamil,Trifluridine may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Trifluridine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Trifluridine.,decrease,no risk
Trifluridine,Vilanterol,The risk or severity of adverse effects can be increased when Trifluridine is combined with Vilanterol.,increase,risk
Trifluridine,Viloxazine,Trifluridine may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Trifluridine,Vinblastine,The risk or severity of adverse effects can be increased when Trifluridine is combined with Vinblastine.,increase,risk
Trifluridine,Vincristine,The risk or severity of adverse effects can be increased when Trifluridine is combined with Vincristine.,increase,risk
Trifluridine,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Trifluridine.,increase,risk
Trifluridine,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Trifluridine.,increase,risk
Trifluridine,Voclosporin,The risk or severity of adverse effects can be increased when Trifluridine is combined with Voclosporin.,increase,risk
Trifluridine,Vorinostat,The risk or severity of adverse effects can be increased when Trifluridine is combined with Vorinostat.,increase,risk
Trifluridine,Vortioxetine,Trifluridine may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Trifluridine,Warfarin,Trifluridine may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Trifluridine,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Trifluridine.,increase,risk
Trifluridine,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Trifluridine.,decrease,no risk
Trifluridine,Zaleplon,Trifluridine may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Trifluridine,Zanamivir,Trifluridine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Trifluridine,Zidovudine,The risk or severity of adverse effects can be increased when Trifluridine is combined with Zidovudine.,increase,risk
Trifluridine,Zonisamide,Zonisamide may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prochlorperazine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Bromperidol,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Bromperidol.,increase,risk
Prochlorperazine,Brompheniramine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Brompheniramine.,increase,risk
Prochlorperazine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Buprenorphine,Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Prochlorperazine,Bupropion,The metabolism of Prochlorperazine can be decreased when combined with Bupropion.,decrease,no risk
Prochlorperazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Buspirone,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Buspirone.,increase,risk
Prochlorperazine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Butaperazine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Butaperazine.,increase,risk
Prochlorperazine,Butobarbital,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Butobarbital.,increase,risk
Prochlorperazine,Butorphanol,The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Butorphanol.,increase,risk
Prochlorperazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Prochlorperazine.,increase,no risk
Prochlorperazine,Gabapentin,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Gabapentin.,increase,risk
Prochlorperazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Gabapentin enacarbil.,increase,risk
Prochlorperazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Gadobenic acid.,increase,risk
Prochlorperazine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Gallamine triethiodide.,increase,risk
Prochlorperazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Prochlorperazine is combined with Ganaxolone.",increase,risk
Prochlorperazine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Gefitinib,The metabolism of Prochlorperazine can be decreased when combined with Gefitinib.,decrease,no risk
Prochlorperazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Gemifloxacin.,increase,risk
Prochlorperazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Gilteritinib.,increase,risk
Prochlorperazine,Givosiran,The serum concentration of Prochlorperazine can be increased when it is combined with Givosiran.,increase,no risk
Prochlorperazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Glasdegib.,increase,risk
Prochlorperazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Glofitamab,The serum concentration of Prochlorperazine can be increased when it is combined with Glofitamab.,increase,no risk
Prochlorperazine,Glutethimide,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Glutethimide.,increase,risk
Prochlorperazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Glycerol phenylbutyrate,The metabolism of Prochlorperazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Prochlorperazine,Golimumab,The metabolism of Prochlorperazine can be increased when combined with Golimumab.,increase,no risk
Prochlorperazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Granisetron,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Granisetron.,increase,risk
Prochlorperazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Grepafloxacin.,increase,risk
Prochlorperazine,Guanfacine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Guanfacine.,increase,risk
Prochlorperazine,Halazepam,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Halazepam.,increase,risk
Prochlorperazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Haloperidol.,increase,risk
Prochlorperazine,Halothane,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Halothane.,increase,risk
Prochlorperazine,Hexafluronium,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Hexafluronium.,increase,risk
Prochlorperazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Hydrocodone,Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Prochlorperazine,Hydromorphone,The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Hydromorphone.,increase,risk
Prochlorperazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Prochlorperazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Prochlorperazine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Hydroxyzine.,increase,risk
Prochlorperazine,Hyoscyamine,Prochlorperazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Prochlorperazine,Ketamine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Ketamine.,increase,risk
Prochlorperazine,Ketazolam,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Ketazolam.,increase,risk
Prochlorperazine,Ketoconazole,The metabolism of Prochlorperazine can be decreased when combined with Ketoconazole.,decrease,no risk
Prochlorperazine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Ofloxacin.,increase,risk
Prochlorperazine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Prochlorperazine is combined with Oliceridine.",increase,risk
Prochlorperazine,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Omaveloxolone,The serum concentration of Prochlorperazine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Prochlorperazine,Ondansetron,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Ondansetron.,increase,risk
Prochlorperazine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Opium,The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Opium.,increase,risk
Prochlorperazine,Oritavancin,The metabolism of Prochlorperazine can be decreased when combined with Oritavancin.,decrease,no risk
Prochlorperazine,Orphenadrine,Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Prochlorperazine,Osilodrostat,The metabolism of Prochlorperazine can be decreased when combined with Osilodrostat.,decrease,no risk
Prochlorperazine,Ospemifene,The metabolism of Prochlorperazine can be decreased when combined with Ospemifene.,decrease,no risk
Prochlorperazine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Oxamniquine,The metabolism of Prochlorperazine can be decreased when combined with Oxamniquine.,decrease,no risk
Prochlorperazine,Oxatomide,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Oxatomide.,increase,risk
Prochlorperazine,Oxazepam,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Oxazepam.,increase,risk
Prochlorperazine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Oxcarbazepine.,increase,risk
Prochlorperazine,Oxitriptan,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Oxitriptan.,increase,risk
Prochlorperazine,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Prochlorperazine.,increase,no risk
Prochlorperazine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Oxybuprocaine.,increase,risk
Prochlorperazine,Oxybutynin,The metabolism of Prochlorperazine can be decreased when combined with Oxybutynin.,decrease,no risk
Prochlorperazine,Oxycodone,The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Oxycodone.,increase,risk
Prochlorperazine,Oxymorphone,The risk or severity of hypotension and CNS depression can be increased when Prochlorperazine is combined with Oxymorphone.,increase,risk
Prochlorperazine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Quazepam,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Quazepam.,increase,risk
Prochlorperazine,Quetiapine,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Quetiapine.,increase,risk
Prochlorperazine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Prochlorperazine.,decrease,no risk
Prochlorperazine,Quinidine,The risk or severity of QTc prolongation can be increased when Quinidine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Quinine,The metabolism of Prochlorperazine can be decreased when combined with Quinine.,decrease,no risk
Prochlorperazine,Quinupramine,The serum concentration of Quinupramine can be increased when it is combined with Prochlorperazine.,increase,no risk
Prochlorperazine,Quizartinib,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Quizartinib.,increase,risk
Prochlorperazine,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Prochlorperazine.,decrease,no risk
Prochlorperazine,Urethane,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Urethane.,increase,risk
Prochlorperazine,Vadadustat,The serum concentration of Prochlorperazine can be increased when it is combined with Vadadustat.,increase,no risk
Prochlorperazine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Prochlorperazine.,decrease,no risk
Prochlorperazine,Valproate bismuth,Prochlorperazine may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Prochlorperazine,Valproic acid,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Valproic acid.,increase,risk
Prochlorperazine,Vandetanib,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Vandetanib.,increase,risk
Prochlorperazine,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Vecuronium,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Vecuronium.,increase,risk
Prochlorperazine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Vemurafenib.,increase,risk
Prochlorperazine,Venetoclax,The metabolism of Prochlorperazine can be decreased when combined with Venetoclax.,decrease,no risk
Prochlorperazine,Venlafaxine,The metabolism of Prochlorperazine can be decreased when combined with Venlafaxine.,decrease,no risk
Prochlorperazine,Verapamil,The metabolism of Prochlorperazine can be decreased when combined with Verapamil.,decrease,no risk
Prochlorperazine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Vigabatrin,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Vigabatrin.,increase,risk
Prochlorperazine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Vilazodone,The metabolism of Prochlorperazine can be decreased when combined with Vilazodone.,decrease,no risk
Prochlorperazine,Viloxazine,The metabolism of Prochlorperazine can be decreased when combined with Viloxazine.,decrease,no risk
Prochlorperazine,Vinblastine,The metabolism of Prochlorperazine can be decreased when combined with Vinblastine.,decrease,no risk
Prochlorperazine,Vincristine,Prochlorperazine may increase the neurotoxic activities of Vincristine.,increase,no risk
Prochlorperazine,Vinorelbine,The metabolism of Prochlorperazine can be decreased when combined with Vinorelbine.,decrease,no risk
Prochlorperazine,Viomycin,Prochlorperazine may increase the neurotoxic activities of Viomycin.,increase,no risk
Prochlorperazine,Voriconazole,The metabolism of Prochlorperazine can be decreased when combined with Voriconazole.,decrease,no risk
Prochlorperazine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Yohimbine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Yohimbine.,increase,risk
Prochlorperazine,Zaleplon,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Zaleplon.,increase,risk
Prochlorperazine,Ziconotide,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Ziconotide.,increase,risk
Prochlorperazine,Zimelidine,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Zimelidine.,increase,risk
Prochlorperazine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Ziprasidone.,increase,risk
Prochlorperazine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Prochlorperazine.,increase,risk
Prochlorperazine,Zolpidem,Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Prochlorperazine,Zonisamide,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Zonisamide.,increase,risk
Prochlorperazine,Zopiclone,The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Zopiclone.,increase,risk
Prochlorperazine,Zotepine,The risk or severity of CNS depression can be increased when Prochlorperazine is combined with Zotepine.,increase,risk
Prochlorperazine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Prochlorperazine is combined with Zuclopenthixol.,increase,risk
Prochlorperazine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Prochlorperazine.,increase,risk
Cyproheptadine,Gabapentin,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Gabapentin.,increase,risk
Cyproheptadine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Gabapentin enacarbil.,increase,risk
Cyproheptadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Gadobenic acid.,increase,risk
Cyproheptadine,Galantamine,The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Galantamine.,decrease,no risk
Cyproheptadine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Gallamine triethiodide.,increase,risk
Cyproheptadine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cyproheptadine is combined with Ganaxolone.",increase,risk
Cyproheptadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Gatifloxacin.,increase,risk
Cyproheptadine,Gemfibrozil,The metabolism of Cyproheptadine can be decreased when combined with Gemfibrozil.,decrease,no risk
Cyproheptadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Gemifloxacin.,increase,risk
Cyproheptadine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Gilteritinib,The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cyproheptadine,Ginkgo biloba,The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Cyproheptadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Glasdegib.,increase,risk
Cyproheptadine,Glucagon,Cyproheptadine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Cyproheptadine,Glutethimide,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Glutethimide.,increase,risk
Cyproheptadine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Cyproheptadine.,decrease,no risk
Cyproheptadine,Glycopyrronium,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Glycopyrronium.,increase,risk
Cyproheptadine,Goserelin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Goserelin.,increase,risk
Cyproheptadine,Granisetron,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Granisetron.,increase,risk
Cyproheptadine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Grepafloxacin.,increase,risk
Cyproheptadine,Guanabenz,The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Guanabenz.,increase,risk
Cyproheptadine,Guanfacine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Guanfacine.,increase,risk
Cyproheptadine,Halazepam,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Halazepam.,increase,risk
Cyproheptadine,Halofantrine,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Halofantrine.,increase,risk
Cyproheptadine,Haloperidol,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Haloperidol.,increase,risk
Cyproheptadine,Halothane,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Halothane.,increase,risk
Cyproheptadine,Hexafluronium,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Hexafluronium.,increase,risk
Cyproheptadine,Hexocyclium,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Hexocyclium.,increase,risk
Cyproheptadine,Histrelin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Histrelin.,increase,risk
Cyproheptadine,Homatropine,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Homatropine.,increase,risk
Cyproheptadine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Homatropine methylbromide.,increase,risk
Cyproheptadine,Huperzine A,The therapeutic efficacy of Cyproheptadine can be decreased when used in combination with Huperzine A.,decrease,no risk
Cyproheptadine,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Cyproheptadine.,increase,no risk
Cyproheptadine,Hydrocodone,Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cyproheptadine,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Cyproheptadine.,increase,no risk
Cyproheptadine,Hydromorphone,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Hydromorphone.,increase,risk
Cyproheptadine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Hydroxyzine.,increase,risk
Cyproheptadine,Hyoscyamine,Cyproheptadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Cyproheptadine,Ketamine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Ketamine.,increase,risk
Cyproheptadine,Ketazolam,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Ketazolam.,increase,risk
Cyproheptadine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ketoconazole.,increase,risk
Cyproheptadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ofloxacin.,increase,risk
Cyproheptadine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Cyproheptadine is combined with Oliceridine.",increase,risk
Cyproheptadine,Olodaterol,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Olodaterol.,increase,risk
Cyproheptadine,Ondansetron,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Ondansetron.,increase,risk
Cyproheptadine,Opium,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Opium.,increase,risk
Cyproheptadine,Orciprenaline,The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Orciprenaline.,increase,risk
Cyproheptadine,Orphenadrine,Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Cyproheptadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Oxatomide.,increase,risk
Cyproheptadine,Oxazepam,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxazepam.,increase,risk
Cyproheptadine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxcarbazepine.,increase,risk
Cyproheptadine,Oxitriptan,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxitriptan.,increase,risk
Cyproheptadine,Oxprenolol,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxprenolol.,increase,risk
Cyproheptadine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Oxybuprocaine.,increase,risk
Cyproheptadine,Oxybutynin,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Oxybutynin.,increase,risk
Cyproheptadine,Oxycodone,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Oxycodone.,increase,risk
Cyproheptadine,Oxymetazoline,The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Oxymetazoline.,increase,risk
Cyproheptadine,Oxymorphone,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Oxymorphone.,increase,risk
Cyproheptadine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Cyproheptadine.,decrease,no risk
Cyproheptadine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Quazepam,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Quazepam.,increase,risk
Cyproheptadine,Quetiapine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Quetiapine.,increase,risk
Cyproheptadine,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Cyproheptadine.,increase,no risk
Cyproheptadine,Quinidine,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Quinidine.,increase,risk
Cyproheptadine,Quinine,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Quinine.,increase,risk
Cyproheptadine,Quinupramine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Quinupramine.,increase,risk
Cyproheptadine,Quizartinib,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Quizartinib.,increase,risk
Cyproheptadine,Umeclidinium,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Umeclidinium.,increase,risk
Cyproheptadine,Urethane,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Urethane.,increase,risk
Cyproheptadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Valproic acid.,increase,risk
Cyproheptadine,Vandetanib,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vandetanib.,increase,risk
Cyproheptadine,Vardenafil,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vardenafil.,increase,risk
Cyproheptadine,Vecuronium,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Vecuronium.,increase,risk
Cyproheptadine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Vernakalant,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vernakalant.,increase,risk
Cyproheptadine,Verteporfin,Cyproheptadine may increase the photosensitizing activities of Verteporfin.,increase,no risk
Cyproheptadine,Vigabatrin,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Vigabatrin.,increase,risk
Cyproheptadine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Vilazodone,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Vilazodone.,increase,risk
Cyproheptadine,Viloxazine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Viloxazine.,increase,risk
Cyproheptadine,Voriconazole,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Voriconazole.,increase,risk
Cyproheptadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Vorinostat.,increase,risk
Cyproheptadine,Vortioxetine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Vortioxetine.,increase,risk
Cyproheptadine,Warfarin,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Warfarin.,increase,risk
Cyproheptadine,Xamoterol,The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Xamoterol.,increase,risk
Cyproheptadine,Xylometazoline,The risk or severity of Tachycardia can be increased when Cyproheptadine is combined with Xylometazoline.,increase,risk
Cyproheptadine,Yohimbine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Yohimbine.,increase,risk
Cyproheptadine,Zaleplon,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Zaleplon.,increase,risk
Cyproheptadine,Ziconotide,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Ziconotide.,increase,risk
Cyproheptadine,Zimelidine,The therapeutic efficacy of Zimelidine can be decreased when used in combination with Cyproheptadine.,decrease,no risk
Cyproheptadine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Ziprasidone.,increase,risk
Cyproheptadine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Cyproheptadine.,increase,risk
Cyproheptadine,Zolpidem,Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Cyproheptadine,Zonisamide,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Zonisamide.,increase,risk
Cyproheptadine,Zopiclone,The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Zopiclone.,increase,risk
Cyproheptadine,Zotepine,The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Zotepine.,increase,risk
Cyproheptadine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Zuclopenthixol.,increase,risk
Cyproheptadine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Cyproheptadine.,increase,risk
Nitric Oxide,Buspirone,Nitric Oxide may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Butabarbital,Butabarbital may increase the hypotensive activities of Nitric Oxide.,increase,no risk
Nitric Oxide,Butalbital,Butalbital may increase the hypotensive activities of Nitric Oxide.,increase,no risk
Nitric Oxide,Gabapentin enacarbil,Nitric Oxide may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadobenic acid,Nitric Oxide may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadodiamide,Gadodiamide may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadofosveset trisodium,Nitric Oxide may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadopentetic acid,Nitric Oxide may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadoteric acid,Nitric Oxide may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gadoteridol,Nitric Oxide may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Ganciclovir,Nitric Oxide may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gemcitabine,Nitric Oxide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gemfibrozil,Nitric Oxide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gentamicin,Nitric Oxide may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Nitric Oxide.,increase,no risk
Nitric Oxide,Gimeracil,Nitric Oxide may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Givosiran,Givosiran may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Glipizide,Nitric Oxide may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Glycerol phenylbutyrate,Nitric Oxide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Golodirsen,Nitric Oxide may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Goserelin,Goserelin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Guanabenz,Nitric Oxide may increase the hypotensive activities of Guanabenz.,increase,no risk
Nitric Oxide,Guanadrel,Nitric Oxide may increase the hypotensive activities of Guanadrel.,increase,no risk
Nitric Oxide,Guanethidine,Nitric Oxide may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Guanfacine,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Guanfacine.,increase,risk
Nitric Oxide,Guanoxan,Nitric Oxide may increase the hypotensive activities of Guanoxan.,increase,no risk
Nitric Oxide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nitric Oxide.,increase,no risk
Nitric Oxide,Halothane,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Halothane.,increase,risk
Nitric Oxide,Hydralazine,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Hydralazine.,increase,risk
Nitric Oxide,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitric Oxide,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitric Oxide,Hydromorphone,Hydromorphone may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Hydroxyethyl Starch,Nitric Oxide may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Hydroxyurea,The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Hydroxyurea.,increase,risk
Nitric Oxide,Kanamycin,Nitric Oxide may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Ketamine,Nitric Oxide may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Ketazolam,Nitric Oxide may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Ketoprofen,Ketoprofen may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Ketorolac,Ketorolac may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Obinutuzumab,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Obinutuzumab.,increase,risk
Nitric Oxide,Octinoxate,Nitric Oxide may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Nitric Oxide.,increase,risk
Nitric Oxide,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Nitric Oxide.,increase,risk
Nitric Oxide,Olsalazine,Olsalazine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Opicapone,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Opicapone.,increase,risk
Nitric Oxide,Opium,Nitric Oxide may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oseltamivir,Oseltamivir may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxacillin,Nitric Oxide may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxaprozin,Oxaprozin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxazepam,Nitric Oxide may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxprenolol,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Oxprenolol.,increase,risk
Nitric Oxide,Oxybenzone,Nitric Oxide may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Oxyquinoline,Nitric Oxide may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Quetiapine,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Quetiapine.,increase,risk
Nitric Oxide,Quinapril,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Quinapril.,increase,risk
Nitric Oxide,Quinethazone,Quinethazone may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitric Oxide,Quinidine,Nitric Oxide may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Quinine,The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Quinine.,increase,risk
Nitric Oxide,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Nitric Oxide.,increase,risk
Nitric Oxide,Vaborbactam,Nitric Oxide may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Valaciclovir,Valaciclovir may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Valbenazine,Nitric Oxide may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Valdecoxib,Valdecoxib may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Valganciclovir,Nitric Oxide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Valproic acid,The risk or severity of methemoglobinemia can be increased when Valproic acid is combined with Nitric Oxide.,increase,risk
Nitric Oxide,Valsartan,The risk or severity of adverse effects can be increased when Valsartan is combined with Nitric Oxide.,increase,risk
Nitric Oxide,Vancomycin,Nitric Oxide may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Nitric Oxide.,decrease,no risk
Nitric Oxide,Varenicline,Nitric Oxide may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Venlafaxine,Venlafaxine may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Verapamil,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Verapamil.,increase,risk
Nitric Oxide,Vericiguat,The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Vericiguat.,increase,risk
Nitric Oxide,Vilanterol,Nitric Oxide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Viloxazine,Nitric Oxide may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Vortioxetine,Nitric Oxide may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Nitric Oxide.,increase,no risk
Nitric Oxide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Nitric Oxide.,increase,no risk
Nitric Oxide,Zaleplon,Nitric Oxide may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Zanamivir,Nitric Oxide may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Nitric Oxide,Zofenopril,Nitric Oxide may increase the hypotensive activities of Zofenopril.,increase,no risk
Nitric Oxide,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Nitric Oxide.,decrease,no risk
Nitric Oxide,Zonisamide,Zonisamide may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nitric Oxide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Nitric Oxide.,decrease,no risk
Bendroflumethiazide,Benzatropine,Bendroflumethiazide may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Benzhydrocodone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Benzhydrocodone.,decrease,no risk
Bendroflumethiazide,Benziodarone,The therapeutic efficacy of Benziodarone can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Benznidazole,Bendroflumethiazide may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Benzphetamine,Benzphetamine may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Benzthiazide,The therapeutic efficacy of Bendroflumethiazide can be increased when used in combination with Benzthiazide.,increase,no risk
Bendroflumethiazide,Benzydamine,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Benzydamine.,decrease,no risk
Bendroflumethiazide,Benzylpenicillin,Bendroflumethiazide may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Bendroflumethiazide,Bepotastine,Bendroflumethiazide may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bepridil,The therapeutic efficacy of Bepridil can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Beractant,Bendroflumethiazide may increase the bradycardic activities of Beractant.,increase,no risk
Bendroflumethiazide,Betamethasone,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Betamethasone phosphate,The risk or severity of electrolyte imbalance can be increased when Betamethasone phosphate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Betaxolol,The therapeutic efficacy of Betaxolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Bethanidine,The therapeutic efficacy of Bethanidine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Betrixaban,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Bexarotene,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Bexarotene.,increase,risk
Bendroflumethiazide,Bicisate,Bendroflumethiazide may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bimatoprost,The therapeutic efficacy of Bimatoprost can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Biperiden,The serum concentration of Bendroflumethiazide can be increased when it is combined with Biperiden.,increase,no risk
Bendroflumethiazide,Bisacodyl,The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Bisacodyl.,increase,risk
Bendroflumethiazide,Bismuth subgallate,Bendroflumethiazide may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bisoprolol,The therapeutic efficacy of Bisoprolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Bisoxatin,The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Bisoxatin.,increase,risk
Bendroflumethiazide,Bivalirudin,The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Bleomycin,Bendroflumethiazide may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Blinatumomab,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Blinatumomab.,increase,risk
Bendroflumethiazide,Bortezomib,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Bortezomib.,increase,risk
Bendroflumethiazide,Bosentan,The therapeutic efficacy of Bosentan can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Bosutinib,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Bosutinib.,increase,risk
Bendroflumethiazide,Bretylium,The therapeutic efficacy of Bretylium can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Brexpiprazole,Brexpiprazole may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Brimonidine,Brimonidine may increase the antihypertensive activities of Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Brivaracetam,Bendroflumethiazide may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bromazepam,Bendroflumethiazide may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Brompheniramine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Brompheniramine.,increase,no risk
Bendroflumethiazide,Buclizine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Buclizine.,increase,no risk
Bendroflumethiazide,Budesonide,The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Bumadizone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Bumadizone.,decrease,no risk
Bendroflumethiazide,Bumetanide,Bendroflumethiazide may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Buprenorphine,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Buprenorphine.,decrease,no risk
Bendroflumethiazide,Bupropion,Bendroflumethiazide may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Buspirone,Bendroflumethiazide may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Busulfan,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Busulfan.,increase,risk
Bendroflumethiazide,Butabarbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butabarbital is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Butalbital,The risk or severity of hypotension and orthostatic hypotension can be increased when Butalbital is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Butobarbital,The serum concentration of Bendroflumethiazide can be increased when it is combined with Butobarbital.,increase,no risk
Bendroflumethiazide,Butorphanol,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Butorphanol.,decrease,no risk
Bendroflumethiazide,Butriptyline,Butriptyline may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Butylscopolamine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Butylscopolamine.,increase,no risk
Bendroflumethiazide,Gabapentin enacarbil,Bendroflumethiazide may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadobenic acid,Bendroflumethiazide may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadodiamide,Bendroflumethiazide may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadofosveset trisodium,Bendroflumethiazide may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadopentetic acid,Bendroflumethiazide may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadoteric acid,Bendroflumethiazide may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gadoteridol,Bendroflumethiazide may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Galantamine,Bendroflumethiazide may increase the bradycardic activities of Galantamine.,increase,no risk
Bendroflumethiazide,Gallamine triethiodide,The serum concentration of Bendroflumethiazide can be increased when it is combined with Gallamine triethiodide.,increase,no risk
Bendroflumethiazide,Ganciclovir,Bendroflumethiazide may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gemcitabine,Bendroflumethiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gemfibrozil,Bendroflumethiazide may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gemtuzumab ozogamicin,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Gemtuzumab ozogamicin.,increase,risk
Bendroflumethiazide,Gimeracil,Bendroflumethiazide may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Gluconic Acid,The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Gluconic Acid.,increase,risk
Bendroflumethiazide,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Glycerin,The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Glycerin.,increase,risk
Bendroflumethiazide,Glycerol phenylbutyrate,Bendroflumethiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Glycol salicylate,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Bendroflumethiazide,Glycopyrronium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Glycopyrronium.,increase,no risk
Bendroflumethiazide,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Golodirsen,Bendroflumethiazide may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Goserelin,Bendroflumethiazide may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Guanabenz,The therapeutic efficacy of Guanabenz can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Guanadrel,The therapeutic efficacy of Guanadrel can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Guanethidine,The therapeutic efficacy of Guanethidine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Guanfacine,The therapeutic efficacy of Guanfacine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Guanoxan,The therapeutic efficacy of Guanoxan can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Halcinonide,The risk or severity of electrolyte imbalance can be increased when Halcinonide is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Haloperidol,Bendroflumethiazide may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Halothane,Halothane may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Hexafluronium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Hexafluronium.,increase,no risk
Bendroflumethiazide,Hexocyclium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Hexocyclium.,increase,no risk
Bendroflumethiazide,Homatropine methylbromide,The serum concentration of Bendroflumethiazide can be increased when it is combined with Homatropine methylbromide.,increase,no risk
Bendroflumethiazide,Hydralazine,The therapeutic efficacy of Hydralazine can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Hydrocodone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Bendroflumethiazide,Hydrocortisone,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone acetate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone acetate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone butyrate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone butyrate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone cypionate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone cypionate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone probutate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone probutate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone succinate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone succinate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydrocortisone valerate,The risk or severity of electrolyte imbalance can be increased when Hydrocortisone valerate is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Hydromorphone,Bendroflumethiazide may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Hydroxocobalamin,Bendroflumethiazide may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Hydroxyethyl Starch,Bendroflumethiazide may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Hydroxyurea,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Hydroxyurea.,increase,risk
Bendroflumethiazide,Hyoscyamine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Hyoscyamine.,increase,no risk
Bendroflumethiazide,Ketamine,Bendroflumethiazide may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Ketazolam,Bendroflumethiazide may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Ketorolac,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Bendroflumethiazide,Obinutuzumab,Bendroflumethiazide may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Bendroflumethiazide,Octinoxate,Bendroflumethiazide may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Olanzapine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Olanzapine.,increase,no risk
Bendroflumethiazide,Olaparib,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Olaparib.,increase,risk
Bendroflumethiazide,Oliceridine,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oliceridine.,decrease,no risk
Bendroflumethiazide,Olmesartan,The therapeutic efficacy of Olmesartan can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Olodaterol,The risk or severity of hypokalemia can be increased when Olodaterol is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Opicapone,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Opicapone.,increase,risk
Bendroflumethiazide,Opium,Bendroflumethiazide may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Orciprenaline,The risk or severity of hypokalemia can be increased when Orciprenaline is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Orphenadrine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Orphenadrine.,increase,no risk
Bendroflumethiazide,Oseltamivir,Bendroflumethiazide may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Ouabain,Bendroflumethiazide may increase the hypokalemic activities of Ouabain.,increase,no risk
Bendroflumethiazide,Oxacillin,Bendroflumethiazide may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Oxaliplatin,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Oxaliplatin.,increase,risk
Bendroflumethiazide,Oxaprozin,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oxaprozin.,decrease,no risk
Bendroflumethiazide,Oxazepam,Bendroflumethiazide may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Oxcarbazepine,The risk or severity of hyponatremia can be increased when Bendroflumethiazide is combined with Oxcarbazepine.,increase,risk
Bendroflumethiazide,Oxprenolol,The therapeutic efficacy of Oxprenolol can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Oxybenzone,Bendroflumethiazide may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Oxybutynin,The serum concentration of Bendroflumethiazide can be increased when it is combined with Oxybutynin.,increase,no risk
Bendroflumethiazide,Oxycodone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oxycodone.,decrease,no risk
Bendroflumethiazide,Oxymetazoline,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Bendroflumethiazide,Oxymorphone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Bendroflumethiazide,Oxyphenbutazone,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Bendroflumethiazide,Oxyphencyclimine,The serum concentration of Bendroflumethiazide can be increased when it is combined with Oxyphencyclimine.,increase,no risk
Bendroflumethiazide,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Bendroflumethiazide is combined with Oxyphenisatin acetate.,increase,risk
Bendroflumethiazide,Oxyphenonium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Oxyphenonium.,increase,no risk
Bendroflumethiazide,Oxyquinoline,Bendroflumethiazide may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Quetiapine,Quetiapine may increase the hypotensive activities of Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Quinapril,The therapeutic efficacy of Quinapril can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Quinidine,Bendroflumethiazide may increase the excretion rate of Quinidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Quinupramine,Quinupramine may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Udenafil,Udenafil may increase the antihypertensive activities of Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Ulobetasol,The risk or severity of electrolyte imbalance can be increased when Ulobetasol is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Umeclidinium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Umeclidinium.,increase,no risk
Bendroflumethiazide,Unoprostone,The therapeutic efficacy of Unoprostone can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Vaborbactam,Bendroflumethiazide may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Valaciclovir,Bendroflumethiazide may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Valbenazine,Bendroflumethiazide may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Valdecoxib,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Valdecoxib.,decrease,no risk
Bendroflumethiazide,Valganciclovir,Bendroflumethiazide may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Valsartan,The therapeutic efficacy of Valsartan can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Vamorolone,The risk or severity of electrolyte imbalance can be increased when Vamorolone is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Vancomycin,Bendroflumethiazide may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Vardenafil,Vardenafil may increase the antihypertensive activities of Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Varenicline,Bendroflumethiazide may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Vecuronium,The serum concentration of Bendroflumethiazide can be increased when it is combined with Vecuronium.,increase,no risk
Bendroflumethiazide,Venlafaxine,Bendroflumethiazide may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Verapamil,Bendroflumethiazide may increase the excretion rate of Verapamil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Vericiguat,The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Vericiguat.,increase,risk
Bendroflumethiazide,Vilanterol,The risk or severity of hypokalemia can be increased when Bendroflumethiazide is combined with Vilanterol.,increase,risk
Bendroflumethiazide,Vilazodone,Vilazodone may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Viloxazine,Bendroflumethiazide may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Vinblastine,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Vinblastine.,increase,risk
Bendroflumethiazide,Vindesine,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Vindesine.,increase,risk
Bendroflumethiazide,Vinorelbine,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Vinorelbine.,increase,risk
Bendroflumethiazide,Vitamin D,The risk or severity of hypercalcemia can be increased when Bendroflumethiazide is combined with Vitamin D.,increase,risk
Bendroflumethiazide,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Vorinostat,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Vorinostat.,increase,risk
Bendroflumethiazide,Vortioxetine,Bendroflumethiazide may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Warfarin,Bendroflumethiazide may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Xamoterol,Xamoterol may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Yohimbine,Yohimbine may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Zaleplon,Bendroflumethiazide may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Zanamivir,Bendroflumethiazide may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Bendroflumethiazide,Ziconotide,The risk or severity of CNS depression can be increased when Bendroflumethiazide is combined with Ziconotide.,increase,risk
Bendroflumethiazide,Zidovudine,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Zidovudine.,increase,risk
Bendroflumethiazide,Zimelidine,The risk or severity of hyponatremia can be increased when Zimelidine is combined with Bendroflumethiazide.,increase,risk
Bendroflumethiazide,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Zofenopril,The therapeutic efficacy of Zofenopril can be increased when used in combination with Bendroflumethiazide.,increase,no risk
Bendroflumethiazide,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Bendroflumethiazide.,decrease,no risk
Bendroflumethiazide,Zonisamide,Bendroflumethiazide may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Allopurinol,Busulfan,The risk or severity of adverse effects can be increased when Allopurinol is combined with Busulfan.,increase,risk
Allopurinol,Butabarbital,Butabarbital may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Gabapentin enacarbil,Allopurinol may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadobenic acid,Allopurinol may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadodiamide,Gadodiamide may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadofosveset trisodium,Allopurinol may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadopentetic acid,Allopurinol may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadoteric acid,Allopurinol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Allopurinol,Gadoteridol,Allopurinol may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Allopurinol,Ganciclovir,The excretion of Allopurinol can be decreased when combined with Ganciclovir.,decrease,no risk
Allopurinol,Gefitinib,Gefitinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Gemcitabine,The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemcitabine.,increase,risk
Allopurinol,Gemfibrozil,The excretion of Allopurinol can be decreased when combined with Gemfibrozil.,decrease,no risk
Allopurinol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Allopurinol is combined with Gemtuzumab ozogamicin.,increase,risk
Allopurinol,Gentamicin,Allopurinol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Allopurinol,Gilteritinib,Gilteritinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Gimeracil,Allopurinol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Allopurinol,Givosiran,Givosiran may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Glasdegib,Glasdegib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Glecaprevir,Glecaprevir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Glipizide,Allopurinol may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Allopurinol,Glycerol phenylbutyrate,Allopurinol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Allopurinol,Golodirsen,Allopurinol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Allopurinol,Goserelin,Goserelin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Grazoprevir,Grazoprevir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Guanethidine,Allopurinol may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Allopurinol,Guanfacine,Allopurinol may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Allopurinol,Guanidine,The excretion of Allopurinol can be decreased when combined with Guanidine.,decrease,no risk
Allopurinol,Haloperidol,Allopurinol may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Allopurinol,Hydralazine,Allopurinol may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Allopurinol,Hydrochlorothiazide,The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydrochlorothiazide.,increase,risk
Allopurinol,Hydroflumethiazide,The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Hydroflumethiazide.,increase,risk
Allopurinol,Hydromorphone,Hydromorphone may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Hydrotalcite,The therapeutic efficacy of Allopurinol can be decreased when used in combination with Hydrotalcite.,decrease,no risk
Allopurinol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Hydroxyethyl Starch,Allopurinol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Allopurinol,Hydroxyurea,The risk or severity of adverse effects can be increased when Allopurinol is combined with Hydroxyurea.,increase,risk
Allopurinol,Kanamycin,Allopurinol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Allopurinol,Ketamine,Allopurinol may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Allopurinol,Ketazolam,Allopurinol may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Allopurinol,Ketoprofen,The excretion of Allopurinol can be decreased when combined with Ketoprofen.,decrease,no risk
Allopurinol,Ketorolac,Ketorolac may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Obinutuzumab,The risk or severity of adverse effects can be increased when Allopurinol is combined with Obinutuzumab.,increase,risk
Allopurinol,Octinoxate,Allopurinol may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Allopurinol,Olaparib,The risk or severity of adverse effects can be increased when Allopurinol is combined with Olaparib.,increase,risk
Allopurinol,Olsalazine,Olsalazine may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Opium,Allopurinol may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Allopurinol,Oseltamivir,Oseltamivir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Osimertinib,Osimertinib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Oteracil,The therapeutic efficacy of Oteracil can be decreased when used in combination with Allopurinol.,decrease,no risk
Allopurinol,Oteseconazole,The serum concentration of Allopurinol can be increased when it is combined with Oteseconazole.,increase,no risk
Allopurinol,Ouabain,The excretion of Allopurinol can be decreased when combined with Ouabain.,decrease,no risk
Allopurinol,Oxacillin,Allopurinol may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxaliplatin,The risk or severity of adverse effects can be increased when Allopurinol is combined with Oxaliplatin.,increase,risk
Allopurinol,Oxaprozin,Oxaprozin may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxazepam,Allopurinol may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxtriphylline,The serum concentration of Oxtriphylline can be increased when it is combined with Allopurinol.,increase,no risk
Allopurinol,Oxybenzone,Allopurinol may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxyquinoline,Allopurinol may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Allopurinol,Oxytetracycline,The excretion of Allopurinol can be decreased when combined with Oxytetracycline.,decrease,no risk
Allopurinol,Quetiapine,Allopurinol may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Allopurinol,Quinapril,The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinapril.,increase,risk
Allopurinol,Quinethazone,The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Quinethazone.,increase,risk
Allopurinol,Quinidine,Allopurinol may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Allopurinol,Vaborbactam,Allopurinol may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Allopurinol,Vadadustat,The serum concentration of Allopurinol can be increased when it is combined with Vadadustat.,increase,no risk
Allopurinol,Valaciclovir,Valaciclovir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Valbenazine,Allopurinol may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Allopurinol,Valdecoxib,Valdecoxib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Valganciclovir,Allopurinol may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Allopurinol,Valproic acid,The excretion of Allopurinol can be decreased when combined with Valproic acid.,decrease,no risk
Allopurinol,Vancomycin,Allopurinol may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Allopurinol,Vandetanib,Vandetanib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Varenicline,Allopurinol may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Allopurinol,Velpatasvir,Velpatasvir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Vemurafenib,Vemurafenib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Venetoclax,Venetoclax may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Venlafaxine,Venlafaxine may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Allopurinol,Verapamil,Allopurinol may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Allopurinol,Vidarabine,The metabolism of Vidarabine can be decreased when combined with Allopurinol.,decrease,no risk
Allopurinol,Vilanterol,Allopurinol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Allopurinol,Viloxazine,Allopurinol may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Allopurinol,Vinblastine,The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinblastine.,increase,risk
Allopurinol,Vindesine,The risk or severity of adverse effects can be increased when Allopurinol is combined with Vindesine.,increase,risk
Allopurinol,Vinorelbine,The risk or severity of adverse effects can be increased when Allopurinol is combined with Vinorelbine.,increase,risk
Allopurinol,Vismodegib,Vismodegib may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Vorinostat,The risk or severity of adverse effects can be increased when Allopurinol is combined with Vorinostat.,increase,risk
Allopurinol,Vortioxetine,Allopurinol may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Allopurinol,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Allopurinol which could result in a higher serum level.,decrease,no risk
Allopurinol,Warfarin,The risk or severity of bleeding can be increased when Allopurinol is combined with Warfarin.,increase,risk
Allopurinol,Zaleplon,Allopurinol may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Allopurinol,Zanamivir,Allopurinol may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Allopurinol,Zidovudine,The risk or severity of adverse effects can be increased when Allopurinol is combined with Zidovudine.,increase,risk
Allopurinol,Zofenopril,The risk of a hypersensitivity reaction to Allopurinol is increased when it is combined with Zofenopril.,increase,risk
Allopurinol,Zonisamide,Zonisamide may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftazidime,Gabapentin enacarbil,Ceftazidime may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadobenic acid,Ceftazidime may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadodiamide,Ceftazidime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadofosveset trisodium,Ceftazidime may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadopentetic acid,Ceftazidime may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadoteric acid,Ceftazidime may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gadoteridol,Ceftazidime may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceftazidime,Ganciclovir,Ceftazidime may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gemcitabine,Ceftazidime may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gemfibrozil,Ceftazidime may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gentamicin,Ceftazidime may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Gimeracil,Ceftazidime may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftazidime,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Givosiran.,increase,risk
Ceftazidime,Glipizide,Ceftazidime may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceftazidime,Glycerol phenylbutyrate,Ceftazidime may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceftazidime,Golodirsen,Ceftazidime may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftazidime,Goserelin,Ceftazidime may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Guanethidine,Ceftazidime may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Guanfacine,Ceftazidime may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Haloperidol,Ceftazidime may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceftazidime,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftazidime.,decrease,no risk
Ceftazidime,Hydralazine,Ceftazidime may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Hydrochlorothiazide.,increase,risk
Ceftazidime,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftazidime,Hydromorphone,Ceftazidime may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceftazidime,Hydroxocobalamin,Ceftazidime may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Hydroxyethyl Starch,Ceftazidime may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftazidime,Kanamycin,Ceftazidime may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Ketamine,Ceftazidime may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Ketazolam,Ceftazidime may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceftazidime,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Ketoprofen.,increase,risk
Ceftazidime,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Ketorolac.,increase,risk
Ceftazidime,Octinoxate,Ceftazidime may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftazidime,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Olsalazine.,increase,risk
Ceftazidime,Opium,Ceftazidime may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftazidime,Oseltamivir,Ceftazidime may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ceftazidime,Oxacillin,Ceftazidime may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceftazidime.,increase,risk
Ceftazidime,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Oxaprozin.,increase,risk
Ceftazidime,Oxazepam,Ceftazidime may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceftazidime,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftazidime is combined with Oxetacaine.,increase,risk
Ceftazidime,Oxybenzone,Ceftazidime may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceftazidime,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftazidime is combined with Oxybuprocaine.,increase,risk
Ceftazidime,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Oxyphenbutazone.,increase,risk
Ceftazidime,Oxyquinoline,Ceftazidime may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftazidime,Quetiapine,Ceftazidime may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Quinethazone,Quinethazone may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ceftazidime,Quinidine,Ceftazidime may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftazidime.,decrease,no risk
Ceftazidime,Vaborbactam,Ceftazidime may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceftazidime,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Valaciclovir.,increase,risk
Ceftazidime,Valbenazine,Ceftazidime may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Valdecoxib.,increase,risk
Ceftazidime,Valganciclovir,Ceftazidime may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ceftazidime,Vancomycin,Ceftazidime may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Varenicline,Ceftazidime may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ceftazidime,Venlafaxine,Ceftazidime may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Verapamil,Ceftazidime may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ceftazidime,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftazidime.,decrease,no risk
Ceftazidime,Vilanterol,Ceftazidime may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceftazidime,Viloxazine,Ceftazidime may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceftazidime.,decrease,no risk
Ceftazidime,Vortioxetine,Ceftazidime may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceftazidime,Warfarin,Ceftazidime may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceftazidime,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceftazidime.,decrease,no risk
Ceftazidime,Zaleplon,Ceftazidime may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ceftazidime,Zanamivir,Ceftazidime may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ceftazidime,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftazidime is combined with Zoledronic acid.,increase,risk
Ceftazidime,Zonisamide,Zonisamide may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cerivastatin,Buspirone,The metabolism of Buspirone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Busulfan,The metabolism of Busulfan can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Galantamine,The metabolism of Galantamine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Ganciclovir.",increase,risk
Cerivastatin,Gefitinib,Gefitinib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Gemfibrozil,"The risk or severity of rhabdomyolysis, myoglobinuria, and elevated creatine kinase (CPK) can be increased when Gemfibrozil is combined with Cerivastatin.",increase,risk
Cerivastatin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Cerivastatin.,increase,no risk
Cerivastatin,Gestrinone,The metabolism of Gestrinone can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Gilteritinib,Gilteritinib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Glasdegib,Glasdegib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Glecaprevir,Glecaprevir may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Glimepiride,Glimepiride may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Glipizide,Cerivastatin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Cerivastatin,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Glofitamab,The serum concentration of Cerivastatin can be increased when it is combined with Glofitamab.,increase,no risk
Cerivastatin,Glyburide,Glyburide may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Glycyrrhizic acid,Cerivastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Cerivastatin,Golimumab,The metabolism of Cerivastatin can be increased when combined with Golimumab.,increase,no risk
Cerivastatin,Grazoprevir,Grazoprevir may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cerivastatin.,increase,no risk
Cerivastatin,Halothane,The metabolism of Halothane can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydrocortisone,The metabolism of Cerivastatin can be increased when combined with Hydrocortisone.,increase,no risk
Cerivastatin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ketamine,The metabolism of Ketamine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ketoconazole,The metabolism of Cerivastatin can be decreased when combined with Ketoconazole.,decrease,no risk
Cerivastatin,Ketoprofen,The metabolism of Cerivastatin can be decreased when combined with Ketoprofen.,decrease,no risk
Cerivastatin,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ofloxacin,Cerivastatin may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Olaparib,The metabolism of Olaparib can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Cerivastatin.,decrease,no risk
Cerivastatin,Olmesartan,Olmesartan may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Omaveloxolone,The serum concentration of Cerivastatin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cerivastatin,Ombitasvir,The metabolism of Cerivastatin can be decreased when combined with Ombitasvir.,decrease,no risk
Cerivastatin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Opium,The metabolism of Opium can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Ospemifene,The metabolism of Ospemifene can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Oteseconazole,The serum concentration of Cerivastatin can be increased when it is combined with Oteseconazole.,increase,no risk
Cerivastatin,Ouabain,The excretion of Ouabain can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Oxcarbazepine,The metabolism of Cerivastatin can be increased when combined with Oxcarbazepine.,increase,no risk
Cerivastatin,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Oxybutynin,The metabolism of Cerivastatin can be decreased when combined with Oxybutynin.,decrease,no risk
Cerivastatin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Quinidine,The metabolism of Quinidine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Quinine,The metabolism of Cerivastatin can be decreased when combined with Quinine.,decrease,no risk
Cerivastatin,Quizartinib,The metabolism of Cerivastatin can be decreased when combined with Quizartinib.,decrease,no risk
Cerivastatin,Ubidecarenone,The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Cerivastatin.,decrease,risk
Cerivastatin,Udenafil,The metabolism of Udenafil can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Vadadustat,The serum concentration of Cerivastatin can be increased when it is combined with Vadadustat.,increase,no risk
Cerivastatin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Valproic acid,The metabolism of Cerivastatin can be decreased when combined with Valproic acid.,decrease,no risk
Cerivastatin,Valsartan,The metabolism of Valsartan can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Vandetanib,The metabolism of Vandetanib can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Velpatasvir,Velpatasvir may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Venetoclax,The metabolism of Venetoclax can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Verapamil,The metabolism of Cerivastatin can be decreased when combined with Verapamil.,decrease,no risk
Cerivastatin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Viloxazine,The metabolism of Cerivastatin can be decreased when combined with Viloxazine.,decrease,no risk
Cerivastatin,Vinblastine,The metabolism of Vinblastine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vincristine,The metabolism of Vincristine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vindesine,The metabolism of Vindesine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vinflunine,The metabolism of Vinflunine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Vismodegib,Vismodegib may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Voriconazole,The metabolism of Cerivastatin can be decreased when combined with Voriconazole.,decrease,no risk
Cerivastatin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Cerivastatin.,increase,no risk
Cerivastatin,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Cerivastatin which could result in a higher serum level.,decrease,no risk
Cerivastatin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cerivastatin.,increase,no risk
Cerivastatin,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Zidovudine,The metabolism of Cerivastatin can be increased when combined with Zidovudine.,increase,no risk
Cerivastatin,Zileuton,The metabolism of Zileuton can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zimelidine,The metabolism of Cerivastatin can be decreased when combined with Zimelidine.,decrease,no risk
Cerivastatin,Ziprasidone,The metabolism of Cerivastatin can be decreased when combined with Ziprasidone.,decrease,no risk
Cerivastatin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cerivastatin.,decrease,no risk
Cerivastatin,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Cerivastatin.,increase,no risk
Cerivastatin,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Cerivastatin.,decrease,no risk
Trimethoprim,Bepridil,The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Bepridil.,increase,risk
Trimethoprim,Berotralstat,The metabolism of Trimethoprim can be decreased when combined with Berotralstat.,decrease,no risk
Trimethoprim,Betamethasone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Betamethasone.",increase,risk
Trimethoprim,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Trimethoprim.,increase,risk
Trimethoprim,Bexarotene,The metabolism of Trimethoprim can be decreased when combined with Bexarotene.,decrease,no risk
Trimethoprim,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Trimethoprim is combined with Bezafibrate.",increase,risk
Trimethoprim,Bicisate,Trimethoprim may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bimekizumab,The metabolism of Trimethoprim can be increased when combined with Bimekizumab.,increase,no risk
Trimethoprim,Bismuth subgallate,Trimethoprim may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bisoprolol,The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Bisoprolol.,increase,risk
Trimethoprim,Bisoxatin,Trimethoprim may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bleomycin,Bleomycin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,decrease,no risk
Trimethoprim,Boceprevir,The metabolism of Trimethoprim can be decreased when combined with Boceprevir.,decrease,no risk
Trimethoprim,Bortezomib,The metabolism of Trimethoprim can be decreased when combined with Bortezomib.,decrease,no risk
Trimethoprim,Bosentan,The metabolism of Trimethoprim can be increased when combined with Bosentan.,increase,no risk
Trimethoprim,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Trimethoprim.,decrease,no risk
Trimethoprim,Brivaracetam,Trimethoprim may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bromazepam,Trimethoprim may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bromotheophylline,Bromotheophylline may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimethoprim,Budesonide,Trimethoprim may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Trimethoprim,Bumadizone,The risk or severity of hyperkalemia can be increased when Trimethoprim is combined with Bumadizone.,increase,risk
Trimethoprim,Bumetanide,Bumetanide may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Trimethoprim,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Trimethoprim.,decrease,no risk
Trimethoprim,Bupropion,Trimethoprim may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Trimethoprim,Buspirone,Trimethoprim may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Trimethoprim,Butabarbital,Butabarbital may decrease the excretion rate of Trimethoprim which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Gemcitabine.,increase,risk
Gemcitabine,Bendamustine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bendamustine.,increase,risk
Gemcitabine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Benorilate,Benorilate may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benserazide,Gemcitabine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benzatropine,Benzatropine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benznidazole,Gemcitabine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Benzocaine.,increase,risk
Gemcitabine,Benzthiazide,Benzthiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Benzydamine,Benzydamine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Benzyl alcohol.,increase,risk
Gemcitabine,Bepotastine,Gemcitabine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Berotralstat,The serum concentration of Gemcitabine can be increased when it is combined with Berotralstat.,increase,no risk
Gemcitabine,Betamethasone,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Betamethasone.,increase,risk
Gemcitabine,Betrixaban,The serum concentration of Gemcitabine can be increased when it is combined with Betrixaban.,increase,no risk
Gemcitabine,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Gemcitabine.,increase,risk
Gemcitabine,Bicisate,Gemcitabine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bimekizumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bimekizumab.,increase,risk
Gemcitabine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Gemcitabine.,increase,no risk
Gemcitabine,Bismuth subgallate,Gemcitabine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bisoprolol,The serum concentration of Gemcitabine can be increased when it is combined with Bisoprolol.,increase,no risk
Gemcitabine,Bisoxatin,Gemcitabine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Gemcitabine.,increase,risk
Gemcitabine,Bleomycin,The risk or severity of pulmonary toxicity can be increased when Gemcitabine is combined with Bleomycin.,increase,risk
Gemcitabine,Blinatumomab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Blinatumomab.,increase,risk
Gemcitabine,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Gemcitabine.",decrease,no risk
Gemcitabine,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Gemcitabine.,increase,risk
Gemcitabine,Bosutinib,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Bosutinib.,increase,risk
Gemcitabine,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin.,increase,risk
Gemcitabine,Brivaracetam,Gemcitabine may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Gemcitabine,Brodalumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brodalumab.,increase,risk
Gemcitabine,Bromazepam,Gemcitabine may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Budesonide,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Budesonide.,increase,risk
Gemcitabine,Bumadizone,Bumadizone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Bumetanide,Bumetanide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Bupivacaine.,increase,risk
Gemcitabine,Bupropion,Gemcitabine may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Gemcitabine,Buspirone,Gemcitabine may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Gemcitabine,Busulfan,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Busulfan.,increase,risk
Gemcitabine,Butabarbital,Butabarbital may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Butacaine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Butacaine.,increase,risk
Gemcitabine,Butamben,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Butamben.,increase,risk
Gemcitabine,Gabapentin enacarbil,Gemcitabine may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadobenic acid,Gemcitabine may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadodiamide,Gadodiamide may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadofosveset trisodium,Gemcitabine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadopentetic acid,Gemcitabine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadoteric acid,Gemcitabine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gadoteridol,Gemcitabine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ganciclovir,Gemcitabine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gemfibrozil,Gemcitabine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Gemcitabine.,increase,risk
Gemcitabine,Gentamicin,Gemcitabine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Gemcitabine,Gilteritinib,The serum concentration of Gemcitabine can be increased when it is combined with Gilteritinib.,increase,no risk
Gemcitabine,Gimeracil,Gemcitabine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Gemcitabine,Givosiran,Givosiran may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Glasdegib,The serum concentration of Gemcitabine can be increased when it is combined with Glasdegib.,increase,no risk
Gemcitabine,Glatiramer,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Glatiramer.,increase,risk
Gemcitabine,Glecaprevir,The serum concentration of Gemcitabine can be increased when it is combined with Glecaprevir.,increase,no risk
Gemcitabine,Glipizide,Gemcitabine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Gemcitabine,Glycerol phenylbutyrate,Gemcitabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Gemcitabine,Golimumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Golimumab.,increase,risk
Gemcitabine,Golodirsen,Gemcitabine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Gemcitabine,Goserelin,Goserelin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Grazoprevir,The serum concentration of Gemcitabine can be increased when it is combined with Grazoprevir.,increase,no risk
Gemcitabine,Guanethidine,Gemcitabine may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Guanfacine,Gemcitabine may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Guselkumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Guselkumab.,increase,risk
Gemcitabine,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Gemcitabine.,decrease,no risk
Gemcitabine,Haloperidol,Gemcitabine may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Gemcitabine,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Gemcitabine.,increase,risk
Gemcitabine,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Gemcitabine.,decrease,no risk
Gemcitabine,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Gemcitabine.,decrease,no risk
Gemcitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Gemcitabine.,increase,risk
Gemcitabine,Hydralazine,Gemcitabine may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydrocortisone acetate.,increase,risk
Gemcitabine,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydrocortisone butyrate.,increase,risk
Gemcitabine,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydrocortisone succinate.,increase,risk
Gemcitabine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gemcitabine,Hydromorphone,Hydromorphone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxychloroquine.,increase,risk
Gemcitabine,Hydroxyethyl Starch,Gemcitabine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Gemcitabine,Hydroxyurea,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Hydroxyurea.,increase,risk
Gemcitabine,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Gemcitabine.,decrease,no risk
Gemcitabine,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Gemcitabine.,decrease,no risk
Gemcitabine,Kanamycin,Gemcitabine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ketamine,Gemcitabine may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ketazolam,Gemcitabine may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ketoconazole,The serum concentration of Gemcitabine can be increased when it is combined with Ketoconazole.,increase,no risk
Gemcitabine,Ketoprofen,Ketoprofen may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ketorolac,Ketorolac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Obinutuzumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Obinutuzumab.,increase,risk
Gemcitabine,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Gemcitabine.,increase,no risk
Gemcitabine,Octinoxate,Gemcitabine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ofatumumab,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ofatumumab.,increase,risk
Gemcitabine,Olaparib,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Olaparib.,increase,risk
Gemcitabine,Olsalazine,Olsalazine may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Omadacycline,The serum concentration of Gemcitabine can be increased when it is combined with Omadacycline.,increase,no risk
Gemcitabine,Ombitasvir,The serum concentration of Gemcitabine can be increased when it is combined with Ombitasvir.,increase,no risk
Gemcitabine,Opium,Gemcitabine may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oseltamivir,Oseltamivir may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Gemcitabine.,increase,no risk
Gemcitabine,Oxacillin,Gemcitabine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oxaliplatin,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Oxaliplatin.,increase,risk
Gemcitabine,Oxaprozin,Oxaprozin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oxazepam,Gemcitabine may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Oxetacaine.,increase,risk
Gemcitabine,Oxybenzone,Gemcitabine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gemcitabine is combined with Oxybuprocaine.,increase,risk
Gemcitabine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Gemcitabine,Oxyquinoline,Gemcitabine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Gemcitabine,Ozanimod,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ozanimod.,increase,risk
Entecavir,Ganciclovir,The risk or severity of cytopenia can be increased when Ganciclovir is combined with Entecavir.,increase,risk
Entecavir,Gatifloxacin,The metabolism of Entecavir can be decreased when combined with Gatifloxacin.,decrease,no risk
Entecavir,Gemfibrozil,The metabolism of Entecavir can be decreased when combined with Gemfibrozil.,decrease,no risk
Entecavir,Gemifloxacin,The metabolism of Entecavir can be decreased when combined with Gemifloxacin.,decrease,no risk
Entecavir,Givosiran,The serum concentration of Entecavir can be increased when it is combined with Givosiran.,increase,no risk
Entecavir,Glofitamab,The serum concentration of Entecavir can be increased when it is combined with Glofitamab.,increase,no risk
Entecavir,Golimumab,The metabolism of Entecavir can be increased when combined with Golimumab.,increase,no risk
Entecavir,Grepafloxacin,The metabolism of Entecavir can be decreased when combined with Grepafloxacin.,decrease,no risk
Entecavir,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Entecavir.,decrease,no risk
Entecavir,Ketoconazole,The metabolism of Entecavir can be decreased when combined with Ketoconazole.,decrease,no risk
Entecavir,Obeticholic acid,The metabolism of Entecavir can be decreased when combined with Obeticholic acid.,decrease,no risk
Entecavir,Olanzapine,The metabolism of Entecavir can be decreased when combined with Olanzapine.,decrease,no risk
Entecavir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Orphenadrine,The metabolism of Entecavir can be decreased when combined with Orphenadrine.,decrease,no risk
Entecavir,Osilodrostat,The metabolism of Entecavir can be decreased when combined with Osilodrostat.,decrease,no risk
Entecavir,Osimertinib,The serum concentration of Entecavir can be decreased when it is combined with Osimertinib.,decrease,no risk
Entecavir,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Quinidine,The metabolism of Entecavir can be decreased when combined with Quinidine.,decrease,no risk
Entecavir,Quinine,The metabolism of Quinine can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Valganciclovir,The risk or severity of cytopenia can be increased when Valganciclovir is combined with Entecavir.,increase,risk
Entecavir,Valproic acid,The metabolism of Entecavir can be decreased when combined with Valproic acid.,decrease,no risk
Entecavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Entecavir.,decrease,no risk
Entecavir,Vemurafenib,The serum concentration of Entecavir can be increased when it is combined with Vemurafenib.,increase,no risk
Entecavir,Verapamil,The metabolism of Verapamil can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Entecavir.,decrease,no risk
Entecavir,Viloxazine,The metabolism of Entecavir can be decreased when combined with Viloxazine.,decrease,no risk
Entecavir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Warfarin,The metabolism of Warfarin can be decreased when combined with Entecavir.,decrease,no risk
Entecavir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Entecavir.,decrease,no risk
Entecavir,Zileuton,The metabolism of Entecavir can be decreased when combined with Zileuton.,decrease,no risk
Entecavir,Zolmitriptan,The metabolism of Entecavir can be decreased when combined with Zolmitriptan.,decrease,no risk
Entecavir,Zolpidem,The metabolism of Entecavir can be decreased when combined with Zolpidem.,decrease,no risk
Entecavir,Zotepine,The metabolism of Zotepine can be decreased when combined with Entecavir.,decrease,no risk
Betamethasone,Benzphetamine,The metabolism of Benzphetamine can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Benzthiazide,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Benzthiazide.,increase,risk
Betamethasone,Benzydamine,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Benzydamine.,increase,risk
Betamethasone,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Berotralstat,The metabolism of Betamethasone can be decreased when combined with Berotralstat.,decrease,no risk
Betamethasone,Betaine,The therapeutic efficacy of Betaine can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Bexagliflozin,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Bexagliflozin.,increase,risk
Betamethasone,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Betamethasone.,increase,risk
Betamethasone,Bezafibrate,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Bezafibrate.",increase,risk
Betamethasone,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Bimekizumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Bimekizumab.,increase,risk
Betamethasone,Binimetinib,The metabolism of Binimetinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Bismuth subsalicylate,The serum concentration of Bismuth subsalicylate can be decreased when it is combined with Betamethasone.,decrease,no risk
Betamethasone,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Betamethasone.,increase,risk
Betamethasone,Blinatumomab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Blinatumomab.,increase,risk
Betamethasone,Boceprevir,The metabolism of Betamethasone can be decreased when combined with Boceprevir.,decrease,no risk
Betamethasone,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Betamethasone.",decrease,no risk
Betamethasone,Bortezomib,The metabolism of Bortezomib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Bosutinib,The metabolism of Bosutinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Botulinum toxin type A,The risk or severity of myopathy and weakness can be increased when Botulinum toxin type A is combined with Betamethasone.,increase,risk
Betamethasone,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Brigatinib,The metabolism of Brigatinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Brodalumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Brodalumab.,increase,risk
Betamethasone,Bromocriptine,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Bromocriptine.,increase,risk
Betamethasone,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Budesonide,The risk or severity of adverse effects can be increased when Betamethasone is combined with Budesonide.,increase,risk
Betamethasone,Bumadizone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Bumadizone.,increase,risk
Betamethasone,Bumetanide,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Bumetanide.,increase,risk
Betamethasone,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Bupropion,The metabolism of Bupropion can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Buspirone,The metabolism of Buspirone can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Busulfan,The metabolism of Busulfan can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Galantamine,The therapeutic efficacy of Galantamine can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Ganciclovir.",increase,risk
Betamethasone,Gatifloxacin,The risk or severity of tendinopathy can be increased when Betamethasone is combined with Gatifloxacin.,increase,risk
Betamethasone,Gefitinib,The metabolism of Gefitinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Betamethasone.,increase,risk
Betamethasone,Gemfibrozil,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Gemfibrozil.",increase,risk
Betamethasone,Gemifloxacin,The risk or severity of tendinopathy can be increased when Betamethasone is combined with Gemifloxacin.,increase,risk
Betamethasone,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Betamethasone.,increase,risk
Betamethasone,Gestrinone,The serum concentration of Betamethasone can be increased when it is combined with Gestrinone.,increase,no risk
Betamethasone,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Ginkgo biloba,The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Glasdegib,The metabolism of Glasdegib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Glatiramer,The risk or severity of adverse effects can be increased when Betamethasone is combined with Glatiramer.,increase,risk
Betamethasone,Gliclazide,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Gliclazide.,increase,risk
Betamethasone,Glimepiride,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Glimepiride.,increase,risk
Betamethasone,Glipizide,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Glipizide.,increase,risk
Betamethasone,Gliquidone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Gliquidone.,increase,risk
Betamethasone,Glofitamab,The serum concentration of Betamethasone can be increased when it is combined with Glofitamab.,increase,no risk
Betamethasone,Glyburide,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Glyburide.,increase,risk
Betamethasone,Glycerol phenylbutyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Glycol salicylate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Glycol salicylate.,increase,risk
Betamethasone,Glymidine,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Glymidine.,increase,risk
Betamethasone,Golimumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Golimumab.,increase,risk
Betamethasone,Grepafloxacin,The risk or severity of tendinopathy can be increased when Betamethasone is combined with Grepafloxacin.,increase,risk
Betamethasone,Guselkumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Guselkumab.,increase,risk
Betamethasone,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Halofantrine,The metabolism of Halofantrine can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Betamethasone.,increase,no risk
Betamethasone,Halothane,The metabolism of Halothane can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hexafluronium,The therapeutic efficacy of Hexafluronium can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Huperzine A,The therapeutic efficacy of Huperzine A can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Hydrochlorothiazide,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Hydrochlorothiazide.,increase,risk
Betamethasone,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydrocortisone acetate.,increase,risk
Betamethasone,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydrocortisone butyrate.,increase,risk
Betamethasone,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydrocortisone succinate.,increase,risk
Betamethasone,Hydroflumethiazide,The risk or severity of electrolyte imbalance can be increased when Betamethasone is combined with Hydroflumethiazide.,increase,risk
Betamethasone,Hydrotalcite,The bioavailability of Betamethasone can be decreased when combined with Hydrotalcite.,decrease,no risk
Betamethasone,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydroxychloroquine.,increase,risk
Betamethasone,Hydroxyprogesterone caproate,The serum concentration of Betamethasone can be increased when it is combined with Hydroxyprogesterone caproate.,increase,no risk
Betamethasone,Hydroxyurea,The risk or severity of adverse effects can be increased when Betamethasone is combined with Hydroxyurea.,increase,risk
Betamethasone,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Ketamine,The therapeutic efficacy of Ketamine can be decreased when used in combination with Betamethasone.,decrease,no risk
Betamethasone,Ketoconazole,The metabolism of Betamethasone can be decreased when combined with Ketoconazole.,decrease,no risk
Betamethasone,Ketoprofen,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Ketoprofen.,increase,risk
Betamethasone,Ketorolac,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Ketorolac.,increase,risk
Betamethasone,Obinutuzumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Obinutuzumab.,increase,risk
Betamethasone,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Betamethasone.,increase,no risk
Betamethasone,Ofatumumab,The risk or severity of adverse effects can be increased when Betamethasone is combined with Ofatumumab.,increase,risk
Betamethasone,Ofloxacin,The risk or severity of tendinopathy can be increased when Betamethasone is combined with Ofloxacin.,increase,risk
Betamethasone,Olaparib,The metabolism of Olaparib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Betamethasone.,decrease,no risk
Betamethasone,Olodaterol,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Olodaterol.,increase,risk
Betamethasone,Olsalazine,The serum concentration of Olsalazine can be decreased when it is combined with Betamethasone.,decrease,no risk
Betamethasone,Omaveloxolone,The serum concentration of Betamethasone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Betamethasone,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Ondansetron,The metabolism of Ondansetron can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Orciprenaline,The risk or severity of hypokalemia can be increased when Betamethasone is combined with Orciprenaline.,increase,risk
Betamethasone,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Osimertinib,The metabolism of Osimertinib can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Ospemifene,The metabolism of Ospemifene can be increased when combined with Betamethasone.,increase,no risk
Betamethasone,Oxaliplatin,The risk or severity of adverse effects can be increased when Betamethasone is combined with Oxaliplatin.,increase,risk
Betamethasone,Oxandrolone,The risk or severity of fluid retention can be increased when Betamethasone is combined with Oxandrolone.,increase,risk
Teniposide,Belumosudil,The risk or severity of adverse effects can be increased when Teniposide is combined with Belumosudil.,increase,risk
Teniposide,Belzutifan,The serum concentration of Teniposide can be decreased when it is combined with Belzutifan.,decrease,no risk
Teniposide,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Teniposide.,increase,risk
Teniposide,Bendamustine,The risk or severity of adverse effects can be increased when Teniposide is combined with Bendamustine.,increase,risk
Teniposide,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Teniposide.,increase,risk
Teniposide,Benperidol,Teniposide may increase the neurotoxic activities of Benperidol.,increase,no risk
Teniposide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Benzocaine.,increase,risk
Teniposide,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Teniposide.,increase,risk
Teniposide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Benzyl alcohol.,increase,risk
Teniposide,Berotralstat,The serum concentration of Teniposide can be increased when it is combined with Berotralstat.,increase,no risk
Teniposide,Betamethasone,The metabolism of Teniposide can be increased when combined with Betamethasone.,increase,no risk
Teniposide,Betamethasone phosphate,The metabolism of Teniposide can be increased when combined with Betamethasone phosphate.,increase,no risk
Teniposide,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Teniposide.,increase,risk
Teniposide,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Teniposide.,increase,risk
Teniposide,Bexarotene,The metabolism of Teniposide can be increased when combined with Bexarotene.,increase,no risk
Teniposide,Bicalutamide,The metabolism of Teniposide can be decreased when combined with Bicalutamide.,decrease,no risk
Teniposide,Bifonazole,The metabolism of Teniposide can be decreased when combined with Bifonazole.,decrease,no risk
Teniposide,Bimekizumab,The metabolism of Teniposide can be increased when combined with Bimekizumab.,increase,no risk
Teniposide,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Bismuth subcitrate potassium,Teniposide may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Teniposide,Bismuth subgallate,Teniposide may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Teniposide,Bismuth subnitrate,Teniposide may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Teniposide,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Teniposide.,increase,risk
Teniposide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Teniposide.,increase,risk
Teniposide,Blinatumomab,The risk or severity of adverse effects can be increased when Teniposide is combined with Blinatumomab.,increase,risk
Teniposide,Boceprevir,The metabolism of Teniposide can be decreased when combined with Boceprevir.,decrease,no risk
Teniposide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Teniposide.",decrease,no risk
Teniposide,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Bosentan,The metabolism of Teniposide can be increased when combined with Bosentan.,increase,no risk
Teniposide,Bosutinib,The metabolism of Teniposide can be decreased when combined with Bosutinib.,decrease,no risk
Teniposide,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Brexpiprazole,Teniposide may increase the neurotoxic activities of Brexpiprazole.,increase,no risk
Teniposide,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Brodalumab,The risk or severity of adverse effects can be increased when Teniposide is combined with Brodalumab.,increase,risk
Teniposide,Bromperidol,Teniposide may increase the neurotoxic activities of Bromperidol.,increase,no risk
Teniposide,Budesonide,The metabolism of Teniposide can be increased when combined with Budesonide.,increase,no risk
Teniposide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Bupivacaine.,increase,risk
Teniposide,Buprenorphine,The metabolism of Teniposide can be decreased when combined with Buprenorphine.,decrease,no risk
Teniposide,Bupropion,The metabolism of Bupropion can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Buspirone,The metabolism of Teniposide can be decreased when combined with Buspirone.,decrease,no risk
Teniposide,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Butabarbital,The serum concentration of Teniposide can be decreased when it is combined with Butabarbital.,decrease,no risk
Teniposide,Butacaine,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Butacaine.,increase,risk
Teniposide,Butalbital,The serum concentration of Teniposide can be decreased when it is combined with Butalbital.,decrease,no risk
Teniposide,Butamben,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Butamben.,increase,risk
Teniposide,Butaperazine,Teniposide may increase the neurotoxic activities of Butaperazine.,increase,no risk
Teniposide,Butriptyline,Teniposide may increase the neurotoxic activities of Butriptyline.,increase,no risk
Teniposide,Gefitinib,The metabolism of Teniposide can be decreased when combined with Gefitinib.,decrease,no risk
Teniposide,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Teniposide.,increase,risk
Teniposide,Gemfibrozil,The metabolism of Teniposide can be decreased when combined with Gemfibrozil.,decrease,no risk
Teniposide,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teniposide.,increase,risk
Teniposide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Gilteritinib,The metabolism of Teniposide can be decreased when combined with Gilteritinib.,decrease,no risk
Teniposide,Ginkgo biloba,The metabolism of Teniposide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Teniposide,Glasdegib,Glasdegib may decrease the excretion rate of Teniposide which could result in a higher serum level.,decrease,no risk
Teniposide,Glatiramer,The risk or severity of adverse effects can be increased when Teniposide is combined with Glatiramer.,increase,risk
Teniposide,Glecaprevir,The metabolism of Teniposide can be decreased when combined with Glecaprevir.,decrease,no risk
Teniposide,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Glipizide,The metabolism of Glipizide can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Glofitamab,The serum concentration of Teniposide can be increased when it is combined with Glofitamab.,increase,no risk
Teniposide,Glyburide,The metabolism of Teniposide can be decreased when combined with Glyburide.,decrease,no risk
Teniposide,Glycerol phenylbutyrate,The metabolism of Teniposide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Teniposide,Golimumab,The metabolism of Teniposide can be increased when combined with Golimumab.,increase,no risk
Teniposide,Grapefruit,The serum concentration of Teniposide can be increased when it is combined with Grapefruit.,increase,no risk
Teniposide,Grazoprevir,Grazoprevir may decrease the excretion rate of Teniposide which could result in a higher serum level.,decrease,no risk
Teniposide,Griseofulvin,The metabolism of Teniposide can be increased when combined with Griseofulvin.,increase,no risk
Teniposide,Guselkumab,The risk or severity of adverse effects can be increased when Teniposide is combined with Guselkumab.,increase,risk
Teniposide,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Halofantrine,The metabolism of Teniposide can be decreased when combined with Halofantrine.,decrease,no risk
Teniposide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Halothane,The metabolism of Halothane can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Teniposide.,increase,risk
Teniposide,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Teniposide.,increase,risk
Teniposide,Hydralazine,The serum concentration of Teniposide can be increased when it is combined with Hydralazine.,increase,no risk
Teniposide,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Teniposide.,increase,risk
Teniposide,Hydrocortamate,The metabolism of Teniposide can be increased when combined with Hydrocortamate.,increase,no risk
Teniposide,Hydrocortisone,The metabolism of Teniposide can be increased when combined with Hydrocortisone.,increase,no risk
Teniposide,Hydrocortisone acetate,The metabolism of Teniposide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Teniposide,Hydrocortisone butyrate,The metabolism of Teniposide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Teniposide,Hydrocortisone cypionate,The metabolism of Teniposide can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Teniposide,Hydrocortisone phosphate,The metabolism of Teniposide can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Teniposide,Hydrocortisone succinate,The metabolism of Teniposide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Teniposide,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Teniposide.,increase,risk
Teniposide,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Teniposide is combined with Hydroxychloroquine.,increase,risk
Teniposide,Hydroxyprogesterone caproate,The metabolism of Teniposide can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Teniposide,Hydroxyurea,The risk or severity of adverse effects can be increased when Teniposide is combined with Hydroxyurea.,increase,risk
Teniposide,Hydroxyzine,The metabolism of Teniposide can be decreased when combined with Hydroxyzine.,decrease,no risk
Teniposide,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Ketamine,The metabolism of Ketamine can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Ketazolam,The serum concentration of Teniposide can be increased when it is combined with Ketazolam.,increase,no risk
Teniposide,Ketoconazole,The metabolism of Teniposide can be decreased when combined with Ketoconazole.,decrease,no risk
Teniposide,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Obinutuzumab,The risk or severity of adverse effects can be increased when Teniposide is combined with Obinutuzumab.,increase,risk
Teniposide,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Teniposide.,increase,no risk
Teniposide,Octreotide,The serum concentration of Teniposide can be increased when it is combined with Octreotide.,increase,no risk
Teniposide,Ofatumumab,The risk or severity of adverse effects can be increased when Teniposide is combined with Ofatumumab.,increase,risk
Teniposide,Olanzapine,The metabolism of Teniposide can be decreased when combined with Olanzapine.,decrease,no risk
Teniposide,Olaparib,The metabolism of Teniposide can be decreased when combined with Olaparib.,decrease,no risk
Teniposide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Olutasidenib,The metabolism of Teniposide can be increased when combined with Olutasidenib.,increase,no risk
Teniposide,Omaveloxolone,The serum concentration of Teniposide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Teniposide,Omeprazole,The metabolism of Teniposide can be decreased when combined with Omeprazole.,decrease,no risk
Teniposide,Ondansetron,The metabolism of Teniposide can be decreased when combined with Ondansetron.,decrease,no risk
Teniposide,Oritavancin,The metabolism of Teniposide can be increased when combined with Oritavancin.,increase,no risk
Teniposide,Orphenadrine,The metabolism of Teniposide can be decreased when combined with Orphenadrine.,decrease,no risk
Teniposide,Osilodrostat,The serum concentration of Teniposide can be increased when it is combined with Osilodrostat.,increase,no risk
Teniposide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Oteseconazole,The serum concentration of Teniposide can be increased when it is combined with Oteseconazole.,increase,no risk
Teniposide,Ouabain,Ouabain may decrease the cardiotoxic activities of Teniposide.,decrease,no risk
Teniposide,Oxaliplatin,The risk or severity of adverse effects can be increased when Teniposide is combined with Oxaliplatin.,increase,risk
Teniposide,Oxcarbazepine,The metabolism of Teniposide can be increased when combined with Oxcarbazepine.,increase,no risk
Teniposide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Oxetacaine.,increase,risk
Teniposide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Teniposide is combined with Oxybuprocaine.,increase,risk
Teniposide,Oxybutynin,The serum concentration of Teniposide can be increased when it is combined with Oxybutynin.,increase,no risk
Teniposide,Oxycodone,The metabolism of Teniposide can be decreased when combined with Oxycodone.,decrease,no risk
Teniposide,Ozanimod,The risk or severity of adverse effects can be increased when Teniposide is combined with Ozanimod.,increase,risk
Teniposide,Quetiapine,The metabolism of Teniposide can be decreased when combined with Quetiapine.,decrease,no risk
Teniposide,Quinidine,The metabolism of Teniposide can be decreased when combined with Quinidine.,decrease,no risk
Teniposide,Quinine,The metabolism of Teniposide can be increased when combined with Quinine.,increase,no risk
Teniposide,Quinupramine,Teniposide may increase the neurotoxic activities of Quinupramine.,increase,no risk
Teniposide,Quinupristin,The metabolism of Teniposide can be decreased when combined with Quinupristin.,decrease,no risk
Teniposide,Quizartinib,The metabolism of Teniposide can be decreased when combined with Quizartinib.,decrease,no risk
Teniposide,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Teniposide.,increase,risk
Teniposide,Udenafil,The metabolism of Teniposide can be decreased when combined with Udenafil.,decrease,no risk
Teniposide,Upadacitinib,The risk or severity of adverse effects can be increased when Teniposide is combined with Upadacitinib.,increase,risk
Teniposide,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Teniposide.,increase,risk
Teniposide,Vadadustat,The serum concentration of Teniposide can be increased when it is combined with Vadadustat.,increase,no risk
Teniposide,Valbenazine,The metabolism of Teniposide can be decreased when combined with Valbenazine.,decrease,no risk
Teniposide,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Valproate bismuth,Teniposide may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Teniposide,Valproic acid,The serum concentration of Teniposide can be increased when it is combined with Valproic acid.,increase,no risk
Teniposide,Valsartan,The metabolism of Valsartan can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Teniposide.,increase,risk
Teniposide,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Vedolizumab,The risk or severity of adverse effects can be increased when Teniposide is combined with Vedolizumab.,increase,risk
Teniposide,Velpatasvir,Velpatasvir may decrease the excretion rate of Teniposide which could result in a higher serum level.,decrease,no risk
Teniposide,Vemurafenib,The metabolism of Teniposide can be increased when combined with Vemurafenib.,increase,no risk
Teniposide,Venetoclax,The metabolism of Teniposide can be decreased when combined with Venetoclax.,decrease,no risk
Teniposide,Venlafaxine,Venlafaxine may increase the excretion rate of Teniposide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Teniposide,Verapamil,The metabolism of Teniposide can be decreased when combined with Verapamil.,decrease,no risk
Teniposide,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Teniposide.,decrease,no risk
Teniposide,Vilanterol,The risk or severity of adverse effects can be increased when Teniposide is combined with Vilanterol.,increase,risk
Teniposide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Viloxazine,The metabolism of Teniposide can be decreased when combined with Viloxazine.,decrease,no risk
Teniposide,Vinblastine,The metabolism of Teniposide can be increased when combined with Vinblastine.,increase,no risk
Teniposide,Vincristine,Teniposide may increase the neurotoxic activities of Vincristine.,increase,no risk
Teniposide,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Viomycin,Teniposide may increase the neurotoxic activities of Viomycin.,increase,no risk
Teniposide,Vismodegib,Vismodegib may decrease the excretion rate of Teniposide which could result in a higher serum level.,decrease,no risk
Teniposide,Vitamin E,The metabolism of Teniposide can be increased when combined with Vitamin E.,increase,no risk
Teniposide,Voclosporin,The risk or severity of adverse effects can be increased when Teniposide is combined with Voclosporin.,increase,risk
Teniposide,Vonoprazan,The metabolism of Teniposide can be decreased when combined with Vonoprazan.,decrease,no risk
Teniposide,Vorapaxar,The metabolism of Teniposide can be decreased when combined with Vorapaxar.,decrease,no risk
Teniposide,Voriconazole,The metabolism of Teniposide can be decreased when combined with Voriconazole.,decrease,no risk
Teniposide,Vorinostat,The risk or severity of adverse effects can be increased when Teniposide is combined with Vorinostat.,increase,risk
Teniposide,Vortioxetine,The metabolism of Teniposide can be decreased when combined with Vortioxetine.,decrease,no risk
Teniposide,Voxelotor,The serum concentration of Teniposide can be increased when it is combined with Voxelotor.,increase,no risk
Teniposide,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Teniposide which could result in a higher serum level.,decrease,no risk
Teniposide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Teniposide.,increase,risk
Teniposide,Zafirlukast,The serum concentration of Teniposide can be increased when it is combined with Zafirlukast.,increase,no risk
Teniposide,Zaleplon,The metabolism of Teniposide can be decreased when combined with Zaleplon.,decrease,no risk
Teniposide,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Teniposide.,increase,no risk
Teniposide,Zidovudine,The risk or severity of adverse effects can be increased when Teniposide is combined with Zidovudine.,increase,risk
Teniposide,Zileuton,The metabolism of Zileuton can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Zimelidine,The metabolism of Teniposide can be decreased when combined with Zimelidine.,decrease,no risk
Teniposide,Ziprasidone,The metabolism of Teniposide can be decreased when combined with Ziprasidone.,decrease,no risk
Teniposide,Zolpidem,The metabolism of Teniposide can be decreased when combined with Zolpidem.,decrease,no risk
Teniposide,Zonisamide,The metabolism of Teniposide can be decreased when combined with Zonisamide.,decrease,no risk
Teniposide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Teniposide.,decrease,no risk
Teniposide,Zotepine,Teniposide may increase the neurotoxic activities of Zotepine.,increase,no risk
Teniposide,Zuclopenthixol,The metabolism of Teniposide can be decreased when combined with Zuclopenthixol.,decrease,no risk
Epirubicin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Epirubicin.,increase,risk
Epirubicin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Epirubicin.,increase,risk
Epirubicin,Glatiramer,The risk or severity of adverse effects can be increased when Epirubicin is combined with Glatiramer.,increase,risk
Epirubicin,Golimumab,The risk or severity of adverse effects can be increased when Epirubicin is combined with Golimumab.,increase,risk
Epirubicin,Guselkumab,The risk or severity of adverse effects can be increased when Epirubicin is combined with Guselkumab.,increase,risk
Epirubicin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Epirubicin.,increase,risk
Epirubicin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Epirubicin.,increase,risk
Epirubicin,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Epirubicin.,increase,risk
Epirubicin,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Epirubicin is combined with Hydrocortisone acetate.,increase,risk
Epirubicin,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Epirubicin is combined with Hydrocortisone butyrate.,increase,risk
Epirubicin,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Epirubicin is combined with Hydrocortisone succinate.,increase,risk
Epirubicin,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Epirubicin.,increase,risk
Epirubicin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Epirubicin is combined with Hydroxychloroquine.,increase,risk
Epirubicin,Hydroxyurea,The risk or severity of adverse effects can be increased when Epirubicin is combined with Hydroxyurea.,increase,risk
Epirubicin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Ketoconazole,The metabolism of Epirubicin can be decreased when combined with Ketoconazole.,decrease,no risk
Epirubicin,Obinutuzumab,The risk or severity of adverse effects can be increased when Epirubicin is combined with Obinutuzumab.,increase,risk
Epirubicin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Epirubicin.,increase,no risk
Epirubicin,Ofatumumab,The risk or severity of adverse effects can be increased when Epirubicin is combined with Ofatumumab.,increase,risk
Epirubicin,Olaparib,The risk or severity of adverse effects can be increased when Epirubicin is combined with Olaparib.,increase,risk
Epirubicin,Ouabain,Ouabain may decrease the cardiotoxic activities of Epirubicin.,decrease,no risk
Epirubicin,Oxaliplatin,The risk or severity of adverse effects can be increased when Epirubicin is combined with Oxaliplatin.,increase,risk
Epirubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Epirubicin is combined with Oxetacaine.,increase,risk
Epirubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Epirubicin is combined with Oxybuprocaine.,increase,risk
Epirubicin,Ozanimod,The risk or severity of adverse effects can be increased when Epirubicin is combined with Ozanimod.,increase,risk
Epirubicin,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Epirubicin.,increase,risk
Epirubicin,Upadacitinib,The risk or severity of adverse effects can be increased when Epirubicin is combined with Upadacitinib.,increase,risk
Epirubicin,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Epirubicin.,increase,risk
Epirubicin,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Epirubicin.,increase,risk
Epirubicin,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Vedolizumab,The risk or severity of adverse effects can be increased when Epirubicin is combined with Vedolizumab.,increase,risk
Epirubicin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Epirubicin.,decrease,no risk
Epirubicin,Vilanterol,The risk or severity of adverse effects can be increased when Epirubicin is combined with Vilanterol.,increase,risk
Epirubicin,Vinblastine,The risk or severity of adverse effects can be increased when Epirubicin is combined with Vinblastine.,increase,risk
Epirubicin,Vincristine,The risk or severity of adverse effects can be increased when Epirubicin is combined with Vincristine.,increase,risk
Epirubicin,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Epirubicin.,increase,risk
Epirubicin,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Epirubicin.,increase,risk
Epirubicin,Voclosporin,The risk or severity of adverse effects can be increased when Epirubicin is combined with Voclosporin.,increase,risk
Epirubicin,Vorapaxar,The risk or severity of bleeding can be increased when Vorapaxar is combined with Epirubicin.,increase,risk
Epirubicin,Vorinostat,The risk or severity of adverse effects can be increased when Epirubicin is combined with Vorinostat.,increase,risk
Epirubicin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Epirubicin.,increase,risk
Epirubicin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Epirubicin.,increase,risk
Epirubicin,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Epirubicin.,increase,risk
Epirubicin,Zidovudine,The risk or severity of adverse effects can be increased when Epirubicin is combined with Zidovudine.,increase,risk
Chloramphenicol,Brodalumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Brodalumab.,increase,risk
Chloramphenicol,Budesonide,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Budesonide.,increase,risk
Chloramphenicol,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Bupivacaine.,increase,risk
Chloramphenicol,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Buspirone,The metabolism of Buspirone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Butabarbital,The metabolism of Butabarbital can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Butacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Butacaine.,increase,risk
Chloramphenicol,Butalbital,The metabolism of Butalbital can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Butamben,The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Butamben.,increase,risk
Chloramphenicol,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Glatiramer,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Glatiramer.,increase,risk
Chloramphenicol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Glipizide,The metabolism of Glipizide can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Glyburide,The metabolism of Glyburide can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Golimumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Golimumab.,increase,risk
Chloramphenicol,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Guselkumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Guselkumab.,increase,risk
Chloramphenicol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydrocortisone acetate.,increase,risk
Chloramphenicol,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydrocortisone butyrate.,increase,risk
Chloramphenicol,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydrocortisone succinate.,increase,risk
Chloramphenicol,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydroxychloroquine.,increase,risk
Chloramphenicol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Hydroxyurea,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Hydroxyurea.,increase,risk
Chloramphenicol,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Obinutuzumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Obinutuzumab.,increase,risk
Chloramphenicol,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Chloramphenicol.,increase,no risk
Chloramphenicol,Ofatumumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ofatumumab.,increase,risk
Chloramphenicol,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Oxaliplatin,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Oxaliplatin.,increase,risk
Chloramphenicol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Oxetacaine.,increase,risk
Chloramphenicol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Chloramphenicol is combined with Oxybuprocaine.,increase,risk
Chloramphenicol,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Ozanimod,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Ozanimod.,increase,risk
Chloramphenicol,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Quinine,The metabolism of Quinine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Udenafil,The metabolism of Udenafil can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Upadacitinib,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Upadacitinib.,increase,risk
Chloramphenicol,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vedolizumab,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vedolizumab.,increase,risk
Chloramphenicol,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Verapamil,The metabolism of Verapamil can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vilanterol,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vilanterol.,increase,risk
Chloramphenicol,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Voclosporin,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Voclosporin.,increase,risk
Chloramphenicol,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Vorinostat,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Vorinostat.,increase,risk
Chloramphenicol,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Chloramphenicol.,increase,risk
Chloramphenicol,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Chloramphenicol.,increase,no risk
Chloramphenicol,Zidovudine,The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Zidovudine.,increase,risk
Chloramphenicol,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Chloramphenicol.,decrease,no risk
Chloramphenicol,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Chloramphenicol.,decrease,no risk
Loracarbef,Gabapentin enacarbil,Loracarbef may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadobenic acid,Loracarbef may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadodiamide,Loracarbef may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadofosveset trisodium,Loracarbef may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadopentetic acid,Loracarbef may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadoteric acid,Loracarbef may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Loracarbef,Gadoteridol,Loracarbef may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Loracarbef,Ganciclovir,Loracarbef may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Loracarbef,Gemcitabine,Loracarbef may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Loracarbef,Gemfibrozil,Loracarbef may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Loracarbef,Gentamicin,Loracarbef may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Loracarbef,Gimeracil,Loracarbef may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Loracarbef,Givosiran,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Givosiran.,increase,risk
Loracarbef,Glipizide,Loracarbef may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Loracarbef,Glycerol phenylbutyrate,Loracarbef may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Loracarbef,Golodirsen,Loracarbef may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Loracarbef,Goserelin,Loracarbef may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Loracarbef,Guanethidine,Loracarbef may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Loracarbef,Guanfacine,Loracarbef may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Loracarbef,Haloperidol,Loracarbef may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Loracarbef,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Loracarbef.,decrease,no risk
Loracarbef,Hydralazine,Loracarbef may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Loracarbef,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Hydrochlorothiazide.,increase,risk
Loracarbef,Hydromorphone,Loracarbef may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Loracarbef,Hydroxocobalamin,Loracarbef may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Loracarbef,Hydroxyethyl Starch,Loracarbef may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Loracarbef,Kanamycin,Loracarbef may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Loracarbef,Ketamine,Loracarbef may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Loracarbef,Ketazolam,Loracarbef may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Loracarbef,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Ketoprofen.,increase,risk
Loracarbef,Ketorolac,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Ketorolac.,increase,risk
Loracarbef,Octinoxate,Loracarbef may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Loracarbef,Olsalazine,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Olsalazine.,increase,risk
Loracarbef,Opium,Loracarbef may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Loracarbef,Oseltamivir,Loracarbef may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Loracarbef,Oxacillin,Loracarbef may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Loracarbef,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Loracarbef.,increase,risk
Loracarbef,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Oxaprozin.,increase,risk
Loracarbef,Oxazepam,Loracarbef may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Loracarbef,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Loracarbef is combined with Oxetacaine.,increase,risk
Loracarbef,Oxybenzone,Loracarbef may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Loracarbef,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Loracarbef is combined with Oxybuprocaine.,increase,risk
Loracarbef,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Oxyphenbutazone.,increase,risk
Loracarbef,Oxyquinoline,Loracarbef may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Loracarbef,Quetiapine,Loracarbef may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Loracarbef,Quinidine,Loracarbef may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Loracarbef,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Loracarbef.,decrease,no risk
Loracarbef,Vaborbactam,Loracarbef may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Loracarbef,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Valaciclovir.,increase,risk
Loracarbef,Valbenazine,Loracarbef may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Loracarbef,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Valdecoxib.,increase,risk
Loracarbef,Valganciclovir,Loracarbef may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Loracarbef,Vancomycin,Loracarbef may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Loracarbef,Varenicline,Loracarbef may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Loracarbef,Venlafaxine,Loracarbef may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Loracarbef,Verapamil,Loracarbef may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Loracarbef,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Loracarbef.,decrease,no risk
Loracarbef,Vilanterol,Loracarbef may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Loracarbef,Viloxazine,Loracarbef may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Loracarbef,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Loracarbef.,decrease,no risk
Loracarbef,Vortioxetine,Loracarbef may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Loracarbef,Warfarin,Loracarbef may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Loracarbef,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Loracarbef.,decrease,no risk
Loracarbef,Zaleplon,Loracarbef may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Loracarbef,Zanamivir,Loracarbef may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Loracarbef,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Loracarbef is combined with Zoledronic acid.,increase,risk
Loracarbef,Zonisamide,Loracarbef may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Dipivefrin,Bendroflumethiazide,The risk or severity of hypokalemia can be increased when Dipivefrin is combined with Bendroflumethiazide.,increase,risk
Dipivefrin,Benzthiazide,The risk or severity of hypokalemia can be increased when Dipivefrin is combined with Benzthiazide.,increase,risk
Dipivefrin,Bromotheophylline,The risk or severity of hypokalemia can be increased when Bromotheophylline is combined with Dipivefrin.,increase,risk
Dipivefrin,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Dipivefrin is combined with Hydrochlorothiazide.,increase,risk
Dipivefrin,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Dipivefrin is combined with Hydroflumethiazide.,increase,risk
Dipivefrin,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Dipivefrin.,increase,risk
Dipivefrin,Oxymetazoline,Dipivefrin may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Dipivefrin,Vasopressin,Vasopressin may increase the hypertensive activities of Dipivefrin.,increase,no risk
Droperidol,Bupropion,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Bupropion.,increase,no risk
Droperidol,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Droperidol.,increase,risk
Droperidol,Buspirone,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Buspirone.,increase,no risk
Droperidol,Butabarbital,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Droperidol,Butalbital,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.,increase,no risk
Droperidol,Butaperazine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butaperazine.,increase,no risk
Droperidol,Butobarbital,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Droperidol,Butorphanol,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.,increase,no risk
Droperidol,Butriptyline,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Butriptyline.,increase,no risk
Droperidol,Gabapentin,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Droperidol,Gabapentin enacarbil,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Droperidol,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Gadobenic acid.,increase,risk
Droperidol,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Droperidol.,increase,risk
Droperidol,Gallamine triethiodide,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Droperidol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Droperidol is combined with Ganaxolone.",increase,risk
Droperidol,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Droperidol.,increase,risk
Droperidol,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Gemifloxacin.,increase,risk
Droperidol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Droperidol.,increase,risk
Droperidol,Gilteritinib,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Gilteritinib.,increase,risk
Droperidol,Glasdegib,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Glasdegib.,increase,risk
Droperidol,Glutethimide,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Droperidol,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Droperidol.,increase,risk
Droperidol,Granisetron,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Droperidol,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Grepafloxacin.,increase,risk
Droperidol,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Droperidol.,decrease,no risk
Droperidol,Guanadrel,Droperidol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Droperidol,Guanethidine,Droperidol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Droperidol,Guanfacine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Droperidol,Guanoxan,Droperidol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Droperidol,Halazepam,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Droperidol,Halofantrine,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Halofantrine.,increase,risk
Droperidol,Haloperidol,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Haloperidol.,increase,risk
Droperidol,Halothane,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Droperidol,Hexafluronium,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Droperidol,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Droperidol.,increase,risk
Droperidol,Hydralazine,Droperidol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Droperidol,Hydrochlorothiazide,Droperidol may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Droperidol,Hydrocodone,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Droperidol,Hydroflumethiazide,Droperidol may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Droperidol,Hydromorphone,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Droperidol,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Droperidol.,increase,risk
Droperidol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Hydroxyzine.,increase,risk
Droperidol,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Droperidol.,increase,risk
Droperidol,Ketamine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Droperidol,Ketazolam,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Droperidol,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Droperidol.,increase,risk
Droperidol,Ketoprofen,The risk or severity of hypertension can be increased when Droperidol is combined with Ketoprofen.,increase,risk
Droperidol,Ketorolac,The risk or severity of hypertension can be increased when Droperidol is combined with Ketorolac.,increase,risk
Droperidol,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Droperidol.,increase,risk
Droperidol,Ofloxacin,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Ofloxacin.,increase,risk
Droperidol,Olanzapine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Droperidol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Droperidol is combined with Oliceridine.",increase,risk
Droperidol,Olmesartan,Droperidol may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Droperidol,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Droperidol.,decrease,no risk
Droperidol,Ondansetron,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Droperidol,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Droperidol.,decrease,no risk
Droperidol,Opium,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Droperidol,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Droperidol.,decrease,no risk
Droperidol,Orphenadrine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Droperidol,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Droperidol.,increase,risk
Droperidol,Oxaprozin,The risk or severity of hypertension can be increased when Droperidol is combined with Oxaprozin.,increase,risk
Droperidol,Oxatomide,The risk or severity of QTc prolongation can be increased when Droperidol is combined with Oxatomide.,increase,risk
Droperidol,Oxazepam,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Droperidol,Oxcarbazepine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Droperidol,Oxitriptan,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Droperidol,Oxprenolol,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Droperidol,Oxybuprocaine,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Droperidol,Oxycodone,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Droperidol,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Droperidol.,decrease,no risk
Droperidol,Oxymorphone,Droperidol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Droperidol,Oxyphenbutazone,The risk or severity of hypertension can be increased when Droperidol is combined with Oxyphenbutazone.,increase,risk
Droperidol,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Droperidol.,increase,risk
Levothyroxine,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Gefitinib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Gefitinib.,decrease,no risk
Levothyroxine,Gemcitabine,The serum concentration of Gemcitabine can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Gemfibrozil,The metabolism of Levothyroxine can be decreased when combined with Gemfibrozil.,decrease,no risk
Levothyroxine,Gilteritinib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Levothyroxine,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Glecaprevir,The metabolism of Levothyroxine can be decreased when combined with Glecaprevir.,decrease,no risk
Levothyroxine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Heparin,The therapeutic efficacy of Heparin can be increased when used in combination with Levothyroxine.,increase,no risk
Levothyroxine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levothyroxine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Ketamine,The risk or severity of hypertension and Tachycardia can be increased when Ketamine is combined with Levothyroxine.,increase,risk
Levothyroxine,Ketoconazole,The metabolism of Levothyroxine can be decreased when combined with Ketoconazole.,decrease,no risk
Levothyroxine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Olsalazine,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Olsalazine.,increase,no risk
Levothyroxine,Ombitasvir,The metabolism of Levothyroxine can be decreased when combined with Ombitasvir.,decrease,no risk
Levothyroxine,Omeprazole,Omeprazole can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levothyroxine,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Levothyroxine.,increase,risk
Levothyroxine,Orlistat,The serum concentration of Levothyroxine can be decreased when it is combined with Orlistat.,decrease,no risk
Levothyroxine,Osimertinib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Osimertinib.,decrease,no risk
Levothyroxine,Ouabain,The excretion of Ouabain can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Oxandrolone,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Oxandrolone.,increase,no risk
Levothyroxine,Oxprenolol,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Oxprenolol.,decrease,no risk
Levothyroxine,Oxtriphylline,Levothyroxine may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levothyroxine,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Levothyroxine.,increase,risk
Levothyroxine,Oxymetholone,The therapeutic efficacy of Levothyroxine can be increased when used in combination with Oxymetholone.,increase,no risk
Levothyroxine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Quinestrol,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Quinestrol.,decrease,no risk
Levothyroxine,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Quinupramine,The risk or severity of Cardiac Arrhythmia and CNS stimulation can be increased when Levothyroxine is combined with Quinupramine.,increase,risk
Levothyroxine,Quizartinib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Quizartinib.,decrease,no risk
Levothyroxine,Valproic acid,The metabolism of Levothyroxine can be decreased when combined with Valproic acid.,decrease,no risk
Levothyroxine,Valsartan,The excretion of Valsartan can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vandetanib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Vandetanib.,decrease,no risk
Levothyroxine,Vasopressin,Levothyroxine may increase the vasoconstricting activities of Vasopressin.,increase,no risk
Levothyroxine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vemurafenib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Vemurafenib.,decrease,no risk
Levothyroxine,Venetoclax,The serum concentration of Venetoclax can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Levothyroxine.,decrease,no risk
Levothyroxine,Vinblastine,The serum concentration of Vinblastine can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vincristine,The serum concentration of Vincristine can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vinflunine,The serum concentration of Vinflunine can be decreased when it is combined with Levothyroxine.,decrease,no risk
Levothyroxine,Vonoprazan,Vonoprazan can cause a decrease in the absorption of Levothyroxine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Levothyroxine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Levothyroxine.,decrease,no risk
Levothyroxine,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Levothyroxine.,increase,no risk
Levothyroxine,Xylometazoline,Levothyroxine may increase the vasoconstricting activities of Xylometazoline.,increase,no risk
Levothyroxine,Zanubrutinib,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Zanubrutinib.,decrease,no risk
Levothyroxine,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Levothyroxine.,increase,no risk
Levothyroxine,Zidovudine,The metabolism of Levothyroxine can be increased when combined with Zidovudine.,increase,no risk
Levothyroxine,Zimelidine,The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Zimelidine.,decrease,no risk
Levothyroxine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Levothyroxine.,decrease,no risk
Framycetin,Gabapentin enacarbil,Framycetin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Framycetin,Gadobenic acid,Framycetin may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Framycetin,Gadodiamide,Framycetin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Framycetin,Gadofosveset trisodium,Framycetin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Framycetin,Gadopentetic acid,Framycetin may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Framycetin,Gadoteric acid,Framycetin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Framycetin,Gadoteridol,Framycetin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Framycetin,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Framycetin.,increase,no risk
Framycetin,Ganciclovir,Framycetin may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Framycetin,Gemcitabine,Framycetin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Framycetin,Gemfibrozil,Framycetin may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Framycetin,Gentamicin,Framycetin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Framycetin,Gimeracil,Framycetin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Framycetin,Givosiran,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Givosiran.,increase,risk
Framycetin,Glipizide,Framycetin may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Framycetin,Glycerol phenylbutyrate,Framycetin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Framycetin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Framycetin.,increase,risk
Framycetin,Golodirsen,Framycetin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Framycetin,Goserelin,Framycetin may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Framycetin,Guanethidine,Framycetin may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Framycetin,Guanfacine,Framycetin may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Framycetin,Haloperidol,Framycetin may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Framycetin,Heparin,The therapeutic efficacy of Framycetin can be decreased when used in combination with Heparin.,decrease,no risk
Framycetin,Hetacillin,The serum concentration of Framycetin can be decreased when it is combined with Hetacillin.,decrease,no risk
Framycetin,Hydralazine,Framycetin may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Framycetin,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Hydrochlorothiazide.,increase,risk
Framycetin,Hydromorphone,Framycetin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Framycetin,Hydroxocobalamin,Framycetin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Framycetin,Hydroxyethyl Starch,Framycetin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Framycetin,Kanamycin,Framycetin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Framycetin,Ketamine,Framycetin may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Framycetin,Ketazolam,Framycetin may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Framycetin,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ketoprofen.,increase,risk
Framycetin,Ketorolac,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Ketorolac.,increase,risk
Framycetin,Octinoxate,Framycetin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Framycetin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Olsalazine.,increase,risk
Framycetin,Opium,Framycetin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Framycetin,Oseltamivir,Framycetin may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Framycetin,Oxacillin,The serum concentration of Framycetin can be decreased when it is combined with Oxacillin.,decrease,no risk
Framycetin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Framycetin.,increase,risk
Framycetin,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Oxaprozin.,increase,risk
Framycetin,Oxazepam,Framycetin may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Framycetin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Oxetacaine.,increase,risk
Framycetin,Oxybenzone,Framycetin may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Framycetin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Framycetin is combined with Oxybuprocaine.,increase,risk
Framycetin,Oxymetazoline,The absorption of Framycetin can be decreased when combined with Oxymetazoline.,decrease,no risk
Framycetin,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Oxyphenbutazone.,increase,risk
Framycetin,Oxyquinoline,Framycetin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Framycetin,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Oxytetracycline.,increase,risk
Framycetin,Quetiapine,Framycetin may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Framycetin,Quinidine,Framycetin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Framycetin,Quinine,The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Quinine.,increase,risk
Framycetin,Vaborbactam,Framycetin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Framycetin,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Valaciclovir.,increase,risk
Framycetin,Valbenazine,Framycetin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Framycetin,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Valdecoxib.,increase,risk
Framycetin,Valganciclovir,Framycetin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Framycetin,Vancomycin,Framycetin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Framycetin,Varenicline,The therapeutic efficacy of Varenicline can be decreased when used in combination with Framycetin.,decrease,no risk
Framycetin,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Framycetin.,increase,no risk
Framycetin,Venlafaxine,Framycetin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Framycetin,Verapamil,Framycetin may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Framycetin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Framycetin.,decrease,no risk
Framycetin,Vilanterol,Framycetin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Framycetin,Viloxazine,Framycetin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Framycetin,Viomycin,The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Viomycin.,increase,risk
Framycetin,Vortioxetine,Framycetin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Framycetin,Warfarin,Framycetin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Framycetin,Zaleplon,Framycetin may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Framycetin,Zanamivir,Framycetin may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Framycetin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Framycetin is combined with Zoledronic acid.,increase,risk
Framycetin,Zonisamide,Framycetin may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Clomocycline,Gallamine triethiodide,The therapeutic efficacy of Gallamine triethiodide can be increased when used in combination with Clomocycline.,increase,no risk
Clomocycline,Gentamicin,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Gentamicin.,increase,risk
Clomocycline,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Clomocycline.,decrease,no risk
Clomocycline,Hetacillin,The therapeutic efficacy of Hetacillin can be decreased when used in combination with Clomocycline.,decrease,no risk
Clomocycline,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Clomocycline.,decrease,no risk
Clomocycline,Kanamycin,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Kanamycin.,increase,risk
Clomocycline,Oxacillin,The therapeutic efficacy of Oxacillin can be decreased when used in combination with Clomocycline.,decrease,no risk
Clomocycline,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clomocycline is combined with Oxetacaine.,increase,risk
Clomocycline,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Clomocycline is combined with Oxybuprocaine.,increase,risk
Clomocycline,Oxytetracycline,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Oxytetracycline.,increase,risk
Clomocycline,Quinapril,Quinapril can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Quinidine,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Quinidine.,increase,risk
Clomocycline,Quinine,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Quinine.,increase,risk
Clomocycline,Ulipristal,The serum concentration of Ulipristal can be decreased when it is combined with Clomocycline.,decrease,no risk
Clomocycline,Vancomycin,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Vancomycin.,increase,risk
Clomocycline,Vecuronium,The therapeutic efficacy of Vecuronium can be increased when used in combination with Clomocycline.,increase,no risk
Clomocycline,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Clomocycline.,decrease,no risk
Clomocycline,Viomycin,The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Viomycin.,increase,risk
Clomocycline,Vitamin A,The risk or severity of pseudotumor cerebri can be increased when Vitamin A is combined with Clomocycline.,increase,risk
Clomocycline,Warfarin,Clomocycline may increase the anticoagulant activities of Warfarin.,increase,no risk
Clomocycline,Zinc,Zinc can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomocycline,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Clomocycline resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Meperidine,Baricitinib,Meperidine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Meperidine,Beclomethasone dipropionate,The metabolism of Meperidine can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Meperidine,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Meperidine.,increase,risk
Meperidine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Meperidine,Benorilate,Benorilate may decrease the excretion rate of Meperidine which could result in a higher serum level.,decrease,no risk
Meperidine,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Meperidine which could result in a higher serum level.,decrease,no risk
Meperidine,Benperidol,The risk or severity of adverse effects can be increased when Meperidine is combined with Benperidol.,increase,risk
Meperidine,Benserazide,Meperidine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Meperidine,Benzatropine,The risk or severity of adverse effects can be increased when Benzatropine is combined with Meperidine.,increase,risk
Meperidine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Meperidine is combined with Benzhydrocodone.,increase,risk
Meperidine,Benznidazole,Meperidine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Meperidine,Benzocaine,The risk or severity of CNS depression can be increased when Meperidine is combined with Benzocaine.,increase,risk
Meperidine,Benzphetamine,The therapeutic efficacy of Meperidine can be increased when used in combination with Benzphetamine.,increase,no risk
Meperidine,Benzthiazide,Benzthiazide may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Meperidine,Benzydamine,Benzydamine may decrease the excretion rate of Meperidine which could result in a higher serum level.,decrease,no risk
Meperidine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Meperidine is combined with Benzyl alcohol.,increase,risk
Meperidine,Bepotastine,Meperidine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Meperidine,Berotralstat,The metabolism of Meperidine can be decreased when combined with Berotralstat.,decrease,no risk
Meperidine,Betamethasone,The metabolism of Meperidine can be increased when combined with Betamethasone.,increase,no risk
Meperidine,Betamethasone phosphate,The metabolism of Meperidine can be increased when combined with Betamethasone phosphate.,increase,no risk
Meperidine,Bexarotene,The metabolism of Meperidine can be increased when combined with Bexarotene.,increase,no risk
Meperidine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Bicisate,Meperidine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Meperidine,Bifonazole,The metabolism of Meperidine can be decreased when combined with Bifonazole.,decrease,no risk
Meperidine,Bimekizumab,The metabolism of Meperidine can be increased when combined with Bimekizumab.,increase,no risk
Meperidine,Biperiden,The risk or severity of adverse effects can be increased when Biperiden is combined with Meperidine.,increase,risk
Meperidine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Meperidine.,decrease,no risk
Meperidine,Bismuth subgallate,Meperidine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Meperidine,Bisoprolol,Meperidine may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Meperidine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Meperidine.,decrease,no risk
Meperidine,Bleomycin,Bleomycin may decrease the excretion rate of Meperidine which could result in a higher serum level.,decrease,no risk
Meperidine,Boceprevir,The metabolism of Meperidine can be decreased when combined with Boceprevir.,decrease,no risk
Meperidine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Bosentan,The metabolism of Meperidine can be increased when combined with Bosentan.,increase,no risk
Meperidine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Meperidine.,increase,risk
Meperidine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Meperidine.,increase,risk
Meperidine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Brexanolone,The risk or severity of CNS depression can be increased when Meperidine is combined with Brexanolone.,increase,risk
Meperidine,Brexpiprazole,The risk or severity of adverse effects can be increased when Meperidine is combined with Brexpiprazole.,increase,risk
Meperidine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Meperidine.,increase,no risk
Meperidine,Brivaracetam,The risk or severity of CNS depression can be increased when Meperidine is combined with Brivaracetam.,increase,risk
Meperidine,Bromazepam,The risk or severity of adverse effects can be increased when Meperidine is combined with Bromazepam.,increase,risk
Meperidine,Bromocriptine,The risk or severity of adverse effects can be increased when Meperidine is combined with Bromocriptine.,increase,risk
Meperidine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Meperidine,Bromperidol,The risk or severity of adverse effects can be increased when Meperidine is combined with Bromperidol.,increase,risk
Meperidine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Meperidine.,increase,risk
Meperidine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Meperidine.,increase,risk
Meperidine,Budesonide,The metabolism of Meperidine can be increased when combined with Budesonide.,increase,no risk
Meperidine,Bumadizone,Bumadizone may decrease the excretion rate of Meperidine which could result in a higher serum level.,decrease,no risk
Meperidine,Bumetanide,Bumetanide may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Meperidine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Meperidine.,increase,risk
Meperidine,Buprenorphine,Meperidine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Meperidine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Meperidine.,increase,risk
Meperidine,Buspirone,The risk or severity of CNS depression can be increased when Meperidine is combined with Buspirone.,increase,risk
Meperidine,Busulfan,The metabolism of Busulfan can be decreased when combined with Meperidine.,decrease,no risk
Meperidine,Butabarbital,Butabarbital may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine.,increase,no risk
Meperidine,Butalbital,Butalbital may increase the hypotensive and central nervous system depressant (CNS depressant) activities of Meperidine.,increase,no risk
Meperidine,Butaperazine,The risk or severity of hypotension and CNS depression can be increased when Butaperazine is combined with Meperidine.,increase,risk
Meperidine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Meperidine.,increase,risk
Meperidine,Butorphanol,The therapeutic efficacy of Meperidine can be decreased when used in combination with Butorphanol.,decrease,no risk
Meperidine,Butriptyline,The risk or severity of CNS depression can be increased when Meperidine is combined with Butriptyline.,increase,risk
Meperidine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Meperidine.,increase,risk
Loratadine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Gadobenic acid.,increase,risk
Loratadine,Galantamine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Galantamine.,increase,risk
Loratadine,Gallamine triethiodide,Gallamine triethiodide may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Gatifloxacin.,increase,risk
Loratadine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Gemifloxacin.,increase,risk
Loratadine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Gilteritinib.,increase,risk
Loratadine,Glasdegib,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Glasdegib.,increase,risk
Loratadine,Glimepiride,Glimepiride may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Glipizide,Loratadine may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Loratadine,Glofitamab,The serum concentration of Loratadine can be increased when it is combined with Glofitamab.,increase,no risk
Loratadine,Glyburide,Glyburide may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Glycopyrronium,Glycopyrronium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Glycyrrhizic acid,Loratadine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Loratadine,Goserelin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Goserelin.,increase,risk
Loratadine,Granisetron,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Granisetron.,increase,risk
Loratadine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Grepafloxacin.,increase,risk
Loratadine,Halofantrine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Halofantrine.,increase,risk
Loratadine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Loratadine.,increase,no risk
Loratadine,Hexafluronium,Hexafluronium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Hexocyclium,Hexocyclium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Histrelin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Histrelin.,increase,risk
Loratadine,Homatropine methylbromide,Homatropine methylbromide may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Hydrochlorothiazide.,increase,risk
Loratadine,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Hydroxyzine.,increase,risk
Loratadine,Hyoscyamine,Loratadine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Loratadine,Ketamine,The metabolism of Ketamine can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Ketoconazole,The metabolism of Loratadine can be decreased when combined with Ketoconazole.,decrease,no risk
Loratadine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Loratadine.,increase,risk
Loratadine,Ofloxacin,Loratadine may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Loratadine,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Loratadine.,increase,risk
Loratadine,Olmesartan,Olmesartan may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Omaveloxolone,The serum concentration of Loratadine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Loratadine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Ondansetron,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Ondansetron.,increase,risk
Loratadine,Orphenadrine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Orphenadrine.,increase,risk
Loratadine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Oxaliplatin.,increase,risk
Loratadine,Oxatomide,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Oxatomide.,increase,risk
Loratadine,Oxybutynin,Oxybutynin may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Oxyphencyclimine,Oxyphencyclimine may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Oxyphenonium,Oxyphenonium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Loratadine.,increase,risk
Loratadine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Quetiapine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Quetiapine.,increase,risk
Loratadine,Quinidine,Quinidine may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Quinine,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Quinine.,increase,risk
Loratadine,Umeclidinium,Umeclidinium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Vadadustat,The serum concentration of Loratadine can be increased when it is combined with Vadadustat.,increase,no risk
Loratadine,Valproic acid,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Valproic acid.,increase,risk
Loratadine,Vandetanib,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Vandetanib.,increase,risk
Loratadine,Vardenafil,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Vardenafil.,increase,risk
Loratadine,Vecuronium,Vecuronium may increase the anticholinergic activities of Loratadine.,increase,no risk
Loratadine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Loratadine.,increase,risk
Loratadine,Venetoclax,The metabolism of Loratadine can be decreased when combined with Venetoclax.,decrease,no risk
Loratadine,Verapamil,The metabolism of Loratadine can be decreased when combined with Verapamil.,decrease,no risk
Loratadine,Vernakalant,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Vernakalant.,increase,risk
Loratadine,Vilanterol,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Vilanterol.,increase,risk
Loratadine,Viloxazine,The metabolism of Loratadine can be decreased when combined with Viloxazine.,decrease,no risk
Loratadine,Vinblastine,Vinblastine may decrease the excretion rate of Loratadine which could result in a higher serum level.,decrease,no risk
Loratadine,Vincristine,Loratadine may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Loratadine,Voriconazole,The metabolism of Loratadine can be decreased when combined with Voriconazole.,decrease,no risk
Loratadine,Vorinostat,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Vorinostat.,increase,risk
Loratadine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Zimelidine,The metabolism of Loratadine can be decreased when combined with Zimelidine.,decrease,no risk
Loratadine,Ziprasidone,The metabolism of Loratadine can be decreased when combined with Ziprasidone.,decrease,no risk
Loratadine,Zonisamide,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Zonisamide.,increase,risk
Loratadine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Loratadine.,decrease,no risk
Loratadine,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Loratadine is combined with Zuclopenthixol.,increase,risk
Prazosin,Ganciclovir,The risk or severity of adverse effects can be increased when Prazosin is combined with Ganciclovir.,increase,risk
Prazosin,Gefitinib,Gefitinib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Gilteritinib,Gilteritinib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Glasdegib,Glasdegib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Glecaprevir,Glecaprevir may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Glycol salicylate,The therapeutic efficacy of Prazosin can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Prazosin,Grazoprevir,Grazoprevir may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Grepafloxacin,The serum concentration of Prazosin can be increased when it is combined with Grepafloxacin.,increase,no risk
Prazosin,Guanabenz,The risk or severity of hypotension can be increased when Prazosin is combined with Guanabenz.,increase,risk
Prazosin,Guanadrel,The risk or severity of hypotension can be increased when Prazosin is combined with Guanadrel.,increase,risk
Prazosin,Guanethidine,The risk or severity of hypotension can be increased when Prazosin is combined with Guanethidine.,increase,risk
Prazosin,Guanfacine,The risk or severity of hypotension can be increased when Prazosin is combined with Guanfacine.,increase,risk
Prazosin,Guanidine,The serum concentration of Prazosin can be increased when it is combined with Guanidine.,increase,no risk
Prazosin,Guanoxan,The risk or severity of hypotension can be increased when Prazosin is combined with Guanoxan.,increase,risk
Prazosin,Halothane,Halothane may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Histamine,The serum concentration of Prazosin can be increased when it is combined with Histamine.,increase,no risk
Prazosin,Hydralazine,The risk or severity of hypotension can be increased when Prazosin is combined with Hydralazine.,increase,risk
Prazosin,Hydrochlorothiazide,The risk or severity of hypotension can be increased when Prazosin is combined with Hydrochlorothiazide.,increase,risk
Prazosin,Hydroflumethiazide,The risk or severity of hypotension can be increased when Prazosin is combined with Hydroflumethiazide.,increase,risk
Prazosin,Ketoprofen,The therapeutic efficacy of Prazosin can be decreased when used in combination with Ketoprofen.,decrease,no risk
Prazosin,Ketorolac,The therapeutic efficacy of Prazosin can be decreased when used in combination with Ketorolac.,decrease,no risk
Prazosin,Obinutuzumab,Prazosin may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Prazosin,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Prazosin.",increase,no risk
Prazosin,Olmesartan,The risk or severity of hypotension can be increased when Prazosin is combined with Olmesartan.,increase,risk
Prazosin,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Opicapone,The risk or severity of adverse effects can be increased when Prazosin is combined with Opicapone.,increase,risk
Prazosin,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Osimertinib,Osimertinib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Oteseconazole,The serum concentration of Prazosin can be increased when it is combined with Oteseconazole.,increase,no risk
Prazosin,Oxaprozin,The therapeutic efficacy of Prazosin can be decreased when used in combination with Oxaprozin.,decrease,no risk
Prazosin,Oxprenolol,The risk or severity of hypotension can be increased when Prazosin is combined with Oxprenolol.,increase,risk
Prazosin,Oxymetazoline,The therapeutic efficacy of Prazosin can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Prazosin,Oxyphenbutazone,The therapeutic efficacy of Prazosin can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Prazosin,Quetiapine,Quetiapine may increase the hypotensive activities of Prazosin.,increase,no risk
Prazosin,Quinapril,The risk or severity of hypotension can be increased when Prazosin is combined with Quinapril.,increase,risk
Prazosin,Quinidine,"Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Prazosin,Quinine,The serum concentration of Prazosin can be increased when it is combined with Quinine.,increase,no risk
Prazosin,Quinupramine,Quinupramine may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Prazosin.,increase,risk
Prazosin,Unoprostone,Prazosin may increase the hypotensive activities of Unoprostone.,increase,no risk
Prazosin,Vadadustat,Vadadustat may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Valdecoxib,The therapeutic efficacy of Prazosin can be decreased when used in combination with Valdecoxib.,decrease,no risk
Prazosin,Valsartan,The risk or severity of hypotension can be increased when Prazosin is combined with Valsartan.,increase,risk
Prazosin,Vandetanib,Vandetanib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Prazosin.,increase,risk
Prazosin,Varenicline,The serum concentration of Prazosin can be increased when it is combined with Varenicline.,increase,no risk
Prazosin,Velpatasvir,Velpatasvir may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Vemurafenib,Vemurafenib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Venetoclax,Venetoclax may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Venlafaxine,Venlafaxine may increase the excretion rate of Prazosin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prazosin,Verapamil,The risk or severity of adverse effects can be increased when Verapamil is combined with Prazosin.,increase,risk
Prazosin,Vericiguat,The risk or severity of adverse effects can be increased when Prazosin is combined with Vericiguat.,increase,risk
Prazosin,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Vilazodone,Vilazodone may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Vismodegib,Vismodegib may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Vortioxetine,Vortioxetine may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Prazosin which could result in a higher serum level.,decrease,no risk
Prazosin,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Prazosin.,decrease,no risk
Prazosin,Yohimbine,Yohimbine may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Ziconotide,The risk or severity of hypotension can be increased when Prazosin is combined with Ziconotide.,increase,risk
Prazosin,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Prazosin.,increase,no risk
Prazosin,Zofenopril,The risk or severity of hypotension can be increased when Prazosin is combined with Zofenopril.,increase,risk
Prazosin,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Prazosin.,decrease,no risk
Prazosin,Zonisamide,The risk or severity of hypotension can be increased when Prazosin is combined with Zonisamide.,increase,risk
Prazosin,Zuclopenthixol,"Prazosin may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Zuclopenthixol.",increase,no risk
Imipramine,Bacitracin,Bacitracin may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Baclofen,The risk or severity of CNS depression and hypotonia can be increased when Baclofen is combined with Imipramine.,increase,risk
Imipramine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Balsalazide.,increase,risk
Imipramine,Baricitinib,Imipramine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Imipramine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Bedaquiline.,increase,risk
Imipramine,Belantamab mafodotin,The serum concentration of Imipramine can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Imipramine,Belinostat,The metabolism of Imipramine can be increased when combined with Belinostat.,increase,no risk
Imipramine,Belladonna,The risk or severity of adverse effects can be increased when Belladonna is combined with Imipramine.,increase,risk
Imipramine,Belumosudil,The serum concentration of Imipramine can be increased when it is combined with Belumosudil.,increase,no risk
Imipramine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Imipramine.,increase,no risk
Imipramine,Benazepril,Imipramine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Imipramine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Bendazac,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Bendazac.,increase,risk
Imipramine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Benorilate.,increase,risk
Imipramine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Benoxaprofen.,increase,risk
Imipramine,Benperidol,The risk or severity of adverse effects can be increased when Imipramine is combined with Benperidol.,increase,risk
Imipramine,Benserazide,Imipramine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Imipramine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Imipramine is combined with Benzhydrocodone.,increase,risk
Imipramine,Benznidazole,Imipramine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Imipramine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Benzphetamine,Benzphetamine may decrease the sedative activities of Imipramine.,decrease,no risk
Imipramine,Benzthiazide,Benzthiazide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Benzydamine.,increase,risk
Imipramine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Benzylpenicilloyl polylysine,Imipramine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Imipramine,Bepotastine,Imipramine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Imipramine,Bepridil,The metabolism of Bepridil can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Berotralstat,The serum concentration of Imipramine can be increased when it is combined with Berotralstat.,increase,no risk
Imipramine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Betaine,The therapeutic efficacy of Imipramine can be decreased when used in combination with Betaine.,decrease,no risk
Imipramine,Betamethasone,The metabolism of Imipramine can be increased when combined with Betamethasone.,increase,no risk
Imipramine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Betrixaban,The serum concentration of Imipramine can be increased when it is combined with Betrixaban.,increase,no risk
Imipramine,Betulinic Acid,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Betulinic Acid.,increase,risk
Imipramine,Bexagliflozin,Imipramine may decrease the hypoglycemic activities of Bexagliflozin.,decrease,no risk
Imipramine,Bicisate,Imipramine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Imipramine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Imipramine.,increase,risk
Imipramine,Bimekizumab,The metabolism of Imipramine can be increased when combined with Bimekizumab.,increase,no risk
Imipramine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Biperiden,The metabolism of Imipramine can be decreased when combined with Biperiden.,decrease,no risk
Imipramine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Bismuth subcitrate potassium,Imipramine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Imipramine,Bismuth subgallate,Imipramine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Imipramine,Bismuth subnitrate,Imipramine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Imipramine,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Imipramine.,increase,no risk
Imipramine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Bleomycin,Bleomycin may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Boceprevir,The metabolism of Imipramine can be decreased when combined with Boceprevir.,decrease,no risk
Imipramine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Bosentan,Imipramine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Imipramine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Imipramine is combined with Botulinum toxin type A.,increase,risk
Imipramine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Imipramine is combined with Botulinum toxin type B.,increase,risk
Imipramine,Bretylium,Imipramine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Imipramine,Brexanolone,The risk or severity of CNS depression can be increased when Imipramine is combined with Brexanolone.,increase,risk
Imipramine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Imipramine.,increase,no risk
Imipramine,Brivaracetam,The risk or severity of CNS depression can be increased when Imipramine is combined with Brivaracetam.,increase,risk
Imipramine,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Bromfenac,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Bromfenac.,increase,risk
Imipramine,Bromocriptine,"Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Bromocriptine.",increase,no risk
Imipramine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Bromperidol,The risk or severity of adverse effects can be increased when Imipramine is combined with Bromperidol.,increase,risk
Imipramine,Brompheniramine,The risk or severity of CNS depression can be increased when Imipramine is combined with Brompheniramine.,increase,risk
Imipramine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Imipramine.,increase,risk
Imipramine,Budesonide,Imipramine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Imipramine,Bufexamac,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Bufexamac.,increase,risk
Imipramine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Bumadizone.,increase,risk
Imipramine,Bumetanide,Bumetanide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Buprenorphine,Imipramine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Imipramine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Imipramine.,increase,risk
Imipramine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Imipramine.,increase,risk
Imipramine,Buspirone,The metabolism of Buspirone can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Butabarbital,The metabolism of Imipramine can be increased when combined with Butabarbital.,increase,no risk
Imipramine,Butalbital,The metabolism of Imipramine can be increased when combined with Butalbital.,increase,no risk
Imipramine,Butaperazine,The serum concentration of Imipramine can be increased when it is combined with Butaperazine.,increase,no risk
Imipramine,Butobarbital,The risk or severity of CNS depression can be increased when Imipramine is combined with Butobarbital.,increase,risk
Imipramine,Butorphanol,The risk or severity of adverse effects can be increased when Imipramine is combined with Butorphanol.,increase,risk
Imipramine,Butriptyline,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Butriptyline.,increase,risk
Imipramine,Butylscopolamine,The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Imipramine.,increase,risk
Imipramine,Gabapentin,The risk or severity of CNS depression can be increased when Imipramine is combined with Gabapentin.,increase,risk
Imipramine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Imipramine is combined with Gabapentin enacarbil.,increase,risk
Imipramine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Gadobenic acid.,increase,risk
Imipramine,Gadodiamide,Gadodiamide may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Gadofosveset trisodium,Imipramine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Imipramine,Gadopentetic acid,Imipramine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Imipramine,Gadoteric acid,Imipramine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Imipramine,Gadoteridol,Imipramine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Imipramine,Galantamine,The metabolism of Galantamine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Imipramine is combined with Gallamine triethiodide.,increase,risk
Imipramine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Imipramine is combined with Ganaxolone.",increase,risk
Imipramine,Ganciclovir,Imipramine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Imipramine,Gatifloxacin,The metabolism of Imipramine can be decreased when combined with Gatifloxacin.,decrease,no risk
Imipramine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Gemcitabine,The serum concentration of Imipramine can be increased when it is combined with Gemcitabine.,increase,no risk
Imipramine,Gemfibrozil,The metabolism of Imipramine can be decreased when combined with Gemfibrozil.,decrease,no risk
Imipramine,Gemifloxacin,The metabolism of Imipramine can be decreased when combined with Gemifloxacin.,decrease,no risk
Imipramine,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Imipramine.,increase,no risk
Imipramine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Imipramine.,increase,risk
Imipramine,Gilteritinib,The therapeutic efficacy of Imipramine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Imipramine,Gimeracil,Imipramine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Imipramine,Ginkgo biloba,The therapeutic efficacy of Imipramine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Imipramine,Givosiran,The serum concentration of Imipramine can be increased when it is combined with Givosiran.,increase,no risk
Imipramine,Glasdegib,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Glasdegib.,increase,risk
Imipramine,Glecaprevir,The serum concentration of Imipramine can be increased when it is combined with Glecaprevir.,increase,no risk
Imipramine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Glimepiride,Imipramine may decrease the hypoglycemic activities of Glimepiride.,decrease,no risk
Imipramine,Glipizide,Imipramine may decrease the hypoglycemic activities of Glipizide.,decrease,no risk
Imipramine,Gliquidone,Imipramine may decrease the hypoglycemic activities of Gliquidone.,decrease,no risk
Imipramine,Glofitamab,The serum concentration of Imipramine can be increased when it is combined with Glofitamab.,increase,no risk
Imipramine,Glucagon,Imipramine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Imipramine,Glutethimide,The risk or severity of CNS depression can be increased when Imipramine is combined with Glutethimide.,increase,risk
Imipramine,Glyburide,The metabolism of Glyburide can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Glycerol phenylbutyrate,The metabolism of Imipramine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Imipramine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Glycol salicylate.,increase,risk
Imipramine,Glycopyrronium,The risk or severity of adverse effects can be increased when Imipramine is combined with Glycopyrronium.,increase,risk
Imipramine,Glymidine,Imipramine may decrease the hypoglycemic activities of Glymidine.,decrease,no risk
Imipramine,Golimumab,The metabolism of Imipramine can be increased when combined with Golimumab.,increase,no risk
Imipramine,Golodirsen,Imipramine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Imipramine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Imipramine.,increase,risk
Imipramine,Granisetron,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Granisetron.,increase,risk
Imipramine,Grazoprevir,The serum concentration of Imipramine can be increased when it is combined with Grazoprevir.,increase,no risk
Imipramine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Grepafloxacin.,increase,risk
Imipramine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Guanadrel,Imipramine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Imipramine,Guanethidine,Imipramine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Imipramine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Guanoxan,Imipramine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Imipramine,Halazepam,The risk or severity of CNS depression can be increased when Imipramine is combined with Halazepam.,increase,risk
Imipramine,Halofantrine,The metabolism of Imipramine can be decreased when combined with Halofantrine.,decrease,no risk
Imipramine,Haloperidol,The serum concentration of Imipramine can be increased when it is combined with Haloperidol.,increase,no risk
Imipramine,Halothane,The risk or severity of CNS depression can be increased when Imipramine is combined with Halothane.,increase,risk
Imipramine,Hexafluronium,The risk or severity of CNS depression can be increased when Imipramine is combined with Hexafluronium.,increase,risk
Imipramine,Hexocyclium,The risk or severity of adverse effects can be increased when Hexocyclium is combined with Imipramine.,increase,risk
Imipramine,Histamine,The serum concentration of Histamine can be increased when it is combined with Imipramine.,increase,no risk
Imipramine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Imipramine.,increase,risk
Imipramine,Homatropine,The risk or severity of adverse effects can be increased when Imipramine is combined with Homatropine.,increase,risk
Imipramine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Imipramine.,increase,risk
Imipramine,Huperzine A,The therapeutic efficacy of Imipramine can be decreased when used in combination with Huperzine A.,decrease,no risk
Imipramine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Hydralazine,Imipramine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Imipramine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Hydrocodone,Imipramine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Imipramine,Hydrocortisone,The metabolism of Imipramine can be increased when combined with Hydrocortisone.,increase,no risk
Imipramine,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Hydromorphone,The risk or severity of adverse effects can be increased when Imipramine is combined with Hydromorphone.,increase,risk
Imipramine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Imipramine.,increase,risk
Imipramine,Hydroxyethyl Starch,Imipramine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Imipramine,Hydroxyprogesterone caproate,The metabolism of Imipramine can be increased when combined with Hydroxyprogesterone caproate.,increase,no risk
Imipramine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Hydroxyzine.,increase,risk
Imipramine,Hyoscyamine,Imipramine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Imipramine,Kanamycin,Imipramine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Imipramine,Ketamine,The risk or severity of CNS depression can be increased when Imipramine is combined with Ketamine.,increase,risk
Imipramine,Ketazolam,The risk or severity of CNS depression can be increased when Imipramine is combined with Ketazolam.,increase,risk
Imipramine,Ketoconazole,The metabolism of Imipramine can be decreased when combined with Ketoconazole.,decrease,no risk
Imipramine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Ketoprofen.,increase,risk
Imipramine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Ketorolac.,increase,risk
Imipramine,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Imipramine.,increase,risk
Imipramine,Obinutuzumab,The risk or severity of adverse effects can be increased when Imipramine is combined with Obinutuzumab.,increase,risk
Imipramine,Octinoxate,Imipramine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Imipramine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Imipramine.,increase,risk
Imipramine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Ofloxacin.,increase,risk
Imipramine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Imipramine is combined with Oliceridine.",increase,risk
Imipramine,Olmesartan,Imipramine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Imipramine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Olsalazine,Olsalazine may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Omadacycline,The serum concentration of Imipramine can be increased when it is combined with Omadacycline.,increase,no risk
Imipramine,Omaveloxolone,The serum concentration of Imipramine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Imipramine,Ombitasvir,The serum concentration of Imipramine can be increased when it is combined with Ombitasvir.,increase,no risk
Imipramine,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Opicapone,The risk or severity of adverse effects can be increased when Imipramine is combined with Opicapone.,increase,risk
Imipramine,Opium,The risk or severity of adverse effects can be increased when Imipramine is combined with Opium.,increase,risk
Imipramine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Oritavancin,The metabolism of Imipramine can be decreased when combined with Oritavancin.,decrease,no risk
Imipramine,Orphenadrine,Imipramine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Imipramine,Oseltamivir,Oseltamivir may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Osilodrostat,The serum concentration of Imipramine can be increased when it is combined with Osilodrostat.,increase,no risk
Imipramine,Osimertinib,The serum concentration of Imipramine can be decreased when it is combined with Osimertinib.,decrease,no risk
Imipramine,Ospemifene,The metabolism of Imipramine can be decreased when combined with Ospemifene.,decrease,no risk
Imipramine,Oxacillin,Imipramine may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Imipramine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Imipramine.,increase,risk
Imipramine,Oxamniquine,The metabolism of Imipramine can be decreased when combined with Oxamniquine.,decrease,no risk
Imipramine,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Oxaprozin.,increase,risk
Imipramine,Oxatomide,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Oxatomide.,increase,risk
Imipramine,Oxazepam,The risk or severity of CNS depression can be increased when Imipramine is combined with Oxazepam.,increase,risk
Imipramine,Oxcarbazepine,The metabolism of Imipramine can be decreased when combined with Oxcarbazepine.,decrease,no risk
Imipramine,Oxitriptan,The risk or severity of CNS depression can be increased when Imipramine is combined with Oxitriptan.,increase,risk
Imipramine,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Oxybenzone,Imipramine may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Imipramine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Imipramine is combined with Oxybuprocaine.,increase,risk
Imipramine,Oxybutynin,The metabolism of Imipramine can be decreased when combined with Oxybutynin.,decrease,no risk
Imipramine,Oxycodone,The risk or severity of adverse effects can be increased when Imipramine is combined with Oxycodone.,increase,risk
Imipramine,Oxymetazoline,Imipramine may increase the vasopressor activities of Oxymetazoline.,increase,no risk
Imipramine,Oxymorphone,The risk or severity of adverse effects can be increased when Imipramine is combined with Oxymorphone.,increase,risk
Imipramine,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Oxyphenbutazone.,increase,risk
Imipramine,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Imipramine.,increase,risk
Imipramine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Imipramine.,increase,risk
Imipramine,Oxyquinoline,Imipramine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Imipramine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Imipramine.,increase,risk
Imipramine,Quazepam,The risk or severity of CNS depression can be increased when Imipramine is combined with Quazepam.,increase,risk
Imipramine,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Quinapril,Imipramine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Imipramine,Quinestrol,The serum concentration of Imipramine can be increased when it is combined with Quinestrol.,increase,no risk
Imipramine,Quinethazone,Quinethazone may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Imipramine,Quinidine,"Imipramine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Quinidine.",increase,no risk
Imipramine,Quinine,The metabolism of Quinine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Quinupramine,The risk or severity of CNS depression can be increased when Imipramine is combined with Quinupramine.,increase,risk
Imipramine,Quizartinib,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Quizartinib.,increase,risk
Imipramine,Ubrogepant,The serum concentration of Imipramine can be increased when it is combined with Ubrogepant.,increase,no risk
Imipramine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Imipramine.,increase,risk
Imipramine,Umbralisib,The serum concentration of Imipramine can be increased when it is combined with Umbralisib.,increase,no risk
Imipramine,Umeclidinium,The risk or severity of adverse effects can be increased when Imipramine is combined with Umeclidinium.,increase,risk
Imipramine,Urethane,The risk or severity of CNS depression can be increased when Imipramine is combined with Urethane.,increase,risk
Imipramine,Vaborbactam,Imipramine may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Imipramine,Vadadustat,The serum concentration of Imipramine can be decreased when it is combined with Vadadustat.,decrease,no risk
Imipramine,Valaciclovir,Valaciclovir may decrease the excretion rate of Imipramine which could result in a higher serum level.,decrease,no risk
Imipramine,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Imipramine is combined with Valdecoxib.,increase,risk
Imipramine,Valganciclovir,Imipramine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Imipramine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Imipramine is combined with Valproate bismuth.,increase,risk
Imipramine,Valproic acid,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Valproic acid.,increase,risk
Imipramine,Valsartan,Imipramine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Imipramine,Vancomycin,Imipramine may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Imipramine,Vandetanib,The serum concentration of Imipramine can be increased when it is combined with Vandetanib.,increase,no risk
Imipramine,Vardenafil,The serum concentration of Imipramine can be increased when it is combined with Vardenafil.,increase,no risk
Imipramine,Varenicline,The excretion of Varenicline can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Vasopressin,Imipramine may increase the fluid retaining and vasopressor activities of Vasopressin.,increase,no risk
Imipramine,Vecuronium,The risk or severity of CNS depression can be increased when Imipramine is combined with Vecuronium.,increase,risk
Imipramine,Velpatasvir,The serum concentration of Imipramine can be increased when it is combined with Velpatasvir.,increase,no risk
Imipramine,Vemurafenib,The serum concentration of Imipramine can be increased when it is combined with Vemurafenib.,increase,no risk
Imipramine,Venetoclax,The serum concentration of Imipramine can be increased when it is combined with Venetoclax.,increase,no risk
Imipramine,Venlafaxine,The metabolism of Imipramine can be decreased when combined with Venlafaxine.,decrease,no risk
Imipramine,Verapamil,The serum concentration of Imipramine can be increased when it is combined with Verapamil.,increase,no risk
Imipramine,Vericiguat,The risk or severity of adverse effects can be increased when Imipramine is combined with Vericiguat.,increase,risk
Imipramine,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Vigabatrin,The risk or severity of CNS depression can be increased when Imipramine is combined with Vigabatrin.,increase,risk
Imipramine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Imipramine.,increase,risk
Imipramine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Vildagliptin,Imipramine may decrease the hypoglycemic activities of Vildagliptin.,decrease,no risk
Imipramine,Viloxazine,The metabolism of Imipramine can be decreased when combined with Viloxazine.,decrease,no risk
Imipramine,Vinblastine,The metabolism of Imipramine can be decreased when combined with Vinblastine.,decrease,no risk
Imipramine,Vincristine,The metabolism of Vincristine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Vinflunine,The serum concentration of Imipramine can be increased when it is combined with Vinflunine.,increase,no risk
Imipramine,Vinorelbine,The metabolism of Imipramine can be decreased when combined with Vinorelbine.,decrease,no risk
Imipramine,Viomycin,Imipramine may increase the neurotoxic activities of Viomycin.,increase,no risk
Imipramine,Voclosporin,The serum concentration of Imipramine can be increased when it is combined with Voclosporin.,increase,no risk
Imipramine,Vonoprazan,The metabolism of Imipramine can be decreased when combined with Vonoprazan.,decrease,no risk
Imipramine,Vorapaxar,The serum concentration of Imipramine can be increased when it is combined with Vorapaxar.,increase,no risk
Imipramine,Voriconazole,The metabolism of Imipramine can be decreased when combined with Voriconazole.,decrease,no risk
Imipramine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Imipramine.,increase,risk
Imipramine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Voxilaprevir,The serum concentration of Imipramine can be increased when it is combined with Voxilaprevir.,increase,no risk
Imipramine,Warfarin,The risk or severity of bleeding can be increased when Imipramine is combined with Warfarin.,increase,risk
Imipramine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Imipramine.,decrease,no risk
Imipramine,Xylometazoline,Imipramine may increase the vasopressor activities of Xylometazoline.,increase,no risk
Imipramine,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Imipramine.,increase,no risk
Imipramine,Zafirlukast,The metabolism of Imipramine can be decreased when combined with Zafirlukast.,decrease,no risk
Imipramine,Zaleplon,The risk or severity of CNS depression can be increased when Imipramine is combined with Zaleplon.,increase,risk
Imipramine,Zanamivir,Imipramine may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Imipramine,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Ziconotide,The risk or severity of CNS depression can be increased when Imipramine is combined with Ziconotide.,increase,risk
Imipramine,Zileuton,The metabolism of Imipramine can be decreased when combined with Zileuton.,decrease,no risk
Imipramine,Zimelidine,The risk or severity of adverse effects can be increased when Imipramine is combined with Zimelidine.,increase,risk
Imipramine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Imipramine is combined with Ziprasidone.,increase,risk
Imipramine,Zofenopril,Imipramine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Imipramine,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Zolpidem,Zolpidem may increase the Decreased alertness activities of Imipramine.,increase,no risk
Imipramine,Zonisamide,The serum concentration of Imipramine can be increased when it is combined with Zonisamide.,increase,no risk
Imipramine,Zopiclone,The risk or severity of adverse effects can be increased when Imipramine is combined with Zopiclone.,increase,risk
Imipramine,Zotepine,The risk or severity of adverse effects can be increased when Imipramine is combined with Zotepine.,increase,risk
Imipramine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Imipramine.,decrease,no risk
Imipramine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Imipramine.,increase,risk
Acitretin,Gestrinone,The therapeutic efficacy of Gestrinone can be decreased when used in combination with Acitretin.,decrease,no risk
Acitretin,Hydroxyprogesterone caproate,The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Acitretin.,decrease,no risk
Acitretin,Omadacycline,The risk or severity of pseudotumor cerebri can be increased when Acitretin is combined with Omadacycline.,increase,risk
Acitretin,Oxytetracycline,The risk or severity of pseudotumor cerebri can be increased when Acitretin is combined with Oxytetracycline.,increase,risk
Acitretin,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Acitretin.,decrease,no risk
Acitretin,Valproic acid,Valproic acid may increase the Pseudotumor Cerebri activities of Acitretin.,increase,no risk
Acitretin,Vitamin A,The risk or severity of adverse effects can be increased when Vitamin A is combined with Acitretin.,increase,risk
Verteporfin,Hexaminolevulinate,Hexaminolevulinate may increase the photosensitizing activities of Verteporfin.,increase,no risk
Verteporfin,Oxcarbazepine,Oxcarbazepine may increase the photosensitizing activities of Verteporfin.,increase,no risk
Verteporfin,Vemurafenib,Vemurafenib may increase the photosensitizing activities of Verteporfin.,increase,no risk
Nabumetone,Baclofen,Nabumetone may decrease the excretion rate of Baclofen which could result in a higher serum level.,decrease,no risk
Nabumetone,Balsalazide,The therapeutic efficacy of Balsalazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Baricitinib,Nabumetone may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Nabumetone,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Nabumetone.,increase,risk
Nabumetone,Belinostat,The metabolism of Nabumetone can be increased when combined with Belinostat.,increase,no risk
Nabumetone,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Bemiparin.,increase,risk
Nabumetone,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Benazepril.",increase,risk
Nabumetone,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Bendazac,The risk or severity of adverse effects can be increased when Nabumetone is combined with Bendazac.,increase,risk
Nabumetone,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Benorilate,The risk or severity of adverse effects can be increased when Nabumetone is combined with Benorilate.,increase,risk
Nabumetone,Benoxaprofen,The risk or severity of adverse effects can be increased when Nabumetone is combined with Benoxaprofen.,increase,risk
Nabumetone,Benserazide,Nabumetone may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Nabumetone,Benzatropine,Nabumetone may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Nabumetone,Benznidazole,Nabumetone may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Nabumetone,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Benzphetamine,The risk or severity of hypertension can be increased when Nabumetone is combined with Benzphetamine.,increase,risk
Nabumetone,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Benzydamine,The risk or severity of adverse effects can be increased when Nabumetone is combined with Benzydamine.,increase,risk
Nabumetone,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Bepotastine,Nabumetone may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Nabumetone,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Nabumetone.,increase,risk
Nabumetone,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Nabumetone.,increase,risk
Nabumetone,Betaxolol,Nabumetone may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Nabumetone,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Nabumetone.,increase,risk
Nabumetone,Betulinic Acid,The risk or severity of adverse effects can be increased when Nabumetone is combined with Betulinic Acid.,increase,risk
Nabumetone,Bexarotene,The metabolism of Nabumetone can be decreased when combined with Bexarotene.,decrease,no risk
Nabumetone,Bicisate,Nabumetone may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Nabumetone,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Bimekizumab,The metabolism of Nabumetone can be increased when combined with Bimekizumab.,increase,no risk
Nabumetone,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Bismuth subgallate,Nabumetone may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Nabumetone,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Bisoprolol,Nabumetone may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Nabumetone,Bisoxatin,Nabumetone may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Nabumetone,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Bivalirudin.,increase,risk
Nabumetone,Bleomycin,Nabumetone may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Nabumetone,Bortezomib,The metabolism of Nabumetone can be decreased when combined with Bortezomib.,decrease,no risk
Nabumetone,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Brexpiprazole,The risk or severity of hypertension can be increased when Nabumetone is combined with Brexpiprazole.,increase,risk
Nabumetone,Brivaracetam,Nabumetone may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Nabumetone,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Bromfenac,The risk or severity of adverse effects can be increased when Nabumetone is combined with Bromfenac.,increase,risk
Nabumetone,Bromocriptine,The risk or severity of hypertension can be increased when Nabumetone is combined with Bromocriptine.,increase,risk
Nabumetone,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Nabumetone.,increase,risk
Nabumetone,Bufexamac,The risk or severity of adverse effects can be increased when Nabumetone is combined with Bufexamac.,increase,risk
Nabumetone,Bumadizone,The risk or severity of adverse effects can be increased when Nabumetone is combined with Bumadizone.,increase,risk
Nabumetone,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Bupropion,Nabumetone may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Nabumetone,Buspirone,The risk or severity of hypertension can be increased when Nabumetone is combined with Buspirone.,increase,risk
Nabumetone,Butabarbital,Nabumetone may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Nabumetone,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Nabumetone.,increase,risk
Nabumetone,Gabapentin enacarbil,Nabumetone may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadobenic acid,Nabumetone may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadodiamide,Nabumetone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadofosveset trisodium,Nabumetone may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadopentetic acid,Nabumetone may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadoteric acid,Nabumetone may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nabumetone,Gadoteridol,Nabumetone may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Nabumetone,Ganciclovir,Nabumetone may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Nabumetone,Gatifloxacin,The metabolism of Nabumetone can be decreased when combined with Gatifloxacin.,decrease,no risk
Nabumetone,Gemcitabine,Nabumetone may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Nabumetone,Gemfibrozil,The metabolism of Nabumetone can be decreased when combined with Gemfibrozil.,decrease,no risk
Nabumetone,Gemifloxacin,The metabolism of Nabumetone can be decreased when combined with Gemifloxacin.,decrease,no risk
Nabumetone,Gentamicin,Nabumetone may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nabumetone,Gimeracil,Nabumetone may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nabumetone,Ginkgo biloba,The metabolism of Nabumetone can be decreased when combined with Ginkgo biloba.,decrease,no risk
Nabumetone,Givosiran,The serum concentration of Nabumetone can be increased when it is combined with Givosiran.,increase,no risk
Nabumetone,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Glipizide,The protein binding of Glipizide can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Glofitamab,The serum concentration of Nabumetone can be increased when it is combined with Glofitamab.,increase,no risk
Nabumetone,Glyburide,The protein binding of Glyburide can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Glycerol phenylbutyrate,Nabumetone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nabumetone,Glycol salicylate,The risk or severity of adverse effects can be increased when Nabumetone is combined with Glycol salicylate.,increase,risk
Nabumetone,Golimumab,The metabolism of Nabumetone can be increased when combined with Golimumab.,increase,no risk
Nabumetone,Golodirsen,Nabumetone may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nabumetone,Goserelin,Nabumetone may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Nabumetone,Grepafloxacin,The metabolism of Nabumetone can be decreased when combined with Grepafloxacin.,decrease,no risk
Nabumetone,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Nabumetone.,increase,no risk
Nabumetone,Halothane,The risk or severity of hypertension can be increased when Nabumetone is combined with Halothane.,increase,risk
Nabumetone,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Heparin.,increase,risk
Nabumetone,Hydralazine,Nabumetone may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nabumetone,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Nabumetone.,increase,risk
Nabumetone,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Nabumetone.,increase,risk
Nabumetone,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Nabumetone.,increase,risk
Nabumetone,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Nabumetone.,increase,risk
Nabumetone,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Nabumetone.,increase,risk
Nabumetone,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Hydromorphone,Nabumetone may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Nabumetone,Hydroxocobalamin,Nabumetone may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Nabumetone,Hydroxyethyl Starch,Nabumetone may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nabumetone,Kanamycin,Nabumetone may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nabumetone,Ketamine,Nabumetone may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Nabumetone,Ketazolam,Nabumetone may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Nabumetone,Ketoconazole,The metabolism of Nabumetone can be decreased when combined with Ketoconazole.,decrease,no risk
Nabumetone,Ketoprofen,The risk or severity of adverse effects can be increased when Nabumetone is combined with Ketoprofen.,increase,risk
Nabumetone,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Nabumetone.,increase,risk
Nabumetone,Obeticholic acid,The metabolism of Nabumetone can be decreased when combined with Obeticholic acid.,decrease,no risk
Nabumetone,Octinoxate,Nabumetone may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nabumetone,Ofloxacin,Nabumetone may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Nabumetone,Olanzapine,The metabolism of Nabumetone can be decreased when combined with Olanzapine.,decrease,no risk
Nabumetone,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Nabumetone.",increase,risk
Nabumetone,Olodaterol,The risk or severity of hypertension can be increased when Nabumetone is combined with Olodaterol.,increase,risk
Nabumetone,Olsalazine,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Olsalazine.,increase,risk
Nabumetone,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Nabumetone is combined with Omacetaxine mepesuccinate.,increase,risk
Nabumetone,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Opium,Nabumetone may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Nabumetone,Orciprenaline,The risk or severity of hypertension can be increased when Nabumetone is combined with Orciprenaline.,increase,risk
Nabumetone,Oritavancin,The metabolism of Nabumetone can be decreased when combined with Oritavancin.,decrease,no risk
Nabumetone,Orphenadrine,The metabolism of Nabumetone can be decreased when combined with Orphenadrine.,decrease,no risk
Nabumetone,Oseltamivir,Nabumetone may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Nabumetone,Osilodrostat,The metabolism of Nabumetone can be decreased when combined with Osilodrostat.,decrease,no risk
Nabumetone,Osimertinib,The serum concentration of Nabumetone can be decreased when it is combined with Osimertinib.,decrease,no risk
Nabumetone,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Oxacillin,Nabumetone may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Nabumetone,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Nabumetone.,increase,risk
Nabumetone,Oxandrolone,The metabolism of Nabumetone can be decreased when combined with Oxandrolone.,decrease,no risk
Nabumetone,Oxaprozin,The risk or severity of adverse effects can be increased when Nabumetone is combined with Oxaprozin.,increase,risk
Nabumetone,Oxazepam,Nabumetone may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Nabumetone,Oxprenolol,Nabumetone may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Nabumetone,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Oxybenzone,Nabumetone may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Nabumetone,Oxymetazoline,The risk or severity of hypertension can be increased when Nabumetone is combined with Oxymetazoline.,increase,risk
Nabumetone,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Nabumetone is combined with Oxyphenbutazone.,increase,risk
Nabumetone,Oxyquinoline,Nabumetone may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Nabumetone,Quetiapine,The risk or severity of hypertension can be increased when Nabumetone is combined with Quetiapine.,increase,risk
Nabumetone,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Quinapril.",increase,risk
Nabumetone,Quinestrol,Nabumetone may increase the thrombogenic activities of Quinestrol.,increase,no risk
Nabumetone,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Quinidine,The metabolism of Nabumetone can be decreased when combined with Quinidine.,decrease,no risk
Nabumetone,Quinine,The metabolism of Quinine can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Nabumetone.,increase,risk
Nabumetone,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Nabumetone.,decrease,no risk
Nabumetone,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Urokinase.,increase,risk
Nabumetone,Vaborbactam,Nabumetone may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Nabumetone,Vadadustat,The metabolism of Nabumetone can be decreased when combined with Vadadustat.,decrease,no risk
Nabumetone,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Valaciclovir.,increase,risk
Nabumetone,Valbenazine,Nabumetone may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Nabumetone,Valdecoxib,The risk or severity of adverse effects can be increased when Nabumetone is combined with Valdecoxib.,increase,risk
Nabumetone,Valganciclovir,Nabumetone may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Nabumetone,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Nabumetone.",increase,risk
Nabumetone,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Nabumetone.,increase,risk
Nabumetone,Vancomycin,Nabumetone may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Nabumetone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Varenicline,Nabumetone may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Nabumetone,Vemurafenib,The serum concentration of Nabumetone can be increased when it is combined with Vemurafenib.,increase,no risk
Nabumetone,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Nabumetone.,increase,no risk
Nabumetone,Verapamil,The metabolism of Verapamil can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Vilanterol,The risk or severity of hypertension can be increased when Nabumetone is combined with Vilanterol.,increase,risk
Nabumetone,Vilazodone,The risk or severity of hypertension can be increased when Nabumetone is combined with Vilazodone.,increase,risk
Nabumetone,Viloxazine,The metabolism of Nabumetone can be decreased when combined with Viloxazine.,decrease,no risk
Nabumetone,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Vorapaxar.,increase,risk
Nabumetone,Voriconazole,The serum concentration of Nabumetone can be increased when it is combined with Voriconazole.,increase,no risk
Nabumetone,Vortioxetine,The risk or severity of hypertension can be increased when Nabumetone is combined with Vortioxetine.,increase,risk
Nabumetone,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Warfarin.,increase,risk
Nabumetone,Xamoterol,The risk or severity of hypertension can be increased when Nabumetone is combined with Xamoterol.,increase,risk
Nabumetone,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Nabumetone is combined with Ximelagatran.,increase,risk
Nabumetone,Xylometazoline,The risk or severity of hypertension can be increased when Nabumetone is combined with Xylometazoline.,increase,risk
Nabumetone,Yohimbine,The risk or severity of hypertension can be increased when Nabumetone is combined with Yohimbine.,increase,risk
Nabumetone,Zafirlukast,The metabolism of Nabumetone can be decreased when combined with Zafirlukast.,decrease,no risk
Nabumetone,Zaleplon,Nabumetone may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Nabumetone,Zanamivir,Nabumetone may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Nabumetone,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Nabumetone.,increase,risk
Nabumetone,Zileuton,The metabolism of Nabumetone can be decreased when combined with Zileuton.,decrease,no risk
Nabumetone,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Nabumetone.,increase,risk
Nabumetone,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Nabumetone.,increase,risk
Nabumetone,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Nabumetone is combined with Zofenopril.",increase,risk
Nabumetone,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Nabumetone is combined with Zoledronic acid.,increase,risk
Nabumetone,Zolmitriptan,The metabolism of Nabumetone can be decreased when combined with Zolmitriptan.,decrease,no risk
Nabumetone,Zolpidem,The metabolism of Nabumetone can be decreased when combined with Zolpidem.,decrease,no risk
Nabumetone,Zonisamide,The risk or severity of hyperkalemia can be increased when Nabumetone is combined with Zonisamide.,increase,risk
Nabumetone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Nabumetone.,decrease,no risk
Nabumetone,Zotepine,The metabolism of Zotepine can be decreased when combined with Nabumetone.,decrease,no risk
Methscopolamine bromide,Galantamine,The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Galantamine.,decrease,no risk
Methscopolamine bromide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Gallamine triethiodide.,increase,risk
Methscopolamine bromide,Ginkgo biloba,The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Methscopolamine bromide,Glucagon,Methscopolamine bromide may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Methscopolamine bromide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Methscopolamine bromide.,decrease,no risk
Methscopolamine bromide,Glycopyrronium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Glycopyrronium.,increase,risk
Methscopolamine bromide,Guanabenz,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Guanabenz.,increase,risk
Methscopolamine bromide,Guanfacine,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Guanfacine.,increase,risk
Methscopolamine bromide,Hexafluronium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Hexafluronium.,increase,risk
Methscopolamine bromide,Hexocyclium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Hexocyclium.,increase,risk
Methscopolamine bromide,Homatropine,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Homatropine.,increase,risk
Methscopolamine bromide,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Homatropine methylbromide.,increase,risk
Methscopolamine bromide,Huperzine A,The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Huperzine A.,decrease,no risk
Methscopolamine bromide,Hydrochlorothiazide,The serum concentration of Hydrochlorothiazide can be increased when it is combined with Methscopolamine bromide.,increase,no risk
Methscopolamine bromide,Hydrocodone,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Hydrocodone.,increase,risk
Methscopolamine bromide,Hydroflumethiazide,The serum concentration of Hydroflumethiazide can be increased when it is combined with Methscopolamine bromide.,increase,no risk
Methscopolamine bromide,Hydromorphone,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Hydromorphone.,increase,risk
Methscopolamine bromide,Hyoscyamine,The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Methscopolamine bromide.,increase,risk
Methscopolamine bromide,Ketamine,The therapeutic efficacy of Methscopolamine bromide can be decreased when used in combination with Ketamine.,decrease,no risk
Methscopolamine bromide,Olanzapine,The risk or severity of adverse effects can be increased when Olanzapine is combined with Methscopolamine bromide.,increase,risk
Methscopolamine bromide,Oliceridine,"The risk or severity of urinary retention, reduced gastrointestinal motility, and constipation can be increased when Methscopolamine bromide is combined with Oliceridine.",increase,risk
Methscopolamine bromide,Olodaterol,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Olodaterol.,increase,risk
Methscopolamine bromide,Opium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Opium.,increase,risk
Methscopolamine bromide,Orciprenaline,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Orciprenaline.,increase,risk
Methscopolamine bromide,Orphenadrine,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Orphenadrine.,increase,risk
Methscopolamine bromide,Oxybutynin,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Oxybutynin.,increase,risk
Methscopolamine bromide,Oxycodone,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Oxycodone.,increase,risk
Methscopolamine bromide,Oxymetazoline,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Oxymetazoline.,increase,risk
Methscopolamine bromide,Oxymorphone,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Oxymorphone.,increase,risk
Methscopolamine bromide,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Methscopolamine bromide.,increase,risk
Methscopolamine bromide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Methscopolamine bromide.,decrease,no risk
Methscopolamine bromide,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Methscopolamine bromide.,increase,risk
Methscopolamine bromide,Quetiapine,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Quetiapine.,increase,risk
Methscopolamine bromide,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Methscopolamine bromide.,increase,no risk
Methscopolamine bromide,Quinidine,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Quinidine.,increase,risk
Methscopolamine bromide,Quinupramine,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Quinupramine.,increase,risk
Methscopolamine bromide,Umeclidinium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Umeclidinium.,increase,risk
Methscopolamine bromide,Vecuronium,The risk or severity of adverse effects can be increased when Methscopolamine bromide is combined with Vecuronium.,increase,risk
Methscopolamine bromide,Venlafaxine,The risk or severity of Tachycardia can be increased when Venlafaxine is combined with Methscopolamine bromide.,increase,risk
Methscopolamine bromide,Vilanterol,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Vilanterol.,increase,risk
Methscopolamine bromide,Xamoterol,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Xamoterol.,increase,risk
Methscopolamine bromide,Xylometazoline,The risk or severity of Tachycardia can be increased when Methscopolamine bromide is combined with Xylometazoline.,increase,risk
Methscopolamine bromide,Ziprasidone,The risk or severity of adverse effects can be increased when Ziprasidone is combined with Methscopolamine bromide.,increase,risk
Ketorolac,Gabapentin enacarbil,Ketorolac may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadobenic acid,Ketorolac may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadodiamide,Ketorolac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadofosveset trisodium,Ketorolac may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadopentetic acid,Ketorolac may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadoteric acid,Ketorolac may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ketorolac,Gadoteridol,Ketorolac may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ketorolac,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Ketorolac is combined with Gallamine triethiodide.,increase,risk
Ketorolac,Ganciclovir,Ketorolac may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ketorolac,Gatifloxacin,Ketorolac may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Ketorolac,Gemcitabine,Ketorolac may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ketorolac,Gemfibrozil,The metabolism of Ketorolac can be decreased when combined with Gemfibrozil.,decrease,no risk
Ketorolac,Gemifloxacin,Ketorolac may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Ketorolac,Gentamicin,Ketorolac may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ketorolac,Gimeracil,Ketorolac may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ketorolac,Ginkgo biloba,The metabolism of Ketorolac can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ketorolac,Givosiran,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Givosiran.,increase,risk
Ketorolac,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Glipizide,The protein binding of Glipizide can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Glofitamab,The serum concentration of Ketorolac can be increased when it is combined with Glofitamab.,increase,no risk
Ketorolac,Glyburide,The protein binding of Glyburide can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Glycerol phenylbutyrate,Ketorolac may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ketorolac,Glycol salicylate,The risk or severity of adverse effects can be increased when Ketorolac is combined with Glycol salicylate.,increase,risk
Ketorolac,Golimumab,The metabolism of Ketorolac can be increased when combined with Golimumab.,increase,no risk
Ketorolac,Golodirsen,Ketorolac may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ketorolac,Goserelin,Ketorolac may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ketorolac,Grepafloxacin,Ketorolac may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Ketorolac,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Ketorolac.,increase,no risk
Ketorolac,Halothane,The risk or severity of hypertension can be increased when Ketorolac is combined with Halothane.,increase,risk
Ketorolac,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Heparin.,increase,risk
Ketorolac,Hydralazine,Ketorolac may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ketorolac,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Ketorolac.,increase,risk
Ketorolac,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Ketorolac.,increase,risk
Ketorolac,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Ketorolac.,increase,risk
Ketorolac,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Ketorolac.,increase,risk
Ketorolac,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Ketorolac.,increase,risk
Ketorolac,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Hydromorphone,Ketorolac may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ketorolac,Hydroxocobalamin,Ketorolac may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ketorolac,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Hydroxyethyl Starch,Ketorolac may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ketorolac,Kanamycin,Ketorolac may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ketorolac,Ketamine,The metabolism of Ketamine can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Ketazolam,Ketorolac may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ketorolac,Ketoconazole,The metabolism of Ketorolac can be decreased when combined with Ketoconazole.,decrease,no risk
Ketorolac,Ketoprofen,The risk or severity of adverse effects can be increased when Ketorolac is combined with Ketoprofen.,increase,risk
Ketorolac,Octinoxate,Ketorolac may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ketorolac,Ofloxacin,Ketorolac may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Ketorolac,Olanzapine,The metabolism of Ketorolac can be decreased when combined with Olanzapine.,decrease,no risk
Ketorolac,Olmesartan,The therapeutic efficacy of Olmesartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Olsalazine.,increase,risk
Ketorolac,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Ketorolac is combined with Omacetaxine mepesuccinate.,increase,risk
Ketorolac,Omaveloxolone,The serum concentration of Ketorolac can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ketorolac,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Opium,Ketorolac may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ketorolac,Orciprenaline,The risk or severity of hypertension can be increased when Ketorolac is combined with Orciprenaline.,increase,risk
Ketorolac,Oritavancin,The metabolism of Ketorolac can be decreased when combined with Oritavancin.,decrease,no risk
Ketorolac,Oseltamivir,Ketorolac may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ketorolac,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Oxacillin,Ketorolac may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ketorolac,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ketorolac.,increase,risk
Ketorolac,Oxandrolone,The metabolism of Ketorolac can be decreased when combined with Oxandrolone.,decrease,no risk
Ketorolac,Oxaprozin,The risk or severity of adverse effects can be increased when Ketorolac is combined with Oxaprozin.,increase,risk
Ketorolac,Oxazepam,Ketorolac may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ketorolac,Oxprenolol,Ketorolac may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Ketorolac,Oxybenzone,Ketorolac may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ketorolac,Oxybutynin,The metabolism of Ketorolac can be decreased when combined with Oxybutynin.,decrease,no risk
Ketorolac,Oxymetazoline,The risk or severity of hypertension can be increased when Ketorolac is combined with Oxymetazoline.,increase,risk
Ketorolac,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Ketorolac is combined with Oxyphenbutazone.,increase,risk
Ketorolac,Oxyquinoline,Ketorolac may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ketorolac,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Quetiapine,The risk or severity of hypertension can be increased when Ketorolac is combined with Quetiapine.,increase,risk
Ketorolac,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Quinapril.",increase,risk
Ketorolac,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Quinidine,Ketorolac may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ketorolac,Quinine,The metabolism of Ketorolac can be decreased when combined with Quinine.,decrease,no risk
Ketorolac,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Ketorolac.,increase,risk
Ketorolac,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Urokinase.,increase,risk
Ketorolac,Vaborbactam,Ketorolac may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ketorolac,Vadadustat,The serum concentration of Ketorolac can be increased when it is combined with Vadadustat.,increase,no risk
Ketorolac,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Valaciclovir.,increase,risk
Ketorolac,Valbenazine,Ketorolac may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ketorolac,Valdecoxib,The risk or severity of adverse effects can be increased when Ketorolac is combined with Valdecoxib.,increase,risk
Ketorolac,Valganciclovir,Ketorolac may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ketorolac,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Valsartan,The therapeutic efficacy of Valsartan can be decreased when used in combination with Ketorolac.,decrease,no risk
Ketorolac,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Ketorolac.,increase,risk
Ketorolac,Vancomycin,Ketorolac may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ketorolac,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Varenicline,Ketorolac may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ketorolac,Vecuronium,The risk or severity of adverse effects can be increased when Ketorolac is combined with Vecuronium.,increase,risk
Ketorolac,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Vemurafenib,The metabolism of Ketorolac can be decreased when combined with Vemurafenib.,decrease,no risk
Ketorolac,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Ketorolac.,increase,no risk
Ketorolac,Verapamil,Ketorolac may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ketorolac,Vilanterol,The risk or severity of hypertension can be increased when Ketorolac is combined with Vilanterol.,increase,risk
Ketorolac,Vilazodone,The risk or severity of hypertension can be increased when Ketorolac is combined with Vilazodone.,increase,risk
Ketorolac,Viloxazine,Ketorolac may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ketorolac,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Vorapaxar.,increase,risk
Ketorolac,Voriconazole,The serum concentration of Ketorolac can be increased when it is combined with Voriconazole.,increase,no risk
Ketorolac,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Warfarin.,increase,risk
Ketorolac,Xamoterol,The risk or severity of hypertension can be increased when Ketorolac is combined with Xamoterol.,increase,risk
Ketorolac,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Ximelagatran.,increase,risk
Ketorolac,Xylometazoline,The risk or severity of hypertension can be increased when Ketorolac is combined with Xylometazoline.,increase,risk
Ketorolac,Yohimbine,The risk or severity of hypertension can be increased when Ketorolac is combined with Yohimbine.,increase,risk
Ketorolac,Zafirlukast,The metabolism of Ketorolac can be decreased when combined with Zafirlukast.,decrease,no risk
Ketorolac,Zaleplon,Ketorolac may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ketorolac,Zanamivir,Ketorolac may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ketorolac,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Ketorolac.,increase,risk
Ketorolac,Zileuton,The metabolism of Zileuton can be decreased when combined with Ketorolac.,decrease,no risk
Ketorolac,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Ketorolac.,increase,risk
Ketorolac,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Ketorolac.,increase,risk
Ketorolac,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Ketorolac is combined with Zofenopril.",increase,risk
Ketorolac,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Zoledronic acid.,increase,risk
Ketorolac,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Ketorolac.,increase,risk
Ketorolac,Zolpidem,The metabolism of Ketorolac can be decreased when combined with Zolpidem.,decrease,no risk
Ketorolac,Zonisamide,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Zonisamide.,increase,risk
Ketorolac,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ketorolac.,decrease,no risk
Quinine,Baclofen,The therapeutic efficacy of Quinine can be decreased when used in combination with Baclofen.,decrease,no risk
Quinine,Balsalazide,Balsalazide may increase the hypoglycemic activities of Quinine.,increase,no risk
Quinine,Beclomethasone dipropionate,The risk or severity of hyperglycemia can be increased when Beclomethasone dipropionate is combined with Quinine.,increase,risk
Quinine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Quinine is combined with Bedaquiline.,increase,risk
Quinine,Belantamab mafodotin,The serum concentration of Belantamab mafodotin can be increased when it is combined with Quinine.,increase,no risk
Quinine,Belinostat,The serum concentration of Belinostat can be increased when it is combined with Quinine.,increase,no risk
Quinine,Belumosudil,The serum concentration of Quinine can be increased when it is combined with Belumosudil.,increase,no risk
Quinine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Quinine.,increase,no risk
Quinine,Bemiparin,The therapeutic efficacy of Bemiparin can be increased when used in combination with Quinine.,increase,no risk
Quinine,Benazepril,The risk or severity of hypoglycemia can be increased when Benazepril is combined with Quinine.,increase,risk
Quinine,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Quinine.,increase,no risk
Quinine,Bendroflumethiazide,The therapeutic efficacy of Quinine can be decreased when used in combination with Bendroflumethiazide.,decrease,no risk
Quinine,Benperidol,The risk or severity of CNS depression can be increased when Quinine is combined with Benperidol.,increase,risk
Quinine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Quinine.,decrease,no risk
Quinine,Benzhydrocodone,The risk or severity of respiratory depression can be increased when Benzhydrocodone is combined with Quinine.,increase,risk
Quinine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Quinine.,decrease,no risk
Quinine,Benzphetamine,The risk or severity of CNS depression can be increased when Quinine is combined with Benzphetamine.,increase,risk
Quinine,Benzthiazide,The therapeutic efficacy of Quinine can be decreased when used in combination with Benzthiazide.,decrease,no risk
Quinine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Quinine.,decrease,no risk
Quinine,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Quinine.,decrease,no risk
Quinine,Bepridil,The metabolism of Bepridil can be decreased when combined with Quinine.,decrease,no risk
Quinine,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Quinine.,increase,no risk
Quinine,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Quinine.,increase,risk
Quinine,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Quinine.,increase,risk
Quinine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Quinine.,decrease,no risk
Quinine,Bethanidine,Quinine may increase the hypotensive activities of Bethanidine.,increase,no risk
Quinine,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Quinine.,increase,no risk
Quinine,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Quinine.,increase,no risk
Quinine,Bexarotene,The metabolism of Quinine can be decreased when combined with Bexarotene.,decrease,no risk
Quinine,Bezafibrate,The metabolism of Quinine can be decreased when combined with Bezafibrate.,decrease,no risk
Quinine,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Quinine.,increase,no risk
Quinine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Quinine.,increase,risk
Quinine,Bimatoprost,Quinine may increase the hypotensive activities of Bimatoprost.,increase,no risk
Quinine,Bimekizumab,The metabolism of Quinine can be increased when combined with Bimekizumab.,increase,no risk
Quinine,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Quinine.,increase,no risk
Quinine,Biperiden,The metabolism of Quinine can be decreased when combined with Biperiden.,decrease,no risk
Quinine,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Quinine.,increase,no risk
Quinine,Bisoprolol,The therapeutic efficacy of Quinine can be increased when used in combination with Bisoprolol.,increase,no risk
Quinine,Bivalirudin,The therapeutic efficacy of Bivalirudin can be increased when used in combination with Quinine.,increase,no risk
Quinine,Boceprevir,The metabolism of Quinine can be decreased when combined with Boceprevir.,decrease,no risk
Quinine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Quinine.,decrease,no risk
Quinine,Bosentan,The therapeutic efficacy of Quinine can be increased when used in combination with Bosentan.,increase,no risk
Quinine,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Quinine.,increase,no risk
Quinine,Botulinum toxin type A,The therapeutic efficacy of Botulinum toxin type A can be increased when used in combination with Quinine.,increase,no risk
Quinine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Quinine.,increase,risk
Quinine,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine.,increase,no risk
Quinine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Quinine.,increase,risk
Quinine,Brexanolone,The risk or severity of CNS depression can be increased when Quinine is combined with Brexanolone.,increase,risk
Quinine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Quinine.,decrease,no risk
Quinine,Brigatinib,The metabolism of Brigatinib can be increased when combined with Quinine.,increase,no risk
Quinine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Quinine.,increase,no risk
Quinine,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Quinine.,increase,no risk
Quinine,Brivaracetam,The risk or severity of CNS depression can be increased when Quinine is combined with Brivaracetam.,increase,risk
Quinine,Bromazepam,The risk or severity of CNS depression can be increased when Quinine is combined with Bromazepam.,increase,risk
Quinine,Bromocriptine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Bromocriptine.,increase,risk
Quinine,Bromotheophylline,The serum concentration of Bromotheophylline can be increased when it is combined with Quinine.,increase,no risk
Quinine,Bromperidol,The risk or severity of CNS depression can be increased when Quinine is combined with Bromperidol.,increase,risk
Quinine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Quinine.,increase,risk
Quinine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Quinine.,increase,risk
Quinine,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Quinine.,increase,risk
Quinine,Bumetanide,The therapeutic efficacy of Quinine can be decreased when used in combination with Bumetanide.,decrease,no risk
Quinine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Quinine.,decrease,no risk
Quinine,Buprenorphine,Quinine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Quinine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Quinine.,increase,risk
Quinine,Buserelin,The therapeutic efficacy of Quinine can be decreased when used in combination with Buserelin.,decrease,no risk
Quinine,Buspirone,The metabolism of Buspirone can be decreased when combined with Quinine.,decrease,no risk
Quinine,Busulfan,The metabolism of Busulfan can be increased when combined with Quinine.,increase,no risk
Quinine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Quinine.,increase,risk
Quinine,Butacaine,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Butacaine.,increase,risk
Quinine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Quinine.,increase,risk
Quinine,Butamben,The risk or severity of methemoglobinemia can be increased when Quinine is combined with Butamben.,increase,risk
Quinine,Butaperazine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Butaperazine.,increase,risk
Quinine,Butobarbital,The risk or severity of CNS depression can be increased when Quinine is combined with Butobarbital.,increase,risk
Quinine,Butorphanol,The risk or severity of CNS depression can be increased when Quinine is combined with Butorphanol.,increase,risk
Quinine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Quinine.,increase,risk
Tenoxicam,Baricitinib,The serum concentration of Baricitinib can be increased when it is combined with Tenoxicam.,increase,no risk
Tenoxicam,Beclomethasone dipropionate,The risk or severity of gastrointestinal irritation can be increased when Beclomethasone dipropionate is combined with Tenoxicam.,increase,risk
Tenoxicam,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Bemiparin.,increase,risk
Tenoxicam,Benazepril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tenoxicam is combined with Benazepril.",increase,risk
Tenoxicam,Bendazac,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Bendazac.,increase,risk
Tenoxicam,Bendroflumethiazide,The therapeutic efficacy of Bendroflumethiazide can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Benorilate,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Benorilate.,increase,risk
Tenoxicam,Benoxaprofen,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Benoxaprofen.,increase,risk
Tenoxicam,Benserazide,Tenoxicam may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Tenoxicam,Benzatropine,Tenoxicam may decrease the excretion rate of Benzatropine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Benznidazole,Tenoxicam may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Tenoxicam,Benzphetamine,The risk or severity of hypertension can be increased when Tenoxicam is combined with Benzphetamine.,increase,risk
Tenoxicam,Benzthiazide,The therapeutic efficacy of Benzthiazide can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Benzydamine,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Benzydamine.,increase,risk
Tenoxicam,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Bepotastine,Tenoxicam may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bepridil,The therapeutic efficacy of Bepridil can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Betamethasone,The risk or severity of gastrointestinal irritation can be increased when Betamethasone is combined with Tenoxicam.,increase,risk
Tenoxicam,Betamethasone phosphate,The risk or severity of gastrointestinal irritation can be increased when Betamethasone phosphate is combined with Tenoxicam.,increase,risk
Tenoxicam,Betaxolol,Tenoxicam may decrease the antihypertensive activities of Betaxolol.,decrease,no risk
Tenoxicam,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Tenoxicam.,increase,risk
Tenoxicam,Betulinic Acid,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Betulinic Acid.,increase,risk
Tenoxicam,Bexarotene,The metabolism of Tenoxicam can be decreased when combined with Bexarotene.,decrease,no risk
Tenoxicam,Bicisate,Tenoxicam may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bimatoprost,The therapeutic efficacy of Bimatoprost can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Bimekizumab,The metabolism of Tenoxicam can be increased when combined with Bimekizumab.,increase,no risk
Tenoxicam,Bismuth subgallate,Tenoxicam may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bismuth subsalicylate,The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Bisoprolol,Tenoxicam may decrease the antihypertensive activities of Bisoprolol.,decrease,no risk
Tenoxicam,Bisoxatin,Tenoxicam may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Bivalirudin.,increase,risk
Tenoxicam,Bleomycin,Tenoxicam may decrease the excretion rate of Bleomycin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bortezomib,The metabolism of Tenoxicam can be decreased when combined with Bortezomib.,decrease,no risk
Tenoxicam,Bosentan,The therapeutic efficacy of Bosentan can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Bretylium,The therapeutic efficacy of Bretylium can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Brexpiprazole,The risk or severity of hypertension can be increased when Tenoxicam is combined with Brexpiprazole.,increase,risk
Tenoxicam,Brivaracetam,Tenoxicam may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bromazepam,Tenoxicam may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Tenoxicam,Bromfenac,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Bromfenac.,increase,risk
Tenoxicam,Bromocriptine,The risk or severity of hypertension can be increased when Tenoxicam is combined with Bromocriptine.,increase,risk
Tenoxicam,Budesonide,The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Tenoxicam.,increase,risk
Tenoxicam,Bufexamac,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Bufexamac.,increase,risk
Tenoxicam,Bumadizone,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Bumadizone.,increase,risk
Tenoxicam,Bumetanide,The therapeutic efficacy of Bumetanide can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Bupropion,Tenoxicam may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Tenoxicam,Buspirone,The risk or severity of hypertension can be increased when Tenoxicam is combined with Buspirone.,increase,risk
Tenoxicam,Butabarbital,Tenoxicam may decrease the excretion rate of Butabarbital which could result in a higher serum level.,decrease,no risk
Tenoxicam,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Tenoxicam.,increase,risk
Tenoxicam,Gabapentin enacarbil,Tenoxicam may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadobenic acid,Tenoxicam may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadodiamide,Tenoxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadofosveset trisodium,Tenoxicam may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadopentetic acid,Tenoxicam may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadoteric acid,Tenoxicam may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gadoteridol,Tenoxicam may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ganciclovir,Tenoxicam may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gatifloxacin,Tenoxicam may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Tenoxicam,Gemcitabine,Tenoxicam may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gemfibrozil,The metabolism of Tenoxicam can be decreased when combined with Gemfibrozil.,decrease,no risk
Tenoxicam,Gemifloxacin,Tenoxicam may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Tenoxicam,Gentamicin,Tenoxicam may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Gimeracil,Tenoxicam may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ginkgo biloba,The metabolism of Tenoxicam can be decreased when combined with Ginkgo biloba.,decrease,no risk
Tenoxicam,Givosiran,The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Givosiran.,increase,risk
Tenoxicam,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Glipizide,The protein binding of Glipizide can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Glofitamab,The serum concentration of Tenoxicam can be increased when it is combined with Glofitamab.,increase,no risk
Tenoxicam,Glyburide,The protein binding of Glyburide can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Glycerol phenylbutyrate,Tenoxicam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Tenoxicam,Glycol salicylate,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Glycol salicylate.,increase,risk
Tenoxicam,Golimumab,The metabolism of Tenoxicam can be increased when combined with Golimumab.,increase,no risk
Tenoxicam,Golodirsen,Tenoxicam may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Tenoxicam,Goserelin,Tenoxicam may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Grepafloxacin,Tenoxicam may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Tenoxicam,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Tenoxicam.,increase,no risk
Tenoxicam,Halothane,The risk or severity of hypertension can be increased when Tenoxicam is combined with Halothane.,increase,risk
Tenoxicam,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Heparin.,increase,risk
Tenoxicam,Hydralazine,Tenoxicam may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Tenoxicam,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Tenoxicam.,increase,risk
Tenoxicam,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Tenoxicam.,increase,risk
Tenoxicam,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Tenoxicam.,increase,risk
Tenoxicam,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Tenoxicam.,increase,risk
Tenoxicam,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Tenoxicam.,increase,risk
Tenoxicam,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Hydromorphone,Tenoxicam may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Tenoxicam,Hydroxocobalamin,Tenoxicam may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Hydroxyethyl Starch,Tenoxicam may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Tenoxicam,Kanamycin,Tenoxicam may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ketamine,Tenoxicam may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ketazolam,Tenoxicam may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ketoconazole,The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Ketoconazole.,increase,risk
Tenoxicam,Ketoprofen,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Ketoprofen.,increase,risk
Tenoxicam,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Tenoxicam.,increase,risk
Tenoxicam,Octinoxate,Tenoxicam may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Tenoxicam,Ofloxacin,Tenoxicam may increase the neuroexcitatory activities of Ofloxacin.,increase,no risk
Tenoxicam,Olanzapine,The metabolism of Tenoxicam can be decreased when combined with Olanzapine.,decrease,no risk
Tenoxicam,Olmesartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Tenoxicam.",increase,risk
Tenoxicam,Olodaterol,The risk or severity of hypertension can be increased when Tenoxicam is combined with Olodaterol.,increase,risk
Tenoxicam,Olsalazine,The risk or severity of nephrotoxicity can be increased when Tenoxicam is combined with Olsalazine.,increase,risk
Tenoxicam,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Tenoxicam is combined with Omacetaxine mepesuccinate.,increase,risk
Tenoxicam,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Opium,Tenoxicam may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Tenoxicam,Orciprenaline,The risk or severity of hypertension can be increased when Tenoxicam is combined with Orciprenaline.,increase,risk
Tenoxicam,Oritavancin,The metabolism of Tenoxicam can be decreased when combined with Oritavancin.,decrease,no risk
Tenoxicam,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Oxacillin,Tenoxicam may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Tenoxicam.,increase,risk
Tenoxicam,Oxandrolone,The metabolism of Tenoxicam can be decreased when combined with Oxandrolone.,decrease,no risk
Tenoxicam,Oxaprozin,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Oxaprozin.,increase,risk
Tenoxicam,Oxazepam,Tenoxicam may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Tenoxicam,Oxprenolol,Tenoxicam may decrease the antihypertensive activities of Oxprenolol.,decrease,no risk
Tenoxicam,Oxybenzone,Tenoxicam may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Tenoxicam,Oxymetazoline,The risk or severity of hypertension can be increased when Tenoxicam is combined with Oxymetazoline.,increase,risk
Tenoxicam,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Oxyphenbutazone.,increase,risk
Tenoxicam,Oxyquinoline,Tenoxicam may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Tenoxicam,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Quetiapine,The risk or severity of hypertension can be increased when Tenoxicam is combined with Quetiapine.,increase,risk
Tenoxicam,Quinapril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tenoxicam is combined with Quinapril.",increase,risk
Tenoxicam,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Quinidine,Tenoxicam may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Quinine,The metabolism of Tenoxicam can be decreased when combined with Quinine.,decrease,no risk
Tenoxicam,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Tenoxicam.,increase,risk
Tenoxicam,Unoprostone,The therapeutic efficacy of Unoprostone can be decreased when used in combination with Tenoxicam.,decrease,no risk
Tenoxicam,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Urokinase.,increase,risk
Tenoxicam,Vaborbactam,Tenoxicam may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Tenoxicam,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Tenoxicam.,increase,no risk
Tenoxicam,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Valbenazine,Tenoxicam may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Valdecoxib,The risk or severity of adverse effects can be increased when Tenoxicam is combined with Valdecoxib.,increase,risk
Tenoxicam,Valganciclovir,Tenoxicam may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Tenoxicam,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Valsartan,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Tenoxicam.",increase,risk
Tenoxicam,Vamorolone,The risk or severity of gastrointestinal irritation can be increased when Vamorolone is combined with Tenoxicam.,increase,risk
Tenoxicam,Vancomycin,Tenoxicam may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Tenoxicam,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Varenicline,Tenoxicam may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Tenoxicam,Vemurafenib,The metabolism of Tenoxicam can be decreased when combined with Vemurafenib.,decrease,no risk
Tenoxicam,Venlafaxine,Venlafaxine may increase the antiplatelet activities of Tenoxicam.,increase,no risk
Tenoxicam,Verapamil,Tenoxicam may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Tenoxicam,Vilanterol,The risk or severity of hypertension can be increased when Tenoxicam is combined with Vilanterol.,increase,risk
Tenoxicam,Vilazodone,The risk or severity of hypertension can be increased when Tenoxicam is combined with Vilazodone.,increase,risk
Tenoxicam,Viloxazine,Tenoxicam may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Tenoxicam,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Vorapaxar.,increase,risk
Tenoxicam,Voriconazole,The serum concentration of Tenoxicam can be increased when it is combined with Voriconazole.,increase,no risk
Tenoxicam,Vortioxetine,The risk or severity of hypertension can be increased when Tenoxicam is combined with Vortioxetine.,increase,risk
Tenoxicam,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Warfarin.,increase,risk
Tenoxicam,Xamoterol,The risk or severity of hypertension can be increased when Tenoxicam is combined with Xamoterol.,increase,risk
Tenoxicam,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Tenoxicam is combined with Ximelagatran.,increase,risk
Tenoxicam,Xylometazoline,The risk or severity of hypertension can be increased when Tenoxicam is combined with Xylometazoline.,increase,risk
Tenoxicam,Yohimbine,The risk or severity of hypertension can be increased when Tenoxicam is combined with Yohimbine.,increase,risk
Tenoxicam,Zafirlukast,The metabolism of Tenoxicam can be decreased when combined with Zafirlukast.,decrease,no risk
Tenoxicam,Zaleplon,Tenoxicam may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Tenoxicam,Zanamivir,Tenoxicam may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Tenoxicam,Zidovudine,The risk or severity of bleeding can be increased when Zidovudine is combined with Tenoxicam.,increase,risk
Tenoxicam,Zileuton,The metabolism of Zileuton can be decreased when combined with Tenoxicam.,decrease,no risk
Tenoxicam,Zimelidine,The risk or severity of gastrointestinal bleeding can be increased when Zimelidine is combined with Tenoxicam.,increase,risk
Tenoxicam,Ziprasidone,The risk or severity of hypertension can be increased when Ziprasidone is combined with Tenoxicam.,increase,risk
Tenoxicam,Zofenopril,"The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Tenoxicam is combined with Zofenopril.",increase,risk
Tenoxicam,Zoledronic acid,The risk or severity of gastrointestinal bleeding can be increased when Tenoxicam is combined with Zoledronic acid.,increase,risk
Tenoxicam,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Tenoxicam.,increase,risk
Tenoxicam,Zolpidem,The metabolism of Tenoxicam can be decreased when combined with Zolpidem.,decrease,no risk
Tenoxicam,Zonisamide,The risk or severity of hyperkalemia can be increased when Tenoxicam is combined with Zonisamide.,increase,risk
Tenoxicam,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Tenoxicam.,decrease,no risk
Dronabinol,Bosutinib,The serum concentration of Dronabinol can be increased when it is combined with Bosutinib.,increase,no risk
Dronabinol,Botulinum toxin type A,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Botulinum toxin type A.,increase,no risk
Dronabinol,Botulinum toxin type B,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Botulinum toxin type B.,increase,no risk
Dronabinol,Brentuximab vedotin,The serum concentration of Dronabinol can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Dronabinol,Brexanolone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Brexanolone.,increase,no risk
Dronabinol,Brexpiprazole,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Brexpiprazole.,increase,no risk
Dronabinol,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.,increase,no risk
Dronabinol,Brivaracetam,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Brivaracetam.,increase,no risk
Dronabinol,Bromazepam,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Bromazepam.,increase,no risk
Dronabinol,Bromocriptine,The serum concentration of Dronabinol can be increased when it is combined with Bromocriptine.,increase,no risk
Dronabinol,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Bromperidol,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Bromperidol.,increase,no risk
Dronabinol,Brompheniramine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Brompheniramine.,increase,no risk
Dronabinol,Buclizine,The risk or severity of Tachycardia and drowsiness can be increased when Buclizine is combined with Dronabinol.,increase,risk
Dronabinol,Bupivacaine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Bupivacaine.,increase,no risk
Dronabinol,Buprenorphine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Dronabinol,Bupropion,The serum concentration of Bupropion can be increased when it is combined with Dronabinol.,increase,no risk
Dronabinol,Buspirone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Buspirone.,increase,no risk
Dronabinol,Butabarbital,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Dronabinol,Butalbital,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butalbital.,increase,no risk
Dronabinol,Butaperazine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butaperazine.,increase,no risk
Dronabinol,Butobarbital,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butobarbital.,increase,no risk
Dronabinol,Butorphanol,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butorphanol.,increase,no risk
Dronabinol,Butriptyline,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Butriptyline.,increase,no risk
Dronabinol,Butylscopolamine,The risk or severity of Tachycardia and drowsiness can be increased when Butylscopolamine is combined with Dronabinol.,increase,risk
Dronabinol,Gabapentin,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Dronabinol,Gabapentin enacarbil,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Dronabinol,Galantamine,The metabolism of Galantamine can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Gallamine triethiodide,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Dronabinol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dronabinol is combined with Ganaxolone.",increase,risk
Dronabinol,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Gemfibrozil,The metabolism of Dronabinol can be decreased when combined with Gemfibrozil.,decrease,no risk
Dronabinol,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dronabinol.,increase,no risk
Dronabinol,Ginkgo biloba,The serum concentration of Dronabinol can be increased when it is combined with Ginkgo biloba.,increase,no risk
Dronabinol,Glecaprevir,The metabolism of Dronabinol can be decreased when combined with Glecaprevir.,decrease,no risk
Dronabinol,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Glipizide,The metabolism of Glipizide can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Glofitamab,The serum concentration of Dronabinol can be increased when it is combined with Glofitamab.,increase,no risk
Dronabinol,Glutethimide,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Dronabinol,Glyburide,The serum concentration of Dronabinol can be increased when it is combined with Glyburide.,increase,no risk
Dronabinol,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Dronabinol.,increase,risk
Dronabinol,Golimumab,The metabolism of Dronabinol can be increased when combined with Golimumab.,increase,no risk
Dronabinol,Granisetron,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Dronabinol,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Guanfacine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Dronabinol,Halazepam,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Dronabinol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dronabinol.,increase,risk
Dronabinol,Halothane,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Dronabinol,Hexafluronium,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Dronabinol,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Dronabinol.,increase,risk
Dronabinol,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Dronabinol.,increase,risk
Dronabinol,Hydralazine,The serum concentration of Dronabinol can be increased when it is combined with Hydralazine.,increase,no risk
Dronabinol,Hydrocodone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dronabinol,Hydromorphone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Dronabinol,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dronabinol.,increase,no risk
Dronabinol,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Dronabinol.,increase,risk
Dronabinol,Ketamine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Dronabinol,Ketazolam,The serum concentration of Dronabinol can be increased when it is combined with Ketazolam.,increase,no risk
Dronabinol,Ketoconazole,The serum concentration of Dronabinol can be increased when it is combined with Ketoconazole.,increase,no risk
Dronabinol,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Octreotide,The serum concentration of Dronabinol can be increased when it is combined with Octreotide.,increase,no risk
Dronabinol,Olanzapine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Dronabinol,Olaparib,The serum concentration of Dronabinol can be increased when it is combined with Olaparib.,increase,no risk
Dronabinol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dronabinol is combined with Oliceridine.",increase,risk
Dronabinol,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Omaveloxolone,The serum concentration of Dronabinol can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dronabinol,Ombitasvir,The metabolism of Dronabinol can be decreased when combined with Ombitasvir.,decrease,no risk
Dronabinol,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Ondansetron,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Dronabinol,Opium,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Dronabinol,Orciprenaline,The risk or severity of Tachycardia can be increased when Dronabinol is combined with Orciprenaline.,increase,risk
Dronabinol,Oritavancin,The metabolism of Dronabinol can be decreased when combined with Oritavancin.,decrease,no risk
Dronabinol,Orphenadrine,The serum concentration of Dronabinol can be increased when it is combined with Orphenadrine.,increase,no risk
Dronabinol,Osilodrostat,The serum concentration of Dronabinol can be increased when it is combined with Osilodrostat.,increase,no risk
Dronabinol,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Oxandrolone,The serum concentration of Dronabinol can be increased when it is combined with Oxandrolone.,increase,no risk
Dronabinol,Oxazepam,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Dronabinol,Oxcarbazepine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Dronabinol,Oxetacaine,The serum concentration of Dronabinol can be increased when it is combined with Oxetacaine.,increase,no risk
Dronabinol,Oxitriptan,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Dronabinol,Oxprenolol,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Dronabinol,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Oxybuprocaine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Dronabinol,Oxybutynin,The serum concentration of Dronabinol can be increased when it is combined with Oxybutynin.,increase,no risk
Dronabinol,Oxycodone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Dronabinol,Oxymetazoline,The risk or severity of Tachycardia can be increased when Dronabinol is combined with Oxymetazoline.,increase,risk
Dronabinol,Oxymetholone,The serum concentration of Dronabinol can be increased when it is combined with Oxymetholone.,increase,no risk
Dronabinol,Oxymorphone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Dronabinol,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Dronabinol.,increase,risk
Dronabinol,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Dronabinol.,increase,risk
Dronabinol,Quazepam,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Dronabinol,Quetiapine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Dronabinol,Quinidine,The serum concentration of Dronabinol can be increased when it is combined with Quinidine.,increase,no risk
Dronabinol,Quinine,The serum concentration of Dronabinol can be increased when it is combined with Quinine.,increase,no risk
Dronabinol,Quinupramine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Dronabinol,Quinupristin,The serum concentration of Dronabinol can be increased when it is combined with Quinupristin.,increase,no risk
Dronabinol,Quizartinib,The metabolism of Dronabinol can be decreased when combined with Quizartinib.,decrease,no risk
Dronabinol,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Dronabinol.,increase,risk
Dronabinol,Urethane,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Dronabinol,Vadadustat,The serum concentration of Dronabinol can be increased when it is combined with Vadadustat.,increase,no risk
Dronabinol,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Valproic acid,The serum concentration of Dronabinol can be increased when it is combined with Valproic acid.,increase,no risk
Dronabinol,Valsartan,The serum concentration of Dronabinol can be increased when it is combined with Valsartan.,increase,no risk
Dronabinol,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Vecuronium,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Dronabinol,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Vemurafenib,The serum concentration of Dronabinol can be increased when it is combined with Vemurafenib.,increase,no risk
Dronabinol,Venetoclax,The serum concentration of Dronabinol can be increased when it is combined with Venetoclax.,increase,no risk
Dronabinol,Venlafaxine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Dronabinol,Verapamil,The serum concentration of Dronabinol can be increased when it is combined with Verapamil.,increase,no risk
Dronabinol,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Vigabatrin,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Dronabinol,Vilanterol,The risk or severity of Tachycardia can be increased when Dronabinol is combined with Vilanterol.,increase,risk
Dronabinol,Vilazodone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Dronabinol,Viloxazine,The serum concentration of Dronabinol can be increased when it is combined with Viloxazine.,increase,no risk
Dronabinol,Vinblastine,The serum concentration of Dronabinol can be increased when it is combined with Vinblastine.,increase,no risk
Dronabinol,Voriconazole,The serum concentration of Dronabinol can be increased when it is combined with Voriconazole.,increase,no risk
Dronabinol,Vortioxetine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Dronabinol,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dronabinol.,increase,no risk
Dronabinol,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dronabinol.,increase,no risk
Dronabinol,Xamoterol,The risk or severity of Tachycardia can be increased when Dronabinol is combined with Xamoterol.,increase,risk
Dronabinol,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Xylometazoline,The risk or severity of Tachycardia can be increased when Dronabinol is combined with Xylometazoline.,increase,risk
Dronabinol,Yohimbine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Dronabinol,Zafirlukast,The serum concentration of Dronabinol can be increased when it is combined with Zafirlukast.,increase,no risk
Dronabinol,Zaleplon,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Dronabinol,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Ziconotide,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Dronabinol,Zidovudine,The metabolism of Dronabinol can be increased when combined with Zidovudine.,increase,no risk
Dronabinol,Zileuton,The metabolism of Zileuton can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Zimelidine,The serum concentration of Dronabinol can be increased when it is combined with Zimelidine.,increase,no risk
Dronabinol,Ziprasidone,The risk or severity of adverse effects can be increased when Dronabinol is combined with Ziprasidone.,increase,risk
Dronabinol,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Dronabinol.,decrease,no risk
Dronabinol,Zolpidem,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dronabinol,Zonisamide,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Dronabinol,Zopiclone,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Dronabinol,Zotepine,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Dronabinol,Zuclopenthixol,Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Dronabinol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dronabinol.,increase,risk
Montelukast,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ganciclovir.",increase,risk
Montelukast,Gemfibrozil,The metabolism of Montelukast can be decreased when combined with Gemfibrozil.,decrease,no risk
Montelukast,Ginkgo biloba,The metabolism of Montelukast can be decreased when combined with Ginkgo biloba.,decrease,no risk
Montelukast,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Glimepiride,The metabolism of Montelukast can be decreased when combined with Glimepiride.,decrease,no risk
Montelukast,Glipizide,The metabolism of Glipizide can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Glofitamab,The serum concentration of Montelukast can be increased when it is combined with Glofitamab.,increase,no risk
Montelukast,Glyburide,The metabolism of Montelukast can be decreased when combined with Glyburide.,decrease,no risk
Montelukast,Golimumab,The metabolism of Montelukast can be increased when combined with Golimumab.,increase,no risk
Montelukast,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Montelukast.,increase,no risk
Montelukast,Halothane,The metabolism of Halothane can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Hydrocortisone,The metabolism of Montelukast can be increased when combined with Hydrocortisone.,increase,no risk
Montelukast,Hydromorphone,The metabolism of Montelukast can be decreased when combined with Hydromorphone.,decrease,no risk
Montelukast,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Ketamine,The metabolism of Ketamine can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Ketoconazole,The metabolism of Montelukast can be decreased when combined with Ketoconazole.,decrease,no risk
Montelukast,Ketoprofen,The metabolism of Montelukast can be decreased when combined with Ketoprofen.,decrease,no risk
Montelukast,Ketorolac,The metabolism of Montelukast can be decreased when combined with Ketorolac.,decrease,no risk
Montelukast,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ofloxacin.",increase,risk
Montelukast,Olanzapine,The metabolism of Montelukast can be decreased when combined with Olanzapine.,decrease,no risk
Montelukast,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Omaveloxolone,The serum concentration of Montelukast can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Montelukast,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Oritavancin,The metabolism of Montelukast can be decreased when combined with Oritavancin.,decrease,no risk
Montelukast,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Oxandrolone,The metabolism of Montelukast can be decreased when combined with Oxandrolone.,decrease,no risk
Montelukast,Oxybutynin,The metabolism of Montelukast can be decreased when combined with Oxybutynin.,decrease,no risk
Montelukast,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Quinidine,The metabolism of Montelukast can be decreased when combined with Quinidine.,decrease,no risk
Montelukast,Quinine,The metabolism of Montelukast can be decreased when combined with Quinine.,decrease,no risk
Montelukast,Ubidecarenone,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Ubidecarenone.",increase,risk
Montelukast,Vadadustat,The serum concentration of Montelukast can be increased when it is combined with Vadadustat.,increase,no risk
Montelukast,Valdecoxib,The metabolism of Montelukast can be decreased when combined with Valdecoxib.,decrease,no risk
Montelukast,Valproic acid,The metabolism of Montelukast can be decreased when combined with Valproic acid.,decrease,no risk
Montelukast,Valsartan,The metabolism of Montelukast can be decreased when combined with Valsartan.,decrease,no risk
Montelukast,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Vemurafenib,The metabolism of Montelukast can be decreased when combined with Vemurafenib.,decrease,no risk
Montelukast,Venetoclax,The metabolism of Montelukast can be decreased when combined with Venetoclax.,decrease,no risk
Montelukast,Verapamil,The metabolism of Montelukast can be decreased when combined with Verapamil.,decrease,no risk
Montelukast,Viloxazine,The metabolism of Montelukast can be decreased when combined with Viloxazine.,decrease,no risk
Montelukast,Vincristine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Vincristine.",increase,risk
Montelukast,Voriconazole,The metabolism of Montelukast can be decreased when combined with Voriconazole.,decrease,no risk
Montelukast,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Warfarin,The metabolism of Montelukast can be increased when combined with Warfarin.,increase,no risk
Montelukast,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Zafirlukast,The metabolism of Montelukast can be decreased when combined with Zafirlukast.,decrease,no risk
Montelukast,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Zidovudine.",increase,risk
Montelukast,Zileuton,The metabolism of Zileuton can be decreased when combined with Montelukast.,decrease,no risk
Montelukast,Zimelidine,The metabolism of Montelukast can be decreased when combined with Zimelidine.,decrease,no risk
Montelukast,Ziprasidone,The metabolism of Montelukast can be decreased when combined with Ziprasidone.,decrease,no risk
Montelukast,Zolpidem,The metabolism of Montelukast can be decreased when combined with Zolpidem.,decrease,no risk
Montelukast,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Montelukast.,decrease,no risk
Fluoxetine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Balsalazide.,increase,risk
Fluoxetine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Bedaquiline.,increase,risk
Fluoxetine,Belinostat,The metabolism of Fluoxetine can be increased when combined with Belinostat.,increase,no risk
Fluoxetine,Belladonna,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Belladonna.,increase,risk
Fluoxetine,Belzutifan,The serum concentration of Belzutifan can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Bemiparin,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Bemiparin.,increase,risk
Fluoxetine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bendroflumethiazide,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Bendroflumethiazide.,increase,risk
Fluoxetine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Benorilate.,increase,risk
Fluoxetine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Benoxaprofen.,increase,risk
Fluoxetine,Benperidol,Benperidol may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Benzatropine,The serum concentration of Benzatropine can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Fluoxetine.,increase,risk
Fluoxetine,Benzocaine,The serum concentration of Benzocaine can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Benzphetamine,The risk or severity of serotonin syndrome can be increased when Benzphetamine is combined with Fluoxetine.,increase,risk
Fluoxetine,Benzthiazide,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Benzthiazide.,increase,risk
Fluoxetine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Benzydamine.,increase,risk
Fluoxetine,Benzyl alcohol,The serum concentration of Benzyl alcohol can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Bepridil,The serum concentration of Bepridil can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Berotralstat,The metabolism of Fluoxetine can be decreased when combined with Berotralstat.,decrease,no risk
Fluoxetine,Besifloxacin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Besifloxacin.,increase,risk
Fluoxetine,Betaine,The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Betaine.,decrease,no risk
Fluoxetine,Betamethasone,The metabolism of Fluoxetine can be increased when combined with Betamethasone.,increase,no risk
Fluoxetine,Betaxolol,The serum concentration of Betaxolol can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Betrixaban,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Betrixaban.,increase,risk
Fluoxetine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Bexagliflozin.,increase,risk
Fluoxetine,Bexarotene,The metabolism of Bexarotene can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bicalutamide,The metabolism of Bicalutamide can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bilastine,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Bilastine.,increase,risk
Fluoxetine,Bimekizumab,The metabolism of Fluoxetine can be increased when combined with Bimekizumab.,increase,no risk
Fluoxetine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Biperiden,The metabolism of Fluoxetine can be decreased when combined with Biperiden.,decrease,no risk
Fluoxetine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Fluoxetine.,decrease,no risk
Fluoxetine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Fluoxetine.,decrease,no risk
Fluoxetine,Bivalirudin,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Bivalirudin.,increase,risk
Fluoxetine,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Bosentan,The metabolism of Bosentan can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Botulinum toxin type A.,increase,risk
Fluoxetine,Botulinum toxin type B,Botulinum toxin type B may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bretylium,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Bretylium.,increase,risk
Fluoxetine,Brexanolone,Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Brexpiprazole,The serum concentration of Brexpiprazole can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Brivaracetam,Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Bromazepam,The serum concentration of Bromazepam can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Bromocriptine,Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Bromperidol,Bromperidol may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Brompheniramine,Brompheniramine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Buclizine,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Buclizine.,increase,risk
Fluoxetine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Bumadizone.,increase,risk
Fluoxetine,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Buprenorphine,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Fluoxetine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Fluoxetine.,increase,risk
Fluoxetine,Buserelin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Buserelin.,increase,risk
Fluoxetine,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Busulfan,The metabolism of Busulfan can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Butabarbital,Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Butalbital,Butalbital may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Butamben,Butamben may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Butaperazine,Butaperazine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Butobarbital,Butobarbital may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Fluoxetine.,increase,risk
Fluoxetine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Butylscopolamine,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Butylscopolamine.,increase,risk
Fluoxetine,Gabapentin,Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Gabapentin enacarbil,Gabapentin enacarbil may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Gadobenic acid.,increase,risk
Fluoxetine,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Gallamine triethiodide,Gallamine triethiodide may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Ganaxolone,Ganaxolone may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Gatifloxacin.,increase,risk
Fluoxetine,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Gemfibrozil,The metabolism of Fluoxetine can be decreased when combined with Gemfibrozil.,decrease,no risk
Fluoxetine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Gemifloxacin.,increase,risk
Fluoxetine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Fluoxetine.,increase,risk
Fluoxetine,Gilteritinib,The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Fluoxetine,Ginkgo biloba,The metabolism of Fluoxetine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Fluoxetine,Givosiran,The serum concentration of Fluoxetine can be increased when it is combined with Givosiran.,increase,no risk
Fluoxetine,Glasdegib,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Glasdegib.,increase,risk
Fluoxetine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Glimepiride,The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Glimepiride.,increase,risk
Fluoxetine,Glipizide,The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Glipizide.,increase,risk
Fluoxetine,Gliquidone,The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Gliquidone.,increase,risk
Fluoxetine,Glofitamab,The serum concentration of Fluoxetine can be increased when it is combined with Glofitamab.,increase,no risk
Fluoxetine,Glutethimide,Glutethimide may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Glyburide,The metabolism of Glyburide can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Fluoxetine.,decrease,no risk
Fluoxetine,Glycerol phenylbutyrate,The metabolism of Fluoxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Fluoxetine,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Glycol salicylate.,increase,risk
Fluoxetine,Glycopyrronium,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Glycopyrronium.,increase,risk
Fluoxetine,Glymidine,The risk or severity of hypoglycemia can be increased when Fluoxetine is combined with Glymidine.,increase,risk
Fluoxetine,Golimumab,The metabolism of Fluoxetine can be increased when combined with Golimumab.,increase,no risk
Fluoxetine,Goserelin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Goserelin.,increase,risk
Fluoxetine,Granisetron,The risk or severity of serotonin syndrome can be increased when Granisetron is combined with Fluoxetine.,increase,risk
Fluoxetine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Grepafloxacin.,increase,risk
Fluoxetine,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Guanfacine,Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Halazepam,The serum concentration of Halazepam can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Halofantrine,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Halofantrine.,increase,risk
Fluoxetine,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Fluoxetine.,decrease,no risk
Fluoxetine,Halothane,Halothane may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Heparin,The risk or severity of hemorrhage can be increased when Fluoxetine is combined with Heparin.,increase,risk
Fluoxetine,Hexafluronium,Hexafluronium may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Hexocyclium,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Hexocyclium.,increase,risk
Fluoxetine,Histrelin,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Histrelin.,increase,risk
Fluoxetine,Homatropine,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Homatropine.,increase,risk
Fluoxetine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Fluoxetine is combined with Homatropine methylbromide.,increase,risk
Fluoxetine,Huperzine A,The therapeutic efficacy of Fluoxetine can be decreased when used in combination with Huperzine A.,decrease,no risk
Fluoxetine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Hydrochlorothiazide.,increase,risk
Fluoxetine,Hydrocodone,Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Fluoxetine,Hydrocortisone,The metabolism of Fluoxetine can be increased when combined with Hydrocortisone.,increase,no risk
Fluoxetine,Hydroflumethiazide,The risk or severity of hyponatremia can be increased when Fluoxetine is combined with Hydroflumethiazide.,increase,risk
Fluoxetine,Hydromorphone,The risk or severity of serotonin syndrome can be increased when Hydromorphone is combined with Fluoxetine.,increase,risk
Fluoxetine,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Fluoxetine.,increase,risk
Fluoxetine,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Hydroxyzine.,increase,risk
Fluoxetine,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Hyoscyamine.,increase,risk
Fluoxetine,Ketamine,Ketamine may increase the central nervous system depressant (CNS depressant) activities of Fluoxetine.,increase,no risk
Fluoxetine,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Fluoxetine.,increase,no risk
Fluoxetine,Ketoconazole,The risk or severity of QTc prolongation can be increased when Fluoxetine is combined with Ketoconazole.,increase,risk
Fluoxetine,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Ketoprofen.,increase,risk
Fluoxetine,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Ketorolac.,increase,risk
Methohexital,Gabapentin,The risk or severity of CNS depression can be increased when Methohexital is combined with Gabapentin.,increase,risk
Methohexital,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Methohexital is combined with Gabapentin enacarbil.,increase,risk
Methohexital,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Methohexital is combined with Gallamine triethiodide.,increase,risk
Methohexital,Gamolenic acid,The therapeutic efficacy of Methohexital can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Methohexital,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Methohexital is combined with Ganaxolone.",increase,risk
Methohexital,Ganciclovir,The therapeutic efficacy of Methohexital can be decreased when used in combination with Ganciclovir.,decrease,no risk
Methohexital,Gepirone,The risk or severity of CNS depression can be increased when Methohexital is combined with Gepirone.,increase,risk
Methohexital,Gestrinone,The metabolism of Gestrinone can be increased when combined with Methohexital.,increase,no risk
Methohexital,Glutethimide,The risk or severity of CNS depression can be increased when Methohexital is combined with Glutethimide.,increase,risk
Methohexital,Granisetron,The risk or severity of CNS depression can be increased when Methohexital is combined with Granisetron.,increase,risk
Methohexital,Griseofulvin,The serum concentration of Griseofulvin can be decreased when it is combined with Methohexital.,decrease,no risk
Methohexital,Guanfacine,Methohexital may increase the hypotensive activities of Guanfacine.,increase,no risk
Methohexital,Halazepam,The risk or severity of CNS depression can be increased when Methohexital is combined with Halazepam.,increase,risk
Methohexital,Halofantrine,The therapeutic efficacy of Methohexital can be decreased when used in combination with Halofantrine.,decrease,no risk
Methohexital,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Methohexital.,increase,risk
Methohexital,Halothane,Methohexital may increase the hypotensive activities of Halothane.,increase,no risk
Methohexital,Hexafluronium,The risk or severity of CNS depression can be increased when Methohexital is combined with Hexafluronium.,increase,risk
Methohexital,Hydralazine,Methohexital may increase the hypotensive activities of Hydralazine.,increase,no risk
Methohexital,Hydrochlorothiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Methohexital is combined with Hydrochlorothiazide.,increase,risk
Methohexital,Hydrocodone,Methohexital may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Methohexital,Hydroflumethiazide,The risk or severity of hypotension and orthostatic hypotension can be increased when Methohexital is combined with Hydroflumethiazide.,increase,risk
Methohexital,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Methohexital.,increase,risk
Methohexital,Hydroxychloroquine,The therapeutic efficacy of Methohexital can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Methohexital,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Methohexital.,increase,no risk
Methohexital,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Methohexital.,increase,no risk
Methohexital,Ketamine,The risk or severity of CNS depression can be increased when Methohexital is combined with Ketamine.,increase,risk
Methohexital,Ketazolam,The risk or severity of CNS depression can be increased when Methohexital is combined with Ketazolam.,increase,risk
Methohexital,Obinutuzumab,Methohexital may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Methohexital,Olanzapine,Methohexital may increase the hypotensive activities of Olanzapine.,increase,no risk
Methohexital,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Methohexital is combined with Oliceridine.",increase,risk
Methohexital,Olmesartan,Methohexital may increase the hypotensive activities of Olmesartan.,increase,no risk
Methohexital,Ondansetron,The risk or severity of CNS depression can be increased when Methohexital is combined with Ondansetron.,increase,risk
Methohexital,Opicapone,Methohexital may increase the hypotensive activities of Opicapone.,increase,no risk
Methohexital,Opium,The risk or severity of CNS depression can be increased when Methohexital is combined with Opium.,increase,risk
Methohexital,Orlistat,Orlistat can cause a decrease in the absorption of Methohexital resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Methohexital,Orphenadrine,Methohexital may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Methohexital,Oxazepam,The risk or severity of CNS depression can be increased when Methohexital is combined with Oxazepam.,increase,risk
Methohexital,Oxcarbazepine,The risk or severity of CNS depression can be increased when Methohexital is combined with Oxcarbazepine.,increase,risk
Methohexital,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Methohexital is combined with Oxetacaine.,increase,risk
Methohexital,Oxitriptan,The risk or severity of CNS depression can be increased when Methohexital is combined with Oxitriptan.,increase,risk
Methohexital,Oxprenolol,Methohexital may increase the hypotensive activities of Oxprenolol.,increase,no risk
Methohexital,Oxtriphylline,The serum concentration of Oxtriphylline can be decreased when it is combined with Methohexital.,decrease,no risk
Methohexital,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Methohexital is combined with Oxybuprocaine.,increase,risk
Methohexital,Oxycodone,The risk or severity of CNS depression can be increased when Methohexital is combined with Oxycodone.,increase,risk
Methohexital,Oxymorphone,The risk or severity of CNS depression can be increased when Methohexital is combined with Oxymorphone.,increase,risk
Methohexital,Quazepam,The risk or severity of CNS depression can be increased when Methohexital is combined with Quazepam.,increase,risk
Methohexital,Quetiapine,Methohexital may increase the hypotensive activities of Quetiapine.,increase,no risk
Methohexital,Quinapril,Methohexital may increase the hypotensive activities of Quinapril.,increase,no risk
Methohexital,Quinethazone,The risk or severity of hypotension and orthostatic hypotension can be increased when Methohexital is combined with Quinethazone.,increase,risk
Methohexital,Quinidine,The therapeutic efficacy of Methohexital can be decreased when used in combination with Quinidine.,decrease,no risk
Methohexital,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Methohexital.,increase,risk
Methohexital,Quinupramine,The metabolism of Quinupramine can be increased when combined with Methohexital.,increase,no risk
Chlordiazepoxide,Gabapentin,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Gabapentin.,increase,risk
Chlordiazepoxide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Gabapentin enacarbil.,increase,risk
Chlordiazepoxide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Gallamine triethiodide.,increase,risk
Chlordiazepoxide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlordiazepoxide is combined with Ganaxolone.",increase,risk
Chlordiazepoxide,Gepirone,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Gepirone.,increase,risk
Chlordiazepoxide,Glutethimide,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Glutethimide.,increase,risk
Chlordiazepoxide,Granisetron,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Granisetron.,increase,risk
Chlordiazepoxide,Guanfacine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Guanfacine.,increase,risk
Chlordiazepoxide,Halazepam,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Halazepam.,increase,risk
Chlordiazepoxide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Halothane,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Halothane.,increase,risk
Chlordiazepoxide,Hexafluronium,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Hexafluronium.,increase,risk
Chlordiazepoxide,Hydrocodone,Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlordiazepoxide,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Chlordiazepoxide.,increase,no risk
Chlordiazepoxide,Ketamine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Ketamine.,increase,risk
Chlordiazepoxide,Ketazolam,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Ketazolam.,increase,risk
Chlordiazepoxide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Chlordiazepoxide is combined with Oliceridine.",increase,risk
Chlordiazepoxide,Ondansetron,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Ondansetron.,increase,risk
Chlordiazepoxide,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Orphenadrine,Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Chlordiazepoxide,Oxazepam,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Oxazepam.,increase,risk
Chlordiazepoxide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Oxcarbazepine.,increase,risk
Chlordiazepoxide,Oxitriptan,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Oxitriptan.,increase,risk
Chlordiazepoxide,Oxprenolol,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Oxprenolol.,increase,risk
Chlordiazepoxide,Oxtriphylline,The therapeutic efficacy of Chlordiazepoxide can be decreased when used in combination with Oxtriphylline.,decrease,no risk
Chlordiazepoxide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Oxybuprocaine.,increase,risk
Chlordiazepoxide,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Quazepam,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Quazepam.,increase,risk
Chlordiazepoxide,Quetiapine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Quetiapine.,increase,risk
Chlordiazepoxide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Quinupramine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Quinupramine.,increase,risk
Chlordiazepoxide,Urethane,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Urethane.,increase,risk
Chlordiazepoxide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Vecuronium,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Vecuronium.,increase,risk
Chlordiazepoxide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Vigabatrin,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Vigabatrin.,increase,risk
Chlordiazepoxide,Vilazodone,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Vilazodone.,increase,risk
Chlordiazepoxide,Viloxazine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Viloxazine.,increase,risk
Chlordiazepoxide,Voriconazole,The serum concentration of Chlordiazepoxide can be increased when it is combined with Voriconazole.,increase,no risk
Chlordiazepoxide,Vortioxetine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Vortioxetine.,increase,risk
Chlordiazepoxide,Yohimbine,The therapeutic efficacy of Chlordiazepoxide can be increased when used in combination with Yohimbine.,increase,no risk
Chlordiazepoxide,Zaleplon,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Zaleplon.,increase,risk
Chlordiazepoxide,Ziconotide,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Ziconotide.,increase,risk
Chlordiazepoxide,Zimelidine,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zimelidine.,increase,risk
Chlordiazepoxide,Ziprasidone,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ziprasidone.,increase,risk
Chlordiazepoxide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Chlordiazepoxide.,increase,risk
Chlordiazepoxide,Zolpidem,Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Chlordiazepoxide,Zonisamide,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Zonisamide.,increase,risk
Chlordiazepoxide,Zopiclone,The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Zopiclone.,increase,risk
Chlordiazepoxide,Zotepine,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Zotepine.,increase,risk
Chlordiazepoxide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Chlordiazepoxide is combined with Zuclopenthixol.,increase,risk
Chlordiazepoxide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Chlordiazepoxide.,increase,risk
Duloxetine,Bacitracin,Bacitracin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,decrease,no risk
Duloxetine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Duloxetine.,increase,no risk
Duloxetine,Balsalazide,The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Balsalazide.,increase,risk
Duloxetine,Baricitinib,Duloxetine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Duloxetine,Bemiparin,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Bemiparin.,increase,risk
Duloxetine,Benazepril,The risk or severity of orthostatic hypotension and syncope can be increased when Benazepril is combined with Duloxetine.,increase,risk
Duloxetine,Bendroflumethiazide,The risk or severity of orthostatic hypotension and syncope can be increased when Bendroflumethiazide is combined with Duloxetine.,increase,risk
Duloxetine,Benorilate,The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Benorilate.,increase,risk
Duloxetine,Benoxaprofen,The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Benoxaprofen.,increase,risk
Duloxetine,Benperidol,The risk or severity of adverse effects can be increased when Benperidol is combined with Duloxetine.,increase,risk
Duloxetine,Benserazide,Duloxetine may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Duloxetine,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Benzhydrocodone,The risk or severity of serotonin syndrome can be increased when Benzhydrocodone is combined with Duloxetine.,increase,risk
Duloxetine,Benznidazole,Duloxetine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Duloxetine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Benzphetamine,The risk or severity of adverse effects can be increased when Benzphetamine is combined with Duloxetine.,increase,risk
Duloxetine,Benzthiazide,The risk or severity of hyponatremia can be increased when Duloxetine is combined with Benzthiazide.,increase,risk
Duloxetine,Benzydamine,The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Benzydamine.,increase,risk
Duloxetine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Bepotastine,Duloxetine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Duloxetine,Bepridil,The risk or severity of orthostatic hypotension and syncope can be increased when Bepridil is combined with Duloxetine.,increase,risk
Duloxetine,Berotralstat,The metabolism of Duloxetine can be decreased when combined with Berotralstat.,decrease,no risk
Duloxetine,Betaxolol,The risk or severity of orthostatic hypotension and syncope can be increased when Betaxolol is combined with Duloxetine.,increase,risk
Duloxetine,Bethanidine,Duloxetine may increase the tachycardic activities of Bethanidine.,increase,no risk
Duloxetine,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Duloxetine.,increase,risk
Duloxetine,Bexagliflozin,The risk or severity of hypoglycemia can be increased when Duloxetine is combined with Bexagliflozin.,increase,risk
Duloxetine,Bexarotene,The metabolism of Duloxetine can be decreased when combined with Bexarotene.,decrease,no risk
Duloxetine,Bicisate,Duloxetine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Duloxetine,Bimekizumab,The metabolism of Duloxetine can be increased when combined with Bimekizumab.,increase,no risk
Duloxetine,Biperiden,The metabolism of Duloxetine can be decreased when combined with Biperiden.,decrease,no risk
Duloxetine,Bismuth subgallate,Duloxetine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Duloxetine,Bisoprolol,The risk or severity of orthostatic hypotension and syncope can be increased when Bisoprolol is combined with Duloxetine.,increase,risk
Duloxetine,Bisoxatin,Duloxetine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Duloxetine,Bivalirudin,The risk or severity of hemorrhage can be increased when Duloxetine is combined with Bivalirudin.,increase,risk
Duloxetine,Bleomycin,Bleomycin may decrease the excretion rate of Duloxetine which could result in a higher serum level.,decrease,no risk
Duloxetine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Bosentan,The metabolism of Duloxetine can be increased when combined with Bosentan.,increase,no risk
Duloxetine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Duloxetine.,increase,risk
Duloxetine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Botulinum toxin type B is combined with Duloxetine.,increase,risk
Duloxetine,Bretylium,The risk or severity of orthostatic hypotension and syncope can be increased when Bretylium is combined with Duloxetine.,increase,risk
Duloxetine,Brexanolone,The risk or severity of adverse effects can be increased when Brexanolone is combined with Duloxetine.,increase,risk
Duloxetine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Duloxetine.,increase,no risk
Duloxetine,Brivaracetam,The risk or severity of adverse effects can be increased when Brivaracetam is combined with Duloxetine.,increase,risk
Duloxetine,Bromazepam,The risk or severity of adverse effects can be increased when Bromazepam is combined with Duloxetine.,increase,risk
Duloxetine,Bromocriptine,The risk or severity of orthostatic hypotension and syncope can be increased when Bromocriptine is combined with Duloxetine.,increase,risk
Duloxetine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Duloxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Duloxetine,Bromperidol,The risk or severity of adverse effects can be increased when Bromperidol is combined with Duloxetine.,increase,risk
Duloxetine,Brompheniramine,The risk or severity of adverse effects can be increased when Brompheniramine is combined with Duloxetine.,increase,risk
Duloxetine,Buclizine,The risk or severity of Tachycardia can be increased when Buclizine is combined with Duloxetine.,increase,risk
Duloxetine,Budesonide,Duloxetine may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Duloxetine,Bumadizone,The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Bumadizone.,increase,risk
Duloxetine,Bumetanide,The risk or severity of orthostatic hypotension and syncope can be increased when Bumetanide is combined with Duloxetine.,increase,risk
Duloxetine,Bupivacaine,The risk or severity of orthostatic hypotension and syncope can be increased when Bupivacaine is combined with Duloxetine.,increase,risk
Duloxetine,Buprenorphine,Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Duloxetine,Bupropion,The metabolism of Duloxetine can be decreased when combined with Bupropion.,decrease,no risk
Duloxetine,Buspirone,The metabolism of Buspirone can be decreased when combined with Duloxetine.,decrease,no risk
Duloxetine,Butabarbital,The risk or severity of adverse effects can be increased when Butabarbital is combined with Duloxetine.,increase,risk
Duloxetine,Butalbital,The risk or severity of adverse effects can be increased when Butalbital is combined with Duloxetine.,increase,risk
Duloxetine,Butaperazine,The risk or severity of adverse effects can be increased when Butaperazine is combined with Duloxetine.,increase,risk
Duloxetine,Butobarbital,The risk or severity of adverse effects can be increased when Butobarbital is combined with Duloxetine.,increase,risk
Duloxetine,Butorphanol,The risk or severity of serotonin syndrome can be increased when Butorphanol is combined with Duloxetine.,increase,risk
Duloxetine,Butriptyline,The risk or severity of adverse effects can be increased when Butriptyline is combined with Duloxetine.,increase,risk
Duloxetine,Butylscopolamine,The risk or severity of Tachycardia can be increased when Duloxetine is combined with Butylscopolamine.,increase,risk
Chlorpromazine,Bacitracin,Bacitracin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Baclofen,Baclofen may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.,increase,no risk
Chlorpromazine,Balsalazide,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Balsalazide.,increase,risk
Chlorpromazine,Baricitinib,Chlorpromazine may decrease the excretion rate of Baricitinib which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Beclomethasone dipropionate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Beclomethasone dipropionate.,decrease,no risk
Chlorpromazine,Bedaquiline,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Bedaquiline.,increase,risk
Chlorpromazine,Belantamab mafodotin,Chlorpromazine may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Belinostat,The metabolism of Chlorpromazine can be increased when combined with Belinostat.,increase,no risk
Chlorpromazine,Belladonna,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Belladonna.,increase,risk
Chlorpromazine,Benazepril,Chlorpromazine may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Chlorpromazine,Bendamustine,The metabolism of Bendamustine can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Benorilate,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Benorilate.,increase,risk
Chlorpromazine,Benoxaprofen,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Benoxaprofen.,increase,risk
Chlorpromazine,Benperidol,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Benperidol.,increase,risk
Chlorpromazine,Benserazide,The therapeutic efficacy of Benserazide can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Benzatropine,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzatropine.,increase,risk
Chlorpromazine,Benzhydrocodone,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Benzhydrocodone.,increase,risk
Chlorpromazine,Benznidazole,Chlorpromazine may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Benzocaine,The metabolism of Benzocaine can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Benzonatate,Chlorpromazine may increase the neuromuscular blocking activities of Benzonatate.,increase,no risk
Chlorpromazine,Benzphetamine,The therapeutic efficacy of Benzphetamine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Benzthiazide,Benzthiazide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Benzydamine,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Benzydamine.,increase,risk
Chlorpromazine,Benzyl alcohol,The metabolism of Benzyl alcohol can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Benzylpenicilloyl polylysine,Chlorpromazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Chlorpromazine,Bepotastine,Chlorpromazine may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Bepridil,The metabolism of Bepridil can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Berotralstat,The metabolism of Chlorpromazine can be decreased when combined with Berotralstat.,decrease,no risk
Chlorpromazine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Betaine,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Betaine.,decrease,no risk
Chlorpromazine,Betamethasone,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Betamethasone.,decrease,no risk
Chlorpromazine,Betamethasone phosphate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Betamethasone phosphate.,decrease,no risk
Chlorpromazine,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bethanechol,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Bethanechol.,increase,risk
Chlorpromazine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bexarotene,The metabolism of Chlorpromazine can be increased when combined with Bexarotene.,increase,no risk
Chlorpromazine,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Bicisate,Chlorpromazine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Bifonazole,The metabolism of Chlorpromazine can be decreased when combined with Bifonazole.,decrease,no risk
Chlorpromazine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Bimekizumab,The metabolism of Chlorpromazine can be increased when combined with Bimekizumab.,increase,no risk
Chlorpromazine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bisacodyl,The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bismuth subcitrate potassium,Chlorpromazine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Chlorpromazine,Bismuth subgallate,Chlorpromazine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Chlorpromazine,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Bisoxatin,The therapeutic efficacy of Bisoxatin can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bleomycin,Bleomycin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Boceprevir,The metabolism of Chlorpromazine can be decreased when combined with Boceprevir.,decrease,no risk
Chlorpromazine,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bosentan,The metabolism of Chlorpromazine can be increased when combined with Bosentan.,increase,no risk
Chlorpromazine,Bosutinib,The metabolism of Bosutinib can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Botulinum toxin type A,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Botulinum toxin type A.,increase,risk
Chlorpromazine,Botulinum toxin type B,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Botulinum toxin type B.,increase,risk
Chlorpromazine,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Bretylium,Chlorpromazine may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Chlorpromazine,Brexanolone,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Brexanolone.,increase,risk
Chlorpromazine,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Brigatinib,The metabolism of Brigatinib can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Chlorpromazine.,increase,no risk
Chlorpromazine,Brivaracetam,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Brivaracetam.,increase,risk
Chlorpromazine,Bromazepam,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Bromazepam.,increase,risk
Chlorpromazine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Bromperidol,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Bromperidol.,increase,risk
Chlorpromazine,Brompheniramine,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Brompheniramine.,increase,risk
Chlorpromazine,Buclizine,The risk or severity of adverse effects can be increased when Buclizine is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Budesonide,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Budesonide.,decrease,no risk
Chlorpromazine,Bumadizone,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Bumadizone.,increase,risk
Chlorpromazine,Bumetanide,Bumetanide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Buprenorphine,Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Chlorpromazine,Bupropion,The risk or severity of seizure can be increased when Bupropion is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Buspirone,The metabolism of Buspirone can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Busulfan,The metabolism of Busulfan can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Butabarbital,Butabarbital may increase the hypotensive activities of Chlorpromazine.,increase,no risk
Chlorpromazine,Butalbital,Butalbital may increase the hypotensive activities of Chlorpromazine.,increase,no risk
Chlorpromazine,Butaperazine,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Butaperazine.,increase,risk
Chlorpromazine,Butobarbital,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Butobarbital.,increase,risk
Chlorpromazine,Butorphanol,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Butorphanol.,increase,risk
Chlorpromazine,Butriptyline,The serum concentration of Butriptyline can be increased when it is combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Butylscopolamine,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Butylscopolamine.,increase,risk
Chlorpromazine,Gabapentin,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Gabapentin.,increase,risk
Chlorpromazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Gabapentin enacarbil.,increase,risk
Chlorpromazine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Gadobenic acid.,increase,risk
Chlorpromazine,Gadodiamide,Gadodiamide may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gadofosveset trisodium,Chlorpromazine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gadopentetic acid,Chlorpromazine may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gadoteric acid,Chlorpromazine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gadoteridol,Chlorpromazine may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Galantamine,The metabolism of Galantamine can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Gallamine triethiodide.,increase,risk
Chlorpromazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Chlorpromazine is combined with Ganaxolone.",increase,risk
Chlorpromazine,Ganciclovir,Chlorpromazine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gatifloxacin,The metabolism of Chlorpromazine can be decreased when combined with Gatifloxacin.,decrease,no risk
Chlorpromazine,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Chlorpromazine.,decrease,no risk
Chlorpromazine,Gemcitabine,Gemcitabine may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gemfibrozil,The metabolism of Chlorpromazine can be decreased when combined with Gemfibrozil.,decrease,no risk
Chlorpromazine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Gemifloxacin.,increase,risk
Chlorpromazine,Gentamicin,Chlorpromazine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Gilteritinib,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Chlorpromazine,Gimeracil,Chlorpromazine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Ginkgo biloba,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Chlorpromazine,Givosiran,The serum concentration of Chlorpromazine can be increased when it is combined with Givosiran.,increase,no risk
Chlorpromazine,Glasdegib,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Glasdegib.,increase,risk
Chlorpromazine,Glecaprevir,The metabolism of Chlorpromazine can be decreased when combined with Glecaprevir.,decrease,no risk
Chlorpromazine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Glofitamab,The serum concentration of Chlorpromazine can be increased when it is combined with Glofitamab.,increase,no risk
Chlorpromazine,Glucagon,Chlorpromazine may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Chlorpromazine,Glutethimide,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Glutethimide.,increase,risk
Chlorpromazine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Glycerol phenylbutyrate,The metabolism of Chlorpromazine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Chlorpromazine,Glycopyrronium,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Glycopyrronium.,increase,risk
Chlorpromazine,Glycyrrhizic acid,Chlorpromazine may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Golimumab,The metabolism of Chlorpromazine can be increased when combined with Golimumab.,increase,no risk
Chlorpromazine,Golodirsen,Chlorpromazine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Granisetron,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Granisetron.,increase,risk
Chlorpromazine,Grapefruit,The metabolism of Chlorpromazine can be decreased when combined with Grapefruit.,decrease,no risk
Chlorpromazine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Grepafloxacin.,increase,risk
Chlorpromazine,Griseofulvin,The metabolism of Chlorpromazine can be increased when combined with Griseofulvin.,increase,no risk
Chlorpromazine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Guanadrel,Chlorpromazine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Chlorpromazine,Guanethidine,Chlorpromazine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Chlorpromazine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Guanoxan,Chlorpromazine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Chlorpromazine,Halazepam,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Halazepam.,increase,risk
Chlorpromazine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Haloperidol,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Haloperidol.,increase,risk
Chlorpromazine,Halothane,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Halothane.,increase,risk
Chlorpromazine,Hexafluronium,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Hexafluronium.,increase,risk
Chlorpromazine,Hexocyclium,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Hexocyclium.,increase,risk
Chlorpromazine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Homatropine,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Homatropine.,increase,risk
Chlorpromazine,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Homatropine methylbromide.,increase,risk
Chlorpromazine,Huperzine A,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Huperzine A.,decrease,no risk
Chlorpromazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Chlorpromazine.,decrease,no risk
Chlorpromazine,Hydralazine,The metabolism of Chlorpromazine can be decreased when combined with Hydralazine.,decrease,no risk
Chlorpromazine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Hydrocodone,Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Chlorpromazine,Hydrocortamate,The metabolism of Chlorpromazine can be increased when combined with Hydrocortamate.,increase,no risk
Chlorpromazine,Hydrocortisone,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Chlorpromazine,Hydrocortisone acetate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Chlorpromazine,Hydrocortisone butyrate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Chlorpromazine,Hydrocortisone cypionate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Chlorpromazine,Hydrocortisone succinate,The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Chlorpromazine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Chlorpromazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Chlorpromazine,Hydromorphone,The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Hydromorphone.,increase,risk
Chlorpromazine,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Chlorpromazine resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Chlorpromazine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Hydroxychloroquine,The risk or severity of seizure can be increased when Hydroxychloroquine is combined with Chlorpromazine.,increase,risk
Chlorpromazine,Hydroxyethyl Starch,Chlorpromazine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Chlorpromazine.,increase,no risk
Chlorpromazine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Chlorpromazine is combined with Hydroxyzine.,increase,risk
Chlorpromazine,Hyoscyamine,Chlorpromazine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Chlorpromazine,Kanamycin,Chlorpromazine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Chlorpromazine,Ketamine,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Ketamine.,increase,risk
Chlorpromazine,Ketazolam,The risk or severity of CNS depression can be increased when Chlorpromazine is combined with Ketazolam.,increase,risk
Chlorpromazine,Ketoconazole,The metabolism of Chlorpromazine can be decreased when combined with Ketoconazole.,decrease,no risk
Chlorpromazine,Ketoprofen,The risk or severity of hypertension can be increased when Chlorpromazine is combined with Ketoprofen.,increase,risk
Chlorpromazine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Chlorpromazine.,increase,risk
Rimantadine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rimantadine.,decrease,no risk
Rimantadine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Rimantadine.,decrease,no risk
Amikacin,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadodiamide,Gadodiamide may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadoteric acid,Gadoteric acid may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gadoteridol,Gadoteridol may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Ganciclovir,Ganciclovir may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gemcitabine,Gemcitabine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Gentamicin,Amikacin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Amikacin,Gimeracil,Gimeracil may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Givosiran,Givosiran may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Glipizide,Glipizide may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Glycol salicylate,The risk or severity of nephrotoxicity can be increased when Glycol salicylate is combined with Amikacin.,increase,risk
Amikacin,Golodirsen,Golodirsen may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Goserelin,Goserelin may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Guanethidine,Guanethidine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Guanfacine,Guanfacine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Haloperidol,Haloperidol may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Heparin,The therapeutic efficacy of Amikacin can be decreased when used in combination with Heparin.,decrease,no risk
Amikacin,Hetacillin,The serum concentration of Amikacin can be decreased when it is combined with Hetacillin.,decrease,no risk
Amikacin,Hydralazine,Hydralazine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Hydrochlorothiazide,Hydrochlorothiazide may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Hydromorphone,Hydromorphone may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Hydroxyethyl Starch,Hydroxyethyl Starch may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Kanamycin,Amikacin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Amikacin,Ketamine,Ketamine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Ketazolam,Ketazolam may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Ketoprofen,Ketoprofen may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Ketorolac,Ketorolac may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Octinoxate,Octinoxate may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Olsalazine,The risk or severity of nephrotoxicity can be increased when Amikacin is combined with Olsalazine.,increase,risk
Amikacin,Opium,Opium may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oseltamivir,Oseltamivir may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Ouabain,The risk or severity of adverse effects can be increased when Amikacin is combined with Ouabain.,increase,risk
Amikacin,Oxacillin,Oxacillin may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Amikacin.,increase,risk
Amikacin,Oxaprozin,Oxaprozin may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oxazepam,Oxazepam may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Amikacin is combined with Oxetacaine.,increase,risk
Amikacin,Oxybenzone,Oxybenzone may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Amikacin is combined with Oxybuprocaine.,increase,risk
Amikacin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Oxyquinoline,Oxyquinoline may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Quetiapine,Quetiapine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Quinidine,Amikacin may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Amikacin,Vaborbactam,Vaborbactam may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Valaciclovir,Valaciclovir may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Valbenazine,Valbenazine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Valdecoxib,Valdecoxib may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Valganciclovir,Valganciclovir may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Vancomycin,Amikacin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Amikacin,Varenicline,Varenicline may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Venlafaxine,Venlafaxine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Verapamil,Verapamil may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Amikacin.,decrease,no risk
Amikacin,Vilanterol,Vilanterol may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Viloxazine,Viloxazine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Vortioxetine,Vortioxetine may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Warfarin,Amikacin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Amikacin,Zaleplon,Zaleplon may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Zanamivir,Zanamivir may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Amikacin,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Amikacin is combined with Zoledronic acid.,increase,risk
Amikacin,Zonisamide,Zonisamide may decrease the excretion rate of Amikacin which could result in a higher serum level.,decrease,no risk
Lenalidomide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Lenalidomide is combined with Benzyl alcohol.,increase,risk
Lenalidomide,Bepotastine,Lenalidomide may decrease the excretion rate of Bepotastine which could result in a higher serum level.,decrease,no risk
Lenalidomide,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Lenalidomide.,increase,risk
Lenalidomide,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Lenalidomide.,increase,risk
Lenalidomide,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Lenalidomide.,increase,risk
Lenalidomide,Bicisate,Lenalidomide may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bimekizumab,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Bimekizumab.,increase,risk
Lenalidomide,Bismuth subgallate,Lenalidomide may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bisoprolol,Lenalidomide may decrease the excretion rate of Bisoprolol which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bisoxatin,Lenalidomide may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Lenalidomide.,increase,risk
Lenalidomide,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Lenalidomide.,increase,risk
Lenalidomide,Blinatumomab,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Blinatumomab.,increase,risk
Lenalidomide,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Lenalidomide.",decrease,no risk
Lenalidomide,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Lenalidomide.,increase,risk
Lenalidomide,Bosutinib,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Bosutinib.,increase,risk
Lenalidomide,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Brentuximab vedotin.,increase,risk
Lenalidomide,Brivaracetam,Lenalidomide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.,decrease,no risk
Lenalidomide,Brodalumab,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Brodalumab.,increase,risk
Lenalidomide,Bromazepam,Lenalidomide may decrease the excretion rate of Bromazepam which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bromotheophylline,Bromotheophylline may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lenalidomide,Budesonide,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Budesonide.,increase,risk
Lenalidomide,Bumadizone,Bumadizone may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,decrease,no risk
Lenalidomide,Bumetanide,Bumetanide may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lenalidomide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Lenalidomide is combined with Bupivacaine.,increase,risk
Lenalidomide,Bupropion,Lenalidomide may decrease the excretion rate of Bupropion which could result in a higher serum level.,decrease,no risk
Lenalidomide,Buspirone,Lenalidomide may decrease the excretion rate of Buspirone which could result in a higher serum level.,decrease,no risk
Lenalidomide,Busulfan,The risk or severity of adverse effects can be increased when Lenalidomide is combined with Busulfan.,increase,risk
Lenalidomide,Butabarbital,Butabarbital may decrease the excretion rate of Lenalidomide which could result in a higher serum level.,decrease,no risk
